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Preface to “Electrospun Nanofibers for Biomedical
Applications”
Nanomaterial-based substrates and devices offer opportunities to develop promising therapies
to face the increasing incidence of cardiovascular, respiratory, musculoskeletal, cancer, and
neurodegenerative diseases. Nanofiber meshes have already been proposed as devices to be used in
the treatment of many diseases, taking advantage of their specific properties. The versatility in their
composition, the high specific surface area, the high porosity, and the interconnectivity of the porosity
of electrospun nanofiber meshes allow exploring different biological functionalities. Additionally,
drug delivery systems and tissue-engineered scaffolds have been developed to address specific needs
of particular tissues and organs.
Electrospun nanofibrous meshes can physically mimic the native extracellular matrix of most
connective tissues. However, they present three important drawbacks (i.e., limited thickness, pore
size in the micrometer range, and mechanical properties more compatible to skin than to bone)
which can hinder their use in biomedical applications, namely, in tissue engineering and regenerative
medicine. Therefore, many efforts have been made to enhance the performance of electrospun
nanofibrous meshes, ranging from morphological to compositional and biochemical cues.
Despite the many efforts to translate electrospun nanofibrous meshes into medical devices,
only few have reached clinical practice. It is expected that in the near future, long-lasting and
highly-effective solutions will be developed that are able to address relevant clinical needs, increasing
the quality of life of millions of patients and reducing healthcare costs.
This Special Issue assembles a set of original and highly-innovative contributions showcasing
advanced devices and therapies based on or involving electrospun meshes. It comprises 13 original
research papers covering topics that span from biomaterial scaffolds structure and functionalization,
nanocomposites, antibacterial nanofibrous systems, wound dressings, monitoring devices, electrical
stimulation, bone tissue engineering to first in human clinical trials. This publication also includes 4
review papers focused on drug delivery and tissue engineering applications.
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Abstract: Electrospun fiber mats (EFMs) are highly versatile biomaterials used in a myriad of
biomedical applications. Whereas some facets of EFMs are well studied and can be highly tuned (e.g.,
pore size, fiber diameter, etc.), other features are under characterized. For example, although substrate
mechanics have been explored by several groups, most studies rely on Young’s modulus alone as a
characterization variable. The influence of fiber mat thickness and the effect of supports are variables
that are often not considered when evaluating cell-mechanical response. To assay the role of these
features in EFM scaffold design and to improve understanding of scaffold mechanical properties, we
designed EFM scaffolds with varying thickness (50–200 μm) and supporting methodologies. EFM
scaffolds were comprised of polycaprolactone and were either electrospun directly onto a support,
suspended across an annulus (3 or 10 mm inner diameter), or “tension-released” and then suspended
across an annulus. Then, single cell spreading (i.e., Feret diameter) was measured in the presence of
these different features. Cells were sensitive to EFM thickness and suspended gap diameter. Overall,
cell spreading was greatest for 50 μm thick EFMs suspended over a 3 mm gap, which was the smallest
thickness and gap investigated. These results are counterintuitive to conventional understanding
in mechanobiology, which suggests that stiffer materials, such as thicker, supported EFMs, should
elicit greater cell polarization. Additional experiments with 50 μm thick EFMs on polystyrene and
polydimethylsiloxane (PDMS) supports demonstrated that cells can “feel” the support underlying
the EFM if it is rigid, similar to previous results in hydrogels. These results also suggest that EFM
curvature may play a role in cell response, separate from Young’s modulus, possibly because of
internal tension generated. These parameters are not often considered in EFM design and could
improve scaffold performance and ultimately patient outcomes.
Keywords: electrospun fiber mats; mechanobiology; glioblastoma; biomaterials; finite
element modeling
1. Introduction
Electrospun fibers are used widely across a range of applications, including filtration [1], drug
delivery [2] and tissue engineering [3]. This is a result of the high degree of tunability of their
pore size [4], fiber diameter [5] and degradation rate [6]. Generally the most important aspect of
Nanomaterials 2019, 9, 644; doi:10.3390/nano9040644 www.mdpi.com/journal/nanomaterials1
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electrospun fiber mats (EFMs) as biomedical scaffolds is their fibrous topography [7], which influences
cell morphology [8], migration [9] and gene regulation [10]. This has enabled their use in vascular
grafts [11], organ replacement [12] and cancer treatment [13]. Thus, EFM features, such as fiber
diameter and pore size features [14–16] have been well studied. Further, many studies address the
mechanics of EFMs, which are powerful regulators of cell phenotype [17,18]. However, few of these go
beyond Young’s modulus, which assumes linear elasticity that may be inconsistent with the polymers
used in EFM scaffolds.
Further, EFMs can be presented in a variety of conformations that may alter their mechanical
properties. For example, EFMs are often synthesized on the surface of a much stiffer solid support,
such as tissue culture polystyrene [19]. These mechanical nuances could potentially have a large
effect on observed cell response, as we and others have shown the presence of edge effects in similar
hydrogel culture models supported on glass or polystyrene that influence cell morphology [20,21].
Additionally, EFMs may be synthesized across an annular gap with support on the outer edges only
(i.e., suspended). Such a configuration increases internal tension in the fibers as the EFM curvature
increases. The effects of this configuration have not been widely explored. Addressing mechanical
nuances in EFM scaffolds represents a valuable opportunity to advance understanding and to enable
the design of next generation of EFM biomaterials.
Here, we employed EFMs in different scaffold configurations to correlate features of the mechanical
environment to changes in cell morphology, extending our studies beyond Young’s modulus. In
particular, similar to our previous study in hydrogels [20], we examined cell morphology as a function
of interfacial mechanics by altering the EFM support material to determine if cells cultured on EFM
supports can “feel” the underlying substrate. Cell morphology often relates to or precedes other
cell behavior in a myriad of conditions [17,22–24], and thus is a critical characteristic reporter of
cell behaviors. We also evaluated the effect of EFM presentation: such as suspension across a gap,
which induces curvature and may increase deformability versus support on a solid material; and
we investigated the effect of releasing EFM internal residual tension that occurs during the spinning
process, which would also alter deformability, alignment and presentation of focal adhesion sites.
In the latter cases, the EFM material stiffness, as measured by Young’s modulus, remains relatively
constant; however, deformability of the fibers is altered, permitting subtle mechanical effects to be
observed. As a model system, glioblastoma cells were employed because of their highly invasive nature
and dysregulation in cell signaling related to migration and morphology. These studies highlight
the importance of considering factors beyond Young’s modulus in materials design to more fully
understand the interaction between substrate mechanics and cell response.
2. Materials and Methods
2.1. Preparation of Aligned Polycaprolactone Electrospun Fiber Mat Constructs
Aligned polycaprolactone (PCL) fiber mats were prepared by electrospinning onto a rotating
mandrel, as described previously [25]. Briefly, 5 wt% PCL (Mn 70,000–90,000, Sigma-Aldrich, St. Louis,
MO, USA) solution in 1,1,1,3,3,3-hexafluoro-2-propanol (HFP) (>99% purity; Oakwood Products, Inc.,
Columbia, SC, USA) was electrospun at 4 mL/h at a 20 cm needle-to-collector distance [26]. The rotating
mandrel was set to maintain a linear velocity at the collecting surface of 15 m/s. Fiber mat thickness
was varied from 50, 100 and 200 microns by spinning for ~45 min, ~1 h 30 min and ~4 h, respectively.
Fiber mats were spun either directly onto a supporting material or across an annular gap (Figure 1).
Fiber mats were rendered hydrophilic for cell culture by air plasma treatment (Harrick Plasma, Ithaca,
NY, USA) under vacuum at ~700 mTorr and with a plasma radio frequency of 8–12 MHz for 3 min.
Fiber mats were used immediately in experiments.
2
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Figure 1. Schematic of Electrospun Fiber Mats. Electrospun fiber mats (EFMs) were either spun directly
onto a stiff support (A), spun across a gap (B), or spun unto foil, removed, and then fixed across a gap (C).
2.1.1. Polydimethylsiloxane- and Polystyrene-Supported Fiber Mats
Supported fiber mats (Figure 1A) were synthesized by fixing polydimethylsiloxane (PDMS) and
polystyrene (PS) wafers to the rotating mandrel with double sided tape. PS wafers (Multi-Plastics
Inc., Lewis Center, OH, USA) were 0.2 mm thick and cut to a 10 mm diameter with an arch punch
(Grainger, Columbus, OH, USA). PDMS was made from a combination of SylGard 184 and SylGard 527
(Dow Corning, Midland, MI, USA) to vary stiffness without changing surface charge or chemistry [27].
Stiffer “PDMS 100/0” was made of 100% SylGard 184, and less stiff “PDMS 50/50” was made of 50%
SylGard 184 and 50% SylGard 527. Each was cured at 65 ◦C for 18 h. PDMS wafers were ~1 mm thick
and 12 mm in diameter. Electrospinning on these substrates produced a layer of electrospun fibers that
was irreversibly bound to the support, such that fiber-support adhesion was not considered to be a
confounding variable.
2.1.2. Suspended Fiber Mats
Suspended fiber mats (Figure 1B) were produced by fixing PS rings of varying inner diameter to
the rotating mandrel with double sided tape. The rings were cut so that the outer diameter of the ring
was 16 mm and the inner gap diameter was either 3 or 10 mm. After electrospinning, a free, suspended
EFM area was produced inside the annular ring.
2.1.3. Tension-Released Fiber Mats
Tension-released fiber mats (Figure 1C) were produced by electrospinning on non-stick aluminum
foil attached to the rotating mandrel. EFM sections were carefully cut with a scalpel, removed from
the foil, and fixed to PDMS annular rings (as above) with gap diameters of 10 mm using Sylastic
(Dow Corning, Midland, MI, USA). This produced a layer of electrospun fibers irreversibly bound to
the support.
2.2. PDMS Control Substrates
As a control for supported EFM studies, cell adhesion was also compared to bare PDMS wafers
free of EFMs. PDMS was synthesized as above, then air plasma treated for 10 min without cracking
the PDMS surface to render surfaces hydrophilic for cell adhesion [28].
2.3. Scanning Electron Microscopy
For examination of fiber alignment, each type of EFM construct was attached to an aluminum
stub using carbon tape (Ted Pella, Inc., Redding, CA, USA), sputter coated with gold for 30 s (Model 3
3
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Sputter Coater 91000, Pelco, Reading, CA, USA) and imaged using a scanning electron microscope
(SEM) (Quanta 200 SEM, FEI Company, Hillsboro, OR, USA). Fast Fourier Transform (FFT) was used
to quantitatively validate fiber alignment [29,30].
2.4. Mechanical Characterization
The mechanics of the EFM constructs were characterized by measuring the Young’s modulus and
calculating the indentation moduli using finite element modeling (FEM).
2.4.1. Elastic Stress Characterization
Tensile testing (RSA2, New Castle, DE, USA) was carried out on PDMS 100/0, PDMS 50/50, and PS
supports as well as 50 μm and 200 μm thick EFMs. EFMs were oriented in the aligned fiber direction
for testing. Each was cut to a standard dogbone shape and tested up to a strain of 10% at a strain rate
of 0.6% per second. The linear portion of the stress–strain curve was used to determine the Young’s
modulus of the samples.
2.4.2. Finite Element Model Indentation Characterization
A Finite Element Model (FEM) was created using ABAQUS/CAE 6.13-1 software (Dassault
Systèmes Simulia Corporation, Providence, RI, USA, 2013). This model featured a 10 μm diameter
spherical indentation (E = 200 GPa, Poisson’s ratio = 0.3) impressed into each EFM by 5 μm. Based on
EFM morphology, we assume rigid, non-slip contact with the support. In the model, EFMs were either
fixed along the base and outside edge (supported fiber mats) or solely on the outside edge (suspended
fiber mats) (shown in Supplementary Figure S1 and further described in the Supplementary Material).
We tested suspended EFM gap diameters of 3 and 10 mm, with EFM thicknesses of 50, 100 and 200 μm.
An axisymmetric model captured the geometry of the EFMs and spherical indentation. The EFMs were
assumed to be elastic and isotropic with a Young’s modulus of 7.9 MPa and a Poisson’s ratio of 0.35.
Isotropy was assumed as shear modulus for PCL electrospun fibers is not statistically significantly
different in perpendicular directions [31]. The indentation modulus of each EFM was determined by the
Hertzian-contact method, which is valid for ideal elastic materials under infinitesimal deformation [32].
The elastic modulus of the substrate, given a rigid spherical indenter, is based on the load-displacement






where E is the elastic modulus of the substrate, ν is Poisson’s ratio of the substrate, R is the nominal
radius of curvature of the indenter tip, P is the applied load, and S is the material stiffness (S = dP/dh)
evaluated at P.
2.5. Cell Culture
Human glioblastoma U87 MG cells (ATCC) were used for all experiments because of their highly
invasive nature. Cells were cultured at 37 ◦C in a 5% CO2 atmosphere in DMEM/F12 (Sigma-Aldrich,
St. Louis, MO, USA) supplemented with 10% fetal bovine serum (Fisher Scientific, Hampton, NH, USA),
1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA) and 1% MycoZap (Life Technologies,
Carlsbad, CA, USA). Cells were fed 2–3 times a week and passaged at confluence prior to use.
2.6. Analysis of Cell Morphology on PDMS Substrates and PCL Electrospun Fiber Mats
Supported fiber mats were fixed to the bottom of a 12 well plate using Sylastic to prevent floating.
Suspended or tension-released EFMs were first fixed to a PDMS ring to prevent the unsupported area
from touching the bottom of the well. Then, the PDMS ring was fixed to the bottom of the plate using
Sylastic. PDMS wafers and EFMs were sterilized by soaking with 70% ethanol under UV for 20 min,
then rinsed twice with PBS and once with media. Materials were then inoculated in cell culture media
4
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for 30 min. Cells were stained with CellTracker Green (Invitrogen, Carlsbad, CA, USA), then seeded at
40 k per well. After 18 h, cells were imaged using reflectance microscopy (Olympus IX-2, Shinjuku,
Tokyo, Japan) near the center of the fiber mat to avoid potential edge effects. Feret diameter is the
largest distance between any two points of an object and was measured using Image J Image Analysis
Software (v1.52n, Bethesda, MD, USA) freely available from the National Institutes of Health.
2.7. Statistical Analysis
All data was analyzed using JMP statistical analysis software (JMP Pro 14, Cary, NC, USA).
Statistical differences in cell response were detected with ANOVA and Tukey–Kramer HSD tests. In all
cases, p < 0.05 was considered statistically significant.
3. Results
3.1. Fiber Mat Characterization
Correlating to standard EFM characterization methods, we first characterized EFM morphology
and stiffness. Aligned EFMs were spun directly onto PS or PDMS to create supported (solid) or
suspended (annulus) scaffolds (Figure 1A,B). Alternatively, EFMs were spun onto non-stick foil, cut
and removed from foil to release internal tension arising from the electrospinning process, and fixed to
a PDMS annulus to create tension-released scaffolds (Figure 1C). As-spun EFMs demonstrated excellent
alignment (Figure 2A), some of which was preserved in the tension-released EFMs, though a clear
non-linearity is introduced to the fibers (Figure 2B). In these representative EFM images, individual
fiber diameter was consistent at 0.97 ± 0.04 μm and 1.00 ± 0.04 μm for 100 μm thick supported and
tension-released EFMs, respectively (n = 127 total individual fibers). Fiber diameter distribution was
normal (Gaussian) for PS-supported EFMs, but not for the tension-released EFMs (Supplementary
Figure S2). Fiber densities in these EFMs were statistically different at 595.8 ± 17.6 mm−1 and
539.3 ± 11.7 mm−1 for 100 μm thick supported and tension-released EFMs, respectively (p = 0.0318,
two-sided t-test). At the cellular level (~10 μm across), this is a difference between cells interacting
with 5.96 fibers or 5.39 fibers. This may be negligible when considering that out-of-plane fibers were
quantified, while cells largely interact with the top layer of fibers and do not penetrate the EFM. These
fiber diameters and densities are very similar to our previously published results from the same
electrospinning process [19].
 
Figure 2. Representative scanning electron microscope (SEM) images of EFMs. Aligned (A)
and tension-released (B) 100 μm thick EFMs showing differences in fiber morphology following
release of internal tension. Insets: Fourier transform of the figure, indicating degree of alignment.
Scale bar = 50 μm.
Mechanical properties of EFMs were first characterized by calculating an FEM-generated
indentation modulus (Table 1). The indentation modulus is based on an axisymmetric model simulating
a rigid steel indenter impressing an EFM at its center. The indentation modulus for PS-supported
5
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EFMs was up to ~500×, or 8.233 MPa, higher than the indentation modulus for suspended EFMs of
the same thickness. However, moduli for supported EFMs of different thicknesses were similar (e.g.,
8.250 vs. 7.443 MPa). In contrast for suspended EFMs, the indentation modulus increased by ~50×, or
0.79 MPa, as the thickness of the suspended EFM increased from 50 to 200 μm at constant gap diameter
(i.e., 10 mm). Finally, indentation modulus decreased by ~10×, or 0.145 MPa, as the gap diameter
increased from 3 to 10 mm. Thus, the weight of each factor on indentation modulus from greatest to
least was supported vs. suspended, EFM thickness (suspended), and gap diameter. Based on this
model, supported presentations, increasing EFM thickness (suspended), and decreasing gap diameter
all lead to a higher indentation modulus. Supported EFMs are generally stiffer than suspended EFMs.
This suggests that decreasing gap diameter leads to a mechanical response more similar to a stiffer,
supported EFM.
Table 1. Indentation modulus (MPa) for electrospun fiber mat constructs.
50 μm 100 μm 200 μm
Supported, PS 8.250 7.814 7.443
Suspended, 3 mm gap diameter 0.162 1.069 3.932
Suspended, 10 mm gap diameter 0.017 0.118 0.807
Indentation modulus generated by finite element modeling.
A uniaxial tensile test was then performed on the EFM support materials (i.e., PS and PDMS)
and on the unsupported EFMs. The PDMS 100/0 was made of 100% SylGard 184 and PDMS 50/50
was mixed with 50% SylGard 527 to make it less stiff while keeping surface charge and chemistry
constant [27]. As expected, PDMS 50/50 was less stiff, by about 1.5×, than PDMS 100/0 (Table 2). For
EFMs with different thicknesses, the mean Young’s modulus increased with thickness, although results
were not statistically significant. The 200 μm EFM was 1.4× stiffer than the 50 μm EFM (Table 2). These
results are similar to indentation modulus calculations for supported EFMs (Table 1), which show that
modulus is not a strong function of thickness. Thus, we conclude that EFM thickness does not play a
strong role in the mechanical response as measured by Young’s modulus.
Table 2. Young’s modulus of electrospun fiber mats and support materials.
Material Young’s Modulus (MPa)
50 μm EFM 15.00 ± 1.01
200 μm EFM 20.76 ± 3.37
PS 2160.63 ± 51.35
PDMS 50/50 1.29 ± 0.10
PDMS 100/0 3.13 ± 0.35
Data are displayed as mean ± standard error.
3.2. The Role of the Support in EFM Scaffolds
In our previous work [20], we showed that the mechanics of an underlying support material can
influence the response of cells cultured at close proximity by inducing edge effects in an interfacial
region. To investigate how such edge effects can potentially be utilized in EFM scaffolds, cells were
grown on EFMs of varying thickness and with differing support materials (Figure 1A). Cell morphology
was assessed by the Feret diameter (Figure 3A, red lines), which is the longest distance between any
two points of an object. We have previously shown that cells exhibit polarized morphologies on
aligned EFMs and that Feret diameter correlates with migration speed for glioblastoma cells [19],
the model system employed here. Increasing EFM thickness from 50 to 200 μm led to a statistically
significant increase of ~19% in cell Feret diameter for PS-supported EFMs (Figure 3B). Thus, although
a statistically significant difference in Young’s modulus could not be detected, statistically significant
cell responses were still observed.
6
Nanomaterials 2019, 9, 644
Figure 3. Glioblastoma cell Feret diameter (A) as a function of polystyrene (PS)-supported EFM
thickness (B). Feret diameter is indicated for a representative cell (red lines). A total of 979 cells were
analyzed across at least two independent experiments. Levels connected by a star (*) are statistically
significant from each other (p < 0.05).
Cells were also cultured on EFMs at a thickness of 50 μm using support materials of decreasing
Young’s modulus (i.e., PS, PDMS 100/0 and PDMS 50/50) (Figure 4A). PS was selected because it
exhibits a Young’s modulus several orders of magnitude higher than that of the EFMs employed (i.e.,
~2200 vs. ~15 MPa for EFMs), similar to our previous work examining Matrigel (e.g., 1 kPa) supported
on glass (e.g., GPa) [20]. For comparison, two types of softer PDMS were employed; both with Young’s
moduli lower than that of the EFMs (3.13 and 1.29 MPa, respectively vs. 15.00 MPa for EFMs). We
observed a ~26% decline in Feret diameter between the PS and the PDMS 50/50-supported 50 μm EFMs.
In contrast, no difference in Feret diameter was detected between the two PDMS-supported models.
However, when the cells were cultured directly on PDMS 100/0 and PDMS 50/50 support materials
without an EFM, a significant difference in Feret diameter was seen (Figure 4B). This suggests that
the mechanical response of the EFM scaffold is a combination of the support material and the EFM
itself. Thus, tuning the mechanobiological response of cells to EFM scaffolds may be achieved either
by altering the EFM thickness or by altering the stiffness of the underlying support material and that
cells are able to sense the stiffer material in the interfacial region of composites.
 
Figure 4. Glioblastoma cell Feret diameter in response to culture on 50 μm EFMs supported on
substrates of declining stiffness (A) and on polydimethylsiloxane (PDMS) supports of declining stiffness
with no EFM present (B). A total of 1623 cells were analyzed across at least two independent experiments.
Levels connected by a star (*) are statistically significant.
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3.3. The Role of Suspension in EFM Scaffolds
To further elucidate how mechanical nuances can influence cell behavior, we investigated EFMs
lacking support in a central region, i.e., EFMs suspended across an annulus (Figure 1B). This architecture
resembles tissue engineered constructs in which a support material may be missing or only partially
present [12,13], such as artificial trachea constructs. PS disks were used to suspend EFMs of different
thicknesses (i.e., 50, 100 and 200 μm) over two inner gap diameters (i.e., 3 and 10 mm). Compared
to 50 μm PS-supported EFMS, cells cultured on 50 μm EFMs supported across a 10 mm annular gap
displayed Feret diameters similar in magnitude, but cells on the 3 mm gap scaffold had a significantly
higher mean Feret diameter than either support (Figure 5). According to FEM, the 3 mm gap scaffold
would have an indentation modulus between that of the 10 mm gap scaffold and the PS support.
Figure 5. Glioblastoma cell Feret diameter on supported (PS) and suspended (10 mm, 3 mm) 50 μm
EFMs. Scaffolds are arranged left to right by increasing indentation modulus. A total of 935 cells were
analyzed across at least two independent experiments. Levels connected by a star (*) are statistically
significant from each other (p < 0.05).
To gain additional information on these responses, we investigated the effect of EFM thickness
coupled to annular diameter (Figure 6). As EFM thickness increased from 50 to 200 μm, Feret diameter
decreased by ~37% for a fixed 3 mm gap diameter. At the larger 10 mm gap, this decrease was much
less pronounced (~18%). In addition, there was a statistically significant difference in Feret diameter as
a function of gap diameter for the 50 μm thick and 100 μm thick EFMs. This difference was abrogated
at the 200 μm EFM thickness. Thus, increasing gap diameter correlates with a decreased indentation
modulus and an observed decrease in Feret diameter. Interestingly, increased EFM thickness correlates
with increased indentation moduli, but in this case caused a decreased Feret diameter. This highlights
the mechanical complexity of EFM scaffolds, especially in the more nuanced scenario of a suspended
EFM. These results are likely influenced by the role of curvature, which could be pronounced at
the length scale of a cell. Alternatively, these responses may reflect internal residual tension that is
introduced by deformation of the EFM in the central region.
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Figure 6. Glioblastoma cell Feret diameter measured on supports with 3 and 10 mm diameter annular
gaps supporting EFMs of different thicknesses. A total of 1097 cells were analyzed across at least two
independent experiments. Levels connected by a star (*) are statistically significant from each other
(p < 0.05).
3.4. The Role of Tension in EFM Scaffolds
To further explore the role of internal tension, suspended EFMs were modified to reduce internal
residual tension by electrospinning onto non-stick aluminum foil, cutting the fibers and removing
them from the foil, and fixing free-standing EFMs to PDMS annular rings with an inner gap diameter
of 10 mm (Figure 1C). These “tension-released” EFMs produced a statistically significant increase of
9.7% in Feret diameter compared to suspended EFM without released tension at the same gap diameter
(Figure 7A). In addition, increasing EFM thickness led to lower Feret diameter (Figure 7B). This is the
same trend observed for suspended EFMs. In this case, we have empirically reduced the stiffness of
the EFMs by releasing internal tension, yet EFM thickness remains inversely correlated with Feret
diameter in contrast to results on supported EFMs (Figure 3B). Taken together, this data suggests that
the mechanical environment of EFM scaffolds is complex and that cells may react to this environment
in different ways on depending on the stiffness and presentation of the support.
 
Figure 7. Average cell Feret diameter observed on tension-released and suspended EFM constructs,
pooled data across all EFM thicknesses (A) and between tension-released mats at different fiber mat
thicknesses (B). A total of 1651 cells were analyzed across at least two independent experiments. Levels
connected by a star (*) are statistically significant from each other (p < 0.05).
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4. Discussion
This work explores the impact of EFM mechanical parameters, beyond Young’s modulus, on cell
morphology as measured by the Feret diameter. In particular, the effect of the mechanics of the support,
the presence or absence of the support, inherent tension in EFMs and EFM thickness were explored.
For supported EFMs, changing the stiffness of the support material underlying the EFM caused a
large change in cell morphology, but only if the support was much stiffer than the EFM (Figure 4A).
This is not because cells could not sense differences in stiffness between the underlying substrates;
indeed, Feret diameter was different when grown directly on softer flat PDMS supports without an
EFM (Figure 4B). However, when the much stiffer EFM was added, these differences were abrogated.
Although this could result from topography differences, EFMs are fibrous whereas PDMS supports
are relatively smooth and flat, others have shown that cells can “feel” the underlying substrate when
cultured on thin hydrogels. Experiments in which cells spread more on thin gels than on thicker gels
demonstrate this interplay of support substrates [33].
We are the first to demonstrate such edge effects in EFMs. Buxboim et al. described a “threshold
matrix thickness,” the length scale at which cells respond not only to the stiffness of the matrix, but
also to the rigidity of the underlying support for hydrogel models [21]. However, these length scales
were on the order of 10–20 μm compared to our observed responses on 50–200 μm thick EFMs. Cells
may be able to “feel” further when grown on EFMs than when grown on hydrogels because of the
orders of magnitude difference in length scales of individual fibers. Electrospun fiber length can range
upwards of 35–50 cm [34], whereas collagen fibers in hydrogels are only 0.5–3 μm long [35]. Other
factors aside (e.g., fiber strength, fiber interconnectivity, etc.), this difference in length scale may lead to
differences in how well the matrix transmits tension. This likely permits stress to be transferred over a
larger distance.
Suspended EFMs produced perhaps the most intriguing results. From a design perspective, the
50 μm thick, 3 mm gap EFM scaffolds yielded a key finding; these substrates elicited the highest mean
Feret diameter of all (Figure 5). Cells on a thin EFM suspended over a small gap spread more than
cells on a thin EFM fixed to a rigid support with a higher indentation modulus (Table 1). In general,
cells on stiffer substrates demonstrate higher contractility and spreading [36], i.e., Feret diameter.
Engler et al. demonstrated cells grown on hydrogels show a bell curve-shaped response to ligand
density, though ligand density and substrate stiffness are highly difficult to decouple in gels [37]. We
have previously shown that this bell curve-shaped response also exists in EFMs for cell mechanics
when ligand density and stiffness were decoupled through the use of core-shell electrospinning [19].
Here, we have extended upon that work by decoupling material properties from more complex
composite and structural mechanics by suspending fiber mats across gaps of different diameter
without changing surface ligand density or Young’s modulus. We also interrogated focal adhesion
kinase (FAK) expression through Western blotting and found no significant differences in expression
(Supplementary Figure S3). Although FAK phosphorylation could play a role, this suggests that this
mechanosensing mechanism may not be mediated by classical focal adhesion kinase machinery, which
we have previously implicated in EFM mechanotransduction [19]. These data help to illustrate the
complex interplay of substrate mechanics, cell adhesion molecules, and mechanosensing.
For suspended EFMs, changing gap diameter caused significant changes in cell morphology
(Figure 6). Releasing the internal tension in EFMs also altered mean Feret diameter (Figure 7A). These
results highlight the interplay of substrate mechanics and mechanosensing beyond Young’s modulus.
It is generally believed that cells spread more on stiffer substrates [36]. Our investigation into the effect
of support material stiffness (Figure 4) generally corroborates this belief; Feret diameter correlated
positively with stiffness, as measured by Young’s modulus. However, these results were inverted
with EFM thickness for both supported and suspended EFM presentations (Figures 3B and 6). Feret
diameter inversely correlated with stiffness, as measured by indentation modulus. In supported and
suspended EFMs, increasing EFM thickness had opposite effects on indentation modulus. Increasing
supported EFM thickness results in only a slight decrease in indentation modulus; however, increasing
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suspended EFM thickness resulted in ~50× increase in indentation modulus (Table 1). For supported
scaffolds, a given cell at the center of the EFM is only hundreds of microns from the rigid support
(i.e., one EFM thickness away), whereas for suspended scaffolds the rigid support is millimeters away.
This likely affects how the cell feels mechanics between these models. Suspending EFMs may also
cause an impactful change in the curvature of the EFM. These complexities that arise from inverted cell
response to stiffness and suspending EFMs are reflected in part by the bell curve-shaped response to
indentation modulus when comparing suspended and supported presentations (Figure 5). Further
experiments are warranted to decouple these variables to explain these differences.
In addition, improved characterization employing more advanced FEM models that consider
individual fibers over different length scales or empirical data that recapitulates cell contractility would
yield helpful insights. We employ an FEM-generated indentation modulus and an experimentally
derived Young’s modulus. Neither completely describes the results seen herein. Young’s modulus is
especially poorly-suited to provide insights because the most challenging data arise specifically from
changes in structural mechanics, not changes in the materials themselves. Thus, systems have identical
Young’s moduli.
These data highlight a gap in understanding between cell sensing and response to the mechanical
environment. Further, the large differences generated by small, nuanced changes in the mechanical
environment, for example a ~37% change in morphology with a change in EFM thickness (Figure 6),
suggest caution in interpreting data from mechanical studies that may lack scientific rigor. In addition,
these data suggest new variables (i.e., support material, suspension diameter) that can be tuned to
alter material mechanobiology effects. The field of biomaterials has historically progressed from early
generation scaffolds that are bioinert to later generations that are bioactive or bioresorbable. For
example, earlier generation bioinert alumina vs. more recent bioresorbable tri-calcium phosphate dental
implants [38]. Whereas it is acceptable to “avoid” biological complexity early, this complexity also
provides powerful opportunities to improve patient outcomes. Impending generations of biomedical
scaffolds will need to harness the powerful, yet relatively untapped realm of nuanced mechanobiology.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4991/9/4/644/s1,
Figure S1: Boundary conditions and interactions for indentation FE models, Figure S2: Individual fiber diameter
distributions. Frequency distributions for PS-supported (A) and tension-released (B) EFMs, Figure S3: Focal
adhesion kinase expression.
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Abstract: Electrospinning uses an electric field to produce fine fibers of nano and micron scale
diameters from polymer solutions. Despite innovation in jet initiation, jet path control and
fiber collection, it is common to only fabricate planar and tubular-shaped electrospun products.
For applications that encapsulate cells and tissues inside a porous container, it is useful to develop
biocompatible hollow core-containing devices. To this end, by introducing a 3D-printed framework
containing a sodium chloride pellet (sacrificial core) as the collector and through post-electrospinning
dissolution of the sacrificial core, we demonstrate that hollow core containing polyamide 66 (nylon 66)
devices can be easily fabricated for use as cell encapsulation systems. ATR-FTIR and TG/DTA studies
were used to verify that the bulk properties of the electrospun device were not altered by contact with
the salt pellet during fiber collection. Protein diffusion investigations demonstrated that the capsule
allowed free diffusion of model biomolecules (insulin, albumin and Ig G). Cell encapsulation studies
with model cell types (fibroblasts and lymphocytes) revealed that the capsule supports the viability of
encapsulated cells inside the capsule whilst compartmentalizing immune cells outside of the capsule.
Taken together, the use of a salt pellet as a sacrificial core within a 3D printed framework to support
fiber collection, as well as the ability to easily remove this core using aqueous dissolution, results in
a biocompatible device that can be tailored for use in cell and tissue encapsulation applications.
Keywords: electrospinning; 3D printing; nanofibers; encapsulation; protein diffusion; in vivo tissue
engineering; immuno-isolation; transplantation
1. Introduction
Electrospinning is a process in which a charged polymer jet is deposited on a grounded collector.
Introduced in the early 1900s, the technology is now a well-established and an intensively investigated
way of producing continuous fibers from a wide variety of polymer solutions, with diameters ranging
from several microns down to several nanometers [1]. With a high surface area to volume ratio,
tunable porosity and flexibility in surface modification, electrospun fibers have been successfully
used in various applications including the fabrication of protective clothing, electronics, catalysis
and pharmaceutics, as well as in the fields of filtration, environmental engineering and regenerative
medicine. Typically, a syringe is used to load the polymer solution and a syringe pump controls
the solution flow rate from a tip charged by a high-voltage power unit. The charged polymer
jet takes a torturous path, elongating and drying as it is pulled towards a grounded collector.
Many modifications to the electrospinning setup have been investigated over the last couple of
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Nanomaterials 2018, 8, 863
decades [2,3]. For instance, a co-axial electrospinning system was developed to fabricate core-shell
fibrous structures, wherein the inclusion of a sacrificial core can be used to yield hollow fibers or the
inclusion of multiple cores can be used to yield multi-core fibers [4,5]. An axillary cylindrical electrode
has also been used to facilitate multiple spinneret electrospinning that dramatically increases the rate
of fiber production [6]. Similarly, conductive patterned collector-based electrospinning has been used
to generate fibrous materials with controlled architectures [7].
Despite innovations in jet facilitation and control over path and fiber collection, the most
commonly fabricated electrospun forms are flat membranes produced using flat collector plates,
and tubular structures produced using rod-like collectors. In the context of biomedical applications,
flat membranes are widely used as substrates for culturing a variety of cells and engineering tissues,
such as skin [8], whereas the tubular structures are used to engineer tissues such as blood vessels
and neural conduits [9]. Beyond these two forms, there is demand and scope for novel products
and devices such as encapsulation systems that expand the reach of electrospinning applications in
regenerative medicine. For example, a common approach used to treat type 1 diabetes mellitus is to
infuse pancreatic islets into the hepatic portal vein; however, this implantation site has proven to be
sub-optimal. The development of devices that encapsulate cells within a protective environment would
facilitate the choice of alternative sites. In the field of tissue engineering, current in vitro approaches
are unable to replicate native cell niche environments and hence there is interest in the development
of in vivo bio-incubators that better replicate the tissue environment. Similarly, in the field of allo- or
xeno-cell and tissue transplantation, the side effects of using immune suppressants are undesirable
and there is increasing demand to develop suitable immuno-isolating devices [10,11].
In this report, we describe the fabrication of a macro-scale encapsulation device, produced
through manipulation of the collection of electrospun fibers. It was hypothesized that the introduction
of a water-soluble pellet (sacrificial core), such as a custom-made sodium chloride pellet, as the collector
would allow for post-electrospinning dissolution of this sacrificial core, making it possible to fabricate
a hollow polymeric macro-scale encapsulation device. Fabrication of capsules with varying size, shape
and thickness would be possible by modifying the size, shape and thickness of the sacrificial core. It was
further hypothesized that a framework would be required to prevent the collapse of the electrospun
device upon sacrificial core dissolution, and therefore, it was proposed that a 3D printed framework
would be used to support the sacrificial core during preparation and electrospinning, and that this
framework would remain in place to prevent collapse following core dissolution. Polyamide 6,6 (PA66)
was selected as the polymer of choice. This is a non-degradable and biocompatible polymer that has
been widely explored in biomedical applications. The electrospun capsules produced were evaluated
through the use of scanning electron microscopy (SEM), attenuated total reflectance Fourier transform
infrared spectroscopy (ATR-FTIR) and simultaneous thermo gravimetric/differential thermal analysis
(TG/DTA). Finally, protein diffusion studies using model biomolecules (insulin, albumin and Ig
G) were performed to study the free diffusion of essential proteins through the capsule walls, and
cell encapsulation studies with model cell types (fibroblasts and lymphocytes) were performed to
investigate whether the device could support the viability of encapsulated cells whilst restricting
immune cell access from the surrounding space.
2. Materials and Methods
2.1. Materials
Polyamide 6,6 (PA66, also known as nylon 6,6 or Poly(N,N′-hexamethyleneadipinediamide)),
2,2,2-Trifluoroethanol (TFE), formic acid (FA), 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP), human insulin,
human Ig G and bovine serum albumin (BSA) were purchased from Sigma-Aldrich, Dorset, UK, and
the protein determination kit was purchased from Cayman Chemical, Ann Arbor, MI, USA. Dulbecco’s
Modified Eagle Medium (DMEM), Roswell Park Memorial Institute 1640 (RPMI-1640) medium,
fetal bovine serum (FBS), trypsin-Ethylenediaminetetraacetic acid (EDTA), phosphate-buffered
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saline (PBS, 1×), Penicillin-Streptomycin (Pen-Strep, 100×) and Alamar blue were purchased from
Thermo Fisher Scientific, Waltham, MA, USA.
2.2. Preparation of Macroscale Capsules by Sacrificial Core Electrospinning
2.2.1. Preparation of a 3D Printed Supporting Framework
An online computer-assisted design tool (Tinkercad, AUTODESK, San Rafael, CA, USA) was used
to prepare a 3D stereolithographic design in STL (stereolithography) file format. As shown in Figure 1a,
a typical framework contains an external thick skeletal structure with a thin internal lattice of crisscross
elements used to create a luminal space. An opening injection port to one side allows access to the
internal space. The design was uploaded to a computer-assisted 3D printer manufacturing system
(Form 2, FormLabs, Somerville, MA, USA). The 3D printer uses a laser to cure solid isotropic parts
from a liquid photopolymer resin. A biocompatible resin was used (EN-ISO 10993-1:2009/AC:2010,
USP Class VI, Dental SG, FormLabs, Somerville, MA, USA). Removal of non-cured resin was achieved
by post-fabrication washing in absolute ethanol for 15 min, as per the supplier’s recommendation.
Figure 1. Schematic showing sacrificial core electrospinning capsule fabrication and use: (a) Images
show the CAD 3D model of the supporting framework (frame). (b) Work flow showing the
steps involved in device assembly, detailing supporting framework production, salt embedding,
electrospinning and salt dissolution. (c) Electrospinning setup, highlighting how the salt aggregate
contacting supporting frame was placed directly in front of the grounded collecting plate and rotated
during fiber collection. (d) Loading of the electrospun capsule with cells for use in cell and tissue
encapsulation applications, highlighting how the capsule allows free diffusion on nutrients, gases,
cellular products and waste, whilst blocking access to immune cell penetration.
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2.2.2. Embedding Salt into the Printed Framework
The printed framework was kept on a flat surface and sodium chloride crystals were packed into
the lumen of the framework. Water was used to wet the packed crystals, partially solubilizing the salt
at the crystal boundaries, and fusing the crystals into a single aggregate. After allowing to dry at room
temperature on an open bench for 24 h, the salt pellet containing the framework was ready to be used
as a collector during electrospinning (Figure 1b).
2.2.3. Sacrificial Core Electrospinning
PA66 pellets were suspended in different organic solvents at various concentrations (see Table 1)
and stirred continuously until completely dissolved. The solution was electrospun at ambient
temperature (20–22 ◦C) in a low humidity environment (25 ± 5% RH – relative humidity, controlled
by purging the chamber with nitrogen gas). The sacrificial core electrospinning setup included
a high-voltage power supply, a digital syringe pump and a specialized collecting unit, composed of the
sacrificial core and printed framework connected to a DC (direct current) motor and placed directly
in front of a grounded metal plate (Figure 1c). The entire setup was enclosed inside a custom-made
plastic chamber with fume extraction and safety interlocks. To reduce variability in fiber diameter
and packing density, the DC motor was run at a constant speed during the fabrication of all capsules.
Systematic optimization was performed by varying the processing parameters, as detailed in Table 1.
Table 1. Details of electrospinning parameters varied during optimization.
Parameter Test Conditions Constant Variables
Solvent type FA, TFE and HFIP Polymer conc. = 7.5% (w/v); Voltage = 15 kV;Distance = 15 cm; Flow rate = 0.05 mL/min
Polymer concentration 5, 7.5 and 10% (w/v) Solvent = HFIP; Voltage = 15 kV;Distance = 15 cm; Flow rate = 0.05 mL/min
Voltage 10, 15, 20 and 30 kV Polymer conc. = 7.5% (w/v); Solvent = HFIP;Distance = 15 cm; Flow rate = 0.05 mL/min
Tip to collector distance 10, 15, 20 and 30 cm Polymer conc. = 7.5% (w/v); Solvent = HFIP;Voltage = 15 kV; Flow rate = 0.05 mL/min
Voltage: Tip to collector distance 1:2 (15 kV:30 cm), 1:1 (15 kV:15 cm)and 2:1 (30 kV:15 cm)
Polymer conc. = 7.5% (w/v); Solvent = HFIP;
Flow rate = 0.05 mL/min
Flow rate 0.025, 0.050, 0.075 and 0.100 mL/min Polymer conc. = 7.5% (w/v); Solvent = HFIP;Voltage = 15 kV; Distance = 15 cm
2.3. Characterization Studies
The morphological features of the electrospun PA66 materials were imaged and analyzed using
SEM (Evo LS15, Carl Zeiss, Oberkochen, Germany). For this purpose, the samples were air dried
in a chemical fume hood. They were then mounted on the specimen holder with double adhesive
electro-conductive carbon tape, sputter-coated with platinum for 90 seconds under argon gas in
a coating unit (Polaron range SC7620, Quorum Technologies Ltd, East Sussex, UK), and imaged.
Fiber diameter was calculated manually by analyzing the images using Image J software (NIH,
Bethesda, MD, USA).
Changes to the chemistry of PA66 after electrospinning were tracked using Attenuated Total
Reflection-Fourier-transform infrared spectroscopy (ATR-FTIR, Tensor 37, Bruker, Billerica, MA, USA).
For each measurement, 16 scans were recorded with a resolution of 1 cm−1 and wave numbers
ranging from 800 to 4000 cm−1. During the measurements, the instrument was continuously purged
with nitrogen using blow-off from a liquid nitrogen tank to eliminate the spectral contributions of
atmospheric water vapor.
The thermal properties of PA66 before and after electrospinning were analyzed by simultaneous
thermogravimetry/differential thermal analysis (TG/DTA, Diamond, PerkinElmer, Waltham, MA,
USA). In each measurement, the sample was heated from 40 to 600 ◦C at a rate of 10 ◦C/min. During
the measurements, the instrument was continuously purged with nitrogen gas at a rate of 20 mL/min
to eliminate the spectral alterations due to the presence of ambient air.
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2.4. Protein Diffusion Assay
PA66 capsules (1 cm width × 2 cm length × 1 mm thickness) made from 7.5% (w/v) polymer
solution with 15 kV voltage, 15 cm distance and 0.5 mL/min flow rate, were sterilized by autoclaving
and saturated with 1× PBS for 3 h in an incubator (5% CO2, 37 ◦C). Capsules were placed in a 6-well
plate and simultaneously loaded with insulin, Ig G or BSA solution (1 mg/mL). The capsule loading
port was tied tightly with a sterile nylon thread and kept in a CO2 incubator overnight. The contents
were manually mixed at regular intervals. The spent protein solution released from the capsule was
collected and assayed by the Bradford method following the kit instructions (Cayman Chemical,
Ann Arbor, MI, USA). Briefly, 100 μL of diluted protein solution was mixed with equal amounts of
assay reagent. The contents were incubated at room temperature for 5 min and the absorbance was
read at 595 nm in a multi-well plate reader (Spectra Max i3x, Molecular Devices, San Jose, CA, USA).
Results were compared with a standard curve made using known concentrations of insulin, Ig G
and BSA.
2.5. Cell Encapsulation Studies
Human dermal fibroblasts (HDF, Thermo Fisher Scientific, Waltham, MA, USA) and Jurkat cells
(ATCC, Manassas, VA, USA) were routinely cultured in DMEM and RMPI-1640 medium respectively,
in a CO2 incubator. The medium was supplemented with 10% FBS and 1% Pen-Strep. PA66 capsules
were prepared as described in Section 2.4. The capsules were saturated in complete medium overnight,
and 5.0 × 105 cells/mL of exponentially growing cells were loaded into each capsule through the
injection port. The injection port was closed tightly with a sterile nylon thread, and they were cultured
in a CO2 incubator. After 3 d of incubation, the cell-laden capsules were transferred to a fresh plate with
fresh medium. The presence of cells, both inside and outside the capsules, was measured using the
metabolic Alamar blue assay, comparing the medium in the spent and receiving plates. In the case of
HDF cells, if any cells migrate out of the capsule, they would attach to the bottom of the plate; the spent
medium was exchanged directly with the fresh medium. In the case of Jurkat cells, the spent medium
was centrifuged to collect cells at the bottom of the well prior to replacing the spent medium with
fresh medium. Briefly, 1 mL of fresh medium together with 100μL of Alamar blue reagent was added
to both the wells containing the cell-laden capsules and the wells of the spent plate. The contents were
mixed well and incubated in a CO2 incubator. After 4 h of incubation, the absorbance was measured at
a wavelength of 570 nm, using a 600 nm wavelength as a reference. An equal number of cells cultured
in a standard tissue culture treated polystyrene (TCPS) plate, under similar conditions, were treated
as the positive control. Cell-free Alamar blue reagent, under similar conditions, was treated as the
negative control. The cell viability was measured using the following Equation:
Cell viability% =
Absorbance of Test Sample
Absorbance of Control Sample
× 100 (1)
2.6. Statistical Analysis
The quantitative values were averaged and expressed as mean ± standard deviation. One-way
ANOVA was performed to compare significance across groups, and the differences were denoted with
*, # and ‡ representing p < 0.05, p < 0.01 and p < 0.001 respectively.
3. Results and Discussion
Inspired by techniques such as freeze-drying [12] and salt-leaching [13] where ice crystals or salt
crystals are used as porogens, it was hypothesized that it should be possible to use a similar approach
to modify the macroscale form of fibers collected using conventional electrospinning. This setup,
termed “sacrificial core electrospinning”, could be used to produce devices for potential cell and tissue
encapsulation applications. As presented in Figure 1, the setup was simple and extends conventional
systems though inclusion of a sacrificial core (a sodium chloride pellet) rotated directly in front
19
Nanomaterials 2018, 8, 863
of a grounded plate. Fibers deposited onto the pellet conform to the shape and size of the pellet.
After electrospinning, the sacrificial core pellet can be dissolved by suspending in ultrapure water.
Whilst this results in the creation of a hollow capsule with a port for cell or tissue injection, the
electrospun fibers do not provide sufficient internal support and the device is susceptible to collapse
(Figure S1). To overcome this issue, a custom-made 3D printed supporting frame was developed
(Figure S2) and used both as a former for the sacrificial core and to provide internal support once the
core has been dissolved (it is worthwhile to mention here that use of 3D printed frame without salt
embedding was not efficient - check Figure S3). Using this approach, it was possible to successfully
fabricate devices with varying length, width (Figure 2a), shape (Figure 2b) and thickness (Figure 2c).
Figure 2. Sacrificial core electrospun products: With sacrificial core-based electrospinning, it was
possible to prepare PA66 macro-capsules with variable size (a), shape (b), and thickness (c).
Whilst conventional electrospinning techniques enable control to be gained over the microscale
properties of fiber diameter and density, the use of a printed framework and salt core facilities the
ability to control the macro-scale features of the fabricated construct. Of the 21 parameters commonly
observed to influence fiber formation and the properties of the resultant product, we studied the
effects of solvent type, polymer concentration, flow rate, applied voltage, tip-to-collector distance
and voltage–to–distance ratio using polyamide 66 (PA66 or nylon 66) (Table 1 and Figure 3) [14].
In accordance with the literature, electrospunPA66 dissolved in formic acid (FA) resulted in thinner
fibers (121 ± 12 nm), in comparison to PA66 electrospun in 2,2,2-Trifluoroethanol (TFE, 388 ± 127 nm)
or 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP, 967 ± 127 nm) (Figure 3a). Differences in the evaporation
rate of the solvents, as well as the conductivity and viscosity of the resultant solutions may have
also contributed to the differences observed in fiber diameter [14]. Similarly, an increase in the PA66
concentration from 5 to 7.5 to 10% (w/v) resulted in an increase in fiber diameter from 486 ± 159 nm
to 967 ± 127 nm to 1908 ± 258 nm respectively (Figure 3b). The viscosity and elastic modulus of the
solution increases with polymer concentration and this may be attributable for the changes in the fiber
diameter observed [14]. The change in fiber diameter in relation to voltage was found to follow a slight
inverse relationship, with fiber diameters of 1113 ± 258 nm, 967 ± 127 nm and 904 ± 247 nm recorded
at 10, 15 and 20 kV (Figure 3c). These changes may be attributed to the differences in volumetric charge
density associated with the applied voltage, which would significantly affect the initial jet diameter
at the tip of the Taylor cone [14]. Whilst the distance (Figure 3d) and the voltage–to–distance ratio
(Figure 3e) do not seem to have any significant influence on fiber diameter, we noticed a change in
fiber morphology in relation to the voltage–to–distance ratio. Finally, the fiber diameters were found
to be 937 ± 189 nm, 967 ± 127 nm, 1165 ± 412 nm and 1292 ± 194 nm, when the flow rates were 0.025,
0.050, 0.075 and 0.100 mL/min respectively (Figure 3f). It has previously been noted that, with other
parameters constant, the lowest flow rate typically results in a small jet radius that yields the thinnest
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fibers, whereas higher flow rates typically result in a larger jet radius and yield thicker fibers [14].
Our observations were in agreement with earlier reports [14–16].
 
Figure 3. Effect of electrospinning parameters on fiber morphology: scanning electron microscopy
(SEM) images of electrospun PA66 samples showing the effects of solvent type (a), polymer
concentration (b), voltage (c), distance (d), voltage–to–distance ratio (e), and flow rate (f).
Corresponding plots of fiber diameter are presented in (a’) to (f’) respectively. Fiber width was
analyzed by manually measuring the width of individual fibers against a given scale using Image
J software (n = 25). # and ‡ denotes statistical differences at p < 0.01 and p < 0.001 respectively.
Scale bar = 2 μm.
The bulk properties of the polymer were compared before and after the electrospinning process.
Electricity, a physical property, does not typically affect the material properties of the polymer
unless reactive additives are present in the polymer solution. In the current approach, the sodium
chloride core was in direct contact with the deposited fibers within the electric field. Attenuated
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total reflectance—Fourier transform infrared spectroscopy (ATR-FTIR) revealed similar spectral
patterns with characteristic peaks related to N–H stretching at ~3330 cm−1, CH2 stretching at
~2840 cm−1, amide I at ~1650 cm−1, amide II at ~1545 cm−1, and amide III at ~1370 cm−1 [15,17]
(Figure 4a). A simultaneous TG/DTA investigation also suggested comparable heat flow patterns with
a characteristic peak melting temperature (Tm) at ~264.5 ◦C for pristine and ~262.5 ◦C for electrospun
PA66, and decomposition patterns with the onset decomposition temperature of ~380 ◦C for pristine
and ~373 ◦C for electrospun PA66 samples (Figure 4b,c). The spectral peak values were in good
agreement with previously reported values for PA66 [16,18]. Collectively, ATR-FTIR and TG/DTA
studies confirmed that the sacrificial core electrospinning was similar to the typical electrospinning
process and did not influence the bulk properties of the polymer used in this study.
Figure 4. Material characteristics before and after sacrificial core electrospinning: Attenuated Total
Reflection-Fourier-transform infrared spectroscopy (ATR-FTIR) (a), and thermogravimetry /differential
thermal analysis (TG/DTA) (b—DSC, c—TGA) confirmed that the use of sodium chloride within the
collector has no significant influence on the bulk properties of the polymer (PA66).
Since the devices fabricated using the sacrificial core electrospinning technique are intended
to be used in cell and tissue encapsulation applications, it is of prime importance to verify the
free movement of biomolecules, such as cytokines and growth factors, across the capsule walls.
To investigate this, fabricated capsules were independently loaded with three model proteins: insulin,
albumin and immunoglobulin G (Ig G) (1 mg/mL in PBS), with molecular weights of 5.8, 66 and
150 kDa, respectively, and incubated in protein-free PBS. Following overnight incubation at 37 ◦C,
the capsule was removed, and the solution taken from around the capsule was assayed using the
Bradford method. The presence of protein was detected in the solutions from all tested capsules
(see Figure 5). However, minor differences were observed between the solutions from the 5, 7.5
and 10% (w/v) PA66 capsules. This may be due to the differences in the total surface area of the
fibrous constructs. However, these differences were negligible. The results suggested that, in contrast
to conventional hydrogel-based encapsulation systems, where the rate of biomolecule diffusion is
restricted, the electrospun membranes produced in this study allow free diffusion of biomolecules.
This may be beneficial for cell and tissues encapsulation applications that require rapid biomolecule
transport [19].
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Figure 5. Protein diffusion study: Biomolecules such as insulin (a), albumin (b), and Ig G (c) loaded
(1 mg/mL) into the sacrificial core electrospun capsules, were found to diffuse through the membrane
into the incubation buffer. * denotes statistical differences at p < 0.05.
Finally, the ability of the electrospun capsule to support cells was assessed in vitro using two
different model cell types: adherent fibroblasts (from human dermis) and non-adherent lymphocytes
(Jurkat cells from human peripheral blood). In each case, 5.0 × 105 cells were loaded into the capsule
and the cell-laden capsule was incubated in a CO2 incubator. After 3 d of incubation, cell viability
was indirectly measured using the metabolic Alamar blue assay. Cells cultured in a well plate under
similar conditions were treated as the positive control. The purpose of the study was to investigate
whether the porous structure of the capsule posed a barrier to diffusion that would affect the cell
viability. Cell viability remained unchanged across all capsules tested (Figure 6). These results
suggest that the electrospun membranes posed no limitation to the exchange of gases, nutrients and
metabolic wastes essential for cell survival. We also collected the spent medium and performed further
Alamar blue assays to determine if the encapsulated cells were released through the porous wall of
the capsule. Both the fibroblasts and lymphocytes were not detected in the spent media, indicating
that the porosity of the device (Figure S4) was efficient enough to restrict access to cells (Figure 6).
The results indicate that the resultant electrospun device could be potentially used in various cell
and tissue encapsulation applications. Considering the lymphocyte-based results, the capsule could
also be used as an immuno-isolating system; however, detailed experiments are required to prove the
immuno-protective properties of the device.
Figure 6. Cell encapsulation study: (a) Adherent cells (human dermis fibroblasts, HDF) and
(b) non-adherent cells (lymphocytes from human peripheral blood, Jurkat cells) were encapsulated in
the electrospun capsules. The number of cells present at day 3 remained unaffected in comparison to
cultures on standard tissue culture-treated polystyrene dishes. Spent media showed no detectable cell
activity, suggesting that the capsules effectively compartmentalized the cells. No statistical differences
were found within the capsule and spent medium groups.
Previously, Lathuilièreet al., generated flat sheet devices consisting of an outer polymeric frame,
porous membranes and a reinforcement mesh assembled using ultrasonic welding [20]. These devices
were used for the implantation of genetically engineered allogeneic cells and passive immunization
against amyloid-β. Similarly, Nyitrayet al., reported a two-step heat-sealing process to fabricate a
polycaprolactone-based thin-film device and used this device to transplant pancreatic islets [21],
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whilst Park et al., described the assembly of a bacterial cellulose, collagen and alginate-based
composite device for encapsulation of neuronal cells [22]. Recently, David et al., showed how
a Polytetrafluoroethylene-based bilaminar device (Theracyte) can be used in the encapsulation of
ovarian allograft to restore ovarian endocrine function [23]. While these reports suggest that there are
a wide range of potential applications for bio-encapsulation technology, they also reveal the unmet
need for an efficient macro-encapsulation device and illustrate the complexity of fabrication processes
currently being investigated. In contrast, the sacrificial core electrospinning approach presented in
this report is relatively simple as it follows well-known electrospinning principles and there is no
complicated assembly or other processing steps involved. It is also versatile as it allows the fabrication
of a device with a wide range of macro- and micro-scale features. The resultant device can be used as a
cell-based drug delivery device or as a cell reservoir to treat conditions such as diabetes, neurological
disorders and sensory diseases; however, the true efficiency of the device can only be determined by
further in vivo studies.
4. Conclusions
In conclusion, this report describes a technological advancement in the field of electrospinning.
While retaining all the benefits of the electrospinning process, a sodium chloride-based pellet (sacrificial
core) has been introduced to act as a rotating collector, placed directly in front of a grounded plate.
Subsequently, the dissolution of the salt pellet results in a hollow core containing capsule. With this
technique, we have developed nylon (PA66)-based devices with varying macroscale features such as
size (2 × 4, 1 × 2 and 0.5 × 1 cm), shape (rectangular, triangular and circular) and thickness (1, 1.5
and 2 mm). Additionally, it was possible to control the morphological properties of the capsule, such
as fiber diameter by altering the conventional electrospinning parameters, including solvent type,
polymer concentration, voltage, distance, voltage–to–distance ratio and flow rate. The results from
the ATR-FTIR and TG/DTA studies performed suggest that the use of the sodium chloride pellet as
the sacrificial core had no influence on the bulk properties of the polymer. Protein diffusion studies
revealed that the capsules allowed free diffusion of biomolecules such as insulin, albumin and Ig G.
Cell encapsulation studies with HDF and Jurkat cells revealed that the optimized capsules could be
used to support the viability of encapsulated cells, whilst the walls of the capsules would restrict the
ingress of immune cells. Further studies to unravel the potential of this system in various cell and
tissue encapsulation applications are in progress.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4991/8/10/863/s1,
Figure S1: Physical state of the sacrificial core electrospun device without a supporting framework; Figure S2:
A representative image of a 3D-printed supporting framework; Figure S3: Electrospinning onto 3D printed
framework without inclusion of a NaCl pellet; Figure S4: Pore area calculations.
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Abstract: The design of biomimetic biomaterials for cell culture has become a great tool to study and
understand cell behavior, tissue degradation, and lesion. Topographical and morphological features
play an important role in modulating cell behavior. In this study, a dual methodology was evaluated
to generate novel gelatin methacrylate (GelMA)-based scaffolds with nano and micro topographical
and morphological features. First, electrospinning parameters and crosslinking processes were
optimized to obtain electrospun nanofibrous scaffolds. GelMA mats were characterized by SEM,
FTIR, DSC, TGA, contact angle, and water uptake. Various nanofibrous GelMA mats with defect-free
fibers and stability in aqueous media were obtained. Then, micropatterned molds produced by
photolithography were used as collectors in the electrospinning process. Thus, biocompatible GelMA
nanofibrous scaffolds with micro-patterns that mimic extracellular matrix were obtained successfully
by combining two micro/nanofabrication techniques, electrospinning, and micromolding. Taking into
account the cell viability results, the methodology used in this study could be considered a valuable
tool to develop patterned GelMA based nanofibrous scaffolds for cell culture and tissue engineering.
Keywords: biomimetic scaffolds; gelatin; electrospinning; micromolding; biomaterials
1. Introduction
The design of biomimetic biomaterials as scaffolds for cell culture is a powerful tool for
studying and understanding fundamental cell behavior, specific tissue environment, degradation,
and reasons for tissue damage [1]. Scaffolding structures should mimic not only biological properties
of extracellular matrix (ECM), but also morphological and topographical features [2–4]. The ECM
directs and modulates cell behavior, is composed of fibrous proteins (mainly collagens and elastin),
glycosaminoglycans (GAGs), proteoglycans, and glycoproteins [5,6].
In order to emulate the natural structure of the ECM, different technologies have been developed.
Current techniques for generating topographical features on polymeric scaffolds for cell culture,
especially those with nano-scale resolution, are typically complex and expensive. Thus, a simple
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and tunable fabrication method for the production of patterned biomimetic scaffold is still pending.
By using electrospinning technology, it is possible to obtain micro- and/or nano-fibrous mats that
mimic ECM [7,8]. The optimization of different processing parameters and the use of post-processing
treatments allow handling dimensions, porosity, morphology, and the spatial arrangement of
nanofibers. A huge variety of natural and/or synthetic polymeric solutions has been electrospun.
Composition and processing techniques determine the scaffold architecture, mechanical performance,
degradation rate, and cell-material interactions. Aligned and randomly oriented electrospun mats have
been also developed to study how morphology affects cell behavior. Gao et al. studied the influence
of aligned and randomly oriented fibrous gelatin/PLLA scaffolds to guide the growth of corneal
stroma cells [9]. The aligned scaffold not only increased cell viability more significantly than that in
a randomly oriented scaffold, but it also provided an external stimulus for the orderly arrangement
of cells. Similar results were observed by Shalumon et al., who prepared aligned and randomly
PLLA/gelatin nanofibrous scaffolds [10]. In these structures, an increase in viability and proliferation
of human umbilical vein endothelial cells (HUVECs) and smooth muscle cells (SMCs) was observed.
On the other hand, substrates with various micro- and nano-features such as lines, wells, and holes
among others have been explored to introduce significant effects on cell behavior [11]. Most of these
reports relate the topographical features with cell orientation, migration, morphology, proliferation,
cell gene expression, and differentiation [12–14].
The main goal of this work is to design gelatin-based scaffolds with micro and nano-topographical
and morphological features, achieving a high resolution, and performance with low cost. In addition,
gelatin, a biocompatible and biofunctional polymer, and benign solvents (Class 3 according to
ICH guidelines) [15] are used for scaffold fabrication. Gelatin is an inexpensive biomacromolecule
obtained from denatured collagen, and presents integrin cell-binding motifs, such as RGD and matrix
metalloproteinases (MMP) degradable sites [16,17]. Compared to native collagen, gelatin has lower
antigenicity and less batch-to-batch variation due to the denaturation process, in which tertiary protein
structures are removed. Functionalization of amine-containing groups of gelatin with methacrylate
groups was used to provide a photopolymerizable biomaterial named GelMA that has been widely
investigated for cell-based studies and tissue engineering applications [18–22]. Crosslinking of the
methacrylic side groups results in hydrogels with stiffness and density that can be controlled by varying
the polymer dry mass, degree of functionalization, photo-initiator concentration, ultraviolet (UV)
intensity, and exposure time. In this work, electrospinning and photolithography techniques were used
to design 3D scaffolds with novel topographical features in micro- and nanoscale, while UV exposition
time was varied. Moreover, the use of micropatterned molds with different sizes as collectors in the
electrospinning process is proposed to produce electrospun fibrous mats.
2. Materials and Methods
2.1. Materials
Gelatin type A from porcine skin Gel Strength 300, methacrylic anhydride (MAA), and glacial
acetic acid (AA) were purchased from Aldrich (Darmstadt, Germany). The photoinitiator
1-[4-(2-hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-1-propan-1-one (Irgacure®2959) was kindly
provided by BASF (Nienburg, Germany). Phosphate-buffered saline (PBS) was freshly prepared
in the laboratory.
2.2. Synthesis of GelMA
The preparation of GelMA has been recently described by the authors [23]. Briefly, gelatin was
dissolved in PBS (pH 7.4) at a concentration of 1% (wt/v) and 50 ◦C. Then, a predetermined amount of
methacrylic anhydride was added, under vigorously magnetic stirring conditions. The mixture was
left to react for one hour at 50 ◦C and was afterwards dialyzed by using a 12–14 kDa cutoff membrane
against distilled water for several days. Finally, functionalized gelatin was frozen and freeze-dried.
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The degree of methacrylation, defined as the percent of amine groups converted to methacrylamide
groups, was determined by Habeeb’s test [24]. Finally, GelMA was characterized by 1H-NMR (Bruker
400 MHz NMR spectrometer, Bruker Biospin, Rheinstetten, Germany) and FTIR spectroscopy (Mattson
Instruments Inc., model Genesis II, Madison, WI, USA).
2.3. Fabrication of Electrospun GelMA Nanofibers
A predetermined amount of GelMA was completely dissolved in acetic acid at a 250 mg/mL
concentration. Then, Irgacure 2959 was added to GelMA solution. The solution was electrospun
through a blunt 18-gauge stainless steel needle onto an aluminum collector plate 10 cm away. A solution
flow rate of 0.2 mL/h and an applied high-voltage of 12 kV were used. All experiments were carried
out at room temperature and a relative humidity of 50%.
2.4. Photocrosslinking of GelMA Nanofibers
The obtained electrospun GelMA scaffolds were crosslinked by UV irradiation. Fibrous meshes
were initially wetted in anhydrous ethanol and then exposed to UV light (UVL-28 lamp, 365 nm),
during different time periods (0, 6, 9 and 12 min) at 2.5 cm (named NG-0UV, NG-6UV, NG-9UV and
NG-12UV, respectively). After crosslinking treatment, samples were removed from aluminum foil and
dried at room temperature in a vacuum oven.
2.5. Fabrication of Micropatterned Molds
Master mold layouts were designed using L-EditTM from Tanner EDA and printed on
polyester-based film using a 3600 DPI printer. Molds were then created on silicon wafers by
spin-coating SU8 2000 negative photoresist (10 s at 500 rpm and 30 s at 3000 rpm, Microchem
Inc., Westborough, MA, USA). Wafers were previously cleaned with the standard piranha solution.
The coated wafers were then soft-baked on a hot plate for 20 min at 65 ◦C, followed by 25 min at 95
◦C, before exposing the photoresist through the photomask. Near UV (365 nm) was applied with an
exposure dose of 650 mJ/cm2 (EVG 620, EV Group). Post exposure bake conditions were 5 min at
65 ◦C, followed by 10 min at 95 ◦C. Molds were finished by 10 min of immersion on the developer
(MicroChem’s SU-8 Developer) with strong agitation, rinsed with isopropyl alcohol, and dried with
nitrogen stream.
2.6. Fabrication of Micropatterned Nanofibrous GelMA Scaffolds
The electrospinning of micropatterned GelMA scaffolds was carried out by using the same
procedure as described above except that the collector plate consisted in a micropatterned mold
obtained by photolithography. After electrospinning, the meshes were crosslinked by UV irradiation
for 9 min just as it was previously described.
2.7. Morphology Characterization
Surface morphology of the nanofibrous scaffolds before and after crosslinking was examined by
scanning electron microscopy (SEM). Samples were placed on double-sided graphite tape, attached
onto a metal surface, and sputter-coated with gold for 10 s. SEM micrographs were acquired
with different magnifications using a SEM (Jeol USA Inc., model JSM-6460LV, Peabody, MA, USA).
The average fiber diameter and fiber diameter distribution were estimated from SEM images, using
ImagePro-Plus 6.0® software.
2.8. Infrared Analysis
Chemical composition of the gelatin scaffolds was assessed by Fourier transform infrared
spectroscopy with attenuated total reflectance (FTIR-ATR) using a Nicolet 6700 Thermo Scientific
(Waltham, MA, USA) spectrometer equipped with a diamond crystal at a nominal incidence angle of
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45◦ and ZnSe lens. Spectra were recorded in the range of 600–4000 cm−1 at 32 scans with a resolution
of 4 cm−1.
2.9. Contact Angle Measurements
Water contact angles of the fibrous scaffolds were measured with a Ramé-hart goniometer using
the sessile drop method. The samples were attached to a glass slide and placed in the sample stage.
A droplet of deionized water (10 μL) was automatically dispersed onto the sample surface and its
evolution with time was recorded using a CCD video camera attached to the equipment. From the film
frames, the water contact angles along time were automatically calculated by the equipment software.
2.10. Water Uptake Measurements
Electrospun GelMA scaffolds discs (1 cm in diameter) were cut and weighted (Wo). Then, samples
were immersed in PBS at room temperature. After predetermined immersion times, mats were
retrieved and weighted (Wt). The water retention (WR) at time t was calculated according to the
following equation:
WR(%) = (Wt − Wo)/Wo × 100, (1)
2.11. Tensile Testing
Tensile properties of the electrospun scaffolds were tested by using an Instron 4467 universal
testing machine (Instron, Norwood, MA, USA). Prior to uniaxial tensile testing, the electrospun fibrous
sheets were cut into rectangular shapes (50 mm × 10 mm). Samples were secured between opposing
clamps which were approximately 30 mm apart from each other. For tensile testing, samples were
stretched until failure at 10 mm/min.
2.12. Thermal Analysis
Thermal properties were determined by thermogravimetric analysis (TGA) and differential
scanning calorimetry (DSC). TGA were performed on a Shimadzu TGA-50 analyzer from ambient
temperature to 300 ◦C at 10 ◦C/min under nitrogen atmosphere. DSC thermograms were obtained in
a Perkin-Elmer Pyris 1 calorimeter (PerkinElmer Inc., Waltham, MA, USA). Scans were carried out
from 25 to 300 ◦C at a heating rate of 10 ◦C/min under a nitrogen atmosphere.
2.13. X-ray Diffraction
The XRD patterns were obtained using a X-ray diffractometer (PANalytical Model X’pert PRO,
Royston, UK). Film samples with dimensions of 4.0 cm × 1.5 cm were cut and fixed in a circular clamp
of the instrument. The analysis was carried out directly and the conditions were as follows: (i) voltage
and current: 40 kV and 40 mA, respectively; (ii) scan range from 3◦ to 30◦; (iii) step: 0.1◦ and (iv) speed
1◦/min, equipped with a secondary monochromator of graphite beam. The samples were stored at
25 ◦C and 50% Relative humidity (RH) and analyzed in triplicate.
2.14. Roughness Measurements
Roughness was measured by using a laser profilometer (UBM™, ISC-2). A measurement length
of 5–7 mm was used with a scanning velocity of 400 points per second. The roughness was calculated
using the LMT Surface View UBM™ software.
2.15. Cell Viability
For cell culture studies MG-63 osteoblast-like cells (Sigma-Aldrich, Darmstadt, Germany) as an
adequate model for bone cells were used [25]. Culture medium Dulbecco’s modified Eagle’s medium
(DMEM, Gibco, Darmstadt, Germany) supplemented with 10% (v/v) fetal bovine serum (FBS, Merck,
Darmstadt, Germany) and 1% (v/v) penicillin/streptomycin (PS, Merck, Darmstadt, Germany) was
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chosen. The electrospun GelMA samples were cut into pieces at a diameter of 10 mm and then placed
onto the bottom of the culture plates, followed by sterilization under UV light. MG-63 cells were seeded
onto the samples in 24-well plate at a density of 1 × 104 cells per well, and conserved into an incubator
at 37 ◦C in a humidified atmosphere of 95% air and 5% CO2 for 48 h. After cell culture, the cell viability
was determinate by the enzymatic conversion of tetrazolium salt (WST-8 assay, Sigma-Aldrich) to
formazan. A volume of 1 mL of a solution of 1% WST-8 assay n cell culture medium was added to each
sample, which were incubated for 4 h. The absorbance at 450 nm was measured with a plate reader
(typo Phomo, Anthos Mikrosysteme GmbH, Krefeld, Germany). As a blank value, the cell media
containing 1% WST-8 without contact to a sample, was used and measured after 4 h of incubation.
3. Results
3.1. GelMA Nanofibrous Mats
3.1.1. Synthesis of GelMA
GelMA was synthesized according to previously reported methods, in which methacrylate
functional groups were grafted onto the gelatin backbone through reactions between methacrylic
anhydride and lysine residues [21]. GelMA infrared spectrum showed peaks at 1645, 1526, and
1240 cm−1 related to the C=O stretching (amide I), N–H bending (amide II), and C–N stretching plus
N–H bending (amide III), respectively. Moreover, a N–H stretching (amide A) could be observed at
3284 cm−1. The modification of lysine residues with methacrylate groups was confirmed by a decrease
in the lysine signal at 2.9 ppm, and the appearance of the methacrylate group signal at 5.4 ppm and
5.7 ppm and the methyl group signal at 1.8 ppm. A degree of methacrylation of 71% was calculated
using Habeeb’s test [24].
3.1.2. Fabrication of Electrospun GelMA Matrices
Electrospun GelMA mats were prepared by electrospinning technique. Defect-free nanofibrous
matrices were obtained as shown in Figure 1 (NG-0UV). Then, electrospun mats were successfully
crosslinked by UV irradiation. As it is well-known, photo-chemical crosslinking takes place only in the
presence of a photoinitiator, and thus hydrogel formation is triggered by the external source of UV
light. Irgacure 2959 is usually chosen as photoinitiator due to its low toxicity at the used concentration
as demonstrated in previous studies [23]. To evaluate the UV irradiation process time, GelMA mats
were immersed in ethanol and exposed at different irradiation times. Figure 1 shows SEM micrographs
of GelMA mats with 0, 6, 9 and 12 min of UV irradiation. In a first step of UV irradiation, fibers
increased their diameter as result of their swelling in polar solvents. After UV irradiation, mats still
exhibited their fibrous structures and their diameters were reduced with respect to the diameter of
NG-0UV. Probably, this decrease in fiber size is related to the crosslinking of GelMA. The increase of
diameter in NG-12UV could be ascribed to the increase in temperature produces by UV device.
The mean fiber diameter is summarized in Table 1.
Table 1. Fiber diameter, contact angle, water uptake (WR), and DSC results, melting temperature (Tm),









NG-0UV 1.05 ± 0.17 0 n/d 57.6 74.1
NG-6UV 0.70 ± 0.10 43.2 390 ± 21 52.3 66.5
NG-9UV 0.60 ± 0.12 66.1 405 ± 10 52.9 71.2
NG-12UV 0.80 ± 0.12 56.0 290 ± 15 53.9 68.6
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Figure 1. SEM micrographs of samples at different irradiation times: 0 (NG-OUV), 6 (NG-6UV), 9
(NG-9UV) and 12 min (NG-12UV).
The FTIR spectra of GelMA mats showed typical peaks of gelatin (Figure 2a) as described for
GelMA. On the other hand, TGA thermograms in Figure 2b show the thermal degradation behavior
of GelMA mats. All samples showed a small loss of mass in the range of 50 ◦C to 120 ◦C, probably
caused by the loss of water molecules. At temperatures above 150 ◦C, the degradation of biopolymer
started for all samples. In addition, their onset points of degradation increased slightly with the time
exposed to UV irradiation. Probably, it is due to an increase in the crosslinking degree.
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Figure 2. Characterization of samples by (a) ATR-FTIR, (b) TGA, (c) DSC, (d) XRD.
Differential scanning calorimetry (DSC) curves of electrospun GelMA mats are shown in Figure 2c.
All samples displayed two endothermic peaks at around 50 and 70 ◦C. The first peak could be attributed
to glass transition of amino acid blocks in the peptide chain relating to the amorphous regions of
gelatin. Uncrosslinked gelatin showed a higher Tg than the observed in crosslinked gelatin due to
peptide chains, could interact physically by intermolecular bonds. In addition, Tg of GelMA increased
with the crosslinking percentage because of the reduced polymeric chain mobility. As suggested in the
literature, the endothermic peak at around 70 ◦C is attributed to denaturation protein [26]. The high
Tm of uncrosslinked gelatin could be associated to physical crosslinking of peptide chains. All samples
showed endotherm falling at around 97 ◦C; this is attributed to water loss and degradation of protein.
In order to correlate thermal behavior with structural organization, XRD patterns of samples were
obtained (Figure 2d). In spite, gelatin has a crystalline structure originated from α-helix and triple
helical; the amorphous structures were observed for all the samples. Probably, the electrospinning
processing hinders the re-crystallization of gelatin and the XRD pattern showed an amorphous halo.
This peak could be associated with the short range order of protein chains. In addition, the intensity
of amorphous peak decreased with the increase in crosslinking degree. Probably, the crosslinking
hindered the peptide chains re-ordering.
The hydrophilicity of the electrospun meshes was evaluated by measuring their water contact
angles (Figure 3a, Table 1). The contact angle of uncrosslinked gelatin mat could not be measured
because it was absorbed instantaneously when the PBS solution was in contact. However, crosslinked
gelatin nanofibers are stable at these conditions. As expected, the CA values of crosslinked gelatin
confirm the hydrophilic character of matrices. UV irradiation time could affect not only crosslinking
extension, but could also modify the structure, as can be seen in SEM images. Thus, CA values are
determined by both chemical and morphological properties.
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Figure 3. Results of (a) CA, (b) WR, (c) Tensile properties, (d) cell viability of GelMA matrices.
Although water uptake measurements were carried out for all samples, only crosslinked gelatin
electrospun mats were stable in the PBS solution (Figure 3b, Table 1). Swelling percentages of the
matrices were around 300%, demonstrating the high hydrophilic character and wettability of matrices.
There were no significant differences between water uptake values of NG-6UV and NG-9UV samples.
However, NG-12UV showed the lowest swelling degree. This fact can be probably ascribed to the
major crosslinking extension of this sample, which clearly affects the water uptake capability.
In order to confirm the crosslinking, the mechanical properties of NG-9UV and NG-0UV nanofiber
mats were tested (Figure 3c). A uniaxial tensile testing was performed and the Young’s modulus (YM)
was determined for both matrices. YM value of NG-9UV sample was seven times higher than the
measured for NG-0UV (0.717 ± 0.001 MPa and 4.89 ± 0.03 MPa, respectively). Thus, the crosslinking
methodology used in this work for GelMA curing was successful. Moreover, a relationship between
the morphological/chemical properties and UV irradiation time was observed. Thus, a UV irradiation
time of 9 min was chosen for further studies, according to the obtained results.
3.2. Micropatterned Nanofibrous GelMA Scaffolds
3.2.1. Fabrication of Micropatterned Molds
3D structures were created by optical lithography of epoxy-based photoresist on silicon wafers,
obtaining 115 μm thick molds. Designs included patterns of 50 μm, 100 μm, 200 μm, and 400 μm.
Figure 4 shows a microscope image (BX 51, Olympus) of a chip with 200 μm structures.
Figure 4. Microscope images of micropatterned mold.
34
Nanomaterials 2019, 9, 120
3.2.2. Fabrication of Micropatterned Nanofibrous GelMA Scaffolds
Once molds were fabricated, micropatterned nanofibrous scaffolds were obtained.
The electrospun mats were collected over micropatterned molds and then they were peeled
out carefully. GelMA nanofibrous mats were obtained using five different types of surface
topographies: concentric-circles, dot, parallel-lines, random-lines (maze), and squares. After
crosslinking, samples were examined by SEM. The electrospun mats successfully reproduced the
micropatterned design of the molds, keeping the nanofibrous structure when the size of structures are
200 μm or more. Two of the micropatterned designs are shown in Figure 5.
Surface roughness is among the key parameters for biomaterials, which affect the cell attachment
and proliferation. Roughness measurements were carried out on the patterned GelMA electrospun
mats (Table 2). Fibers produced with 400 μm of thickness (NG-P400) were rougher than the sample
produced with 200 μm of thickness (NG-P200). The depth of the patterns on the mats can be estimated
from the roughness values recorded at Z-axis. The depth of the step on the mat NG-P400 was around
4 μm, whereas the depth of the step on the NG-P200 was estimated to be 2.5 μm. For all GelMA
fiber mats with different topographies, the measured values of roughness showed an increase of
surface patterning.
Table 2. Roughness values 1 of patterned GelMA electrospun mats.
Sample Ra (μm) Rz (μm) Rmax (μm)
NG-P400 1.5 ± 0.5 4.0 ± 0.2 14 ± 1
NG-P200 0.7 ± 0.05 2.5 ± 0.4 6 ± 1
1 Ra: arithmetical mean deviation of the assessed profile, Rz: arithmetical mean deviation of the assessed profile,
and Rmax: maximum peak-to-valley height.
Figure 5. Optic images of 200 μm row and maze patterned molds (a and d, respectively) and SEM
images of 200 μm patterned GelMA electrospun mats (b and c: row patterns; e and f: maze patterns).
3.3. Cell Viability
GelMA electrospun mats were tested in vitro to determine the biocompatible character of the
process (Figure 3d). Cell viability percentages of all samples were above 90%. The high number of
living cells indicates that the crosslinking process and the modified gelatin were compatible with the
used cell-line MG-63. Thus, gelatin based electrospun mat with micro- and nanotopographical features
have a great potential for tissue engineering.
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4. Discussion
The use of gelatin as a biopolymer scaffolding material for tissue engineering applications is
directly related to its high biocompatibility, hydrophilicity, and bioactivity associated with specific
peptide sequences. Electrospinning is a very attractive, complex, and versatile technique to prepare
advanced functional nanofibrous scaffolds for a variety of tissue engineering and cell culture
applications. Current efforts are focused on preparing electrospun scaffolds with controlled multilevel
hierarchical structures. GelMA electrospun scaffolds have been reported using synthetic polymers
and/or hazard, expensive solvents [27–29]. However, a pure gelatin scaffold that mimics the important
features of natural ECM obtained by electrospinning is still pending. In this work, GelMA nanofibers
without defects were obtained using acetic acid, a low toxic potential solvent. Furthermore, in order
to overcome the limitations of the low stability of gelatin in aqueous media as well as the possible
toxicity of chemical crosslinkers, the as-spun scaffolds were crosslinked by UV irradiation at different
exposition times. The same strategy, but while varying the photoinitiator concentration, was reported
by Lai et al. for cultivation of limbal epithelial cells [30].
The GelMA matrix was soluble in PBS before UV irradiation (NG-0UV) while crosslinked GelMA
nanofibers were stable in PBS (NG-6UV, NG-9UV and NG-12UV). The mechanical properties of UV
irradiated mats (NG-9UV) increased 7 times related to mats unexposed to UV (NG-0UV), indicating
the efficiency of crosslinking.
In the last few decades, surface engineering technologies have been used as important tools to
clarify the effects of the microenvironment on cellular behavior [3,11–14]. The fabrication of the surface
topographies with geometrical micro and nanopatterns, like channels, pillars and pits with controlled
dimensions have been possible through the use of various methods as photolithography, electron beam
lithography and microfluidics. These geometric and topographical factors can have an influence in
cell adhesion, migration, differentiation, and the shape of cells. To modulate cell behavior through
surface engineering methods is not only useful to stimuli stem cell differentiation, but also to generate
a favorable response of the implant. In order to control substrate topography, the micropatterns
molding with different geometries and dimensions, were developed to fabricate scaffolds. Molds were
obtained by photolithography and they were used as collector in electrospinning process. Therefore,
GelMA electrospun mats were obtained with nano structure and microroughness. The SEM images
and roughness analysis showed that micropatterns were successfully copied over GelMA electrospun
mats. To the best of our knowledge, this is the first report in literature in which GelMA nanofibrous
scaffolds with micropattern topographical features were designed and prepared.
By combining molding and electrospinning processing, it was possible to obtain scaffolds which
mimic ECM. Thus, this simple and easy technique can be useful for developing sophisticated and
complex materials for tissue engineering and cell culture. In future works, we will study deeply how
different patterns influence the behavior of specific cell lines.
5. Conclusions
In summary, an inexpensive and rapid method for the fabrication of well-defined micro- and
nanotopographic features on uniform bead-free electrospun GelMA fibers were developed in order to
design 3D scaffolds that mimic ECM. The synthesis of GelMA and its processing by electrospinning
was optimized, so therefore, defect-free GelMA nanofibrous mats were obtained. The results showed
that crosslinking took place successfully and it could modulate the final properties. Furthermore,
the use of micropatterned molds obtained by photolithography as a collector in the electrospinning
process allowed controlling the roughness of mats. Taking into account the cell viability results,
the methodology used in this study is a valuable tool to develop patterned GelMA based nanofibrous
scaffolds for cell culture and tissue engineering.
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Abstract: Recently, three-dimensional (3D) cell culture and tissue-on-a-chip application have attracted
attention because of increasing demand from the industries and their potential to replace conventional
two-dimensional culture and animal tests. As a result, numerous studies on 3D in-vitro cell culture
and microfluidic chip have been conducted. In this study, a microfluidic chip embracing a nanofiber
scaffold is presented. A electrospun nanofiber scaffold can provide 3D cell culture conditions to a
microfluidic chip environment, and its perfusion method in the chip can allow real-time monitoring
of cell status based on the conditioned culture medium. To justify the applicability of the developed
chip to 3D cell culture and real-time monitoring, HepG2 cells were cultured in the chip for 14 days.
Results demonstrated that the cells were successfully cultured with 3D culture-specific-morphology
in the chip, and their albumin and alpha-fetoprotein production was monitored in real-time for
14 days.
Keywords: nanofibers; microfluidic chip; electrospinning; live assay; hepatocellular carcinoma cells
1. Introduction
Over the last century, two-dimensional (2D) in-vitro cell culture has been used in studying the
responses to stimulation from biological and biochemical materials, such as drugs, toxic materials,
and detoxification. Traditional in-vitro cell tests are based on 2D culture on a flat surface, and the 2D
culture environment is completely different from the human body. Cells inside the human body are
surrounded by extracellular matrix (ECM) and tissue fluid in a complex three-dimensional (3D) space.
Thus, cells are difficult to activate in 2D environments to maintain differentiation and expression of
tissue-specific physiological functions and physiological activity [1,2].
Tissue-on-a-chip is a recapitulation of the biological and mechanochemical environment of human
body tissues using a small device chip [1]. This technique includes cells, chemical and physical
environments, and the microenvironment. It is used in the development of in-vitro disease models,
drug screening, toxicity testing, and disease research, by providing a cellular environment that
better mimics human physiological conditions [3–5]. Typical tissue-on-a-chip consists of an integrated
microscale engineering system, several types of cells, and culture medium. The microelectromechanical
Nanomaterials 2019, 9, 588; doi:10.3390/nano9040588 www.mdpi.com/journal/nanomaterials39
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system (MEMS) allows the use of microfluidic devices to reconstitute distinct features of the
tissue–tissue interface, physiological movements, and biochemical environment similar to the human
body. Marino et al. [6] presented a microfluidic system to mimic the blood–brain barrier (BBB).
The system consisted of porous microtubes fabricated using two-photon lithography and enabled
co-culturing brain microcapillary cells and functioning.
Recently, various 3D environmental features, such as microporous membrane [7,8],
hydrogel [9–11], and nanofibers [12,13], have been introduced to tissue-on-a-chip applications to
provide the similar structures and functions of the human body to cell culture. The hydrogel is highly
permeable and an excellent biocompatible material. Annabi et al. coated microfluidic channels with
synthesized photo-crosslinkable gelatin and tropoelastin-based hydrogel to improve cardiomyocyte
culture in a polydimethylsiloxane (PDMS) surface [9]. Au et al. fabricated hepatic tissue models
by encapsulating HepG2 and NIH-3T3 cells in a hydrogel. Their platform showed better results
than 2D cell culture systems in drug screening [14]. Gumuscu et al. [15] proposed a microfluidic cell
culture platform composed of 3D collagen hydrogel compartments, and they applied their system for
co-culture of human intestinal cells and drug screening in preliminary level. Porous membranes are
considered mimic basal membranes of barrier tissue, such as tissue–tissue, tissue–liquid, and tissue–air
interfaces in organ-on-a-chip [16,17].
Nanofibers have diameters ranging from tens to hundreds of nanometers and similar morphology
to the extracellular matrix of the human body. In particular, nanofibers are well suited for cell nutrient
exchange, communication, and efficient cellular responses because of large surface areas, high porosity,
and spatial interconnectivity [18,19]. As a result, nanofibers have been extensively applied to a variety
of applications such as porous membrane and scaffold in biotechnology [20–22]. In addition, cells are
easily attached and better proliferated in electrospun composite nanofiber than in a conventional 2D
culture environment, such as a petri dish [23].
Here, we present a microfluidic chip with a nanofiber scaffold, which can provide a 3D human
body ECM-like environment to cell culture and monitor cell status and activity using a conditioned
culture medium. The nanofiber scaffold was electrospun so that it composed various diameter
fibers, thereby providing highly porous morphology to cells under the well-defined microfluidic
chip conditions. In particular, a perfusion method, which enables real-time monitoring cell status,
was demonstrated. The developed chip was applied to 3D culture of HepG2 cells, which has various
functions, such as cell growth and secretion of proteins. Our results demonstrated that HepG2 cells
were cultured with 3D culture-specific morphology (i.e., large spheroids) [3,24], and their protein
production was successfully monitored for 14 days.
2. Materials and Methods
2.1. Concept of Microfluidic Chip with Nanofiber Mat
Figure 1 shows the schematic concept of the proposed microfluidic chip embracing nanofibers,
which consists of a nanofiber scaffold, a microfluidic chip structure, perfusion environment,
and cells. The chip was designed to mimic the dynamic microenvironment of the human body,
support perfusion-based long-term culture, and allow real-time monitoring of secretions and
functionalities of the cultured cells in vitro. An electrospun nanofiber scaffold was introduced to a
microfluidic chip to provide a 3D extracellular matrix (ECM)-like environment, because the nanofibers
have similar morphology to the human body’s ECM [25]. The nanofiber scaffold was located on the
chamber bottom. The microfluidic chip has a simple structure composed of micro-channels, a chamber,
and gate holes, and it is made of Polydimethylsiloxane (PDMS). The cell suspension was introduced
into the top opening of the chamber before closing the opening with a cover slip. Fresh culture
medium was supplied to the cell-seeded nanofiber scaffold via the inlet microchannel to provide
supplied oxygen and nutrients to the cells. The cell culture-conditioned medium through the outlet
microchannel was collected to monitor cell activity. Fluidic connections to the microfluidic chip were
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made with tubing inserted through the inlet and outlet holes. Culture medium perfusion/flow in the
chip was established with the help of a perfusion environment consisting of a fresh media reservoir
at the side of the inlet and a syringe pump at the side of the outlet. Therefore, medium flow was
derived by negative pressure. The collected conditioned medium in a syringe was easily transferred
for analysis, such as enzyme-linked immunosorbent assay (ELISA).
Figure 1. Concept of a microfluidic chip with a nanofiber scaffold.
As shown in Figure 1, the chip is composed of four layers: a supportive plate (slide glass),
two microfluidics layers (PDMS), and a window to chamber. The microfluidic layer has a microchannel
on the bottom plane and a rectangular hole as a chamber at the center of the layer. A thin coverslip
was used as the window to chamber in this study. After assembling all the layers, the rectangular holes
formed the center chamber with the supportive plate and window to chamber.
Flow rate of the culture medium through the chip was determined by considering the required
amount of culture medium for cell growth, 2D culture condition, and allowable shear stress on the
cells induced by culture medium flow in microfluidics. Information on the required amount of culture
medium can be obtained from the culture product company, whereas the shear stress limit can be
obtained from a previous study [26]. The amount of media supplement per hour (flow rate) can be
determined from the following equation:
M
NR × T × Nchip ≤ q ≤
τmaxbh2
6μ
where M is the amount (volume) of culture medium supply for the number (MR) of cells at a given
culture area. T is the medium exchange period. M, NR, and T are the recommended values under
2D culture condition. Nchip is the number of cells seeded in the chip, τmax is the allowable shear
stress loaded to cells to avoid cellular damage, μ is the viscosity of medium (g/cm·s), q is the flow
rate through the chip (cm3/s), and b and h are the width (cm) and height (cm) of the microchannel,
respectively. The maximum limit of the flow rate, which was calculated from the allowable shear
stress, was 1.54 mL/h. The minimum flow rate, which was calculated from the 2D culture protocol [27]
considering the number of seeded cells in a scaffold and scaffold area, was 0.001 mL/h. We set the
flow rate at 0.1 mL/h between the maximum and minimum limits.
2.2. Fabrication of Microfluidic Chip Structure
The microfluidic chip structure was made of PDMS using well-established soft lithography and
micromolding [28,29] at a preliminary level. The master molds were prepared by cutting adhesive
tape (3M) according to the channel shape, and removing the tape from all areas except the channel
shape on a slide glass (ThermoFisher Scientific, Waltham, MA, USA)). PDMS (Dow Corning, Midland,
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MI, USA) was cast on the master molds using the pre-polymer (base) to curing agent weight ratio of
10:1, and the molds were cured in a dry oven at 60 ◦C for 3 h.
In the microfluidic layer, the microchannels had a cross-section of about 300 × 100 μm and a length
of about 10 mm, whereas the chamber hole had a rectangular shape with a size of about 12 × 12 mm
and a height of about 3 mm. The microchannels were patterned using soft lithography (Figure 2). After
curing, a rectangular chamber hole was made by cutting a rectangle in the cured PDMS slab. A hole to
the inlet microchannel was made by using a biopsy puncher.
Figure 2. Fabrication of patterned microchannels using soft lithography.
All the PDMS structures and slide glass were autoclaved for sterilization and bonded together
after corona treatment (Electro-Technic Products Inc., Chicago, IL, USA) to secure tight bonding
(Figure 1). Before inserting the nanofiber scaffold into the chamber, the scaffold was sterilized in
70% ethanol and thoroughly washed three times with PBS. A nanofiber scaffold was inserted into the
chamber inside the bonded PDMS. The assembled chip samples were stored on a clean bench for a
while. After seeding the cell suspension onto the nanofiber scaffold, the chamber was covered with
glass coverslips. The microfluidic device was immobilized with two polycarbonate (PC) plates and
screws to ensure no leakage.
2.3. Fabrication of Nanofiber Scaffold
In this study, 8 wt% polycaprolactone (PCL) solution was prepared by dissolving PCL with
an average molecular weight (Mw) of 70,000–90,000 (PCL, Sigma-Aldrich, St.Louis, MO, USA) in
99.5% chloroform (Samchun Pure Chemical Co., Seoul, Republic of Korea). The mixture was then
homogenized with a magnetic stirrer for 12 h at room temperature.
The electrospinning setup consisted of a high-voltage power supply, syringe pump, nozzle
spinneret with an inner diameter of 210 μm, and a grounded solid drum collector, which rotated at a
speed of about 30 rpm. The nozzle spinneret tip-to-collector distance was maintained at 100.0 mm.
The electrical potential between the nozzle spinneret and the drum collector was 10.0 kV. The flow
rate of the PCL solution was controlled by a syringe pump at 0.1 mL/h. The thickness uniformity
of the nanofibers was improved by providing the nozzle spinneret with a traveling motion speed of
1 mm/s along the drum axis direction. The nanofibers were electrospun until they reached a thickness
of 100 μm (actually, 113.7 ± 2.7 μm), which was measured using an ultra-precision micrometer
(Mitutoyo) with a constant compression of 0.5 N. During electrospinning, the temperature and relative
humidity were maintained at 19–20 ◦C and 50−55%, respectively. The electrospun nanofibers were
provided with 5 min of heat treatment at 60 ◦C using a dry oven to improve nanofiber interconnectivity.
The nanofibers were then cut into the same size of the chamber (12 × 12 mm) with a scalpel and
carefully placed into the microfluidic chamber using a tweezer. The morphology of the electrospun
nanofibers was observed by scanning electron microscopy (SEM; Hitachi, Tokyo, Japan). The porosity
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of the nanofibers was measured using a mercury porosimeter (Micromeritics Instrument Co., Norcross,
GA, USA). The filling pressure of mercury was 1.23 psi, and the equilibrium time was 10 s.
2.4. Cell Culture and Flow Experiments
Human liver hepatocellular carcinoma cells (HepG2) were obtained from Korean Cell Line
Bank. HepG2 cells in suspension containing 1 × 104 cell/chamber were seeded on the nanofiber
scaffold in the microfluidic chip under static conditions, and allowed to form a stable attachment
for 24 h. After the cells were allowed to settle, the medium was continuously perfused to the
chip at a flow rate of 0.1 mL/h using a commercial syringe pump (New Era Pump Systems,
Farmingdale, NY, USA). The perfused culture medium was Dulbecco’s modified Eagle’s medium
(Life Technologies, ThermoFisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine
serum (Life Technologies, ThermoFisher Scientific, Waltham, MA, USA) and 1% penicillin streptomycin.
The cultures were stored for 14 days in a humidified atmosphere of 5% CO2 in air at 37 ◦C. We could
not find any deterioration in the device operation nor change in the nanofiber morphology during
the culture. Moreover, the nanofibers stuck tightly in the chamber and embedded well on the
chamber bottom.
2.5. Functional Assays
To verify hepatocyte viability of the developed microfluidic chip, the cells on the scaffold after
settling down were stained with Calcein-AM to indicate live cells and ethidium homodimer-1 to
indicate dead cells, according to the manufacturer’s instructions (Life Technologies, ThermoFisher
Scientific, Waltham, MA, USA). The live and dead cells were observed using a confocal microscope
(Carl Zeiss, Oberkochen, Germany). We investigated cell proliferation behavior under static and
perfusion conditions to justify the effect of medium perfusion with microfluidic chip. Unlike cell
culture under perfusion condition, the medium in the chamber was exchanged with fresh medium
daily by using a pipet to compare cell proliferation under both conditions. Cell proliferation was
assessed by measuring the DNA content of the cultured cells in each chip. The DNA content was
measured on days 1 and 14. DNA from cultured cells was extracted using a commercial kit (Qiagen,
Hilden, Germany). The DNA contents for both static and perfusion conditions were quantified by
spectrophotometers (Thermo Fisher Scientific, Waltham, MA, USA).
Here, we quantified the secretion of albumin and alpha-fetoprotein (AFP) using enzyme-linked
immunosorbent assay (ELISA) to demonstrate the applicability of the developed microfluidic chip
to the 3D cell culture and real-time monitoring with HepG2 cells. Therefore, the conditioned culture
medium was continuously collected at a rate of 0.1 mL/h and harvested daily by changing the syringe
in the syringe pump. The amount of albumin secreted from the HepG2 cells was quantified every
2 days until day 14 using a human albumin ELISA kit (Bethyl Laboratories, Montgomery, TX, USA).
AFP secretion was measured using an AFP ELISA kit (CUSABIO, Wuhan, China) every 3 days, from
day 9 to day 14, according to the manufacturer’s instructions. The required volume per sample of
the conditioned medium for the assays was 100 μL, and the volume of the daily collected medium
(2.4 mL) was sufficient to analyze various secreted proteins, up to 12 types, after duplication.
The morphology of the cells cultured in the microfluidic chip was investigated by SEM and
fluorescent imaging. Cells cultured in the chips for 1 and 14 days were harvested with phosphate
buffered saline (PBS) and then fixed with 4% paraformaldehyde solution. The samples for SEM were
dried in a freeze-dryer (Labconco, Kansas City, MO, USA). Sample morphology was observed using
SEM (Hitachi Hitachi, Tokyo, Japan). The cell morphology in the chip was assessed by staining F-actin
with the phalloidin-fluorescein isothiocyanate (Phalloidin-FITC, Sigma-Aldrich, St. Louis, MO, USA)
and nuclei with DAPI (4′,6-diamidino-2-phenylindole, Life Technologies, ThermoFisher Scientific,
Waltham, MA, USA). The cells were then visualized using a confocal laser scanning microscope
(Carl Zeiss, Oberkochen, Germany).
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2.6. Statistical Analysis
All experiments were carried out with 5 samples (N = 5) except DNA content assay with four
samples. All the samples were duplicated in assays. The experimental data are presented as means
± standard deviation (SD). ANOVA was conducted when we compared more than two groups for
statistical comparison. The differences between the mean values of each group were evaluated by
Student’s t-test, in which a p value less than 0.001 was considered significant.
3. Results and Discussion
3.1. Microfluidic Chip Embracing a Nanofiber Scaffold
Figure 3a shows the SEM image of the electrospun nanofiber scaffold for the proposed chip. First,
the electrospun fibers were randomly oriented. Moreover, the nanofiber scaffold in this study had
various diameter fibers due to the combination effect of the chloroform solvent, with faster evaporation,
and the process conditions [30,31]. Some fibers had diameters ranging from several to 10 μm, whereas
others appeared fine with diameters in the nanometer scale. Results of detailed analysis of fiber
diameter distribution are in Figure 3b. The peak frequency diameter of fine fibers (i.e., nanofibers)
was between 600 and 1000 nm, and a significant number of microfibers had a diameter of 2 to 6 μm in
the scaffold. This nanofiber scaffold possibly contained larger pores than the scaffold consisting of
small diameter nanofibers, because the microfibers can introduce larger pores than nanofibers [32].
Figure 3c shows the differential intrusion curve with respect to pore size of the nanofiber scaffold.
From the figure, the pore diameter (equivalently, size) ranged between 0.3 and 100 μm and the peak
frequency pore diameter was about 3 μm. The porosity of the nanofiber scaffold was about 76%.
Therefore, the fabricated nanofiber scaffold may allow the cells to infiltrate into the deep regions
of the scaffold. Figure 4a shows an assembled microfluidic chip embracing a nanofiber scaffold.
The developed chip looks simple and is appropriate for use in a real PDMS fabrication environment.
The microchannel of the chip had a width of 307.6 ± 4.5 μm and depth of 97.2 ± 4.9 μm, as shown in
Figure 4b. The microchannel had a flat and smooth bottom plane, while its side walls had a rough
surface because of the cut edge of tapes. However, the rough wall surface of the microchannel did not
affect the device operation quality because the microchannel engaged only in the delivery of culture





Figure 3. Electrospun nanofiber scaffold: (a) SEM images; (b) diameter distribution of the electrospun
fibers; (c) porosity analysis result.
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Figure 4. Microfluidic chip with a nanofiber scaffold (a) and SEM images of the microchannel of the
chip (b).
3.2. Application to 3D Cell Culture and Real-Time Monitoring
The cell viability of a newly built culture system should be determined. Here, we investigated
HepG2 cell viability of the microfluidic chip, embracing a nanofiber scaffold via live and dead cell
assay. Figure 5 shows the assay results, in which the live cells were stained green, and the red ones
corresponded to dead cells. The cell counting assay revealed that the developed microfluidic chip had
sufficiently high viability for HepG2 cells (>95%).
 
Figure 5. Live and dead cell assay results of the developed microfluidic chip for HepG2 cells (day 1).
Figure 6 shows the comparison results of the proliferation of HepG2 cells cultured under static
and perfused conditions for 1 and 14 days. As shown in Figure 6, the cells cultured for 14 days in the
chip successfully proliferated regardless of the medium supply method used, although the standard
deviations looked relatively large. The large standard deviation possibly resulted from the variation in
cell seeding quality because of the innate uneven fibrous morphology. Even though the cells cultured
under static condition revealed excellent proliferation for 14 days (6.6-fold), the perfused condition
promoted cell proliferation more. The cells cultured under perfused condition proliferated by more
than 12-fold during the same period. Thus, perfusion culture condition in the developed chip gave
rise to about two times higher cell proliferation than the static culture condition (p < 0.001).
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Figure 6. DNA content analysis of the cells cultured under static and perfusion conditions for 1 and
14 days in the chip.
The results demonstrated that the perfusion culture in the developed chip could provide
cell-friendly conditions to the cells. To justify the applicability of the developed chip, 3D cell culture
and real-time monitoring of the cells’ status using the developed chip were carried out. Figure 7
shows the HepG2 cells cultured for 1 and 14 days in the chip with perfusion. As shown in Figure 7a,b,
the cells with the cell length of 16.47 ± 4.84 μm successfully attached and hung on the nanofibers
in the form of small spheroids, with diameters ranging from 20 to 50 μm on day 1. Moreover,
the cytoskeleton organization, visualized by actin staining, revealed that actin filaments stretched
along the nanofibers (Figure 7c). After 14 days, HepG2 cells re-established cell–cell contact and formed
about 300 μm-diameter aggregates (or large spheroid) engulfed on nanofibers (Figure 7d–f), which
has been reported to be the more desirable formation of HepG2 cells because of higher hepatocyte
synthetic functions, higher response for drug toxicity, and better mimicking of in-vivo oxygen gradient
in the hepatic lobule [3,24,33]. These results were far from that under 2D culture conditions based on a
flat surface. In 2D conditions, HepG2 cells grow as monolayers with flat morphology, which results in
short-lived canalicular-like structures [24]. Therefore, the developed microfluidic chip with nanofiber
scaffold could successfully provide a 3D cell culture environment.
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(a) (b) (c) 
(d) (e) (f) 
Figure 7. Confocal microscopy and SEM images of the cells cultured on the nanofiber chamber with
microfluidic system for 1 (a,b,e) and 14 days (c,d,f). Especially, (b,e) are enlarged images of (a,d).
The scale bars in the confocal microscopy images are 100 μm (a,d) and 20 μm (b,e).
The typical specific functionality of HepG2 cells was evaluated through real-time monitoring of
the concentration of secreted albumin and AFP in the conditioned medium for 14 days. Albumin, which
is secreted from HepG2 cells from human hepatocytes, is a marker of metabolic activity of hepatocytes
in vitro, and it can indicate liver-specific functions [24]. Thus, the amount of albumin secreted from
the cell cultured for 14 days in the chip was examined every two days (Figure 8a). The albumin
production rate consistently increased from 3.07 ± 0.61 ng/mL at day 1 to 42.09 ± 1.91 ng/mL at day
14. Moreover, we monitored AFP secretion from the cells because AFP is known as a tumor-associated
protein and important indicator of the differentiation of hepatoma cells and disease progression [34].
As shown in Figure 8b, the increase in secreted AFP level was similar to that in albumin secretion
for the same duration. The AFP concentration in the conditioned medium collected at day 2 was
15.45 ± 5.13 ng/mL, and this value increased to 118.54 ± 3.19 ng/mL at day 14. As shown in these
monitoring results, the developed microfluidic chip embracing nanofiber scaffold enabled the real-time
monitoring of cell status based on the conditioned culture medium.
 
(a) (b) 
Figure 8. Real-time monitoring of secretion of (a) albumin and (b) AFP for 14 days.
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4. Conclusions
In this study, we presented a microfluidic chip with a nanofiber scaffold. Microfluidics can
introduce dynamic conditions, and a nanofiber scaffold provides a 3D environment to an in-vitro
cell culture. Moreover, the perfusion method in the chip allows the real-time monitoring of cell
status with the conditioned culture medium. The microfluidic chip structure was fabricated using
well-established soft-lithography at a preliminary level, and a nanofiber scaffold was prepared using
electrospinning. In particular, the nanofiber scaffold had various diameter fibers. It was highly
porous and heterogeneous in morphology, making it appropriate to provide a human body’s ECM-like
3D environment. To justify the developed chip, HepG2 cells with various protein syntheses and
3D culture-specific morphology were cultured in the chip for 14 days [35]. Results demonstrated
that the developed chip had excellent viability (higher than 95%) for HepG2 cells through live and
dead cell assay. Additionally, the perfusion-based dynamic culture had a positive effect on the
proliferation of HepG2 cells, which was about two-times higher than that under static culture condition.
Finally, we presented the application of the chip to 3D cell culture and real-time monitoring based on
conditioned culture medium. The cells cultured in the chip successfully formed engulfed aggregates
(or large spheroid), which are a 3D culture-specific morphology of the cells. Moreover, albumin levels
and AFP secretion from the cells were successfully monitored for 14 days. We expect the concept of
the developed chip to be useful for studying 3D cell cultures, live assay or real-time monitoring of cell
activity, and in-vitro drug screening and toxicity testing.
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Abstract: Electric potential plays an indispensable role in tissue engineering and wound healing.
Piezoelectric nanogenerators based on direct piezoelectric effects can be self-powered energy
sources for electrical stimulation and have attracted extensive attention. However, the accuracy
of piezoelectric stimuli on piezoelectric polymers membranes in vitro during the dynamic condition
is rarely studied. Here, a self-powered tunable electrical stimulation system for assisting the
proliferation of preosteoblasts was achieved by well-aligned P(VDF-TrFE) piezoelectric nanofiber
membrane (NFM) both as a nanogenerator (NG) and as a scaffold. The effects of electrospinning
and different post-treatments (annealing and poling) on the surface wettability, piezoelectric β phase,
ferroelectric properties, and sensing performance of NFMs were evaluated here. The polarized
P(VDF-TrFE) NFM offered an enhanced piezoelectric value (d31 of 22.88 pC/N) versus pristine
P(VDF-TrFE) NFM (d31 of 0.03 pC/N) and exhibited good sensing performance. The maximum
voltage and current output of the P(VDF-TrFE) piezoelectric nanofiber NGs reached −1.7 V and
41.5 nA, respectively. An accurate electrical response was obtained in real time under dynamic
mechanical stimulation by immobilizing the NGs on the flexible bottom of the culture plate, thereby
restoring the real scene of providing electrical stimulation to the cells in vitro. In addition, we
simulated the interaction between the piezoelectric nanofiber NG and cells through an equivalent
circuit model. To verify the feasibility of P(VDF-TrFE) nanofiber NGs as an exact electrical stimulation,
the effects of different outputs of P(VDF-TrFE) nanofiber NGs on cell proliferation in vitro were
compared. The study realized a significant enhancement of preosteoblasts proliferation. This work
demonstrated the customizability of P(VDF-TrFE) piezoelectric nanofiber NG for self-powered
electrical stimulation system application and suggested its significant potential application for tissue
repair and regeneration.
Keywords: well-aligned nanofibers; P(VDF-TrFE); piezoelectric nanogenerator; preosteoblasts
electrospinning
1. Introduction
Electrical stimulation is widely used to compensate for the altered electrical communication
in diseased tissue and thus improve tissue regeneration [1–3]. External electric fields can improve
physiological strength and can guide cell-orientated growth and influence cell proliferation and
differentiation including for nerves, cardiac cells, and osteoblasts [4–10]. However, traditional electrical
stimulator requires invasive microelectrodes, an external power supply, and electrical wires. This is
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Nanomaterials 2019, 9, 349
very uncomfortable, inconvenient, and unreliable. Thus noninvasive, wireless, portable, self-powered,
and wearable electronic devices are urgently needed for electrical stimulation system. Recent work in
nanogenerators (NGs) has exhibited significant progress in noninvasive and self-powered electrical
stimulation [8,11]. In the framework, piezoelectric nanogenerators (PENGs) based on piezoelectric
polymers that can generate electric surface charges under external mechanical vibration and thus
achieve cordless electrical stimulation, have attracted a lot of attentions [12–15]. The electrical output
produced by the PENG acts as an electrical stimulation signal whose value is related to the piezoelectric
property of the material [16,17]. One such material is poly(vinylidene fluoride-trifluoroethylene)
(P(VDF-TrFE)) with outstanding piezoelectric properties due to steric hindrance from the extra fluorine
atoms in the TrFE inducing an all-trans stereochemical configuration [18,19]. It is well-known that
the β phase is the most highly polar crystalline phase of PVDF and its copolymers [20]. Accordingly,
P(VDF-TrFE) with a high content of piezoelectric β-crystalline offers excellent piezoelectric properties.
The electrospinning process can produce piezoelectric fibers by stretching as well as in situ
poling during the fabrication process, paving the way for piezoelectric nanofiber NGs [21–24].
These electrospun aligned fibers have a higher content of β-crystalline phase versus random
fibers [25]. In addition, various post-treatments, such as annealing and poling treatments, can produce
piezoelectricity via dipole orientations; however, the influence of poling treatments on the β-crystalline
phase content is rarely studied [26]. Therefore, to further improve the piezoelectricity of electrospun
fibers and thus enhance the performance of PENG, it is critical to understand the specific significance
of post-treatments on the piezoelectric performance [27,28].
In addition to its good piezoelectric properties, P(VDF-TrFE) also offers easy processing and
nanomaterial formability. Therein, electrospinning has been widely employed to fabricate the
micro-/nanofibers in ordered, random, and specific patterns. The electrospun fibrous films have
a high surface-area-to-volume ratio similar to the structure and characteristics of extracellular matrix
(ECM) [29]. In this framework, research has demonstrated that the alignment of nanofibers can
structurally mimic the parallel orientation of the tissues and modulate cell adhesion, migration,
proliferation, and differentiation [30–33].
Kai et al. prepared electrospun aligned and randomly oriented poly(e-caprolactone)/gelatin
(PG) scaffolds. They found that the aligned PG scaffold could enhance the cells attachment and
alignment [34]. Hitscherich et al. reported that mouse embryonic stem cell-derived cardiomyocytes
(mES-CM), cultured on the aligned P(VDF-TrFE), were aligned along the fibers and expressed classic
cardiac-specific markers [35]. Therefore, based on its piezoelectric property and processability,
P(VDF-TrFE) has been widely used for biomedical scaffolds for tissue engineering and electrical
stimulation. Genchi et al. fabricated P(VDF-TrFE)/BaTiO3 composite films as a substrate for
piezoelectric stimulation to enhance the differentiation of neuroblastoma cells [36]. Later Deng’s
group used the BaTiO3/P(VDF-TrFE) nanocomposite membrane and leveraged the piezoelectric
properties to promote bone regeneration [37]. However, the exact value of electrical stimulation
induced by the piezoelectric substrate is not clear when external mechanical vibration is also applied
to the cells in vitro. Thus, to better understand the effect of piezoelectric regulation on cell behavior,
there is a need to measure this electrical stimulation.
In this work, we explored the effects of the exact electrical signals generated by the P(VDF-TrFE)
piezoelectric nanofibers NGs on the proliferation fate of preosteoblasts. Here, the fabrication of
self-powered piezoelectric nanofiber NG used as cell scaffold was based on electrospun well-aligned
P(VDF-TrFE) nanofiber membranes (NFMs). The effects of annealing and poling post-treatments on
the surface wettability, piezoelectric β phase, piezoelectricity, and sensing performance of P(VDF-TrFE)
NFMs were investigated. In order to study the dependence of the electrical outputs of NGs on the
degree of polarization, two kinds of NGs processed by different poling electrical fields were prepared.
In particular, they were fixed to the flexible bottom of the culture plate, and the accurate electrical
response was measured in real time under dynamic mechanical stimulation, thereby restoring the real
scene of the electrical stimulation of the cells in vitro. In addition, we simulated the interaction between
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piezoelectric nanofiber NG and cells through an equivalent circuit model. In order to study the role of
NFMs as a scaffold, the effects of well-aligned and random interfaces of NFMs on the morphology of
preosteoblasts were investigated. The well-aligned nanofibrous platforms could guide and elongate the
cells. Finally, we compared the effects of different outputs stimulation of P(VDF-TrFE) nanofiber NGs
on cell proliferation in vitro by applying a dynamic piezoelectric stimulus. This work demonstrates a
significant potential of P(VDF-TrFE) piezoelectric nanofiber NG as self-powered electrical stimulation
system for assisting tissue repair and regeneration.
2. Materials and Methods
2.1. Electrospinning of Nanofiber Membranes (NFMs)
The P(VDF-TrFE) (75/25 mol%, Piezotech Inc., Pierre-Bénite, France) nanofibers were
prepared as described previously [38]. Briefly, P(VDF-TrFE) powders were dissolved in the
N,N-dimethylformamide (DMF) and acetone mixture solution (6:4 v/v) at 20% (w/v). The P(VDF-TrFE)
spinning solution was injected into a 5-ml syringe fitted with a 22 G needle. A syringe pump (KDS101,
KD Scientific, Holliston, MA, USA) was used to supply a constant flow rate of 1 mL/h. A high voltage
of 15 kV was applied between the tip of the syringe needle and the grounded roller collector at a
distance of 10 cm. The thickness of the electrospun NFM was regulated at ~30 μm by controlling the
electrospinning time. The electrospun NFMs were dried at 65 ◦C for 10 h to volatilize the residual
solvent. The annealed NFMs were kept in a vacuum oven at 135 ◦C for 4 h. The poled samples were
pressed via a powder compression machine (BJ-15, BOJUNKEJI Inc., Tianjin, China) after annealing,
in order to ensure no conduction between subsequent sputtering electrodes. Next, the samples were
prepared by sputtering gold electrodes on both the top and bottom surfaces, then placed in a fixture
and immersed completely in silicon oil. Afterwards, the silicon bath was heated to 115 ◦C by a hot plate
(HCT basic, IKA Inc., Staufen, Germany) and then a polarization electric field of 80 to 100 MV/m was
applied. After 30 min of thermal poling treatment, the polarization voltage was kept constant, cooled
down to room temperature and finally the voltage was removed. Next, pristine P(VDF-TrFE) NFMs
without any postprocessing (annealing and poling) were labeled as U-NFM, and the samples treated
by annealing were coded as A-NFM. The poled samples were denoted as P-NFM. The NFMs poled
with the electric field of 80 MV/m and 100 MV/m were labeled as P80-NG and P100-NG, respectively.
2.2. Characterization and Measurements of NFMs
The morphology of electrospun NFMs was observed with a scanning electron microscope (SEM,
SU8020, Hitachi Ltd., Tokyo, Japan) at an accelerating voltage of 5 kV. ImageJ software (National
Institutes of Health, Bethesda, USA) was used to analyze the mean fiber diameter. Tensile testing
was done with a tensile test machine (ESM301, Mark-10, Copiague, NY, USA) at room temperature
with a cross-head velocity of 10 mm/min. The sample was cut to dumbbell shape (10 mm long and
5 mm wide). The contact angles were recorded employing contact angle goniometer (XG-CAMB1,
Xuanzhun co., Ltd, Shanghai, China) by sessile drop method at room temperature. A droplet of
deionized water was dropped from the capillary mouth to stop on the membrane surface and the angle
of the droplet on the upper surface of the membrane was collected and analyzed. X-ray diffraction
(XRD) patterns were done on an X-ray diffractometer (X′pert3 Powder, PANalytical Ltd., Almelo,
The Netherlands) and recorded over an angular range from 10◦ to 50◦. Infrared spectra were recorded
on a Fourier transform infrared spectrometer (FTIR, VERTEX80v, Bruker Corp., Billerica, MA, USA)
from 400 cm−1 to 1600 cm−1. The polarization-electric field (P-E) hysteresis loops were obtained by
precision multiferroic and ferroelectric test systems (Radiant Technologies Inc., Alpharetta, GA, USA )
under a unipolar electric field at a measurement frequency of 10 Hz.
The dynamic piezoelectric coefficient d31 was determined with a homemade measurement system
nearly identical to setup described previously [39]. The output voltage of the samples during the
process of stretching–relaxing was recorded with a DSP lock-in amplifier (SR830, Stanford Research
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Systems, Sunnyvale, CA, USA). The piezoelectricity coefficient d33 was measured using a quasi-static
d33 measuring instrument (Institute of Acoustics, Chinese Academy of Science, ZJ-4AN, Beijing, China).
2.3. Measurements and Stimulation of Piezoelectric Nanofiber Nanogenerators (NGs)
The generated voltage, current, and charge of the NGs generated via dynamic mechanical stimulus
from a speaker (8 Ω, 1 W) were assessed by a Tektronix Keithley electrometer 6514. The speakers were
driven by sinusoidal signals including a 4 V amplitude at different frequencies (2 Hz, 3 Hz, 4 Hz, and
5 Hz) generated by function generator (DS345, Stanford Research Systems, Sunnyvale, CA, USA).
To quantitatively analyze the deformation and potential distribution of P(VDF-TrFE) nanofibers
based on NG by a uniaxial stress (~0.5 Mpa), we performed finite element modeling (FEM) by COMSOL
multiphysics software (5.3, COMSOL Inc., Stockholm, Sweden).
From the analysis of electrical characteristics, the cell membrane can be equivalently modeled as
a resistor capacitor with electrical properties such as extracellular medium resistance (Rcm), membrane
resistance (Rm), membrane capacitance (Cm) and ion equilibrium potential (Vm). According to these
four characteristics, an equivalent circuit can be constructed [40,41]. The external electrical stimulation
is generated by a P (VDF-TrFE) piezoelectric nanofiber NG under a dynamic mechanical vibration,
which can be represented as a voltage source. By using the equivalent circuit model, the expected
behavior of the effective voltage and current applied to the cell membrane by NG was evaluated.
The circuit was simulated by Multism software (14.0, National Instruments Co., Austin, TX, USA).
2.4. Cell Culture
MC3T3-E1 cells (Subclone 14, mouse preosteoblasts, Innochem Ltd., Beijing, China) were cultured
in Alpha Minimum Essential Medium (α-MEM, Gibco) with 2 Mm L-glutamine (Gibco) and 1 mM
sodium pyruvate (Gibco) supplemented with 10% fetal bovine serum (Gibco), 100 U/mL penicillin,
and streptomycin (Gibco) in a humidified atmosphere with 5% CO2 in air at 37 ◦C.
2.5. Cell Alignment Quantification
The cell alignment on the NFM was quantified by a two-dimensional fast Fourier transform (2-D
FFT) image analysis method [42]. Briefly, the fluorescent cell photographs were converted to 8-bit
grayscale and then cropped a 1024 × 1024 pixel square. This was then masked with a transparent
circular pattern, and the corners were filled with black. The processed photograph was analyzed by
FFT function in ImageJ software [43]. Pixel intensities along the radian were summed using the oval
profile plug-in and normalized by the lowest intensity value [44]. The normalized results represent the
percentage of cells aligned along a certain direction.
2.6. Piezoelectric Stimulation and Cell Proliferation Assay
The dynamic piezoelectric stimulus used the custom-made speakers that provided uniform
mechanical vibration to cells in monolayer cultures. Specialized flexible-bottomed culture plates
(BF-3001U, Flexcell Int. Co., Austin, TX, USA) made of silicone elastomer membrane were used to
culture the cells. The strain applied to the silicone elastomer membrane was directly transmitted to
the NGs to generate piezoelectricity. The synthesized function generator and power amplifier were
used to control the frequency and amplitude of deformation applied to the culture plate (experimental
vibration frequency: 2 Hz; amplified voltage: 4 V).
To clarify the feasibility of P(VDF-TrFE) nanofiber NGs as exact electrical stimulation and
demonstrate the effects on the proliferation of MC3T3-E1 cells, P100-NG and P80-NG were selected
as the experimental groups, and the nonpiezoelectric A-NFM served as the control group. The cells
were seeded at a density of 2 × 104 cells per well on the various NGs. The piezoelectric stimulation
was applied to MC3T3-E1 cells for 30 min per day for 1 day, 3 days, or 5 days. The proliferation
of the cultured MC3T3-E1 cells was measured using the cell count kit-8 (CCK-8, Dojindo Molecular
Technology). The culture medium was first replaced with 1.5 mL α-MEM medium plus 10% CCK-8
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solution. After 4 h incubation at 37 ◦C, the production of water-soluble formazan dye was determined
using a microplate reader (MULTISKA NMK3, Thermo Fisher Scientific, Waltham, MA, USA) at a
wavelength of 450 nm. The culture medium was changed every 2 days. Three parallel replicates were
examined each time for each group.
To observe the cell morphology on the NFMs, the MC3T3-E1 cells were fixed with 4%
paraformaldehyde solution in PBS (Sigma) for 10 min and then washed three times with warm 1×
PBS and blocked with 1% bovine serum albumin (BSA, Sigma) solution for 60 min. The cytoskeleton
was stained with Phalloidin (Invitrogen) conjugated to Alexa Fluor 488 (1:200 diluted) for 2 h at 37 ◦C,
and the nucleus was stained with 4’,6-diamidino-2-phenylindole (DAPI, 300 nM, Life Technology) for
10 min.
2.7. Statistical Analysis
The data were expressed as the mean ±standard deviation (SD). Statistical analysis was
determined using one-way ANOVA. Statistical differences were tested with a one-way ANOVA
using the t-test (Tukey test) for independent samples. Statistical significance was accepted at * p < 0.05
and ** p < 0.01.
3. Results and Discussion
3.1. Morphology and Characterization of NFMs
Figure 1 shows a schematic for the electrospinning process and post-treatment process.
The P(VDF-TrFE) nanofibers were fabricated with the optimized electrospun parameters using the
electrospinning setup. They had a strongly aligned and uniform morphology (Figure 1b). The mean
diameter of electrospun nanofibers was 590 nm ± 26 nm with further size analysis in Figure S1a.
After annealing (Figure 1c and Figure S1b), several microvoids appeared clearly on the surface of the
nanofibers and the surface of single fiber became rough. Here, the A-NFM exhibited a porous structure
and a higher surface-area-to-volume ratio than the U-NFM, which is beneficial for the migration of
implanted cells. Although the P-NFM exhibited the flat surface owing to the mechanical pressing to
make the nanofibers flattened, it still had nanofibrous surface. As shown in the insets of Figure 1b–d,
the average contact angle of U-NFM was 129.13◦. Although the single nanofiber surface of A-NFM
was rougher than that of U-NFM, the contact angle of A-NFM decreased to 113.38◦. This phenomenon
can be explained as follows. In addition to the influence of surface roughness, the contact angle is also
related to the surface free energy [45]. The annealing treatment resulted in the transformation of some
nonpolar α phases into polar β phase. The presence of polar β phase increased the dipolar interaction
between the NFM and water molecules, which increased surface energy and reduced the contact
angle [46,47]. The influence of high surface energy on the contact angle of A-NFM is greater than that
of surface roughness. The P-NFM had the smallest contact angle (91.14◦) due to the combined effects
of nanostructure flattening and polar β phase, demonstrating the surface wettability of P(VDF-TrFE)
NFM can be improved by poling treatment. In addition to the highly-aligned and porous properties,
the fibers of the polarized P-NFM samples were arranged more closely, and the fibers were bonded
to each other. This improves the material’s mechanical properties (Figure 1d) [48]. Representative
stress–strain plots are displayed in Figure S2. The mean elastic modulus of U-NFM, A-NFM, and
P-NFM were 0.148 GPa, 0.426 GPa, and 0.876 GPa, respectively. This result proves that the poling
treatment can significantly affect the mechanical robust. A well-aligned and uniform P-NFM with
favorable mechanical properties shows its potential as a scaffold in tissue engineering.
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Figure 1. The morphology and contact angle of electrospun nanofiber membranes (NFMs). (a) Schematic
illustration of the preparation and treatment of different samples. Scanning electron microscope
(SEM) micrographs of (b) U-NFM, (c) A-NFM, and (d) P-NFM. The insets represent the contact
angles corresponding to U-NFM, A-NFM, and P-NFM, respectively. (U-NFM represented pristine
poly(vinylidene fluoride-trifluoroethylene)(P(VDF-TrFE)) NFM without any postprocessing; A-NFM
represented annealed P(VDF-TrFE) NFM; P-NFM represented the poled samples.)
The crystallinity of P(VDF-TrFE) NFMs treated with different postprocessing steps was
determined via the XRD patterns (Figure 2a). There was a distinct reflection peak from 19 to 21 degrees
for all NFMs corresponding to the diffraction of plane (200)/(110) of the β phase crystal [49,50].
The broad shoulder at ~18 degrees for U-NFM is associated with the amorphous phase. After
annealing treatment, the shoulder completely disappeared for both A-NFM and P-NFM, but the
diffraction intensity of the (200)/(110) plane increased. In addition, the increase in diffraction peak
intensity of P-NFM versus A-NFM demonstrates that the β phase is enhanced after poling. By fitting
the XRD patterns [51], the diffraction curve could be resolved into three regions: amorphous as well as
α- and β-crystalline phases. Thus, α and β phases could be measured. The percentage of α phase in
the U-NFM was 23.3% while that of the A-NFM was 26.5%. The P-NFM had less α phase—this might
be due to the phase transformation from α-crystal phase to β-crystal phase after poling treatment.
The percentage of β phase in the U-NFM and A-NFM was 43.1% and 46.6%, respectively; it was 69.2%
in P-NFM.
The crystal phase structures could also be characterized by FTIR spectra (Figure 2b). The characteristic
absorption bands [52,53] at 506, 840, 1285, and 1430 cm−1 are recognized as β phase structures whereas
the absorbance peaks of the α phase structure appears at 532, 614, 765, 870, and 976 cm−1. Versus
U-NFM, the intensity of characteristic bands corresponding to β phase increased for the A-NFM, which
suggests that the annealing treatment improves the β phase content. Furthermore, the highest peak
intensity of β phase was seen with P-NFM. This phenomenon is mainly due to thermal poling that
increases with the degree of dipole orientation and phase transition of the β phase. There are fewer
crystalline defects and enhanced β-crystallinity.
The XRD patterns and FTIR spectra indicate that an annealing treatment can slightly increase the
β phase content while the thermal poling treatment can significantly improve the β phase crystallinity.
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Figure 2. Crystalline characterization of P(VDF-TrFE) NFMs treated with different postprocessing steps.
(a) X-ray diffraction (XRD) patterns and (b) Fourier transform infrared spectroscopy (FTIR) spectra.
3.2. Effect of Postprocessing on NFM Piezoelectric Properties
The polarization-electric field hysteresis loops (P-E loops) of U-NFM, A-NFM, and P-NFM at
various electric fields are presented in Figure 3 and illustrate the ferroelectric behavior of nanofiber
membranes treated with different postprocessing steps. The remnant polarization (Pr) and the
saturated polarization (Ps) of U-NFM was 17.1 mC/m2 and 37.9 mC/m2, respectively (Figure 3a).
After annealing, the Pr and Ps of A-NFM could reach 26.9 mC/m2 and 43.1 mC/m2, respectively
(Table 1 and Figure 3b), indicating that the annealing process can increase the crystallinity. The Pr is
mainly associated with a highly polar β-crystalline phase. Table 1 and Figure 3c show that a higher Pr
of 32.6 mC/m2 could be obtained by P-NFM under a polarizing electric field of 160 MV/m. In addition,
Pr was closer to Ps in sample P-NFM, and the P-E loops tended to be saturated. This suggested that
the ferroelectric domain trends toward a single-domain. In particular, the higher Pr mainly originated
from a β phase crystal domain reflecting the better ferroelectric properties. This result suggests that
thermal poling can increase the β-crystalline phase content. In addition, the coercive electric field
(Ec) increased from 60.9 MV/m for U-NFM and 65.2 MV/m for A-NFM to 88.1 MV/m for P-NFM,
suggesting that the ferroelectric domain of the β-crystal phase is not oriented easily. Consequently, the
P-NFM had a strong ability to maintain polarization and possessed excellent piezoelectric property.
Figure 3. The P-E hysteresis loops of P(VDF-TrFE) NFMs treated with different postprocessing at a
polarization electric field of 160 MV/m.
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The relationship between charge density and applied stress is plotted in Figure 4 and can evaluate
the piezoelectric coefficient d31. The slope of the line represents the piezoelectric coefficient d31
(Figure 4). The calculated d31 and the corresponding linear regression correlation coefficients (R2)
are summarized in Table 1. The data illustrate that there is better agreement between the theoretical
and experimental values of d31 for A-NFM and P-NFM than for U-NFM. The A-NFM and P-NFM
showed good sensing performances. It means that P-NFM can provide accurate electrical stimulation
under varying external stress and that P-NFM is more reliable in the application of NGs that provide
electrical stimulation.
Figure 4. Experimental and theoretical studies of piezoelectric coefficient d31 of nanofiber membranes.
(a) Experimental charge density–stress curve of U-NFM. Experimental (symbols) and linear fitting
(lines) charge density–stress curves of (b) A-NFM and (c) P-NFM.
Table 1. Electric properties of P(VDF-TrFE) NFMs with different postprocessing steps at an electric
field of 160 MV/m.
Sample Ec (MV/m) Ps (mC/m2) Pr (mC/m2) d33 (pC/N) d31 (pC/N) R
2
U-NFM 60.9 37.9 17.1 0 0.03 0.3496
A-NFM 65.2 43.1 26.9 0 0.07 0.9948
P-NFM 88.1 44.1 32.6 −31 22.88 0.9997
In addition, there was almost no piezoelectricity in A-NFM (d31 = 0.07 pC/N) and U-NFM
(d31 = 0.03 pC/N); however, P-NFM showed the highest piezoelectric coefficient (d31 = 22.88 pC/N,
d33 = −31 pC/N) among all samples (Table 1). This is due to the fact that U-NFM has many amorphous
crystalline phases, some nonpolar α phases and a small amount of polar β phases. With an annealing
treatment, the amorphous phase of the nanofibers decreases, the total crystallinity increases and some
nonpolar α phases are transformed to polar β phase, which increases the content of β phase and thus
the remnant polarization was increased compared to U-NFM, nevertheless, the dipole orientation
is disorderly, so the total spontaneous polarization is zero and the piezoelectric property is weak.
After poling treatment, the transformation of the α phase to the β phase is further promoted leading to
high remnant polarization and most electric dipoles are oriented along the direction of the externally
applied electric field, underscoring the high piezoelectric performance. With the favorable mechanical
and ferroelectric properties of P-NFM confirmed, we next used this material as piezoelectric nanofiber
NG and evaluated the electrical response as well as the arrangement and proliferation of cells cultured
on this material.
3.3. Effect of Mechanical Stimulus on Electrical Performances
To study the dependence of the electrical outputs of NGs on the degree of polarization, two
kinds of NGs processed by different poling electrical fields were measured. Figure 5a shows the
illustrative diagram of the experiment setup for imitating the real scene of the electrical stimulation
of the cells in vitro during the dynamic mechanical vibration. The NG was deformed periodically
via a self-designed setup driven with an amplitude of 4 V (peak-to-peak value). The resulting curve
exhibited a periodic alternation of negative and positive responses corresponding to the deformed and
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released states of a piezoelectric nanofiber NG, respectively (Figure 5b). As the frequency increases
from 2 Hz to 5 Hz, the generated peak-to-peak piezoelectric current increased from 18.1 nA to 39.7 nA
in the P80-NG sample (Figure 5c upper); the P100-NG sample was modulated from 23.1 nA to 41.5 nA
(Figure 5c lower). These results confirm that the charge transfer is kept equal at different vibration
frequencies, but the output is due to rapid electron flow.
Figure 5. Effect of mechanical stimulus on electrical performances of different NGs. (a) Schematic
diagram of the home-designed experimental shaker for providing periodic mechanical vibrations.
(b) Piezoelectric output currents recorded during bending and releasing. The insets are the schematics
of NG under mechanical bending deformation and releasing state, respectively, (P100-NG at a frequency
of 3 Hz). (c) Current outputs of P80-NG (above) and P100-NG (below) in the frequency range of 2 to
5 Hz. (d) Comparison of measured current of P80-NG and P100-NG under different frequency from 2
to 5 Hz. (e) Voltage outputs of P80-NG and P100-NG at a frequency of 2 Hz.
Figure 5d shows that the measured current increased with increasing vibration frequency in
both P80-NG and P100-NG. The slope of the P100-NG sample was 1.2-fold higher than that of
P80-NG sample under the same vibration force. Figure 5e shows the results of induced voltage
under a frequency of 2 Hz. The output voltage of P80-NG and P100-NG reached −1.3 V and −1.75 V,
respectively. These results indicate that the electrical performance of the piezoelectric nanofiber NG
are affected by poling treatment and the outputs can be modulated and optimized by adjusting the
polarization treatment. In the following in vitro assay, piezoelectric nanofiber NG as an electrical
stimulator can provide an exact stimulation to cells in real time during the dynamic status.
3.4. Theoretical Modeling of NG-Cell Interaction
To estimate the expected behavior of the effective voltage and current applied to the cell membrane
by NG, an equivalent circuit was used to model the interaction of the piezoelectric nanofiber NG and
cells. Figure 6a shows the diagram of NG-cell and corresponding equivalent circuit model [54,55].
Under external mechanical vibration, the NG deformation produced an external voltage excitation
that could be modeled as a voltage source (VNG). The voltage reached the cell membrane through the
culture medium, the conductivity of the medium would affect the voltage that stimulated the cell.
The cell membrane is composed of a phospholipid bilayer, which can be regarded as an insulator.
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The extracellular fluid, cell membrane and intracellular fluid constitute a capacitor (Cm) [56]. The initial
potential of ion channel is represented as Vm [57]. Figure 6b shows the simulation results of voltage
and current transmitted to the cell membrane through the circuit due to sinusoidal voltage stimulation.
When an excitation of 1.3 V was input, the voltage and current delivered to the cell was ~0.8 V and
0.4 mA, respectively. According to the basic principles of the circuit, when VNG is active, the capacitor
Cm is charged (corresponding to the current that is stimulating cell growth), and the voltage across
the capacitor (the voltage applied to the cell) Vc (t) (t is time, hereinafter abbreviated as Vc), which is
expressed as
Vc = − RmVNGRcm + Rm · e
− Rcm+RmRcm RmCm t + RcmVm + RmVNG
Rcm + Rm
The result calculated by the formula of the voltage applied to the cell was consistent with that of
the circuit simulation.
Figure 6. Electrical model of the NG-cell and FEM model of NG. (a) The diagrammatic sketch of
NG-cell and corresponding equivalent circuit model. (b) The voltage (yellow) and current (black)
applied to the cell membrane due to sinusoidal voltage stimulation (blue). (c) FEM stimulation of
deformation distribution of nanofibers on NG at the stress amplitude of 0.5 Mpa.
Since a large deformation of the substrate will hinders cell adhesion, the deformation of aligned
nanofibers based on NG under 0.5 MPa stress was analyzed by using finite element model (Figure 6c).
The resulting maximum deformation was ~7 μm.
3.5. Cell Morphology on NG without Piezoelectric Stimulaton
For tissue engineering, the scaffold material should have excellent cytocompatibility to support
cell growth and proliferation [58]. The cell viability data were validated by live/dead kit (Figure S3).
The viability was similar between NG and control, suggesting that the P(VDF-TrFE) piezoelectric
nanofiber NG has good cytocompatibility. Furthermore, the highly aligned micro-/nanostructure
of the fiber-based scaffolds can provide morphological cues for cell attachment and behavioral
modulation [59–61]. To study the effect of nanofiber morphology on the alignment of cells, the
high aligned and random P(VDF-TrFE) nanofibers were used for cell culture. Figure 7a,c shows that
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the MC3T3-E1 cells attached nicely on both the aligned and random P(VDF-TrFE) nanofibers. The cell
cytoskeleton and nucleus showed an elongated morphology on the direction of nanofibers alignment
of P(VDF-TrFE) NG, while the MC3T3-E1 cells seeded on random nanofibers displayed a random
orientation. This was further verified in that the aligned P(VDF-TrFE) NGs not only have an excellent
cytocompatibility but can also guide cell elongation and orientation.
Figure 7. Attachment and alignment of MC3T3-E1 cells on well-aligned and random P(VDF-TrFE)
nanofibers after 3 days of culture. (a) The SEM image of well-aligned nanofiber substrate (left column)
and the confocal fluorescence micrographs of MC3T3-E1 cells (right column). (b) 2-D FFT image analysis
of cell nuclei (above) and cytoskeleton alignment (below) on well-aligned P(VDF-TrFE) nanofibers.
(c) SEM image of random nanofiber substrate (left column) and the confocal fluorescence micrographs
of MC3T3-E1 cells (right column). (d) 2-D FFT image analysis of nuclei (above) and cytoskeleton
alignment (below) on random P(VDF-TrFE) nanofibers. F-actin was stained by Alexa Fluor 488-labeled
phalloidin (green); cell nuclei were stained by DAPI (blue). The scale bar for confocal fluorescence
micrographs is 100 μm.
The results of representative 2-D FFT image are shown in Figure 7b,d. There were two significant
symmetrical peaks at 90◦ and 270◦ in the plot of aligned P(VDF-TrFE) NGs illustrating that the direction
of actin filaments is the same as the nanofibers (Figure 7b below) [62]. The frequency distributions
of nuclei were preferentially concentrated along 90◦ (Figure 7b above) suggesting a specific nuclei
orientation. In comparison, the 2-D FFT plot of random samples showed no obvious peaks; the
actin filaments were randomly arranged (Figure 7d blow). The arrangement angles of nuclei on
the random nanofibers were disordered as the angular histogram exhibits. This confirms that the
cell cytoskeleton orientation is caused by the well-aligned surface topography of P(VDF-TrFE) NGs.
The results demonstrate that P(VDF-TrFE) NGs can provide not only electrical stimulation signals but
also morphologic cues.
3.6. Effect of Piezoelectric Stimulation Induced by NG on MC3T3-E1 Cells
We next verified the effect of the piezoelectric response of the P(VDF-TrFE) NG acted as electrical
stimulus on the cell behavior under dynamic mechanical vibration. To further illustrate the effect of
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the accurate electrical stimulation modulated by NG on cell proliferation. Here, P100-NG and P80-NG
were the experimental groups, and A-NFM was the control. The vibration frequency was set at 2 Hz
for mimicking low-frequency biomechanics. The cell proliferation was quantitatively assessed by the
CCK-8 assay to estimate the metabolic activity of the total number of MC3T3-E1 cells. Figure 8a shows
that the MC3T3-E1 had an elongated morphology along the direction of the nanofibers for all the
samples. There was no obvious difference in morphology between cells grown on the two membranes.
Figure 8. Proliferation of MC3T3 cells on P80-NG, P100-NG, and control A-NFM. (a) Fluorescence
microscopy images of MC3T3 cells on A-NFM, P80-NG, and P100-NG. (b) MC3T3 cells proliferation
analyzed by ImageJ software after 1, 3, and 5 days culture. All data represent the mean standard
deviation (n = 3, * p < 0.05). The scale bar is 100 μm.
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The cell counts of all groups increased on days 1, 3, and 5. The CCK-8 assay showed that the
cells grown on both the P100-NG and P80-NG had the higher proliferation rate than those grown
on A-NFM illustrating that the piezoelectricity increased cell proliferation (Figure 8b). On day 3,
the MC3T3-E1 cells proliferation on the P100-NG and P80-NG was enhanced by 1.24- and 1.10-fold
versus that of A-NFM, respectively. No significant difference was observed between the P100-NG and
P80-NG. There were significant statistical differences in proliferation rate between cells on P100-NG,
P80-NG and A-NFM on day 3 and 5. On day 5, the cells proliferation on the P100-NG and P80-NG
was 1.27- and 1.13-fold versus that of A-NFM, respectively; there were significant statistical differences
in proliferation rate between cells on P100-NG and P80-NG. A preliminary in vitro assay suggested
that piezoelectric stimulations induced by the P(VDF-TrFE) NGs are suitable for the biopotential of
MC3T3-E1 cells and can significantly promote cell growth. These results indicate that the combination
of customizable exact piezoelectric stimulation and aligned nanostructured NG show the potential
application to meet the demand of electrical stimulation according to specific tissue repair.
4. Conclusions
In conclusion, we introduced a promising strategy of a self-powered well-aligned P(VDF-TrFE)
piezoelectric nanofiber nanogenerator as an exact piezoelectric stimulator for bone tissue engineering.
We investigated the specific effects of post-treatments on the properties of NG. Poling post-treatment
could effectively improve the mechanical, piezoelectric, and sensing performances of NG. We also
measured the accurate piezoelectric response of NG and emulated the real scene of the electrical
stimulation of the cells in vitro during the dynamic status. The well-aligned piezoelectric P(VDF-TrFE)
NGs with different encouraged the MC3T3-E1 cells to proliferate in vitro under a sustainable
piezoelectric stimulus. To clarify the effect of the exact electrical stimulation on the proliferation
fate of preosteoblasts, two different output voltages of NG as stimulators were compared. Our
work provides additional insights into the application of P(VDF-TrFE) piezoelectric nanofiber NG as
self-powered electrical stimulation system for assisting tissue repair and regeneration.
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Abstract: To provide adequate conditions for the regeneration of damaged bone, it is necessary to
develop piezoelectric porous membranes with antioxidant and anti-inflammatory activities. In this
study, composite nanofibers comprising poly(vinylidene fluoride) (PVDF) and a polyhedral oligomeric
silsesquioxane–epigallocatechin gallate (POSS–EGCG) conjugate were fabricated by electrospinning
methods. The resulting composite nanofibers showed three-dimensionally interconnected porous
structures. Their average diameters, ranging from 936 ± 223 nm to 1094 ± 394 nm, were hardly
affected by the addition of the POSS–EGCG conjugate. On the other hand, the piezoelectric β-phase
increased significantly from 77.4% to 88.1% after adding the POSS–EGCG conjugate. The mechanical
strength of the composite nanofibers was ameliorated by the addition of the POSS–EGCG conjugate.
The results of in vitro bioactivity tests exhibited that the proliferation and differentiation of
osteoblasts (MC3T3-E1) on the nanofibers increased with the content of POSS–EGCG conjugate
because of the improved piezoelectricity and antioxidant and anti-inflammatory properties of the
nanofibers. All results could suggest that the PVDF composite nanofibers were effective for guided
bone regeneration.
Keywords: bone regeneration; poly(vinylidene fluoride); composite nanofiber; piezoelectricity;
antioxidant activity
1. Introduction
A variety of techniques have been tried for the regeneration of bone defects, including bone
grafting, distraction osteogenesis, and guided bone regeneration (GBR) [1–3]. Among them, GBR has
been used as an efficient method for both the reconstruction of the structure of, and reestablishment of
the function in, bone defects and damaged tissues. The GBR approach principally uses a membrane
acting as a barrier membrane in between soft tissue and bone tissue defect. GBR membranes prevent
the migration of faster-growing fibrous tissue into the defect and secure osteoconduction (bone
growth) to promote bone regeneration [3]. Thus, GBR membranes need to have biocompatibility to
support bone tissue reconstruction and mechanical stability to maintain a protective space during bone
restoration process.
Nanofibrous membranes have structural similarity to the extracellular matrix (ECM) and high
specific surface area [4]. GBR membranes composed of ultrafine nanofibers are more suitable for
cell attachment and proliferation than conventional membranes with large scale structures. Various
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Nanomaterials 2019, 9, 184
strategies—such as self-assembly, wet-spinning, and electrospinning—have been used to fabricate GBR
membranes [4–10]. Of these strategies, electrospinning has attracted a great deal of attention because
this method is very simple and versatile, and can produce various polymer nanofibers. Electrospun
polymer nanofibers have unique advantages in the biomedical fields such as drug delivery and tissue
engineering, as they can form porous structures that simulate the features of the ECM [2,4,11,12].
Poly(vinylidene fluoride) (PVDF) is an attractive semicrystalline polymers for use in biomedical
applications because of its efficient piezoelectricity and biocompatibility [13,14]. The strong
piezoelectric effect observed in PVDF is directly linked to the crystalline phase arrangement. PVDF exits
in one of five polymorphic crystalline phases (α, β, γ, δ, and ε) dependent on its distinct chain
conformation [15]. The nonpolar α-phase does not exhibit an efficient conformation for piezoelectric
application, but it does present good mechanical properties and thermal stability. On the other hand,
β- and γ-phases exhibit electroactive and polar properties. Among them, the β-phase has a higher
density net dipole moment and exhibits more promising piezoelectric properties. Therefore, increasing
the piezoelectric β-phase content in PVDF is very important for its biomedical application because
piezoelectric materials can provide electrical stimulation to cells to promote tissue formation and
can use as a scaffold for tissue engineering [14,16]. This phenomenon is very similar that electrically
charged ECM stimulates the cell growth during tissue regeneration [14]. In particular, bone tissue and
its constituent collagen fibers possess intrinsic piezoelectricity to play a significant role in regeneration
of the damaged bone, and thus a variety of piezoelectric materials have been applied to promote bone
regeneration both in vitro and in vivo [16,17].
Polyhedral oligomeric silsesquioxane (POSS) molecules have a unique nanostructure comprised
of an inorganic silsesquioxane cage core and an organic functional group shell [18]. A variety of POSS
molecules contain reactive functionalities, making them suitable precursors for grafting. Therefore,
they have been used in various biomedical applications including tissue engineering due to their
distinctive structure and excellent biocompatibility [19,20]. Epigallocatechin gallate (EGCG) is a
polyphenolic flavonoid derived from a variety of plants and, in particular, is a major bioactive
component in green tea, which has been shown to possess a variety of pharmacological functions;
for instance, it exhibits antioxidant, anticancer, and anti-inflammatory properties [21–23]. EGCG
inhibits lipopolysaccharide (LPS)-induced osteoclastic bone resorption and attenuates inflammatory
bone loss in bone metabolism [24,25]. Moreover, EGCG increases osteoblast proliferation and alkaline
phosphatase (ALP) activity, which leads to increased osteoblastic bone formation [26].
Piezoelectric materials can change their surface charge without external energy power source [14].
Several research papers have reported an observed enhancement of the piezoelectric β-phase content
in PVDF fabricated by electrospinning with the incorporation of fillers, such as metal nanoparticles,
ceramics, and inorganic salts [27–30]. In addition, EGCG-incorporated membranes have been
fabricated and have been observed to promote osteoblastic proliferation and prevent inflammatory
responses [26]. Therefore, in this study, we fabricated PVDF/POSS–EGCG conjugate composite
nanofibers, which showed improved piezoelectric, antioxidant, and anti-inflammatory properties,
to support bone tissue regeneration using an electrospinning method. We systematically examined the
effect of the POSS–EGCG conjugate content on the structure and physicochemical properties of the
composite nanofibers obtained. Furthermore, the in vitro bioactivity of the composite nanofibers was
investigated through the cell proliferation, ALP activity, and bone mineralization assays.
2. Materials and Methods
2.1. Materials
PVDF (Mw = 275000 g/mol), EGCG, lipopolysaccharide (LPS), horseradish peroxidase (HRP),
hydrogen peroxide (H2O2, 30 wt% in H2O), dimethyl sulfoxide (DMSO), N,N-dimethylformamide
(DMF), tetrahydrofuran (THF), and isopropyl alcohol (IPA) were obtained from Sigma-Aldrich Co.
(St. Louis, MO, USA). Xanthine oxidase (XO from buttermilk, EC 1.1.3.22), xanthine, and nitro
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blue tetrazolium (NBT) were purchased from Wako Pure Chemical Industries (Osaka, Japan).
Aminopropylisobutyl polyhedral oligomeric silsesquioxane (API-POSS) was purchased from Hybrid
Plastics (Hattiesburg, MS, USA). Osteoblast-like cell line MC3T3-E1 derived from mouse calvaria was
acquired from the American Type Culture Collection (Manassas, VA, UAS) and a murine macrophage
cell line RAW 264.7 was purchased from the Korean Cell Line Bank (Seoul, South Korea). All materials
were used as received without further purification.
2.2. Synthesis of the POSS–EGCG Conjugate
The POSS–EGCG conjugate was synthesized as follows. API-POSS (174.9 mg, 0.2 mmol) and
EGCG (137.5 mg, 0.3 mmol) were first dissolved in 30 mL of a mixed solvent of THF/IPA/deionized
water (DW) at a ratio of 2:1:1 before adding a solution of HRP (5 mg, 750 units) dissolved in 3 mL of
Dulbecco’s phosphate-buffered saline (DPBS, pH 7.4). To this resultant solution, 5 mL of 5 wt% H2O2
was added five times every 10 min. After 4 h, the resultant POSS–EGCG conjugate was dialyzed in
DW for 48 h. Then, the precipitated conjugate was isolated by centrifugation and washing with DW
in four replicates, followed by drying in vacuo. The amount of EGCG conjugated to API-POSS was
determined by elemental analysis using a Flash 2000 elemental analyzer (Thermo Fisher Scientific,
USA). The structures of EGCG, API-POSS, and the POSS–EGCG conjugate were determined by
1H NMR spectroscopy (AVANCE III 400, Bruker BioSpin, USA).
1H NMR of EGCG (400 MHz, D2O), δ (ppm) = 6.91 (CH of D-ring), 6.52 (CH of B-ring), 6.10,
6.07 (CH of A-ring), 5.48, 4.97 (CH of C-ring), 2.88 (CH2 of C-ring).
1H NMR of API-POSS (400 MHz, CDCl3), δ (ppm) = 2.83 (CH2NH), 1.84 (CHCH3),
1.58 (CH2CH2CH2), 0.95 (CHCH3), 0.56 (SiCH2).
1H NMR of POSS–EGCG (400 MHz, DMSO-d6), δ (ppm) = 6.81 (CH of D-ring), 6.41 (CH of B-ring),
5.95, 5.84 (CH of A-ring), 5.36, 4.98 (CH of C-ring), 2.77 (CH2 of C-ring) for EGCG, 2.69 (CH2NH),
1.82 (CHCH3), 1.58 (CH2CH2CH2), 0.95 (CHCH3), 0.54 (SiCH2) for API-POSS.
2.3. Fabrication of PVDF Composite Nanofibers
Before electrospinning the PVDF composite nanofibers, the PVDF (1.8 g) was dissolved in 10 mL
of a mixed solvent of DMF/THF in a ratio of 1:1 to obtain an 18 wt% solution. After stirring 12 h,
the POSS–EGCG conjugate was added to the PVDF solution with a different weight ratio at 60 ◦C
for 8 h. The contents of POSS–EGCG conjugate in solutions were 0, 2, 4, and 6 wt% with respect to
the weight of the PVDF. The mixed solution of PVDF and the POSS–EGCG conjugate was filled into
a 20 mL standard syringe with a 22 G stainless steel needle (internal diameter = 0.41 mm). Then,
this solution was electrospun into nanofibers at room temperature with a feeding rate of 2 mL/h feed
rate, a voltage of 18 kV, and a working distance of 15 cm. After electrospinning, the PVDF composite
nanofibers were peeled off from the stainless steel plate and vacuum dried for 12 h.
2.4. Characterization of the PVDF Composite Nanofibers
The morphology of the PVDF composite nanofibers was visualized by scanning electron
microscopy (SEM, S-4300, Hitachi, Japan) at an acceleration voltage of 5 kV after sputter coating
of samples with gold. Image-Pro Plus software (Media Cybernetics Inc., Rockville, MD, USA) was used
to determine the average fiber diameters for the composite nanofibers. Energy dispersive spectroscopy
(EDS) spectra were obtained for the determination of the distribution profile of the POSS–EGCG
conjugate on the nanofiber surface.
Fourier transform infrared spectroscopy (FTIR) measurement was performed using an ALPHA
spectrometer (Bruker OpticsBillerica, MA, USA) with a resolution of 4 cm−1. Attenuated total
reflectance (ATR) mode was used to analysis the characteristic bands over a range from 400 to
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where Aα and Aβ represent the absorbance of peaks related to the α- and β-phases at 760 and 840 cm−1,
respectively, and Kα and Kβ are the absorption coefficients at the respective wavenumbers, which are
7.7 × 104 cm2/mol and 6.1 × 104 cm2/mol.
X-ray diffraction (XRD) patterns were also used to evaluate the crystalline phases of the
PVDF composite nanofibers and thus XRD measurements were performed using a Rigaku
D/MAX-2500V/PC X-ray diffractometer (Japan) with high intensity Cu Kα radiation at 40 kV/100 mA.
The diffractograms were scanned in a 2θ range from 10◦ to 50◦. The composite nanofiber samples were
analyzed using X-ray photoelectron spectroscopy (XPS) to obtain the surface elemental composition.
XPS measurements were performed using a Quantera SXM (ULVAC-PHI Inc., Japan) equipped with
a monochromatic Al Kα X-ray source (1486 eV). The photoelectron take-off angle was fixed at 45◦
relative to the sample surface. Besides XPS measurements, static contact angles were measured with
a DSA 100 contact angle meter (KRÜSS, Germany) to examine the hydrophobicity of the composite
nanofiber. Each contact angle of the sample is an average of five measurements. The mechanical
properties of the composite nanofibers were investigated with a TO-101 universal testing machine
(Testone Co., Siheung, South Korea) with 2 kN load capacity at a rate of 10 mm/min. All samples were
cut into rectangular specimens with a size of 3 cm × 1 cm and tested five parallel measurements.
2.5. Cell Proliferation
MC3T3-E1 cells were used to evaluate the in vitro bioactivity of the PVDF composite nanofibers by
a cell proliferation assay in alpha minimum essential medium (α-MEM) containing 10% of fetal bovine
serum (FBS) and 1% of penicillin–streptomycin at 37 ◦C with 5% CO2. Before assaying, the composite
nanofibers were cut into circular shape with a diameter of 15 mm, followed by putting into 24-well
tissue culture plate and fixing with glass ring (inner diameter = 11 mm). Then, they were sterilized
with 70% ethanol and rinsed with DPBS and α-MEM. After drying, the composite nanofibers were
once again sterilized under UV radiation for 3 h.
The proliferation of viable cells on the composite nanofibers was determined using the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. One milliliter of cell
suspension (2 × 104 cells/well) was placed onto the sterilized samples and cells were cultured
for different periods of time. After culturing for 1, 3, 5, 7, and 14 days, culture media were replaced
with 0.2 mL of the MTT solution and further incubation of the cells was maintained for another 4 h.
Next, we removed the remaining media and added 1 mL of DMSO to solubilize the precipitated
formazan crystals. Finally, the resulting supernatant was transferred to 96-well plate with 0.2 mL per
well. The absorbance was determined at 570 nm using a spectrophotometric plate reader (OPSYS-MR,
Dynex Technology Inc., USA). Furthermore, after days 3 and 7 of cell culture, the cell-nanofibers were
fixed in 4% glutaraldehyde for 1 h, and then dehydrated using different concentrations of ethanol (25,
50, 70, and 100%), followed by vacuum-drying. The morphologies of dried samples were observed
using SEM after sputter coating with gold.
2.6. Superoxide Anion Radical Scavenging Capacity Assay
Superoxide anion radicals were generated with xanthine/XO and determined as described in a
previous paper of ours [31]. EGCG and the POSS–EGCG conjugate were first dissolved in the mixed
solvent of DMSO and DPBS (pH 7.4) and diluted with DPBS. To measure the superoxide anion radical
scavenging capacity, xanthine (30 μg/mL) was added to DPBS containing ethylenediaminetetraacetic
acid (EDTA, 15 μg/mL), XO (40 milliunits/mL), NBT (130 μg/mL), and various concentrations of test
70
Nanomaterials 2019, 9, 184
sample. Changes in the absorbance at 560 nm over 10 min were recorded as a measure of the changing
number of superoxide anion radicals.
The superoxide anion radical scavenging capacity of samples was determined according to the
following formula.




where Abscontrol is the absorbance of control in the absence of sample and Abssample is the absorbance
in the presence of samples.
2.7. ALP Activity and Bone Mineralization Assay
ALP activity can provide a useful index of the osteoblastic phenotype. Thus, the osteoblastic
differentiation of MC3T3-E1 cells was assessed by measuring the ALP activity with an ALP assay kit
(DALP-250, BioAssay Systems, USA) at periods of 3, 5, 7, and 14 days after cell seeding. The composite
nanofibers seeded with cells washed with DPBS and incubated in 0.5 mL of DW containing 0.2% Triton
X-100. The cell lysates were mixed with p-nitrophenyl phosphate solution. In the presence of ALP,
p-nitrophenyl phosphate can be hydrolyzed to p-nitrophenol and the rate of p-nitrophenol production
is proportional to the ALP activity. Therefore, the level of p-nitrophenol production was determined
by measuring the absorbance at 405 nm and normalized to 1 × 104 cells.
Bone mineralization capability of the composite nanofibers was assayed by the alizarin red S
(ARS) staining method. ARS can selectively bind to calcium ions and thus calcium deposition is easily
measured by the use of ARS. After 3, 5, 7, and 14 days of cell culture on the different nanofibers, the
cells were fixed with 4% glutaraldehyde for 30 min and then stained with 1 mL of 40 mM ARS (pH 4.1).
After incubation for 20 min, the specimens were washed thrice with DW to remove unreacted ARS
and dissolved in 1 mL of 10% cetylpyridinium chloride. The absorbance of the supernatant at 540 nm
was obtained using microplate reader and was normalized to 1 × 104 cells.
2.8. Quantification of Inflammatory Cytokine
The effect of the PVDF composite nanofibers on the expression of the inflammatory cytokine
interleukin-6 (IL-6) was measured using the RAW 264.7 cells. For the quantification of IL-6 production,
the cells (2 × 104 cells/well) were precultured in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% heat-inactivated FBS, 100 U/mL of penicillin, and 100 μg/mL of streptomycin for
24 h at 37 ◦C before adding 1 μg/mL of LPS into the cell culture plate. After activation of the cells
for 24 h, the amount of IL-6 released into the media was measured by mouse IL-6 enzyme-linked
immunosorbent assay kit (R&D Systems, USA) according to the manufacturer’s protocol.
2.9. Statistical Analysis
All data were represented as mean value ± standard deviation. Differences between two groups
were analyzed with a one-way ANOVA followed by a Turkey test using SigmaPlot 13.0 (Systat Software,
CA). A significant difference was defined for values of p* < 0.05.
3. Results and Discussion
3.1. Synthesis of the POSS–EGCG Conjugate
To prepare the POSS–EGCG conjugate, EGCG was conjugated to API-POSS via a one-step
reaction using HRP as a catalyst (Figure 1). The structure of the resultant POSS–EGCG conjugate was
characterized by 1H NMR spectroscopy (Figure S1). The characteristic signals belonging to EGCG
units were observed at 6.81, 6.41, 5.95, 5.84, 5.36, 4.98, and 2.77 ppm. Moreover, the peaks due to
API-POSS units in the POSS–EGCG conjugate were shown at 2.69, 1.82, 1.58, 0.95, and 0.54 ppm [20,32].
The semiquinone radicals or active oxygen species can easily oxidize either the gallyl moiety (B-ring) or
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the gallate moiety (D-ring) of EGCG, resulting to transform EGCG into reactive species with a quinone
structure [33]. However, gallyl structures are more susceptible to oxidation than gallate structures and
they only form catechol quinones through intermediate semiquinones [34]. In addition, the presence of
a reactive amino group on API-POSS can provide a site for enzymatic conjugation of catechol through
electrophilic addition [35]. The conjugation ratio of EGCG that was introduced to API-POSS was
calculated from the result of elemental analysis to be 0.96.
Figure 1. Schematic diagram of enzymatic synthesis of the polyhedral oligomeric silsesquioxane–
epigallocatechin gallate (POSS–EGCG) conjugate.
3.2. Fabrication of the PVDF Composite Nanofibers
Composite nanofibers have been proven to act as effective mechanical supports and to promote
osteoconduction in bone tissue regeneration [2,4]. In the present study, composite nanofibers were
fabricated by electrospinning PVDF solutions containing different amounts of POSS–EGCG conjugate.
The contents of POSS–EGCG conjugate in the mixed solutions were 0 (PVDF), 2 (PE02), 4 (PE04),
and 6 wt% (PE06) with respect to the weight of the PVDF. In addition, the PVDF nanofiber containing
6 wt% of pure API-POSS (PO06) was also prepared as a control. The SEM observations revealed that
thoroughly interconnected porous structures formed between the composite nanofibers (Figure 2).
The average fiber diameter of the composite nanofibers, which was 1033 ± 270 nm for PVDF,
971 ± 262 nm for PE02, 936 ± 223 nm for PE04, 1094 ± 394 nm for PE06, and 1131 ± 281 nm for
PO06, was hardly affected by adding the POSS–EGCG conjugate. In addition, the distribution of
the POSS–EGCG conjugate in the PVDF composite nanofibers was observed using EDS. The EDS
Si-mapping analyses of the composite nanofibers represented that the POSS–EGCG conjugate was
homogenously distributed over the nanofibers and that a greater density of Si was detected on the
PE06 nanofiber (Figure S2).
Figure 2. SEM images of (a) PVDF, (b) PE02, (c) PE04, (d) PE06, and (e) PO06 composite nanofibers.
(f) Average fiber diameters of the PVDF composite nanofibers analyzed from the SEM images (n = 4).
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3.3. Physicochemical Properties of the PVDF Composite Nanofibers
The FTIR was used to analyze the chemical structure and phase composition of the PVDF
composite nanofibers. Characteristic bands appeared at 1402 and 840 cm−1 in the spectrum of the pure
PVDF nanofiber corresponded to the stretching and rocking vibration of the CH2 groups, respectively
(Figure 3a) [28,29,36]. The four bands observed at 1275, 1178, 760, and 482 cm−1 corresponded to the
deformation, stretching, bending, and wagging modes of the CF2 groups in PVDF. An absorption peak
due to the skeletal vibration of C–C bonds in PVDF was also observed at 880 cm−1. After adding the
POSS–EGCG conjugate or pure API-POSS, the PVDF composite nanofibers exhibited a new absorption
peak at 1110 cm−1 associated with the stretching mode of Si–O–Si bonds, which is the typical absorption
peak of the POSS inorganic framework [37]. In particular, the absorption peaks at 1402, 1275, 880, 840,
and 482 cm−1 represent characteristic vibration modes of the piezoelectric β-phase of PVDF [28,29].
Figure 3. (a) FTIR spectra of the PVDF composite nanofibers and (b) changes in β-phase content in
the nanofibers calculated from the FTIR spectra (n = 5). Significant difference from the pure PVDF
nanofiber was denoted as p* < 0.05.
The FTIR data was used to calculate the relative β-phase content (F(β)) in the PVDF composite
nanofibers. As presented in Figure 3b, the F(β) values of all samples were higher than 75% because
the crystalline phase change of the PVDF from α-phase to β-phase was occurred by the electrostatic
forces applied to the polymer droplet during the electrospinning [30]. In addition, the piezoelectric
β-phase increased from 77.4 ± 2.5% to 88.1 ± 3.2% after adding the POSS–EGCG conjugate. According
to previous reports, converting α-phase to piezoelectric β-phase in PVDF/ceramic composites was
ascribed to the interaction between the negatively charged ceramic nanoparticles and the positively
charged CH2 groups of PVDF [27,28]. Moreover, hydroxylated ceramic nanoparticles interacted more
strongly with PVDF through the hydrogen bonds formed by the fluorine atoms on the PVDF with the
hydroxyl groups on the surface of the ceramic nanoparticles. Therefore, we may deduce that, in our
experiments, PE06 exhibited a higher F(β) value than those of the other composite nanofibers because
of strong dipole and hydrogen bonding interactions between the PVDF and POSS–EGCG conjugates.
The surface elemental composition of the PVDF composite nanofibers was assessed using XPS.
The XPS survey scan spectrum of the pure PVDF nanofiber exhibited two separate peaks which
corresponded to the F 1s orbital (688 eV) and the C 1s orbital (287 eV) (Figure 4a). After adding the
POSS–EGCG conjugate or pure API-POSS, the XPS spectra exhibited six separate peaks assigned to
PVDF, the POSS–EGCG conjugate, and API-POSS: F 1s (688 eV), O 1s (535 eV), N 1s (400 eV), C 1s
(287 eV), Si 2s (155 eV), and Si 2p (105 eV). The intensities of the peaks assigned to the POSS–EGCG
conjugate increased with increasing contents of the POSS–EGCG conjugate. In addition, the crystalline
phases of the PVDF composite nanofibers were examined by means of XRD as shown in Figure 5.
All samples exhibited two diffraction peaks mainly attributed to the piezoelectric β-phase of PVDF at
20.4◦ and 35.9◦, which were indexed to the β(110)/(200) and β(020)/(101) planes, respectively [27,28].
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Figure 4. (a) X-ray photoelectron (XPS) spectra of the PVDF composite nanofibers and (b) the magnified
XPS spectra of the areas in (a) marked by rectangle.
Figure 5. XRD patterns of (a) PVDF, (b) PE02, (c) PE04, (d) PE06, and (e) PO06 composite nanofibers.
The investigation on the surface hydrophilicity of biomedical membranes is very important to
confirm the affinity between and the membranes and the cell. Suitable hydrophilicity can influence the
attachment and proliferation of the cells on the surface of the membranes. Therefore, the performance
of membranes in biomedical applications may depend on the hydrophilicity [38]. Here we measured
the water contact angle to evaluate the hydrophilicity of the composite nanofibers. Figure 6 exhibited
the water contact angle data measured for the composite nanofibers; the PVDF nanofiber revealed a
high water contact angle (127.7 ± 9.5◦) due to its hydrophobic property. In addition, the water contact
angles were hardly changed by the addition of the POSS–EGCG conjugate, i.e., 129.0 ± 8.7◦ for PE02,
128.9 ± 6.8◦ for PE04, and 130.4 ± 8.6◦ for PE06.
GBR membrane should be strong enough to withstand the force during new bone tissue
regeneration. Thus, the effect of the addition of the POSS–EGCG conjugate on the mechanical properties
of the composite nanofibers was assayed. As shown in Table 1, the resulting data obtained on the
basis of stress–strain measurements exhibited that the tensile strength and Young’s modulus increased
with increasing contents of the POSS–EGCG conjugate. This means that the POSS–EGCG conjugate
can cause temporary intermolecular cross-linking of polymer chains and thus can provide enhanced
mechanical strength [39]. However, the addition of POSS–EGCG conjugate induced a slight decrease
in elongation at break of the composite nanofibers.
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Figure 6. Contact angle images for water droplet on (a) PVDF, (b) PE02, (c) PE04, (d) PE06, and (e) PO06
composite nanofibers. (f) Average contact angles on PVDF composite nanofibers determined by contact
angle meter (n = 5). Insets are photographs of PVDF composite nanofibers.












PVDF 0 3.5 ± 0.3 1.1 ± 0.1 72.6 ± 6.0
PE02 2 3.6 ± 0.2 1.1 ± 0.3 71.3 ± 6.5
PE04 4 4.0 ± 0.3 1.4 ± 0.2 69.1 ± 7.7
PE06 6 4.5 ± 0.5 1.6 ± 0.3 65.6 ± 7.2
PO06 6a 5.2 ± 0.4 1.7 ± 0.3 63.4 ± 8.4
a Content of API-POSS (wt%).
3.4. Cell Proliferation
The in vitro bioactivity of the PVDF composite nanofibers was evaluated to assess the potential
of the nanofibers as GBR membranes. The cell proliferation on the PVDF composite nanofibers was
studied by the MTT assay, resulting that the relative cell viability of the MC3T3-E1 cells cultured
on the composite nanofibers indicated good cytocompatibility of the nanofibers (Figure 7). For all
the tested nanofibers, time-dependent actions were observed in cell proliferation. Changes in the
content of the POSS–EGCG conjugate in the composite nanofibers affected the cellular activities.
All the composite nanofibers accelerated more rapid cell proliferation as compared with the pure
PVDF nanofiber. Among the composite nanofibers, cell proliferation was significantly enhanced on
PE06 in comparison with on the other nanofibers. These results were associated with the contents of
piezoelectric β-phase and POSS–EGCG conjugate in the PVDF composite nanofibers.
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Figure 7. Proliferation behavior of MC3T3-E1 cells cultured on the PVDF composite nanofibers (n = 6).
Significant difference from the pure PVDF nanofiber at each time point was denoted as p* < 0.05.
During tissue regeneration, piezoelectricity can induce an increase in the surface charge density
of ECM materials for the delivery of an electrical stimulus without external energy sources and
consequently causes higher levels of cell proliferation and differentiation [14,16]. In addition, EGCG
causes a significant elevation of osteoblastic survival as well as a decrease of osteoblastic apoptosis
caused by reactive oxygen species, resulting that the proliferation and differentiation of osteoblasts
can be stimulated because of antioxidant and free-radical scavenging activities of EGCG [26,40].
As shown in Figure 8, the POSS–EGCG conjugate exhibited excellent superoxide anion radical
scavenging activity similar to that of pure EGCG, which could have a positive effect on cell viability.
Therefore, the piezoelectric property and antioxidant activity of PVDF composite nanofibers may play
an important role in osteoblast cell proliferation.
Figure 8. Superoxide anion scavenging activities of EGCG and the POSS–EGCG conjugate (n = 4).
To confirm cell growth on the PVDF composite nanofibers, the interactions between the cells
and nanofibers was observed using SEM on periods of 3 and 7 days after cell seeding. SEM images
exhibited that the cells adhered and spread on the surface of the composite nanofibers, and cell
proliferation increased time-dependently in all the tested nanofibers (Figure 9). This indicates excellent
biocompatibility of the composite nanofibers. Moreover, almost the whole surface of the PE06 was
covered by the cells at day 7 of cell culture.
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Figure 9. Morphologies of MC3T3-E1 cells on (a) PVDF, (b) PE02, (c) PE04, (d) PE06, and (e) PO06
composite nanofibers after culturing for 3 and 7 days.
3.5. ALP Activity and Bone Mineralization
ALP catalyzes the cleavage of organic phosphate esters and plays an important role during
the formation process of bone nodule [1,2]. ALP activity is considered as an early marker of
osteoblastic differentiation because it significantly increases during the differentiation step. Therefore,
we examined ALP activity to evaluate the capability of the PVDF composite nanofibers for promoting
osteoblastic differentiation. As a result, the cells cultured on PE06 exhibited higher ALP activity
than those cultured on the other composite nanofibers at all time points (Figure 10a). Similar
results have been previously reported, in that various flavonoids—such as green tea catechins,
quercetin, and kaempferol—significantly increased ALP activity by the activation of the extracellular
signal-regulated kinase pathway and endoplasmic reticulum binding [40–42].
Figure 10. (a) ALP activity and (b) quantitative calcium deposition of MC3T3-E1 cells on the PVDF
composite nanofibers after culturing for 3, 5, 7, and 14 days (n = 6). The values of ALP activity
and quantitative calcium deposition were normalized by the cell number (1 × 104 cells). Significant
difference from the pure PVDF nanofiber at each time point was denoted as p* < 0.05.
The mineralized bone nodules are usually formed via three main stages such as cell proliferation,
ECM development, and mineralization. Therefore, the osteogenesis capability of the cells as a late-stage
marker for osteogenic differentiation can be estimated by the determination of bone-like calcium
deposits produced on different PVDF composite nanofibers using ARS staining [1,4]. After the
incubation for 3, 5, 7, and 14 days, the absorbance changes of ARS in the red-stained composite
nanofibers were used to quantify the calcium mineralization. Figure 10b exhibits the absorbance of
ARS extracted from the stained calcium deposits in different composite nanofibers. The increase of
calcium deposition on the composite nanofibers with time was observed in all samples. Among the
samples, PE06 exhibited the highest calcium deposition compared to the other samples at all time
points caused by increased osteogenesis capability [42]. These results indicated that the amount of
77
Nanomaterials 2019, 9, 184
POSS–EGCG conjugate present in the composite nanofibers significantly influenced the bone-forming
ability of the MC3T3-E1 cells.
3.6. Quantification of Inflammatory Cytokine
Osteoblasts can produce bone-active cytokines such as tumor necrosis factor-α and IL-6 [21,38].
In bone metabolism, these cytokines act as potent factors for osteoclast formation and bone resorption
because they can mediate the effects of many stimulators of bone resorption, i.e., parathyroid hormone
and IL-1 [22,23,40]. Among these cytokines, IL-6—the most potent osteoclastogenic factor—promotes
the activation of osteoclast precursors and their subsequent differentiation into mature osteoclasts,
leading to the bone resorption. In addition, a significant release of IL-6 can suppress cell viability.
Thus, we determined the expression of IL-6 in cell cultures to evaluate the bone-forming ability and
cytocompatibility of the PVDF composite nanofibers.
It was found that PVDF and PO06 promoted the expression of the IL-6 markedly due to the
contamination by LPS and subsequent macrophage activation (Figure 11). However, all composite
nanofibers containing the POSS–EGCG conjugate exhibited considerably decreased levels of IL-6
expression compared with the pure PVDF nanofiber. In particular, PE06 exhibited only a very small
amount of IL-6 secretion, suggesting that the POSS–EGCG conjugate can downregulate the production
of bone-active cytokines and improve the cytocompatibility of the composite nanofibers via the
anti-inflammatory effect of EGCG [22,23,40]. Therefore, the content of the POSS–EGCG conjugate
present was an essential factor in decreasing IL-6 production on the PVDF composite nanofibers.
Figure 11. Levels of IL-6 expression by RAW 264.7 cells on the PVDF composite nanofibers (n = 5).
Significant difference from the pure PVDF nanofiber at each time point was denoted as p* < 0.05.
4. Conclusions
In this study, we fabricated PVDF composite nanofibers as potential membranes for bone
tissue regeneration using an electrospinning process. The composite nanofibers obtained had fully
interconnected porous structures adequate to promote the cell proliferation and the efficient transport of
nutrients and metabolic waste. The content of POSS–EGCG conjugate present affected the piezoelectric,
antioxidant, and anti-inflammatory properties of the nanofibers, which finally influenced the in vitro
bioactivity of the PVDF composite nanofibers. PE06 facilitated the proliferation and differentiation
of the MC3T3-E1 cells more effectively compared to the other nanofibers. Based on these results,
our simple method is very useful to prepare PVDF composite nanofibers which may contribute to the
development of new scaffolding materials for bone tissue regeneration.
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Figure S1: 1H NMR spectrum of the POSS–EGCG conjugate. Figure S2: EDS Si-mapping images of the PVDF
composite nanofibers.
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Abstract: Efforts in tissue engineering aim at creating scaffolds that mimic the physiological
environment with its structural, topographical and mechanical properties for restoring the function of
damaged tissue. In this study we introduce composite fibres made by a biodegradable poly(lactic acid)
(PLLA) matrix embedding bioactive silica-based glass particles (SBA2). Electrospinning is performed
to achieve porous PLLA filaments with uniform dispersion of bioactive glass powder. The obtained
composite fibres show in aligned arrays significantly increased elastic modulus compared with that
of neat polymer fibres during uniaxial tensile stress. Additionally, the SBA2 bioactivity is preserved
upon encapsulation as highlighted by the promoted deposition of hydroxycarbonate apatite (HCA)
upon immersion in simulated body fluid solutions. HCA formation is sequential to earlier processes
of polymer erosion and ion release leading to acidification of the surrounding solution environment.
These findings suggest PLLA-SBA2 fibres as a composite, multifunctional system which might be
appealing for both bone and soft tissue engineering applications.
Keywords: poly(lactic acid) (PLLA); bioactive glass; scaffolds; electrospinning; composite fibres
1. Introduction
Bone tissue continuously undergoes shape remodelling and repair at the microscale through
processes of local regeneration, which are regulated by growth factors, hormones and the action of
mechanical stresses. In reconstructive surgeries, the regeneration of bone and cartilage by autologous
cell transplantation after an injury or tumour removal is one of the most promising strategies in order
to reduce issues related to immunocompatibility and consequent immune rejection, as well as to
avoid potential pathogen transfer [1]. However, since autologous grafts are often poorly available, an
appealing approach is represented by the development of scaffold-based tissue engineering approaches
based on bioactive materials for restoring bone morphology and function [2].
Therefore, enormous efforts are being made to create engineered constructs that mimic the
physiological environment with its structural, topographical and mechanical properties. To this aim,
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various biomaterials, metals, natural or synthetic polymers and ceramics, have been investigated
but no single one was proved to show all the crucial features required for an optimal scaffold [3,4].
In this framework, a promising approach relies on composite biomaterials with osteoconductive and
osteoinductive capabilities, which might allow for osteogenesis stimulation while mimicking the
extracellular matrix (ECM) morphology [4,5]. Several studies have been focused on the addition of
inorganic and bioactive fillers, such as bioactive glasses, bioceramics or hydroxyapatite [6] in polymeric
constructs, with the aim to promote chemical links to bone tissue by forming hydroxycarbonate apatite
(HCA) layers as a result of ion leaching, in case of bioactive glass components, into the surrounding
physiological fluids. In this process, the precipitation of microcrystalline HCA onto the scaffold
surface [7] is due to a well-defined ion exchange mechanism between modifier ions (Na+ and Ca2+)
in the glass and hydronium ions (H3O+) in the surrounding fluid, thereby causing dissolution of the
glass network [8,9]. Compared to other bioactive materials, silica-based bioactive glasses are available
in different compositions, which exhibit remarkable osteoinductive behaviour since they feature ionic
dissolution products (Si4+, Mg2+, Ca2+) able to stimulate osteogenesis and angiogenesis [8,9]. In fact,
the potential angiogenic effects of silica-based bioactive glass has been recently highlighted, through
increased secretion of vascular endothelial growth factor involved in vascularization processes [10].
For these reasons, these materials are not only useful for bone tissue engineering but they might also
promote the regeneration of soft tissues as needed in wound healing [11].
In fact, 45S5 Bioglass®has been largely used as inorganic phase in polymer foams and matrices to
realize porous composites [12–16]. Silicate [17], borate [18] and phosphate-based glasses [19,20] have
been recently tested in bulky bioresorbable polymeric sponges or polymer-coated scaffolds. A number
of nano- and micro-fabrication technologies allow these systems to be processed as biocompatible and
biodegradable fillers in polymers retaining higher surface-to-volume ratio and interconnected porous
networks to better support tissue ingrowth and vascularization. In the last years, the electrospinning
technology has been largely developed and notable progress has been made to realize biomimetic
porous scaffolds designed for tissue engineering and for drug delivery [21–23]. Electrospinning
is a versatile technique, which allows for the fabrication of polymer, ceramic or nanocomposite
fibres with diameter ranging from a few tens of nanometres to a few micrometres, which strongly
resemble the morphology of the native ECM and provide a networked architecture suitable for cell
attachment [22–25]. Various different structures, morphologies and compositions can be achieved
in fibres, to make them suitable for different tissue applications including vascular, bone, neural
and tendon or ligament [21,25,26]. Particularly, fibres with nanocomposite materials and complex
internal [27] or surface [28,29] nanostructures can be electrospun by blends of polymers or from
colloidal solutions [30,31].
In this work we introduce nanocomposite electrospun fibres embedding silica-based bioactive
glass (SBA2). SBA2 belongs to the SiO2–Na2O–CaO–P2O5–B2O3–Al2O3 class of systems, previously
investigated as component of antibacterial and bioactive, bulky bone cements [7,32,33]. The FDA-approved
polymer, poly(lactic acid) (PLLA), is chosen as matrix because of its excellent biocompatibility and
biodegradability, already assessed in clinical treatments [1], as well as for its excellent processability
with electrospinning [34]. The obtained PLLA-SBA2 fibres are characterized in their morphology
and in their chemical and mechanical properties. The addition of inorganic particles in a polymeric
matrix [35–38] leads to composites with varied mechanical properties, depending on the filler size
and on their dispersion in the organic phase [35,36,38], as well as on the fabrication parameters,
including the solvent used for electrospinning [38]. Additionally, acellular, in vitro bioactivity and
cell viability are investigated, evidencing the biocompatibility of the PLLA-SBA2 fibrous composites.
Overall, dispersed silica-based bioactive glass in resorbable polymeric composites with microscale
texturing are highly promising systems for supporting cell cultures as well as for the development of
biomedical applications. The novelty of this work is represented by the successful incorporation of
SBA2 in electrospun PLLA fibres, not reported previously in literature and also on the correlation of
the nanopores on the fibres surface with fibres degradation and bioactive glass particles release.
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2. Materials and Methods
2.1. Bioactive Glass Synthesis and Characterization
The SBA2 glass has the following nominal composition (mol %): 48% SiO2, 18% Na2O, 30%
CaO, 3% P2O5, 0.43% B2O3, 0.57% Al2O3 and was synthesised by melt-quenching route, as detailed
elsewhere [7,32,33]. Briefly, reagent-grade reactants [SiO2, Na2CO3, CaCO3, Ca3(PO4)2, H3BO3 and
Al2O3] were melted in a platinum crucible at 1450 ◦C for 1 h (Carbolite HTF 1800, CARBOLITE
GERO, Neuhausen, Germany), the melt was then quenched in water to obtain a frit. The frit was
ball milled in aqueous medium. The grain size distribution of milled SBA2 was estimated using
a particle size analyser (Sympatec Helos H0621, kindly performed at CERICOL Research Centre,
Sovigliana, Vinci (Firenze), Italy); the specific surface area (SSA) of milled SBA2 was assessed by
using the Brunauer-Emmet-Teller (BET, ASAP2020Plus-Micromeritics, Aachen, Germany) method [39].
The obtained glass powder was analysed morphologically and compositionally by scanning electron
microscopy (SEM, FEI QUANTA INSPECT 200, Eindhoven, The Netherlands) and energy dispersive
X-ray spectrometry (EDS) (EDAX PV 9900, Weiterstadt, Germany). Thermal properties were
determined by differential thermal analysis (DTA–404 PC instrument, Netzsch, Selb, Germany),
in a temperature range of 20–1300 ◦C, using a heating rate of 10 ◦C/min and high-purity alumina
as reference.
2.2. Electrospinning
PLLA (molecular weight 85−160 kg mol−1, Sigma-Aldrich, Munich, Germany) was dissolved
in a mixture of dichloromethane and acetone (80:20 v/v) at a concentration of 20% (w/v) at room
temperature. The solution was stirred overnight, then SBA2 was added with a concentration of
7% w/v. The resulting suspension was vigorously mixed and then stirred again overnight to obtain a
homogeneous dispersion of SBA2 in the polymer solution. The solution was put in an ultrasound bath
for 1 hour prior the electrospinning with the aim to reduce SBA2 clustering and then transferred in a
1 mL syringe. The spinning process was performed by a 21G stainless steel needle and a syringe pump
(Harvard Apparatus, Holliston, MA, United States) with feeding rate 0.8 mL h−1 and by applying a
positive high-voltage of 12 kV (EL60R0.6-22, Glassman High Voltage, XP Power, Milano, Italy) between
the needle and a metal collector. Random fibre mats were collected on a static grounded 10 × 10 cm2
collector meanwhile aligned fibre mats were collected on a grounded disk (8 cm diameter, 1 cm
thickness) rotating at a speed of 5000 rpm, maintaining constant all the other processing parameters.
The air relative humidity and temperature during the electrospinning process were about 40% and
20◦C, respectively. The needle-collector distance was adjusted to 15 cm. Neat PLLA fibres were
fabricated as reference material by using identical set-up parameters.
2.3. Morphology and Mechanical Properties of PLLA-SBA2 Fibres
PLLA-SBA2 electrospun fibres were sputtered with gold by using a Sputter Coater (Q150T,
Quorum Technologies, Darmstadt, Germany) and then inspected by SEM and energy dispersive X-ray
spectrometry (EDS) (Auriga 0750, ZEISS, Jena, Germany). Average fibre diameters were calculated
by analysing a total of at least 100 fibres for each sample, using the software ImageJ [40]. Regarding
mechanical properties, as reported by Ricotti et al. [41], mechanical differences in uniaxial aligned
arrays are more pronounced. Thus, aligned fibre mats were used in this paper to investigate more
specifically the mechanical properties of PLLA-SBA2 composite fibre mats. Mechanical properties of
random and aligned composite fibres mats at room temperature were investigated by uniaxial tensile
strength tests using a universal testing machine (K. Frank GmbH, Mannheim, Germany). Each sample
was cut into a rectangular shape (with cross-section area of 5 × 4 mm2) using a paper square framework
and its thickness is measured by using a digital micrometre (0.02–0.06 mm). Then measurements
were carried out at a crosshead speed of 10 mm/min using a 50 N load cell, according to a previous
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study [42] and the resulted stress-strain curves are used to obtain Young’s modulus, elongation at
break and tensile strength.
2.4. Degradation studies
The degradation behaviour of composite fibres was investigated by immersion in Dulbecco’s
phosphate buffered saline (DPBS, Sigma-Aldrich, Munich, Germany) medium at pH 7.4. Resulting pH
values were measured instantly after the immersion of the sample and for different time points, up to
21 days, at 37 ◦C by using a pH meter (HD8705, Delta OHM, Padova, Italy). The pH measurements
of different solutions were correlated to the dissolution of ions in the incubation media. In addition,
the degradation of PLLA-SBA2 fibres in physiological solutions was assessed by measuring the weight
loss [23] for dried fibrous mats after 21 days of DPBS incubation. The percentage of weight loss, WL %,
was computed as 100 × (W0 − Wr)/W0, where W0 and Wr are the initial and the residual weight of
the sample, respectively.
2.5. Acellular Bioactivity
The acellular bioactivity of PLLA-SBA2 fibres, related to the surface deposition of HCA layers,
was evaluated by immersing the samples inserted in scaffold holders (CellCrownTM 24, Scaffdex,
Sigma Aldrich, Munich, Germany) in simulated body fluid (SBF) solution [43] for 1, 7, 14 and 21 days
at 37 ◦C, on an oscillating tray in an incubator. A falcon tube with only SBF was used as control.
After each time point, samples were washed with distilled water, dried at room temperature before
SEM-EDS characterization and Fourier Transform Infrared Spectroscopy (FTIR) analysis in attenuated
total reflectance (ATR) mode. PLLA neat fibres were considered as control. FTIR spectra were recorded
by a spectrometer (IRAffinity-1S, Shimadzu, Kyoto, Japan), repeating 32 scans over the wavenumber
range 4000–500 cm−1, with a resolution of 4 cm−1.
2.6. Cell Cultures
PLLA-SBA2 fibres were disinfected under an ultraviolet lamp for 1 h. Murine-derived stromal
cells ST-2 (obtained from Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und
Zellkulturen GmbH, Braunschweig, Germany), were cultured to confluence in 75 cm2 culture flasks in
Roswell Park Memorial Institute medium (RPMI 1640) (GibcoTM, Thermo Fisher Scientific, Schwerte,
Germany) containing 10% foetal bovine serum (FBS; Lonza) and 1% penicillin/streptomycin (Lonza)
at 37 ◦C and 5 % CO2. Before seeding, cells were detached using Trypsin in DPBS (Sigma Aldrich,
Munich, Germany), stained with 0.4% (v/v) trypan blue solution and counted using a Neubauer
chamber (VWR). Then, ST-2 cells were seeded onto the electrospun scaffolds (including neat PLLA
fibres as control) with a density of 2 × 104 cells/cm2. All samples were assayed in triplicate and each
sample was incubated in the same RPMI medium described above. Cells were cultured for 7 days
renewing the culture medium once after 3 days of culture. Viability analyses of ST-2 cells on composite
fibres was assessed after a cultivation period of 1 day and 7 days by using a WST-8 assay (Cell Counting
Kit-8, Sigma Aldrich, Munich, Germany), which is based on the conversion of tetrazolium salt to highly
water-soluble formazan by mitochondrial enzymes of viable cells. At each time point, the culture
medium was removed from each sample and each well with samples and cells was washed with DPBS
and added with a solution of 10% WST-8 reagent in colourless medium. After an incubation period of
3 hours at 37 ◦C and 5% CO2, the solution was transferred into a 96 well plate to measure absorbance
at 450 nm by using a microplate Elisa reader (PHOmo Elisa reader, Autobio Diagnostics Co. Ltd.,
Zhengzhou, China).
To investigate cell morphology, a preliminary evaluation was provided by SEM analysis after
1 day and 7 days of culture. Samples were fixed by using a solution containing paraformaldehyde,
glutaraldehyde, sodium cacodylate trihydrate and sucrose (Sigma Aldrich, Munich, Germany).
Subsequently, samples dehydration was achieved by using a series of aqueous ethanol solutions.
The samples were then dried in a critical point drier (Leica EM CPD 300, Leica, Wetzlar, Germany) and
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sputtered with gold. The cytoskeleton organization and nucleus morphology of cells on PLLA-SBA2
fibres were studied after 1 day and 7 days following seeding by staining with rhodamine phalloidin
and DAPI (ThermoFisher Scientific, Schwerte, Germany). Briefly, samples were fixed by using a
fixation solution containing 1,4-piperazinediethanesulfonic acid buffer, ethylene glycol tetraacetic
acid, polyethylene glycol, paraformaldehyde, DPBS and sodium hydroxide (Sigma Aldrich, Munich,
Germany), washed with DPBS and immersed in a permeabilization buffer for intracellular staining.
400 μL of a 8 μL/mL DPBS solution of rhodamine phalloidin was added in each well containing
samples, then kept for 1 hour at 37◦C. After the removal of the dye, samples were vigorously
washed with DPBS and 400 μL of a 1 μL/mL DPBS solution of DAPI was added to each well. Then,
samples were washed in DPBS and analysed with a fluorescent microscope (Axio Scope A1, Zeiss,
Jena, Germany).
2.7. Statistical Analysis
Each experiment was repeated three times. All results of cell viability and average fibre diameter
were expressed as (mean ± standard deviation) and a one-way analysis of variance (ANOVA) was
used for statistical analysis. A P value < 0.05 was considered statistically significant.
3. Results and Discussion
The BET analysis evidenced a SSA of 11.6 m2/g, the particle size analysis showed a non-symmetric
distribution with a mode grain size of 2 μm; characteristic particle sizes are d50 = 2.0 μm and
d90 = 4.4 μm, with 94% of grain sizes below 5 μm and the residual 4% below 9 μm.
Figure 1 shows the morphology (a, b) and the compositional analysis (c) of SBA2 glass
powders. The powders display the typical sharp-cornered morphology of ball-milled glass.
Moreover, as previously mentioned, the majority of SBA2 powders showed a grain size <5 μm.
In addition, the performed DTA analysis evidenced a glass transition temperature of about 550 ◦C,
the crystallization onset at 600 ◦C, a crystallization peak at 655 ◦C and a melting temperature of
1220 ◦C.
 
Figure 1. Scanning electron microscopy (SEM) (a,b) and energy dispersive x-ray spectrometry (EDS)
(c) analysis of SBA2 powders after milling process. Scale bars: 40 μm (a), 10 μm (b).
The electrospinning process of PLLA-SBA2 is carried out by adjusting the voltage bias as well as
the solution flow rate to obtain almost bead-free fibres. The morphology of neat PLLA and composite
fibres is shown in SEM micrographs in Figure 2. Composite fibres exhibit a quite homogeneous
distribution of embedded SBA2 particles (arrows in Figure 2b).
The SBA2 incorporation also leads to an increase of the overall roughness in the electrospun mats.
Interestingly, the average diameter of PLLA-SBA2 filaments is around one half of fibres without SBA2
(Table 1), similarly to previous findings on composite fibres made by PCL and commercially available
Bioglass®(45S5) particles [42]. This effect might be explained due to the change of intrinsic solution
properties, including rheology and conductivity, of the polymeric solutions after the addition of SBA2
particles [44]. In addition, the physical effect of particles in the electrified solution is associated to the
onset of enhanced whipping and varicose instabilities, which affect the morphology of the ultimately
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deposited fibres [45], as shown by the local increase of filament radius in the composite fibres close to
the particles. The resulting excess mass due to local polymer accumulation leads to the here found
decrease of diameter along the rest of the fibre length due to the overall polymer mass conservation.
Furthermore, we find that both the types of fibres display cylindrical shape and high surface porosity,
with pore size around 100 nm (Figure 2c,d), which is characteristic of PLLA electrospun with highly
volatile solvents [28] and expected to favour cell attachment. Indeed, it is known that both micro-
and nanoporosity play an important role in protein adhesion and cell function [46]. In addition,
the incorporation of the bioactive glass particles in PLLA-SBA2 fibres is confirmed by SEM-EDS
analysis as shown in Figure 3 and Figure S1.
Figure 2. SEM micrographs of (a) neat polylactic acid (PLLA) fibres and (b) PLLA-SBA2 fibres (scale
bar = 25 μm). Neat PLLA fibres (c) and composite fibres (d) at high magnification, evidencing their
highly porous surface. Scale bar: 2 μm.
Table 1. Average diameters, minimum and maximum values measured for the transversal size of neat








PLLA 2.0 ± 0.2 1.0 3.9
PLLA-SBA2 1.0 ± 0.2 0.3 2.5
Figure 3. EDS spectrum of electrospun PLLA-SBA2 fibres (a) and its comparative SEM-EDS layered
image (b) showing peaks of SBA2 constituents such as Ca (yellow), Na (orange) and Si (cyan). O (bright
green) and C (red) are mainly related to PLLA.
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The mechanical properties of the polymeric and composite fibres mats, determined from their
stress–strain curves, are summarized in Figure 4, in terms of Young’s modulus (Figure 4a), elongation at
break (Figure 4b) and tensile strength (Figure 4c) for either randomly oriented and aligned electrospun
samples. Particularly, in uniaxially aligned arrays, in which the fibres and to some extent polymeric
chains [47–51] are oriented along the traction axis, mechanical differences between composite and neat
PLLA are more pronounced [49]. The elastic modulus of PLLA-SBA2 fibres is found to be (34 ± 5)
MPa, significantly higher than the value measured for pristine PLLA fibres, (20 ± 2) MPa, just for the
aligned fibres. Correspondingly, PLLA-SBA2 exhibits a relatively lower elongation at break (15 ± 2%)
compared to the value of PLLA samples in the same alignment conditions (20 ± 2%), as well as higher
tensile strength (11 ± 1 MPa), compared to (7 ± 1) MPa. The mechanical behaviour of the composites
tightly depends on the interaction at the polymer-bioactive glass interface and on the homogeneity of
the dispersion of glass particles in the fibres, which if poor would lead to agglomeration in clusters [51].
The present findings in terms of increased elasticity and concomitant reduction of the elongation at
break and tensile strength are indicative of a reinforced fibre system where inorganic fillers lead to
embrittlement of the fibres [39,52].
Figure 4. Young’s modulus (a), elongation at break (b) and tensile strength (c) of random and aligned
fibres. Results are expressed as (mean ± standard deviation). Bars show statistically significant
differences (p < 0.05). In the inset of (a) and (c) a zoom view of the properties of randomly oriented
fibres is reported.
The analysis of both PLLA-SBA2 and PLLA fibres, performed by collecting SEM micrographs of
samples soaked in SBF solution, evidences polymer degradation starting from the 7th day following
incubation, resulting in cracks and points of break in the surface of fibres. As highlighted in SEM
micrographs in the top of Figure 5, in PLLA-SBA2 fibres this degradation leads to a progressively
increasing exposure of glass particles to the surrounding microenvironment. In order to investigate the
resulting bioactive glass dissolution from PLLA cracks propagating along the nanopores on the fibre
surface, we perform further in vitro degradation studies, incubating the composite scaffolds in DPBS
in physiological conditions (at pH = 7.4 and 37 ◦C), as showed in Figure S2c. During the immersion
in DPBS for 21 days, the corresponding changes of the solution pH was monitored, as displayed
in Figure 5 together with corresponding SEM micrographs at each time point. PLLA fibres clearly
undergo acid hydrolysis in the solution which leads to a decrease of pH, whereas for the composite
fibres this trend is overcome by the release of SBA2 dissolution products into the solution. The pH
increase related to bioactive glass dissolution products have been already investigated in several
medium by Cerutti et al. [52]. This increased pH associated with the dissolution-precipitation of
bioactive glass is known to affect various cellular processes, being correlated with increased metabolic
activity and proliferation rate in mammalian cells [53]. Our data on pH variations are also supported
by the corresponding measurements of sample weight loss, performed after 21 days, which is found to
be 2.2% of the initial weight for neat PLLA fibres and 9.7% for PLLA-SBA2 fibres.
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Figure 5. In vitro degradation studies and dissolution of PLLA and PLLA-SBA2 electrospun fibres.
Change in the pH of DPBS solution for PLLA and PLLA-SBA2 fibres, which is associated to the acid
hydrolysis of the polymer components and to the release of SBA2 into the solutions at 0, 1, 7, 14, 21 days
from incubation and the relatives SEM micrographs at high magnification of composite and polymeric
fibres along soaking experiments in SBF at the same time point (scale bar = 2 μm).
The acellular bioactivity of the electrospun fibres is evaluated by exploring the formation of HCA
on their surfaces upon soaking in SBF, at 37 ◦C for different time periods. The bioactivity of PLLA-SBA2
fibres can be clearly appreciated when a large quantity of HCA with typical cauliflower-like
morphology is found nearby the electrospun filaments (rightmost SEM micrographs in the top of
Figure 5). Neat fibres, instead, do not lead to HCA formation. These findings are supported by EDS,
detecting high Ca and P peaks belonging to HCA (Figure 6) with Ca/P ratio of 1.9, as well as by
FTIR analysis (Figure 7). Indeed, FTIR spectra of PLLA-SBA2 fibres following incubation feature two
new peaks at 600 cm−1 and 560 cm−1 corresponding to HCA-associated P–O groups asymmetric
bending [54] and the increase in intensity of the peak centred at 960 cm−1 ascribable to the contribution
of Si-OH symmetric stretching characteristic of the bioactive glass after immersion in SBF [54,55].
The formation of HCA following immersion in SBF solution confirms that the incorporation
of the bioactive glass particles in the PLLA filaments is not preventing the characteristic bioactivity
of this specific composition of bioactive glass to be highlighted [32]. In addition, the formation
of HCA after 21 days suggests this class of scaffolds not only as useful systems for bone tissue
engineering but also for soft tissue repair applications, because release of ions is detected since
the earliest time point, as evidenced by the pH variation in the degradation studies. In particular,
these fibrous architectures would be highly suitable for the release of therapeutic ions embedded in
the bioactive glass structure, occurring without simultaneous damage in the fibrous structure of the
scaffolds. Indeed, the double-scale temporal dynamics exhibited by the two mechanisms might be
highly advantageous for wound healing processes, where the composite can still provide mechanical
support while serving as reservoir of therapeutic ions [56]. The ability to modulate ion release through
bioactive glass composition engineering, in relation to the addressed cell type, might be especially
important in this respect. This relevance is also suggested by previous works that emphasized the
influence of ion release in stimulating vascularization and triggering the production of angiogenic
growth factors during soft tissue repair [57,58]. Other application fields potentially benefiting from
interplaying ionic release and gradual morphological changes in composite scaffolds include the
development of biomedical materials able to modulate the inflammatory response [59], to control cell
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proliferation [11], to support the regeneration of the peripheral nerve and the treatment of relevant
pathological conditions such as chronic osteomyelitis [60–62]. The smart combination of biologically
active ion release and nanotopography has been highlighted for tissue engineering [63].
Figure 6. EDS analysis of PLLA-SBA2 samples after 7 days (a,b) and 21 days (c,d) of soaking in SBF.
EDS spectra of PLLA-SBA2 (a,c) and comparative EDS layered images (b,d) reveal an increment of Ca
(yellow) and P (purple) content. SBA2 constituents: Na (orange), Al (green) and Si (cyan). O (bright
green) and C (red) mainly relate to PLLA.
Figure 7. Fourier transform infrared (FTIR) spectra of neat PLLA (PLLA_d0) and composite scaffolds
(PLLA-SBA2_d0) before incubation in simulated body fluid (SBF) and of composite fibres after
14 (PLLA-SBA2_d14) and 21 days (PLLA-SBA2_d21) of incubation in SBF. The inset better highlights
the new peaks ascribable to hydroxycarbonate apatite (HCA) formation mentioned in the text.
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Finally, we investigated the biocompatibility of PLLA-SBA2 fibres using a murine-derived ST2
stromal cell line. The morphology of cells, inspected by SEM, was found to be affected by the fibrous
structure of the scaffold, with significant cells elongation along the directions of supporting fibres
as shown in Figure 8. The cytoskeleton actin and the nuclei of cultured cells were also analysed by
immunofluorescence microscopy (Figure 9). Overall, cells adhesion was efficient on the nanocomposite
filaments embedding bioactive glass particles. In previous works, in vitro cytotoxicity tests of SBA2 in
PMMA-based cement were accomplished using the indirect contact method [33]. Here, the cell viability
is directly evaluated at 1 and 7 days after seeding. WST-8 assays highlight, for absorbance detected at
450 nm at day 1 for cultures on PLLA fibres, an almost double value compared to those measured for
cultures on PLLA-SBA2, results shown in Figure 10. This result correlates well with the increase of
the pH value found during degradation studies, namely with the release of ions from the bioactive
glass particles. Indeed, it is known that the alkalinisation of the medium can influence significantly
cell metabolism [64] and can consequently induce distinct phases in cell cycling on composite and
neat fibres, respectively, as also suggested by previous reports focused on the behaviour of human
osteoblasts exposed to the ionic dissolution products of bioactive glass [65,66].
At day 7 after seeding the values of absorbance measured on PLLA fibres and on PLLA-SBA2
fibres become comparable, as shown in Figure 10, evidencing that the initial conditions of pH changes
do not affect cell viability at longer timescales. ST2 cells cultured on composite fibres generally exhibit
a relatively lower cell density following seeding, then reaching cell densities comparable to those on
PLLA fibres after 7 days. Indeed, despite a significant difference in cell density immediately after cell
seeding, these results evidence the ability of PLLA-SBA2 fibres to providing an effective and viable
environment for subsequent scaffold colonization.
Figure 8. SEM micrographs of dehydrated ST2 cells, cultured on neat (a,b) and composite (c,d) fibres
for 1 (a,c) and 7 (b,d) days. Scale bar: 20 μm.
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Figure 9. Fluorescent labelled actin filaments (red) and nuclei (blue) in ST2 cells cultured on neat PLLA
(a,b) and PLLA-SBA2 (c,d) fibres, after 1 day (a,c) and 7 days from cell seeding. Scale bar: 50 μm.
Figure 10. WST-8 assay: histograms of absorbance at 450 nm for PLLA and PLLA-SBA2, one (d1) and
seven (d7) days after the seeding.
4. Conclusions
This study investigated the potentiality of electrospun PLLA-SBA2 fibres as potential scaffold
material for tissue engineering. The bioactive glass (SBA2) micro-sized powder was effectively
incorporated in electrospun polymer filaments and the obtained composite system was characterized
in terms of morphology and mechanical properties. The acellular bioactivity and biocompatibility
of the PLLA-SBA2 fibres was assessed and HCA deposition after 21 days of immersion in SBF was
found to be promoted by the embedded bioactive glass particles at a later stage compared with ion
release, suggesting this system as multifunctional scaffold appealing for both bone and soft tissue
engineering applications.
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Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4991/9/2/182/s1,
Figure S1: EDS analysis performed on PLLA-SBA2 sample before (top) and after 21 days of immersion in SBF
solution (bottom), Figure S2: SEM micrographs of neat PLLA fibers (a), composite PLLA-SBA2 fibers (b), composite
fibers after 7 days in DPBS (c) and 21 days in SBF (d).
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Abstract: The guided tissue regeneration (GTR) membrane is a barrier intended to maintain a space for
alveolar bone and periodontal ligament tissue regeneration but prevent the migration of fast-growing
soft tissue into the defect sites. This study evaluated the physical properties, in vivo animal study,
and clinical efficacy of hydrophilic PLA95/β-TCP GTR membranes prepared by electrospinning
(ES). The morphology and cytotoxicity of ES PLA95/β-TCP membranes were evaluated by SEM and
3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) respectively. The cementum and
bone height were measured by an animal study at 8 and 16 weeks after surgery. Fifteen periodontal
patients were selected for the clinical trial by using a commercial product and the ES PLA95/β-TCP
membrane. Radiographs and various indexes were measured six months before and after surgery.
The average fiber diameter for this ES PLA95/β-TCP membrane was 2.37 ± 0.86 μm. The MTT result
for the ES PLA95/β-TCP membrane showed negative for cytotoxicity. The significant differences
in the cementum and bone height were observed between empty control and the ES PLA95/β-TCP
membrane in the animal model (p < 0.05). Clinical trial results showed clinical attachment level
(CAL) of both control and ES PLA95/β-TCP groups, with a significant difference from the pre-surgery
results after six months. This study demonstrated that the ES PLA95/β-TCP membrane can be used
as an alternative GTR membrane for clinical applications.
Keywords: PLA95; biocompatibility; guided tissue regeneration (GTR); electrospinning
1. Introduction
Periodontitis is one of the most destructive diseases that destroys the tooth-supporting tissues,
including the alveolar bone, periodontal ligament, and cementum, ultimately leading to tooth loss [1–3].
For patients with severe periodontitis, it is critical to remove dental calculus and plaque by scaling
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and root planning [4]. Guided tissue regeneration (GTR) membranes are typically used to block the
migration of fast-growing connective tissue into the bony defect and to create space for the regeneration
of slow-growing alveolar bone and periodontal ligament [5]. Over the years, the materials of the GTR
barrier matrix from non-resorbable polytetrafluoroethylene-like expanded e-PTFE or dense d-PTFE [6]
and titanium mesh [7], evolved to resorbable polymer to dispense with the operation of secondary
GTR removal [8,9]. Most commercial resorbable synthetic polymer membranes are based on aliphatic
polyesters, such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), poly(ε-caprolactone) (PCL), or
their copolymers, to match the resorption time period for various clinical needs [10]. Among these
polymers, a novel copolymer composed of poly-5D/95L-lactide (PLA95) has been successfully used in
distal radius fractures [11] and craniomaxillofacial applications like skull flap fixation [12] and facial
fracture fixation [13] due to its relatively strong mechanical properties. The feasibility of using PLA95
resorbable GTR membranes is worth exploring.
Due to the potential inflammation risk caused by acid release from the monomer or
crystalline debris during degradation which could result in a foreign body immune response [14],
bio-ceramics such as β-tricalcium phosphate (β-TCP) and hydroxyapatite (HAp) were used for
their pH buffering effects [15] and bone cell response enhancement [16]. In recent years, various
osteo-conductive membranes such as polylactic acid (PLA)/HAp [17,18], gelatin/HAp [19], three-layered
HAp/collagen/PLGA [20], and nano-apatite/polycaprolactone (PCL) [21] have been fabricated using
the electrospinning (ES) technique. These resorbable hybrid membranes help bone reconstruction with
calcium ions releasing and good pH buffering properties.
In this study, we prepared the PLA95/β-TCP GTR membranes by ES and dip-coating
techniques [22], then the safety and effectiveness of this GTR membrane were assayed by cytotoxicity
testing, in vivo, and clinical studies.
2. Materials and Methods
2.1. ES PLA95/β-TCP Fibrous Membranes
Poly-5D/95L-lactide (PLA95) was provided by BioTech One Inc. (Taipei, Taiwan) with inherent
viscosity (I.V.) of 0.6 dL/g. The solution dope was prepared by mixing 20 w/v% PLA95 used a mixed
dichloromethane/dimethylformamide (DCM/DMF: 7/3 (v/v)) solvent and 3% (w/v) β-TCP powders
(<23 μm) under an ultrasonic vibrator to prevent the β-TCP powders from agglomerating, then spun it
via electrospinning (ES) technique using the setup shown in Figure 1.
 
Figure 1. Electrospinning setup and ES PLA95/β-TCP membranes.
The ES PLA95/β-TCP membranes were sterilized by gamma-radiation. The membranes were
gold-coated, and their morphology was examined by scanning electron microscopy (SEM, S-2400;
Hitachi, Tokyo, Japan), followed by characterization with Image J analytical software (NIH, MD, USA)
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2.2. Cytotoxicity Testing
Cytotoxicity testing was performed using the method described in the ISO-10993-5 guideline.
Accordingly, the specimens were divided into the following four groups: test (ES PLA95/β-TCP),
reagent blank control (medium), negative control (HDPE material), and positive control (zinc sulfate).
The samples were extracted with Eagle’s minimal essential medium (α-MEM; GIBCO BRL, OK, USA)
containing 10% fetal bovine serum (GIBCO BRL, USA) at 37 ± 1 ◦C for 24 ± 2 h. Cell line (NCTC clone
929; ATCC) was cultured in each of the extraction medium, with 5% CO2 at 37 ◦C for 48 h (N = 3). A
light microscope was used for qualitative morphological grading of the cytotoxicity test findings.
2.3. In Vivo Test (Animal Model)
Four healthy LanYu pigs (weight: 20–25 kg) were used for animal studies. The protocol was
approved by Taipei Medical University (No. LAC-99-0087). Buccal mucoperiosteal flaps were reflected
in the bilateral mandibular premolar and molar areas. Buccal alveolar bone was reduced to a level 5-mm
apical to the cement–enamel junction (CEJ). The root surface was denuded of the periodontal ligament
(PDL) and cementum (CE), and notches were placed at the bone level of each root as in Figure 2. The
ES PLA95/β-TCP and control membranes were placed on individual bone defect areas without bone
grafting. Flaps were positioned and sutured. All LanYu pigs were sacrificed at the designated times
after surgery. Histological and histometric evaluation at 8 and 16 weeks were performed after surgery
respectively, to determine the healing response of each treatment modality. Hematoxylin and eosin
stain (H&E) staining of the demineralized animal sections were evaluated under a light microscope
(40×), and the CE and bone height were measured using the Image J software (NIH, MD, USA).
  
 
Figure 2. From left to right: Animal model for guided tissue regeneration (GTR) membrane;
representative surgery photo and overview of the animal study: the GTR membranes of ES PLA95 and
ES PLA95/β-TCP were experimental groups, while the Epi-Guide and empty defect site were used as
control groups. Histological and histometric evaluation at week 8 and 16 were performed to determine
the healing response of each modality.
2.4. Clinical Trial
A commercially available PLA dental membrane (PLA; Epi-Guide®, Kensey Nash Corp., Exton,
PA, USA) was purchased as a control group; while the hydrophilic ES PLA95/β-TCP membranes
were used as the experimental group. The protocol was approved by Taipei Medical University Joint
Institutional Review Board (TMU-IRB) (No. 201105011). Fifteen periodontal patients with 20 defects
were enrolled in the study. The exclusion criteria were patients with unstable vital signs, pregnant
women, infection with oral ulcer, participation in other clinical trial, and systemic disease such as
leukemia, aplastic anemia, and diabetes. The inclusion criteria were class II or class III furcation
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defect or intrabony defects with probing depth ≥4 mm in the vertical direction in need of periodontal
surgery at the Dental Department of Wan-Fang Hospital. All patients selected for inclusion in the
study received a comprehensive periodontal examination and radiographs. The patients were assigned
randomly to the control and test groups by the single-blind method. The procedure involved open-flap
surgery, scaling and root planning, and additive bone-grafting (particle size 250–500 μm; BonaGraft™,
BioTech One Inc., New Taipei City, Taiwan). The GTR membranes were used on the defect sites, the
flap was sutured, and patients were instructed on oral health. After 1 week of the surgery, the patients
were recalled for adjustment and evaluation and scheduled for follow-up every 4 weeks. Clinical
indices such as probing depth (PD), plaque index (PI), gingival index (GI), bleeding on probing (BOP),
gingival recession (GR), mobility (MOB), and clinical attachment level (CAL) were assessed 6 months
after the surgery.
2.5. Statistical Analysis
All data are expressed as mean ± standard deviation (SD). For the in vivo test, the Student’s t-test
was used. In the clinical trial, the clinical indices (PD, PI, GI, BOP, GR, MOB, and CAL) were compared
by Wilcoxon signed-rank test. Statistical differences between the control and test groups was analyzed
by Mann–Whitney U test, and differences were considered statistically significant when the p-value
was <0.05.
3. Results and Discussion
3.1. Morphology
The morphology of ES PLA95/β-TCP fibrous membranes are shown in Figure 3. The average fiber
diameter for this ES PLA95/β-TCP membrane was 2.37 ± 0.86 μm. The ES PLA95/β-TCP membranes
were prepared using dip-coating technique with a dimension of 3.0 × 4.0 cm2 (width × length),
thickness of 0.3–0.4 mm, suture pull-out force of >200 gf, average porosity of 53.0 ± 4.5%, and average
pore size of 25.0 ± 1.0 μm. Unlike the ES PLA95/β-TCP-N with contact angle of 122.6 ± 0.1◦, the PEO
(polyethylene oxide) dip-coated ES PLA95/β-TCP-T revealed the contact angle of 50.7 ± 0.2◦ [22]. The
hydrophilic surface would help cell adhesion to prevent the membrane expose and avoid infection
during healing process.
The typical criteria for ideal GTR membranes are known as cell-occlusive, space making,
tissue integrative, clinically manageable and biocompatible [23]. Among the fabrication processes
electrospinning, a versatile physical processing technology that does not affect the inherent material
properties, has substantially more advantages to manufacture membranes for biomedical and
tissue-engineering applications due to their high surface area-to-volume ratio, porosity, and
three-dimensional (3-D) structure to mimic an extracellular matrix for enhancing cell-surface
interactions [24]. The fiber morphology and diameter of electro-spun poly lactic acid (PLA) fibers
were mainly affected by solution properties and process parameters [25,26]. In recent years, growth
factors [27–29], doxycycline [30,31], and bio-ceramic materials [32,33] have been incorporated into
the GTR membranes to improve bioactivity and antibacterial properties. Hydroxyapatite (HAp),
β-tricalcium phosphate (β-TCP), and calcium sulfate (CaSO4), are osteo-conductive bio-ceramics
additives that are widely used in orthopedic and dental applications.
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Figure 3. Scanning electron micrographs of the four electro-spun fibrous membranes: (a) ES PLA95-N,
(b) ES PLA95-T, (c) ES PLA95/β-TCP-N and (d) ES PLA95/β-TCP-T. (N: Without polyethylene oxide
(PEO) dip-coating treatment, T: PEO dip-coating treatment). Images courtesy of [22].
The control group chosen in this study is Epi-Guide®, a porous three-layer self-supporting
poly-d,l-lactic acid (DL-PLA) barrier for up to 20 weeks with complete bio-resorption between 6–12
months. The Epi-Guide® barrier is claimed to be a hydrophilic membrane that quickly absorbs blood
fluid and supports healthy clot formation to maintain gingival flap viability and coverage.
3.2. Cytotoxicity Test
As a surgical implant, it is important to verify the biocompatible properties of the ES PLA95/β-TCP
membrane. In a previous study, the results indicated that the MC-3T3-E1 cells could adhere and
proliferate on the surface of ES PLA95/β-TCP membrane [22]. Therefore, we alternatively evaluated
the cytotoxicity of the ES PLA95/β-TCP membrane to ensure the safety of the manufacturing process
as well as the PLA95 material. In this study, the MEM elution assay was used to verify the cytotoxicity
of the ES PLA95/β-TCP membrane in accordance with the ISO-10993-5 guideline. The results revealed
no cell lysis in the membrane extract, reagent blank, and the negative control extracts under light
microscope. Thus, it was inferred that the ES PLA95/β-TCP membrane did not exhibit cytotoxic
reactivity (Table 1).
Table 1. Cytotoxicity assay of ES PLA95/β-TCP membrane by indirect method.
Extracts of Test Item and Controls Observation Grade Reactivity
Membrane extract, reagent blank, and
negative control extract (N = 3)
Discrete intracytoplasmic granules; no
cell lysis; no reduction of cell growth 0 None
Positive control (N = 3) Complete destruction of the cell layers 4 Severe
Note: (Grade 0: no cell lysis or reduction of cell growth, Grade 1: not more than 20% of the cells are round, Grade 2:
not more than 50% of the cells are round and devoid of intra-cytoplasmic granules, Grade 3: not more than 70% of
the cell layers contain rounded cells or are lysed, Grade 4: nearly complete or complete destruction of the cell layers).
3.3. In Vivo Test (Animal Model)
There were no severe inflammations and swellings at the flaps in the defect. The periodontal
tissues were healthy on the day of sacrifice. The GTR animal model for cementum and bone height
were H&E stained and observed under a light microscope (Figure 4).
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Figure 4. The GTR animal model for cementum and bone height evaluation of (A) empty control
group and (B) representative experimental group. NB: New bone, T: Tooth, AB: Alveolar bone, CE:
Cementum, CEJ: Cementoenamel junction. White scale bar noted as 1 mm. Time of implantation:
8 weeks.
The histological results of various 8-week ES PLA95/β−TCP GTR membranes were shown in
Figure 5. The histometric evaluation were carried out and listed in Table 2 and Figure 6. The cementum
height of the test and control membranes was significantly different between the empty defect after
8 and 16 weeks (p < 0.05). The results of bone height showed difference only at 16 weeks (p > 0.05)
with respective test and control values of 2.67 (±0.33) mm and 2.58 (±0.15) mm; these values were
significantly different from the corresponding value of the empty group at 16 weeks (p < 0.05). The ES
PLA95/β-TCP membrane was effective to block the migration of fast-growing connective tissue into
the defect area and in creating some space for the regeneration of new tissues.
In a typical GTR animal study, the usage of bone grafts usually interferes with the efficacy of
the GTR membrane [34,35]. Therefore, we intentionally adopted the similar procedure but without
bone grafts to confirm the blocking function of the proposed GTR membrane in this study. The results,
however, still showed significant differences between the experimental and empty control groups. In
addition, few previous studies have shown more bone formation after GTR as compared to that in
the empty control without membrane [36,37]. In this study, the cementum height of the experimental
group was larger than that of the empty control group without bone grafts at eight weeks. From these
results, we conjectured that the addition of bone graft would affect the growth of new bone tissues.
The ES PLA95/β-TCP membrane and Epi-Guide® groups were all with similar PLA materials and
mechanical properties, with a limited amount of β-TCP content for buffering properties. Therefore,
the osteoconductive effect on tissue growth was not significantly different from ES PLA95/β-TCP
membrane and Epi-Guide® groups.
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Figure 5. The 8-week H&E stain of various ES PLA95/β-TCP GTR barriers (H&E Stain, 40X) T: Tooth,
B: Cementum, N: New bone, PDL: Periodontal ligament.
Table 2. The GTR model results of cementum and bone height measurements with empty control and
ES PLA95/β-TCP membranes in LanYu pigs after 8 and 16 weeks.
Time Membranes
Cementum Height
(Mean ± SD) mm
Bone Height
(Mean ± SD) mm
8 weeks
Empty control 0.82 ± 0.15 0.98 ± 0.12
ES PLA95/β-TCP 1.82 ±0.38 1.42 ± 0.37
Epi-Guide® membrane 1.65 ± 0.28 1.25 ± 0.36
16 weeks
Empty control 1.18 ± 0.22 *,# 1.28 ± 0.33 *,#
ES PLA95/β-TCP 3.67 ± 0.42 * 2.67 ± 0.33 *
Epi-Guide® membrane 3.42 ±0.33 # 2.58 ± 0.36 #
*,#: Statistical significant differences when p < 0.05. Values are reported as mean (SD) (N = 3).
Figure 6. The cementum and bone height of ES PLA95/β-TCP and commercial membranes were
measured in LanYu pigs after 8 and 16 weeks. *Differences were considered statistically significant
when p < 0.05.
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3.4. Clinical Trial
All patients selected for inclusion in the study received a comprehensive periodontal examination
and radiographs. The study patients were comprised of seven men and eight women with an age range
of 35-65 years (mean age: 53 years). Among the seven patients who used Epi-Guide®, two patients
collected more than one site due to their severity in periodontal disease (7 + 2 = 9 results). Among
the eight patients who used ES PLA95/β-TCP GTR membrane, three patients collected more than one
site due to their severity in periodontal disease (8 + 3 = 11 results). In patient response, four patients
of the control group had a sore tooth at the surgical sites six months after the surgery, while the ES
PLA95/β-TCP membrane group did not. In clinical observation, ES PLA95/β-TCP membrane did not
show early exposure, implying that the hydrophilic membrane might help gingival tissue adhesion.
Six months after the surgery, the clinical indices of each site were measured and re-recorded, such as
PI, GI, PI, GI, BOP, PD, GR, MOB, and CAL. Furthermore, pre-surgery and post-surgery radiographies
were observed, and reconstruction of bony defect was compared (Figure 7). Several new bone tissues
were detected in the defect, indicating that the surgery had good bone-material compatibility outcome.
 
Figure 7. The patient A is with (A) pre-surgical radiograph (Tooth No. 36), (B) post-surgical radiograph
with Epi-Guide® membrane after 6 months. The patent B is with (C) pre-surgical radiograph (Tooth
No. 37), (D) post-surgical radiograph with ES PLA95/β-TCP membrane after 6 months. Arrow (white)
indicates the bone regeneration.
The clinical indices for the commercial Epi-Guide® group in PD, GI, BOP, and CAL, showed
statistically significant differences (p < 0.05; Table 3) after treatment, while the experimental group
of the ES PLA95/β-TCP membrane showed statistically significant differences for PD, GI, GR, and
CAL indices (p < 0.05; Table 4) after treatment. The results showed significantly more attachment
gain (Epi-Guide®, 2 mm; PLA95/β-TCP GTR group, 3 mm; p =0.28) and shallower probing depths
(Epi-Guide®, 3.3 mm; PLA95/β-TCP GTR group, 2.25 mm; p =0.85) than the empty control group. The
change of clinical indices indicated direct improvement of periodontal inflammation and the efficacy
for both the Epi-Guide® and the ES PLA95/β-TCP GTR membrane groups. However, these results did
not show statistically significant differences between them (Table 5).
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Probing depth (PD) mm 9 6.3 (6–7) 3 (2.7–4.5) 0.0039 *
Plaque index (PI)% 9 16 (10–16) 16 (16–16) 0.62
Gingival index (GI) 9 1 (1–1) 0.5 (0.5–0.5) 0.015 *
Bleeding on probing (BOP)% 9 17 (16–33) 0 (0–16) 0.031 *
Gingival recession (GR) mm 9 0 (0–0) 2 (0–2) 0.25
Mobility (MOB) 9 0 (0–1) 0 (0–1) 1.00
Clinical attachment level
(CAL = PD + GR) mm 9 7 (7–8) 5 (4–5) 0.0039 *
*: Differences were considered statistically significant when p < 0.05.





Probing depth (PD) mm 11 5.75 (5–8) 3.5 (3–5) 0.001*
Plaque index (PI)% 11 16 (10–16) 10 (0–16) 0.125
Gingival index (GI) 11 1 (1–1) 0.5 (0–0.5) 0.0098*
Bleeding on probing (BOP)% 11 17 (16–50) 16 (0–16) 0.1250
Gingival recession (GR) mm 11 0 (0–2) 2 (1–3) 0.0078*
Mobility (MOB) 11 0 (0–1) 0 (0–1) 0.7500
Clinical attachment level
(CAL = PD + GR) mm 11 8 (6–9) 5 (5–8) 0.0020*
*: Differences were considered statistically significant when p < 0.05.
Table 5. Itemized clinical index differences between the Epi-Guide® and ES PLA95/β-TCP groups
after treatment.
Clinical Index
Epi-Guide® Group ES PLA95/β-TCP Group p-Value
N Median Q1 Q3 N Median Q1 Q3
Probing depth (PD) mm 9 2 3.7 2 11 2.5 3 1.5 0.85
Plaque index (PI)% 9 0 0 0 11 0 16 0 0.33
Gingival index (GI) 9 0.5 0.5 0.5 11 0.5 0.5 0.5 0.24
Bleeding on probing(BOP) % 9 16 17 0 11 0 34 0 0.60
Gingival recession (GR) mm 9 0 0 2 11 1 0 2 0.31
Mobility (MOB) 9 0 0 0 11 0 0 0 1.00
Clinical attachment level
(CAL = PD + GR) mm 9 2 4 2 11 2 3 1 0.28
Mann–Whitney U test, *: Differences were considered statistically significant when p < 0.05.
In the clinical study, a few patients of the control group showed soreness at the surgical sites 6
months after the surgery, while the ES PLA95/β-TCP membrane did not. We conjectured that the small
amount of β-TCP in this membrane acts as a buffer to reduce the acid releasing during the hydrolysis of
ES PLA95 membrane. Therefore, the ES technique is suitable for manufacturing the ES PLA95/β-TCP
GTR membrane.
4. Conclusions
In this study, ES PLA95/β-TCP membranes were prepared by ES technology. Their effectiveness
and safety with regards to cytotoxicity, in vivo animal, and clinical studies were investigated. The ES
PLA95/β-TCP membrane did not show cytotoxicity, nor did it result in any inflammation. Significant
difference was observed in cementum and bone height before and after surgery using the ES
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PLA95/β-TCP membrane in animal study. Furthermore, the ES PLA95/β-TCP membrane have
a hydrophilic property would prevent early exposure and healing efficacy in this study. In intrabony
defects, the use of Epi-Guide® or ES PLA95/β-TCP membranes in GTR procedures yielded comparable
clinical results in reducing the probing depth and increasing attachment gain for periodontal patients.
The results extended the data bank of resorbable polymer for medical applications where contradictory
use of current commercial solution due to clinical condition/preexisting condition of patients
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Abstract: Rheumatoid arthritis (RA) is an autoimmune disease that affects the synovial cavity of joints,
and its pathogenesis is associated with an increased expression of pro-inflammatory cytokines, namely
tumour necrosis factor-alpha (TNF-α). It has been clinically shown to have an adequate response to
systemic administration of TNF-α inhibitors, although with many shortcomings. To overcome such
limitations, the immobilization of a TNF-α antibody on a nanofibrous substrate to promote a localized
action is herein proposed. By using this approach, the antibody has its maximum therapeutic efficacy
and a prolonged therapeutic benefit, avoiding the systemic side-effects associated with conventional
biological agents’ therapies. To technically achieve such a purpose, the surface of electrospun
nanofibers is initially activated and functionalized, allowing TNF-α antibody immobilization at
a maximum concentration of 6 μg/mL. Experimental results evidence that the biofunctionalized
nanofibrous substrate is effective in achieving a sustained capture of soluble TNF-α over time.
Moreover, cell biology assays demonstrate that this system has no deleterious effect over human
articular chondrocytes metabolism and activity. Therefore, the developed TNF-capturing system may
represent a potential therapeutic approach for the local management of severely affected joints.
Keywords: antibody immobilization; electrospun nanofibers; TNF-α capture; human articular
chondrocytes; rheumatoid arthritis
1. Introduction
Rheumatoid arthritis (RA) is an autoimmune disease that affects primarily the synovial cavity
tissues on the small diarthrodial joints of the hands and feet [1], leading to persistent synovial
inflammation [2] and progressive erosion of the articular structures [3,4]. The triggers for the disease
susceptibility and the pathological cascade of events encompass environmental, genetic and stochastic
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factors [3,4]. For example, RA has special incidence on females [5], which is related with genetic [5–7]
and hormonal factors [5,8–10], but also presents a heterogeneous geographic distribution, being less
common in developing countries [11,12], which confirms the involvement of environmental and
socio-cultural factors [12].
The disease pathophysiology involves several interconnected mechanisms. Specific antibodies
for immunoglobulin G (IgG) mediate the autoimmune process, as well as the imbalanced expression
of the pro-inflammatory cytokine’s profile and its functionality [1,12–14]. Consequently, this leads
to inflammatory processes, autoimmunity enhancement, long-term inflammatory synovitis and joint
damage [13,15]. Additionally, locally expressed degradative enzymes digest the cartilaginous matrix
and destroy the articular surfaces [1]. Infiltration of B cells, CD4+ T cells and macrophages into the
synovium, which in normal conditions is relatively acellular [1,14,16], leads to soft tissue oedema and
stiffness [2]. Moreover, other inflammatory cells such as neutrophils, natural killer cells and mast cells
play key roles in the disease’s progression [13].
From the autoimmune disease (AD) subsets that entail the multiple inflammatory cascades, one of
the most significant players is the TNF-α, particularly the over-expression of the TNF-α [11,13,17].
TNF-α, a 233 amino acid protein [18], is a key signaling cytokine in the immune system mainly
produced by monocytes, macrophages [19], and B and T cells [2,13,17]. TNF-α stimulates the
production of other inflammatory mediators, namely IL’s, as well as the recruitment of immune
and inflammatory cells into the joint [20,21]. As a regulatory cytokine that manages communication
between immune cells and controls many of their functions when deregulated, TNF-α plays a key
role in the pathogenesis of chronic inflammatory diseases, such as RA [22,23]. TNF deregulation
in RA is linked to TNF-α converting enzyme (TACE or ADAM17), a metalloproteinase that
cleaves trans-membrane TNF, releasing the soluble segment [18,24]; and to TNF receptors (mostly
TNFr-I) [18,25,26], which are likely to be related with proinflammatory, cytotoxic and apoptotic
responses [2].
The increasing knowledge on RA pathogenesis stimulated the development of different
therapeutic modalities aiming to avoid joint destruction, minimize the symptomatic profile,
and enhance physical function [27]. These options comprise analgesics, symptomatic management and
inflammatory drugs [11,28]. Analgesics enclose the non-steroidal anti-inflammatory drugs (NSAIDs)
that are commonly used to treat RA. The inflammatory suppressive drugs include glucocorticoids and
disease-modifying anti-rheumatic drugs (DMARDs) both non-biologic and biologic. Due to the disease
heterogeneity, therapeutic strategies must be tailored to the individual patient in order to achieve a low
level of disease activity within a limited period of time [29]. Thus, the combination of two treatment
modalities has been proposed to achieve such a purpose [30].
Considering the significant involvement of TNF-α in RA, as well as the rising evidences that
this cytokine heads the pro-inflammatory cytokine cascade, it becomes a significant therapeutic
target [31,32]. Specifically, these evidences led to the development of TNF inhibitors for the treatment
of ADs [33–37], as they became the first class of biologic agents to be used in RA treatment [38].
A specific high affinity monoclonal antibody is used to recognize and neutralize selectively its antigen,
i.e., TNF-α [18,27,39]. Five different types of TNF-α inhibitors are currently licensed for human
clinical use in RA treatment, namely Infliximab, Entarnecept, Adalimumab, Certalizumab Pegol and
Golimumab. With the exception of Infliximab, which is administrated by intravenous (IV) infusion,
all other medicines are administered subcutaneously [13]. For long-term control of RA, a continuous
treatment is required because of disease flares’ risk when the therapy is discontinued [1]. Although
these therapeutic modalities have been used for quite some time, they present many shortcomings such
as lack of specificity, limited antibody half-life, high cost, response variability, or even lack of response
to treatments [11,40]. Due to the systemic character of these treatments, not only target tissues but also
healthy tissues are exposed to a significant dose of drug, leading to adverse side effects [41]. These
effects are common to many tissues, organs and systems, such as cardiovascular, renal, dermatological,
and neurological, or risk of severe infection [11,27,28,40].
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Furthermore, some attention has been given to drug carriers, in order to maintain effective
concentration levels in plasma for extended periods [41]. Examples of these systems are the
encapsulation of Infliximab in polylactide-co-glycolide microspheres [42] or porous silicon 3D
structures [43], as well as long-term release of Etanercept by polyelectrolyte complex formulated
particles [44]. Despite the promising preliminary results, these systems are still poorly developed.
Considering the shortcomings of these treatments, there is a need for innovative approaches
that circumvent the aforementioned adverse side effects. Therefore, the main objective of this
work was to develop an implantable system capable of capturing excessive TNF-alpha present in
intra-articular cavities of an RA patient. For that, we immobilized a neutralizing TNF-α antibody
at the surface of a polymeric substrate (i.e., electrospun nanofibers). This strategy takes advantage
of specific interactions between the antibody and the antigen, where the antibody (TNF-α antibody)
binds to the antigen (TNF-α) avoiding/limiting its harmful pro-inflammatory effects. After the
system´s assembly and proved ability to capture TNF-α secreted by activated monocyte-derived
macrophages, the cytotoxicity of the biofunctionalized system was tested with human articular
chondrocytes. Indeed, the cytocompatibility and chondrogenic differentiation potential of bare
electrospun nanofibers were previously reported by us [45–47], corroborating their potential use
in cartilage regeneration approaches.
2. Materials and Methods
2.1. Materials
Polycaprolactone (PCL; Mn = 70,000–90,000 determined by Gas Permeation
Chromatography), chloroform, N,N-dimethylformamide (DMF), 1,6-hexamethylenediamine
(HMD), Ellmans reagent (DTNB), 2-iminiothiolane (2IT), 2-(N-morpholino)-ethanesulfonic
acid (MES hydrate), phosphate buffered saline (PBS), N-hydroxysuccinimide (NHS),
and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDC) were purchased
from Sigma-Aldrich (Saint Louis, MO, USA) and kept at room temperature (RT), with the exception of
2IT which was kept at 4 ◦C and EDC which was kept at −20 ◦C. 4-(dimethylamino) pyridine (DMAP)
was purchased from Millipore (Darmstadt, Germany) and kept at RT. Anti-TNF-α antibody [B-C7] was
purchased from Abcam (Cambridge, UK) and kept at 4 ◦C until further use. Alexa Fluor® 488 goat
anti-mouse rabbit IgG (H + L) and TNF-α human ELISA kit were purchased from Life Technologies
(Carlsbad, CA, USA) and kept at 4 ◦C until further use.
2.2. Production and Functionalization of Nanofiber Meshes
2.2.1. Production of Nanofiber Meshes
Nanofiber meshes (NFMs) were prepared as described elsewhere [48,49]. Briefly, the NFMs were
produced by electrospinning of a polymeric solution of 15% (w/v) PCL dissolved in an organic solvent
mixture of chloroform and dimethylformamide (7:3 ratio). This PCL solution was electrospun by
applying a voltage of 12 kV, a needle tip-to-ground collector distance of 20 cm and a flow rate of
1 mL/h. After the complete processing of 1 mL of PCL solution, the NFMs were left to dry for 1 day at
RT inside a chemical hood, in order to completely evaporate the solvents. All further tests described
were performed in samples of 10-mm squares.
2.2.2. Surface Functionalization of Electrospun NFMs
The surface functionalization of electrospun NFMs was performed as described elsewhere [48,49].
Briefly, the NFMs’ surface was activated by 4 min of UV-Ozone irradiation (UV-O-Cleaner®,
ProCleaner 220, Bioforce Nanoscience, Salt Lake City, UT, USA). Afterwards, the amine groups (–NH2)
were inserted by immersion of the irradiated NFM in a 1 M hexanediamine (HMD) solution during
1 hour at 37 ◦C.
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2.2.3. Quantification of Amine Groups Present at the Functionalized NFMs
Quantification of amine groups present in each NFM was performed as described
elsewhere [50,51]. For that, SH groups were inserted at the surface of the aminolysis-treated NFMs
through the reaction of the amine groups with a 20 mM 2IT solution (0.1 mM PBS at pH8) and with a
20 mM DMAP solution during 1 h at 37 ◦C. Ellman’s reagent method was used to quantify the amino
groups. For that, samples were immersed in 0.1 mM DTNB solution (in PBS 0.1 mM at pH 7.27) and
incubated during 1 h at 37 ◦C. The absorbance of supernatants was measured in triplicate at 412 nm
in a quartz plate, using the DTNB solution as blank. For the calculation of the 2-nitro-5-thiobenzoate
(NTB−2) molar absorption coefficient, the value of 14,151 M−1 cm−1 was used [50,51].
2.3. Antibody Immobilization
The TNF-α antibody was immobilized at the surface of activated and functionalized
electrospun NFMs. To determine the substrate’s maximum immobilization capacity, a wide range
of primary antibody concentrations were considered (from 0 to 12 μg/mL). The TNF-α antibody
was firstly activated by a 15-minute incubation with a solution of EDC/NHS (50 mM EDC and
200 mM NHS), dissolved in a 0.1 M 2-(N-morpholino)-ethanesulfonic acid (MES) buffer with 0.9%
(w/w) NaCl, followed by pH adjustment to 4.7 [48].
The functionalized NFMs were incubated with 200 μL of the activated TNF-α antibody overnight
at 4 ◦C. Biofunctionalized NFMs were washed three times with PBS. A 3% bovine serum albumin (BSA)
solution was used as a blocking step. To determine the degree of TNF-α antibody immobilization,
biofunctionalized NFMs were incubated with an Alexa Fluor® 488 solution diluted in PBS (1:200
ratio). As a negative control, NFMs with no antibody immobilized (plotted as 0 μg/mL) were used.
The fluorescence of the supernatant was determined in triplicate, using an excitation of 495/20 nm
and an emission of 519/20 nm, and used to quantify the amount of antibody effectively immobilized.
2.4. Characterization Biofunctionalized NFMs
2.4.1. Scanning Electron Microscopy (SEM)
SEM was used to analyse the morphology of biofunctionalized NFMs. Briefly, the biofunctionalized
NFMs were sputter-coated with a thin layer (9–12 nm) of gold/palladium (Cressington 208 HR) and
then analysed by SEM (NanoSEM, Nova 200, FEI company, Hillsboro, OR, USA). Micrographs were
recorded at 15 kV with magnifications ranging from 100 to 2000 times.
2.4.2. Fluorescence Microscopy
A fluorescence microscope (Axio Imager Z1m, Zeiss, Gottingen, Germany) was used to analyze
the spatial distribution of the TNF-α antibody at the surface of electrospun NFMs. The TNF-α antibody
was linked by a secondary antibody with green fluorescence (Alexa Fluor™ 488). Photographs were
recorded at magnifications of 50, 200 and 400 times.
2.5. Capturing of TNF-α Present in Conditioned Medium of Macrophage Culture
A human monocytic cell line THP-1 was maintained in RPMI 1640 media supplemented
with 2 mM L-glutamine, 100 μg/mL of penicillin, 100 μg/mL of streptomycin, 10 mM HEPES,
and 10% fetal bovine serum (complete RPMI, cRPMI) (Life Technologies, Carlsbad, CA, USA). For the
induction of cell differentiation, cells (106 per mL) were seeded in cRPMI with 100 nM phorbol
12-myristate-13-acetate (PMA) for 24 h. After incubation, non-attached cells were removed by
aspiration, and the adherent cells were washed three times with cRPMI. To ensure reversion of
cells to a resting macrophage phenotype before stimulation, cells were incubated for an additional
48 h in cRPMI without PMA. For stimulation and retrieval of conditioned media, cells were further
incubated for 4 h with 100 ng/mL of lipopolysaccharide (LPS) in fresh cRPMI and the supernatants
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were collected and stored at −80 ◦C. Production of TNF-α was assessed in the conditioned media
by commercial ELISA (Life Technologies, Carlsbad, CA, USA). Four systems were tested at least in
quadruplicates, in two independent assays: (1) the biofunctionalized NFM (with immobilized TNF-α
antibody); (2) a positive control with the soluble TNF-α antibody; (3) a negative control with the
UV-O activated NFM; and (4) the conditioned cell culture medium alone. Each system was placed in
sterile Eppendorf tubes and 2 mL of monocyte-derived macrophage conditioned medium was added
individually, and kept at 37 ◦C in agitation in an orbital shaker at 120 rpm. Initially, a 3 days assay was
performed with a 1 ng/mL TNF-α concentration from monocyte-derived macrophage conditioned
medium. A specimen was collected at the following time points (2, 4, 6, 8, 10, 12, 24, 32, 48, and 72 h of
incubation) without conditioned medium replacement. Afterwards, a 15-day assay was conducted,
where a sample was collected daily and recharged with the same volume of recovered cell culture
medium each day, which had a TNF-α concentration of 500 pg/mL. This concentration was chosen
due to being closer to TNF-α levels in active RA patients (76.1 ± 103.2 pg/mL) [19], considering a
margin of error affected by the TNF-α degradation.
Enzyme-Linked Immunosorbent Assay (ELISA)
For the quantification of TNF-α in the conditioned medium at each time point, sandwich TNF-α
ELISA (KHC3012, TermoFisher Scientific, Carlsbad, CA, USA) was performed according to the
manufacturer. Absorbance was read at 450 nm on a microplate reader (Synergy HT, BioTek, Winooski,
VT, USA). A standard curve was built with concentrations ranging from 0 to 1000 pg/ml. The final
concentrations were calculated by subtracting the value of each sample (i.e., testing conditions 1–3) to
the conditioned culture medium baseline (i.e., testing condition 4), and the average was plotted for
each testing condition along time.
2.6. Biological Assays
2.6.1. Isolation and Cell Culture
Cartilage tissue consists of only one cell type, the chondrocyte, embedded in a dense extracellular
matrix (ECM). To evaluate the cytotoxicity of the developed biofunctionalized nanofibrous substrates,
human articular chondrocytes (hAC) isolated from knee cartilage samples, collected from arthroplasties
surgeries biopsies, were used. These cells were chosen as they were isolated from diseased joints
cartilage. Samples were collected under the cooperation agreement between Centro Hospitalar do
Alto Ave, Guimarães, Portugal, and the 3B’s Research Group, after informed donor consent. Briefly,
cells were isolated by enzymatic digestion, according to the protocol described previously [46].
Dulbecco’s modified Eagle’s medium (DMEM, Sigma D5671), containing 10 mM Hepes buffer
(Life Technologies, Paisley, UK), L-alanyl-L-glutamine (Sigma), Non Essential Aminoacids (Sigma)
10,000 units/ml penicillin, 10,000 μg/mL streptomycin, and 10% foetal calf serum was the basis for the
expansion and differentiation medium used herein (Basic medium). Basic medium was supplemented
with 10 ng/mL of bFGF for hAC expansion. Basic medium was further supplemented with 1 mg/mL
of insulin and 1 mg/mL of ascorbic acid, when hAC were seeded onto the PCL NFM (differentiation
medium). These supplements enhanced extracellular matrix (ECM) deposition by the cultured hACs.
Human articular chondrocytes where used at passage 4. Expansion medium was changed
every 2 days until the cells reached a confluence of 90%. The cells were harvested and seeded
onto both the activated NFM, as well the NFM with the TNF-α antibody immobilized using the
differentiation medium.
2.6.2. Seeding onto NFMs
Electrospun PCL NFMs were sterilized by UV-O treatment. All the surface functionalization
and TNF-α antibody immobilization steps were performed in sterile conditions. For the
biofunctionalized NFMs, antibody immobilization was performed overnight, and after the BSA
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blocking step, cell seeding was performed. Activated and biofunctionalized electrospun NFMs were
used as controls.
Confluent hACs were detached from the culture flask using trypsin, counted on a hemocytometer
and seeded at a density of 200.000 cells/NFM. Seeding was performed using the droplet method,
using a 50 μL drop of cell suspension on all sample groups in 24-well plates. The plates were
placed at 37 ◦C and 5% CO2 over 4 hours. After cell attachment to the NFMs, 1 mL of expansion
medium was added to each well. Afterwards, the medium was changed into differentiation medium.
The seeding was performed in three independent experiments. For each independent experiment,
constructs were cultured for 1, 14, 21 and 28 days under static conditions and collected at each time
point for quantification of cell viability, DNA, total protein analysis, as well as GAGs deposition.
Cell morphology was evaluated by SEM.
2.6.3. DNA Quantification
DNA quantification was assessed using Quant-iT™ PicoGreen® dsDNA Reagent and Kit
(Life Technologies, Eugene, OR, USA), according to the manufacturer´s instructions. Triplicates
of each condition collected at 1, 14, 21 and 28 days were evaluated. The specimens were collected,
1 mL of sterile distilled water was added, and then samples were stored at −80 ◦C until further
analysis. Prior quantification, the samples were defrosted and sonicated for 15 min. To extrapolate the
DNA values for each sample, a set of standards were prepared with concentrations ranging from 0
to 1.5 μg/mL. The fluorescence of each sample was measured on an opaque 96-well plate using an
excitation of 485/20 nm and an emission of 528/20 nm, using a microplate reader (Synergy HT, BioTek,
Winooski, VT, USA).
2.6.4. Total Protein Synthesis Quantification
Total protein was performed using Micro BCA™ Protein Assay Kit (ThermoFisher Scientific,
Rockford, IL, USA) according to the manufacturer´s instructions. Triplicates of each condition collected
at 1, 14, 21, and 28 days were evaluated. The samples were collected as described in Section 2.6.3.
A standard curve was prepared ranging from 0 to 200 μg/mL. The absorbance of each sample was
measured at 562 nm using a microplate reader (Synergy HT, BioTek, Winooski, VT, USA).
2.6.5. Glycosaminoglycan (GAG) Quantification
GAG quantification was performed using papain digestion. Triplicates of each condition collected
at each previously established time point were tested. The samples were collected and stored in
eppendorf tubes at −80 ◦C until further analysis. Digestion solution was prepared by adding papain
(Sigma Aldrich, Saint Louis, MO, USA) and N-acetyl cysteine (Sigma Aldrich) at concentrations of
0.05% and 0.096%, respectively, to 50 mL of digestion buffer (200 mM of phosphate buffer containing
1 mM EDTA (Sigma Aldrich), pH 6.8). Each specimen was incubated with 600 μL of digestion
buffer, overnight at 60 ◦C. After a 10-min centrifugation at 1300 rpm, the supernatant was collected.
Dimethymethylene Blue (DMB) stock solution was prepared dissolving 16 mg of DMB powder in
900 mL of distilled water containing 3.04 g of glycine and 2.73 g of NaCl. pH was adjusted to 3.0
with HCl and the volume adjusted to 1 L. The solution was stored at RT covered by aluminum foil.
Chondroitin sulphate (Sigma, C8529) solution was prepared in water in a 5 mg/mL stock solution and
kept refrigerated. Standards were prepared from serial dilutions of this solution. Three samples per
condition were considered per time point, and the absorbance of each sample was measured at 530 nm
using a microplate reader.
2.6.6. Histological Analysis
Samples were collected at the end of the experiment and processed for histology. Samples were
then fixed in 10% neutral-buffered formalin and then kept at 4 ◦C until the staining procedures. Alcian
Blue staining was performed by rinsing the samples in 3% acetic acid, keeping them in 1% alcian blue
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solution (Sigma, A-3157) for 1 h. After that, the stain was poured off and sections were washed with
water, let to dry, and then rinsed in absolute alcohol, cleared in xylene, and mounted in Entellan rapid
(Merck Millipore, Darmstadt, Germany, 1.07960.0500).
2.7. Statistical Analysis
Statistical analysis of values related with antibody immobilization, TNF-α capturing profiles
and biological studies was performed using IBM SPSS software (version 21; SPSS Inc., Armonk, NY,
USA). Firstly, a Shapiro-Wilk test was used to ascertain the assumption of data normality. For antibody
immobilization, protein capture and biological assays, the results showed that the data was not
following a normal distribution. P values lower than 0.01 were considered statistically significant in
the analysis of the results. A Kruskal-Wallis test was also performed for the comparison of more than
two independent groups of samples for one variable.
3. Results and Discussion
3.1. Antibody Immobilization Efficiency
The primary antibody (anti-TNF-α antibody) immobilization at the surface of electrospun
nanofiber meshes (NFMs) was performed in a wide range of concentrations (0–12 μg/mL) to
determine the maximum antibody immobilization capacity. The fluorescence of the unbound
secondary antibody was measured and the values were plotted against the various primary antibody
concentrations (Figure 1). As this is an indirect quantification method, higher fluorescence values of
the unbound secondary antibody correspond to lower concentrations of anti-TNF-α primary antibody
immobilization. Moreover, when the substrate is saturated, the fluorescence values of unbound
secondary antibody reach a plateau, despite the increment on antibody concentration.
Figure 1. Box plot of anti-TNF-α antibody immobilization at concentrations ranging from
0 to 12 μg/mL. Data were analysed by nonparametric way of a Kruskal-Wallis test followed by Tukey’s
HSD test: (a) denotes significant differences compared to concentration 0, (b) denotes significant
differences compared to concentration 1, (c) denotes significant differences compared to concentration 2,
and (d) denotes significant differences compared to concentration 4.
The statistical analysis showed that the immobilized primary antibody, with concentrations above
4 μg/mL, displayed significantly lower values of fluorescence intensity than 0 μg/mL (p < 0.01).
Concentrations of 6 μg/mL and 8 μg/mL exhibited significantly lower values of fluorescence intensity
when compared to all lower concentrations (p < 0.001). Moreover, these two concentration values
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did not display differences between themselves. Finally, when the antibody was immobilized at a
concentration of 12 μg/mL, the fluorescence intensity of secondary antibody did not present significant
differences when compared to the fluorescence intensity of NFMs with primary antibody immobilized
at concentrations above 2 μg/mL (p < 0.01). Therefore, primary antibody immobilization at the surface
of the nanofibrous substrate reached a maximum concentration of 6 μg/mL, since no statistically
significant differences were found between the concentrations above. This value is within the range
of concentrations systemically administrated in clinical practice using Infliximab (3–10 mg/kg or
3–10 μL/mL, considering water as body mass) [52].
3.2. Spatial Distribution of the Antibody at the Surface of Electrospun Nanofibers
After the optimization of the anti-TNF-α antibody immobilization, its spatial distribution at the
surface of electrospun NFMs was evaluated by fluorescence microscopy (Figure 2). The fluorescence
images display a random mesh-like arrangement comparable to the typical morphology of the
electrospun NFM (Figure 2A), showing that the antibody immobilization was successfully performed
and uniformly distributed along the surface of the nanofibers (Figure 2B). To ensure that the secondary
antibody was only bound to the immobilized primary antibody, a control experiment was defined,
in which all biofunctionalization steps were performed, except for incubation with the primary
antibody. The absence of a fluorescent signal proves that Alexa Fluor 488® secondary antibody was
not immobilized at the surface of activated and functionalized NFMs (data not shown), confirming the
specific bond between the primary and secondary antibodies.
 
Figure 2. SEM micrograph of a biofunctionalized NFM (A). Fluorescence micrograph of a NFM with
the TNF-α antibody immobilized at the maximum concentration (6 μg/mL) (B).
3.3. Quantification of Available Amine Groups
Antibody immobilization was achieved by the amine groups inserted at the nanofibers’ surface,
which provides binding sites. Consequently, the availability of this functional group influences
directly the primary antibody immobilization. To confirm the success of aminolysis functionalization,
as well as to determine if the binding points were enough for primary antibody immobilization,
quantification of available amine groups was performed. For this, SH groups were inserted at the
surface of the aminolysis-treated NFMs and determined by the Ellman’s reagent method [49]. Table 1
presents SH groups quantification at the surface of bare, UV-O irradiated, aminolysis-treated, and fully
biofunctionalized (with primary antibody immobilized) NFMs. The concentration of free SH groups at
the surface of electrospun NFMs is at its maximum value for the aminolysis-treated NFM, whereas
the bare NFM presents the minimum value, as expected. These values are in agreement with the
ones described in the literature [49] and confirm that the insertion of amine groups was successful.
Moreover, it was also proved that the amine groups inserted at the surface of activated NFM were
enough for primary antibody immobilization, since free amine groups were still present. Indeed,
only around 48% of the inserted amine groups were used in the immobilization of the TNF-α antibody
at 6 μg/mL.
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Table 1. Quantification of the free SH groups at the surface of untreated, activated, aminolys-treated,
and biofunctionalized NFMs.
Condition SH/NH2 Groups [mol/cm]
Untreated (3.54 ± 5.61) × 10−9
UV-O activated (5.86 ± 1.12) × 10−9
Aminolysis-treatment (17.9 ± 6.06) × 10−9
Immobilized Antibody (8.65 ± 3.41) × 10−9
3.4. Quantification of Captured TNF-α
The ultimate goal of this work was to engineer a system that could capture TNF-α. Accordingly,
after the primary antibody immobilization optimization, the TNF-α capturing capacity of the
biofunctionalized substrate was assessed. A TNF-α rich conditioned culture medium from stimulated
monocyte-derived macrophages was used over two distinct time intervals: 3 days representing the
half-life of the anti-TNF-α antibody and 15 days representing the time interval of anti-TNF-α antibody
administration in the clinic. Four conditions were tested and compared: (1) the biofunctionalized NFM
(with primary antibody); (2) a positive control with the soluble form of the anti-TNF-α; (3) a negative
control with UV-O activated NFM; and (4) the conditioned culture medium alone. The quantification
of TNF-α levels from the conditioned culture medium (condition 4) was used as a baseline, eliminating
the quantification of degraded TNF-α but not captured. Therefore, to guarantee the values’ accuracy
and reproducibility between experiments, the values herein presented do not correspond to the ones
quantified by ELISA, but just to the concentration of the TNF-α captured.
3.4.1. TNF-α Capturing during 3 days
The proposed system comprising anti-TNF-α immobilized at the surface of NFMs (NFM + Ab)
was found to capture soluble TNF-α in significant amounts after 8 hours of incubation when compared
to the UV-O activated NFM (NFM) (p < 0.01) (Figure 3). This observation was also valid when the
biofunctionalized substrate was compared to the soluble antibody (sAb), as the NFM + Ab exhibited
significantly higher cytokine clearance for time points above the 10th hour of incubation (p < 0.01).
In addition, no significant differences were found between the sAb and the control condition UV-O
activated NFM (NFM).





































Figure 3. TNF-α captured (median and interquartile range) over 72 h. Data were analysed by
nonparametric way of a Kruskal-Wallis test, followed by Tukey’s HSD test: (a) denotes significant
differences compared to immobilized anti-TNF-α at the surface of electrospun NFM (condition
NFM + Ab).
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The initial efficiency of the activated NFM over the TNF-α levels at early time points might
be justified by the presence of free binding sites (such as the available amine groups quantified
in Section 2.4) that unspecifically immobilize/adsorb proteins present in the conditioned medium,
including TNF-α. Nevertheless, the capturing levels in this condition stabilize around zero for time
points above 6 hours, unlike the biofunctionalized NFM + Ab, which maintains the capturing ability
until the last time point. Likewise, the positive control sAb has a similar biological effect to the NFM
+ Ab testing condition during the first 10 hours. The sAb capturing ability decreases after this time
point and becomes comparable to the NFM negative control condition. These results show that the
immobilized form of anti-TNF-α is more stable and has longer action times, when compared to the
non-immobilized one (i.e., sAb). However, this decrease might be partially justified by the gradual
clearance of the soluble anti-TNF-α from the conditioned medium along the samples collection. It is
envisioned that this decrease of sAb mimics its clearance in a living system, since the circulating
antibody has higher propensity to be cleared by biological means [41]. Even if the sAb was locally
administered, part of it would escape the articular cavity and enter into circulation, suffering also the
clearance phenomena.
3.4.2. TNF-α Capturing during 15 Days
To confirm the efficiency of the primary antibody immobilized at the NFMs’ surface to clear TNF-α
from the conditioned medium over time, as well as to evaluate the action time of the immobilized
antibody, an extended assay (15 days) was performed. Experimental results show that the sAb only has
a biological effect for the first 3 days, since from the fourth time point on, it does not present significant
differences when compared to the UV-O activated NFM (Figure 4). The NFM + Ab has a significantly
higher antigen-neutralizing activity ranging from the 2nd day until the 11th day when compared to the
sAb condition. Moreover, the biofunctionalized NFM + Ab does not have a significant biological effect
from the 11th day on, as no significant differences were found when compared to the control NFM.










































Figure 4. TNF-α captured (median and interquartile range) over 15 days. Data were analyzed by
nonparametric way of a Kruskal-Wallis test, followed by Tukey’s HSD test: (a) denotes significant
differences compared to immobilized anti-TNF at the surface of electrospun NFM (condition NFM
+ Ab); and (b) denotes significant differences compared to soluble anti-TNF (condition sAb).
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These results confirm the initial hypothesis that the immobilization of the primary antibody at the
NFMs’ surface had a longer effect than the soluble antibody. This longer effect might be supported
by the increased stability that the antibody immobilization provides [53]. Moreover, the physical
attachment prevents the antibody clearance from the system by biological means. As each NFM
has a high specific surface area, it allows the immobilization of high concentrations of primary
antibody, requiring a small amount of material for the development of an effective cytokine capture
system. Moreover, as the NFMs are made of polycaprolactone (PCL), a well-known biodegradable
polymer, these membranes will be completely degraded within a maximum period of 2 years. Thus,
the degradation time ensures that the captured TNF-α, as well as the attached antibody, may be slowly
degraded/metabolized by biological processes and that there is no abrupt release of these molecules
to the exterior of the synovial cavity.
3.5. Biologic Assays
After the successful assembly of the TNF-capturing system, we then tested it in contact with
arthritic joint cells. Therefore, the toxicity of the biofunctionalized NFMs was assessed by culturing
them with human articular chondrocytes (hACs). These cells were isolated from diseased knee
arthroplasties, thus presenting a phenotype that is associated with RA and osteoarthritis pathologies,
where inflammation was present. Different biological assays were conducted to assess the hACs
morphology, proliferation, total protein, and glycosaminoglycans (GAGs) synthesis. hACs were
cultured at the surface of three different substrates: (1) anti-TNF-α antibody immobilized at the surface
of NFMs (NFM + Ab), (2) UV-O activated NFM (NFM) and (3) tissue culture polystyrene (TCPs)
as positive control. The influence of the anti-TNF-α immobilization at the surface of NFMs over
hACs morphology was assessed by SEM. Micrographs (Figure 5) showed that hACs maintained their
round-shape morphology, typical of these chondrocytic cells.
 
Figure 5. SEM micrographs of hACs cultures on tissue culture polystyrene (TCPs), UV-O treated
electrospun PCL NFM (NFMs) and anti-TNF-α immobilized at the NFMs’ surface (NFM + Ab) for 14,
21 and 28 days.
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Chondrocytes proliferation was also evaluated by quantifying the dsDNA concentration.
Experimental results showed that the TCP’s condition displayed a significantly higher DNA
concentration, for 14 and 28 days of culture, when compared to all other culture conditions (p < 0.001)
(Figure 6A). Furthermore, on the 1st and 21st days of hACs culture, the control condition (TCPs)
present similar proliferation to the NFM + Ab testing condition. Finally, the NFM condition presented
a significantly lower cell proliferation at 21 and 28 days of culture, when compared to the NFM +
AB condition (p < 0.001). Taken together, these results indicate that the immobilized anti-TNF-α may
inhibit chondrocytes growth by mimicking an inflammatory environment, where cells would respond
by limiting their growth and proliferation. This effect is not negative, since our primary goal was
not to promote an extensive cell proliferation, but merely to assess the device’s potential cell toxicity.
Nevertheless, hACs keep proliferating, even if at a lower rate when compared to the controls. Indeed,
IL1-β and TNF-α have been shown to inhibit the migratory potential of chondrogenic progenitor cells
in osteoarthritic cartilage [54]. Furthermore, OA-derived hACs cultures have been reported to excrete
around 3000 pm/μL of TNF-α [55], thus these cells have mechanisms to respond to high concentrations
of this cytokine in the surrounding environment.
Figure 6. Box plot of human articular chondrocytes proliferation (A) and protein synthesis (B)
when cultured on tissue culture polystyrene (TCPs), UV-O treated electrospun PCL NFM (NFM)
and anti-TNF-α immobilized at the NFMs’ surface (NFM + Ab). Data were analysed by nonparametric
way of a Kruskal-Wallis test, followed by Tukey’s HSD test: (a) denotes significant differences compared
to NFM + Ab and (b) denotes significant differences compared to NFM.
Quantification of total protein synthesis is presented in Figure 6B. Experimental data showed that
TCP’s control condition displayed significantly higher concentration values than all the other testing
conditions for the 1st and 21st days of culture (p < 0.01). On the other hand, the NFM + Ab testing
condition displayed a significantly lower protein concentration when compared to all other culture
conditions for 28 days of culture (p < 0.01). At 14 days of hACs culture, no significant differences
between conditions were found (p = 0.148). The protein synthesis in the NFM + Ab condition was
lower for longer culture periods, which is possibly due to the extracellular accumulation of proteins by
hACs, rather than the intracellular synthesizing rate.
Furthermore, the impact of the anti-TNF-α antibody immobilization at the surface of NFMs on
GAG production and accumulation (Figure 7A) by hACs was also assessed. No significant differences
were found between all culture conditions for the 1st (p = 0.186) and 14th days (p = 0.088) of the
experiment. On the 21st day, the NFM + Ab testing condition displayed significantly lower GAG
concentrations than control condition TCPs (p < 0.01). Moreover, on the 28th day, TCPs presented
significant higher GAGs concentration than all other culture conditions (p < 0.01). Concerning the
GAGs production by hACs cultured onto the NFM + Ab, the obtained results confirm the evidences
found in the intracellular protein synthesis. There is a decrease in the total protein concentration values
for longer time points, with a concomitant increase of GAGs production for these same periods of time,
indicating that protein synthesis was being directed by the GAGs production. This increase of GAGs
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concentration for late time points of the experiment are in accordance to our hypothesis, as they will
protect chondrocytes against the inflammatory environment.
Figure 7. Blox plot of human articular chondrocytes GAGs accumulation when cultured on tissue
culture polystyrene (TCPs), UV-O treated electrospun PCL NFM (NFM) and anti-TNF-α immobilized at
the NFMs’ surface (NFM + Ab) (A). Data were analysed by nonparametric way of a Kruskal-Wallis test,
followed by Tukey’s HSD test: (a) denotes significant differences compared to NFM + Ab and
(b) denotes significant differences compared to NFM. Alcian blue staining evidencing sulphated
proteoglycans deposition in samples from TCPs (B), NFMs (C), and NFM + Ab (D) on the 28th day of
the experiment.
As it can be observed in Figure 7B–D, sulphated proteoglycans, an important component of
articular cartilage ECM, were detected on all culture conditions by alcian blue staining. Furthermore,
these observations are reassured by the quantification of GAGs presented in the box plot of Figure 7A.
Altogether, these results on intra- and extra-cellular protein synthesis confirmed that hACs are not only
able to proliferate and maintain their typical round morphology, but are also capable of performing
their metabolic functions properly, in the presence of the NFM + Ab testing system. With this study,
we validated the use of this TNF-α capturing system nearby cartilaginous structures. There is, indeed,
an influence on these parameters when cells are cultured onto NFM + Ab nanofibers, but it is not
enough to restrain human articular chondrocytes functions. In fact, it has been described that the
blockade of TNF-α by Infliximab treatment, during fracture healing, leads to an increased callus size.
This increase was accompanied by an increase in cartilage tissue [56].
4. Conclusions
The present work proposes the use of nanofibrous meshes (NFM) functionalized with a
neutralizing anti-TNF-α antibody, for the selective clearance of TNF-α. From a spectrum of primary
antibody concentrations, 6 μg/mL was determined as the maximum immobilization capacity of a
UV-O activated and aminolysis-functionalized NFM. Experimental results demonstrated the bioactivity
of the developed biofunctional substrate on clearing TNF-α from conditioned culture medium
of macrophages and a longer time of action when compared to the circulating/soluble antibody.
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Furthermore, cell biology data showed that the immobilized anti-TNF-α antibody exhibited no
cytotoxicity over human articular chondrocytes and that these cells were able to maintain their
metabolic functions in the presence of the TNF-capturing system. In conclusion, we herein describe
an effective system for local clearance of TNF-α, which is particularly relevant in a RA scenario,
but adaptable to other autoimmune inflammatory conditions.
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Abstract: Surface modification of biomedical implants is an established strategy to improve tissue
regeneration, osseointegration and also to minimize the bacterial accumulation. In the present
study, electrospun poly(ε-caprolactone)/titania (PCL/TiO2) nanocomposite coatings were developed
on commercially pure titanium (cpTi) substrates for an improved biological and antibacterial
properties for bone tissue engineering. TiO2 nanoparticles in various amounts (2, 5, and 7 wt %)
were incorporated into a biodegradable PCL matrix to form a homogeneous solution. Further,
PCL/TiO2 coatings on cpTi were obtained by electrospinning of PCL/TiO2 solution onto the substrate.
The resulted coatings were structurally characterized and inspected by employing scanning electron
microscope (SEM), X-ray diffraction (XRD), and Fourier transform infrared (FTIR) spectroscopy.
Given the potential biological applications of PCL/TiO2 coated cpTi substrates, the apatite-forming
capacity was examined by immersing in simulated body fluid (SBF) for upto 21 days. Biocompatibility
has been evaluated through adhesion/proliferation of hFOB osteoblast cell lines and cytotoxicity
by MTT assay. Antimicrobial activity of PCL/TiO2 nanocomposites has been tested using UV
light against gram-positive Staphylococcus aureus (S.aureus). The resulting surface displays good
bioactive properties against osteoblast cell lines with increased viability of 40% at day 3 and superior
antibacterial property against S.aureus with a significant reduction of bacteria to almost 76%. Surface
modification by PCL/TiO2 nanocomposites makes a viable approach for improving dual properties,
i.e., biological and antibacterial properties on titanium implants which might be used to prevent
implant-associated infections and promoting cell attachment of orthopedic devices at the same time.
Keywords: titanium; antibacterial coatings; electrospinning; nanocomposite coatings; TiO2
photocatalytic; orthopedic infections
1. Introduction
Biocompatible titanium (Ti) and its alloys are broadly accepted metallic materials for hard
tissue repair (orthopedic and dental) for its exceptional combination of biomedical and mechanical
properties [1]. Even though Ti and its alloys are used as an implant material for more than three
decades, there are still some inadequacies that need to be addressed. Especially, bacterial associated
diseases/infections during surgery always carry serious hazards leading to a severe clinical economic
consequence such as re-hospitalization, complex re-surgeries, implant loosening, high economic
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associated costs and sometimes even death. Recent studies estimated the current incidence of bacterial
infection had incurred a total financial cost of $10 billion with close to 100,000 infections and 8000
reported deaths in the United States alone [2,3]. The reason being, when compared to bioactivity
enhancement modifications, relatively very few efforts have been made to address antibacterial activity
on the surface before the implantation. It is a known fact that treating an infected orthopedic implant
materials post-surgery is hugely complicated, primarily due to the inherent difficulties of treating an
established biofilm formed by microorganisms on the surface [4].
Nevertheless, many preventative strategies have been proposed by academics to improve
the antibacterial ability of the material before the implantation/surgery [5,6]. But, most of the
solutions proposed for obtaining antibacterial surfaces without losing its bioactivity require a complex
coatings technique. In this view, several novel strategies such as topographical modifications
(nanotubes), incorporating antibacterial agents (Ag, Cu) and various surface treatments [7–10]
were suggested/developed to disinfect the bacterial colonization on biomedical implants before
the implantation. However, still traces of evidence of bacterial invasion can be still found even after
the post-surgery. Nevertheless, these findings highlight the crucial need modifications to the material
to prevent bacterial implant-associated infections at early stages. Among these, surface modification
either by treatment or coating on the implant material has been well recognized as the best substitute
to design and alter the biological performance of the Ti and its alloys [11].
Titanium dioxide (titania, TiO2), a bioceramic material have become a focus of significant
research due to its versatile characteristics [12,13]. TiO2 nanoparticles are well-known for its stability,
non-toxicity, UV resistance and found its application in cosmetics, electronics, biomedical, optics and
also as a cleaning reagent [14]. Ever since first reported by Matsunaga et al., TiO2 photocatalytic
properties have drawn more attention in the biomedical field for its specific ability to a kill wide
variety of microorganisms under a strong UV radiation [15,16]. In brief, when the surface of TiO2
is exposed to a strong UV light, electron-hole pairs (e−-h+) are generated in the valence band and
reacts with oxygen and atmospheric water (OH−) thereby yielding to reactive oxygen species (ROS).
The generated ROS acts a powerful oxidizing agent capable of decomposing organic molecules
and inactivating micro-organisms through a series of chemical reactions, leading to the powerful
antibacterial agent [17–19]. Also, for enhancing the composite cell attachment and proliferation
properties, TiO2 nanoparticles are projected as a secondary phase material for biodegradable polymer
matrices [20–25].
Over the past few years, polymer/ceramic nanocomposites as scaffold materials have attracted
more attention for bone tissue engineering. Many works have been described in the literature
which explains the enhancement of Ti-based implants with organic or organic-inorganic substitute
surface coatings [26–28]. In particular, because of the high porosity and large specific surface
area, nanocomposite fiber scaffolds have been successfully explored in tissue engineering for
orthopedic implants. Among the various techniques for nanocomposite scaffold fabrication,
the electrospinning process is described as the most reliable process for producing long and continuous
fibers. Electrospinning is a simple and economical fiber fabrication technique that utilizes electrical
forces to produce ultrafine micro and nanofibers templets with a wide range of polymers for a variety of
applications [29,30]. In most typical tissue engineering strategies, the engineered 3D porous scaffolds
serve as a pattern for cell adhesion, expansion, and proliferation of cells ingrowth. Electrospun
nanofibers are favorably proficient of imitating microarchitecture of native ECMs owing to their high
surface area to volume ratio and relatively large internal porosity. This technique also enables to
entrap inorganic ceramic nanoparticles into the organic polymer in a very convenient way to enhance
physical, chemical and mechanical properties.
Polycaprolactone (PCL), a semi-crystalline biodegradable polymer, known for its superior
mechanical properties, excellent biocompatibility, and slower degradation rate. It is a widely accepted
polymer for drug release carriers, biodegradable packaging materials, and more importantly for the
development of 3D scaffolds for bone tissue engineering applications. Numerous techniques have been
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developed to fabricate PCL-based scaffold to a simple two-dimensional structure (casting) to complex
three-dimensional (3D printing) objects [31,32]. However, PCL in current form is hydrophobic, which
results in lack of wettability and poor cell attachment. Successful blending with bioceramics haven
been reported elsewhere [9,23,27,33] for improved biological properties.
The current study aims to incorporate TiO2 nanoparticles into the PCL scaffolds for improving
mechanical properties, biological properties (bioactivity, anti-bacterial, cell adhesion, and cell
proliferation) and physiochemical properties (hydrophilicity) for orthopedic applications. To achieve
that, PCL/TiO2-nanocomposite scaffolds were synthesized by electrospinning and coated on
cpTi substrates.
2. Materials and Methods
2.1. Sample Preparation
Commercial pure titanium (cpTi), biomedical grade 2 (0.015% carbon, 0.1156% oxygen, 0.0095%
nitrogen, 0.0013% hydrogen, 0.04% iron) plates with dimensions of 10 mm × 10 mm × 2 mm
(MIDHANI, Hyderabad, India) were used as the base material. The substrates were polished using
300, 600, 800 and 1200 emery sheets followed by disc polishing to mirror finish using diamond paste.
The polished samples were further degreased by cleanser, ultrasonically washed with ethanol and
sonicated in acetone several times before drying in air overnight.
2.2. Synthesis of PCL/TiO2 Nanocomposites
PCL/TiO2 polymer-ceramic hybrid composites containing 2, 5 and 7 wt % of the ceramic
content was synthesized by means of the electrospinning process. In brief, poly(ε-caprolactone) (PCL,
80 kDa; Sigma-Aldrich, Singapore) pellets were dissolved in chloroform and methanol (Sigma-Aldrich,
Singapore) at 3:1 ratio to make an 8% (w/v) solution and kept under stirring conditions for 4 h. TiO2
was synthesized as reported earlier via electrospraying method by using titanium isopropoxide as
the main precursor [34]. To prepare PCL/TiO2 nanocomposites with a certain PCL to TiO2 ratio,
a known amount of TiO2 (2, 5 and 7 wt %) powders were added into the solution batch wise under
string conditions. Because of the nature of TiO2 nanoparticles, it was very critical to homogeneously
disperse TiO2 nanoparticles in the PCL matrix to acquire satisfactory dispersion without agglomeration.
The mixed solution was under stirring conditions for 72 h using a magnetic stirrer with sonication
for every 6 h. Upon attaining satisfactory homogeneous conditions, PCL/TiO2 solution was taken
in a 5 mL syringe equipped with a 22-gauge rounded metal needle. A constant flow rate was set to
optimized 500 μL/h through a syringe pump (NE1000, U.S.A). A constant high voltage of 12.0 kV was
applied to the needle tip which was positioned at a distance of 10 cm from the grounded collector.
Previously cut cpTi substrates of dimensions 10 mm × 10 mm × 2 mm were fixed on the aluminum
foil as a collector. Prior to the coating procedure, the substrates were washed, sonicated in dry ethanol
for 1 h and left overnight for drying. After the coating procedure, all the samples were dried under
vacuum for 1 day to completely remove any solvent residues present.
2.3. Characterization
The morphology, phase analysis, and chemical composition of the obtained PCL/TiO2 coatings
were characterized by scanning electron microscopy (SEM, Hitachi, S-4300, Tokyo, Japan) attached with
energy dispersive X-ray spectroscopy (EDX, Thermo Noran, Sonora, CA, USA), X-ray diffractometer
(XRD, D8 DISCOVER, Bruker, Billerica, MA, USA) and Fourier transform infrared spectroscope (FT-IR,
Perkin-Elmer Spectrum Two spectroscopy) respectively. Morphological analysis of the surface before
and after coatings were examined by SEM, operated at an accelerating voltage ranging from 10–15 kV.
To avoid any ‘charging’ and increase conductivity, the dry substrates were sputter-coated for 30 s with
a thin deposits of gold (Au) before observing in SEM. XRD (at 2θ = 10◦–90◦) is used for analyzing
the phases present in the synthesized nanocomposites coatings with Cu-Kα radiation (λ = 1.540 Å)
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at a scanning rate of 0.1 step/s. To analyse the chemical composition, FT-IR measurements were
performed over a range of 4000–500 cm−1. To identify functional groups of the synthesized samples,
KBr powder is mixed and made of pellets. In addition, surface wettability was calculated by measuring
static contact angles of deionized water with a contact angle system (Easy DROP, KRUSS, Stuttgart,
Germany) at the ambient temperature. For each set of samples, a 10 μL drop of water was deposited
on each substrate and allowed to rest for 5 s.
2.4. Biological Studies
2.4.1. Biominerilization Studies
To evaluate the apatite-forming ability (bioactivity), the substrates were immersed in 30 mL
of simulated body fluid (SBF) with material composition and composition nearly equal to human
blood plasma for 14 days. The SBF solution is prepared in the laboratory by mixing laboratory-grade
chemicals (NaCl, NaHCO3, KCl, K2HPO4·3H2O, MgCl2·6H2O, CaCl2, and Na2SO4) in deionized
water and maintained at pH 7.4 with tris (hydroxy-methyl) aminomethane and 1 M HCl. The detailed
information on ion concentrations of SBF proposed by Kokubo et al. without organic species and its
correlation with human blood plasma can be found elsewhere [35]. The falcon tubes containing SBF
and substrates were immersed in water bath, maintained at static conditions at 37 ◦C. After immersing
for 14 days, the substrates were carefully taken out from the SBF solution, washed with deionized
water and freeze dried at room temperature for further morphological and elemental analysis.
2.4.2. Antibacterial Assay
Prior to inoculation, PCL/TiO2 samples with different TiO2 concentration were UV-irradiated for
5 h to stimulate the photocatalytic reaction in the TiO2 material. Other samples (pure PCL and cpTi
substrate) were UV-irradiated and sterilized for the same time interval. These specimens were used for
carrying out the antibacterial assay against bacterium Staphylococcus aureus (NCIM 5021). In brief,
the samples were placed in 12 welled plates containing 2 mL nutrient broth. A bacterial inoculum of
1 × 107 CFU/mL was added to each well. The plates were then allowed to incubate for 24 h at 37 ◦C.
After 24 h the samples were carefully removed and rinsed. The samples were sonicated for one
minute with an interval of one minute. Five cycles were repeated to ensure complete extraction of
bacteria. These samples were centrifuged, and the bacterial pellet obtained, was resuspended in PBS.
The bacterial solution was then spread onto pre-cooled agar plates and incubated for 24 h at 37 ◦C.
The resulting colonies were then counted, and the log values were calculated for them. The reduction
in bacterial growth was estimated as a reduction in log CFU/mL values
2.4.3. Cell Culture Studies
The cytotoxicity, cell adhesion and proliferation of surface coated PCL/TiO2 nanocomposites
were determined by using human fetal osteoblastic cell lines (hFOB 1.19, ATTC CRL 11372) for day
1 and day 3. Five substrates (cpTi, PCL with 2, 5 and 7 wt % of TiO2 content) were adopted to
evaluate the potential of using them for biomedical applications. In brief, cells were cultured in base
medium of hFOB cell lines i.e., Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F12
(1:1 DMEM/F12) and complemented with 10% fetal bovine serum (FBS), 1% of non-essential amino
acids (MEM) and antibiotics (penicillin G, and streptomycin). For the entire duration of experiment,
the culture medium was replaced every alternative day and was preserved in a humidified incubator at
37 ◦C under an atmosphere of 5% CO2. After attaining about 80% confluence, the cells were trypsinated
and digested at a final concentration of 5 × 104 cells/cm2 onto the substrates in 24-well plates. Prior to
cell seeding, the substrates with PCL/TiO2 coatings were sterilized by immersing in 70% ethanol for
1 h followed by washing 3 times with sterilized phosphate buffered saline solution (pH = 7.4, PBS).
MTT assay for toxicity connected with cell viability and proliferation were also observed on
surface coated cpTi substrates for day 1 and day 3. Pure cpTi without any coating is used as the control.
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After removing the culture medium, hFOB cells were quantitatively assessed by seeding 4 mg mL−1
MTT 3-(4,5-dimethylazol-2-yl)-2,5-diphenyltetrazolium bromide (yellow) reagent on to the substrates
and determined at day 1 and day 3. In brief, both days of incubation, culture medium was removed
and washed with 400 μL of prewarmed PBS. Then 400 μL of culture medium accompanied with 60 μL
of MTT solution was added to each well-plate containing samples and incubated at 37 ◦C in a 5%
CO2 humidified atmosphere. After an incubation period of 4 h, 100 μL of the resulting supernatant
was added to each well of 96-well ELISA plate. The plates were gently agitated for 3 min to establish
complete crystal dissolution. Percentage cell viability was determined by recording optical absorbance
at 570 nm with reference to 690 nm using a microplate reader (Bio TEK Instrument, Winooski, VT,
USA, EL307C). To ensure reproducibility, tests were carried out by performing triplicates of samples.
2.4.4. Cell Morphology
Samples for SEM analysis were withdrawn from culture after 3 days incubation. For cell adhesion
and proliferation studies, before fixing with 3% glutaraldehyde solution, cell-seeded substrates were
washed with PBS thrice to confiscate any separated cells. The samples were cleaned again with PBS
after 30 min, then kept at 4 ◦C. After cell fixation, the substrates were dehydrated in a series of ethanol
solutions at varying concentrations from 30% to 100% for 15 min each. 1 mL of hexamethyldisilane
(HMDS) was added on each sample and left to dry for 2 days. Prior to SEM image analysis, all the
samples were gold coated for 20 s.
2.5. Statistical Analysis
All data values are presented a mean ± standard deviation for each group of samples. A paired
sample t-test and one-way analysis of variance (ANOVA) were performed to determine statistically
significant differences between groups. All tests were conducted with 95% confidence intervals
(p-value < 0.05).
3. Results and Discussion
3.1. Surface Characterization
SEM images of unmodified cpTi without any surface coating (Figure 1a) and PCL/TiO2
nanocomposites with and without TiO2 particulate additions were presented in Figure 1b–e
respectively. Due to an exact balance between the solution viscosity and electrical conductivity,
continuous uniformity of the fibrous structures without any beads were observed in all the samples.
Figure 1b shows the pure PCL nanofibers (0 wt % TiO2) in uniform diameter with a smooth surface
with an average diameter of 540 ± 40 nm. But, the morphology of the fibers was adversely affected by
the addition of TiO2 nanoparticles. 8 wt % of PCL was used as the constant polymeric solution for
electrospinning and a gradual growth in fiber diameter was observed when TiO2 content increased
from 2 wt % (Figure 1c) to 5 wt % (Figure 1d) and to 7 wt % (Figure 1e). With the increase of TiO2 particle
concentration, the size of nanofibers tends to become more significant and visible agglomeration to
some extent were observed inside the fibers. For example, the average fiber diameter increases from
640 ± 60 nm to 710 ± 20 nm and 900 ± 89 nm for as-spun PCL/2TiO2, PCL/5TiO2 and PCL/7TiO2
composite nanofibers respectively. The results were in agreement with another study where the
addition of nanoparticles increased the diameter of fiber [33].
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Figure 1. SEM Images displaying (a) cpTi substrate; PCL mat containing (b) 0 wt % TiO2, (c) 3 wt %
TiO2, (d) 5 wt % TiO2, and (e) 7 wt % TiO2.
Also, based on the SEM analysis of Figure 1c,d, the results also indicate that TiO2 nanoparticles
are directly embedded inside the PCL nanofiber matrix rather than exposed on top of the fibers.
The concentration of 7 wt % of ceramic TiO2 (Figure 1e) causes some of the nanoparticles surfaced
on the as-spun nanofiber mats, indicating inhomogeneous mixing of the particles. In view of this,
no further experiments above 7 wt % TiO2 have been conducted as it gives the notion that “outer”
particles on fibers would be leached away easily as no chemical interaction with the PCL nanofibrous
mat is made. Due to this, there may also be a negative effect on the mechanical properties (tensile
strength and Young’s modulus) of the composite. Also, the morphologies of fibers became more
irregular when the increasing of TiO2 content which it might because of the influence of ceramic
particles on the solution viscosity, surface tension, and concentration. So, optimization of nanoparticle
concentration in connection to the mechanical properties of the nanocomposite is sometimes essential.
3.2. Phase Analysis
The XRD patterns of PCL mat and PCL/TiO2 coatings with 2, 5 and 7 wt % of TiO2 content is
shown in Figure 2a along with electrosprayed TiO2 nanoparticles for reference. PCL is a semi-crystalline
polymer, which can be spotted by two characteristic peaks in the region of 20◦–25◦ (2θ = 22.1◦ and
24.5◦). The TiO2 anatase nanoparticles exhibit characteristic peaks at 2θ values of 25.6◦, 35.9◦, 37.9◦,
38.9◦, 48.4◦, 53.9◦ and 56.1◦, corresponding to the diffraction patterns of (101), (103), (004), (112),
(200), (105), and (211) crystalline planes respectively (JCPDS data No. 36–1451). From the Figure 2a,
it can be noted that the relative intensities of TiO2 are increased with increasing TiO2 content. Also,
incorporation of TiO2 nanoparticles into the PCL fibrous structure resulted in the widening of peak
widths and reduction in its peak height implying the decrease in the crystallinity of PCL structure.
FTIR spectra of the PCL/TiO2 coatings with 2, 5 and 7 wt % of TiO2 content and pure PCL mat for
comparison are shown in Figure 2b. The analysis shows the presence of H-bonds between organic (PCL)
and inorganic (TiO2) components of the hybrid materials. The spectrum of the TiO2 coatings are visible
at wavenumber lower than 998 cm−1 are due to Ti-O and Ti-O-Ti vibration bands in the lattice [36].
The peaks located at 1725 cm−1, 1182 cm−1, 1054 cm−1, and 2865 cm−1 corresponds to carbonyl groups
of C=O, C–O–C, C–O, and alkyl group of C=H stretching vibrations of PCL polymer respectively.
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The bands present at 564–647 cm−1 (PO43− bending vibration), 878 cm−1 (P–OH stretching) and
999–1102 cm−1 (PO43− asymmetric stretching) [37]. Most corresponding bands of TiO2 were detected
in the PCL/TiO2 spectrum recommends that TiO2 is effectively incorporated into the PCL nanofibrous
mat to form nanocomposites. The reduced intensities of PCL in PCL-TiO2 nanocomposites is because
of the presence of physical interaction between PCL and TiO2 nanoparticles [38].
Figure 2. (a) XRD and (b) FTIR patterns of PCL/TiO2 (2, 5 and 7 wt %) nanocomposites in comparison
with pure PCL.
3.3. Wettability Studies
To evaluate the effect of TiO2 nanoparticles on the hydrophilicity of electrospun PCL/TiO2
nanocomposites, water contact angles were measured on PCL/TiO2 mats and compared to those of
cpTi and pure PCL. From Figure 3, it can be noted that a considerable reduction in water contact
angle is observed in PCL/TiO2 nanocomposite (2, 5, and 7 wt %), indicating improved wetting
properties. The water contact angle of the pure PCL sample reached above 140◦, demonstrating a
hydrophobic surface. Presence of polar surface groups (TiO2 nanoparticles) inside the PCL matrix
enhanced its hydrophilicity due to a higher interaction between the composite mat and solvent [39].
It is a well-known fact that enhancement in hydrophilicity of a scaffold used in tissue engineering is
desirable for initial cell adhesion and cell migration.
Figure 3. Water contact measurements on various surfaces obtained as a function of TiO2 wt % with
distinctive water droplet images after 5 s from droplet.
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3.4. Bioactivity Studies
The bioactivity features of PCL/TiO2 nanocomposites are well standardized before. Figure 4
presents the SEM images of the cpTi, pure PCL coated and PCL/TiO2 nanocomposites with 2, 5 and 7
wt % TiO2 content after incubating in SBF for 21 days. The control substrates, i.e., cpTi (Figure 4a), and
pure PCL (Figure 4b) exhibit very insignificant mineralization while substantial mineralization takes
place in PCL/TiO2 nanocomposite samples. It was observed that PCL bio-nanocomposite with higher
TiO2 concentration i.e., PCL/5TiO2 (Figure 4d) and PCL/7TiO2 sample (Figure 4e) have the highest
nucleation rate of apatite formation after 21 days. It is worth mentioning that even after immersing
in SBF for 21 days, the scaffold preserved its microstructure and showed better interconnectivity of
the pores.
Development and growth of apatite layer on the substrate is a dynamic process where the material
surfaces dissolve and the new bundle of layers precipitates on the surface [40]. When soaked in SBF,
the high content of TiO2 in PCL/5TiO2 and PCL/7TiO2 composites leads to an increase of Ti–OH
groups on the surface. The unique development of new Ti–OH groups can stimulus the formation of
apatite nucleation. Once the apatite nuclei formed, the growth occurs spontaneously by consuming
the positive ions of calcium (Ca2+) and negative ions of phosphate (PO3−) from the SBF fluid to
form an amorphous phosphate, which impulsively transforms into hydroxyapatite [Ca10(PO4)6(OH)2]
[HA] [41]. Based on the EDS analysis for PCL/5TiO2 (Figure 4f), the Ca/P molar ratio was estimated
to be approximately 1.5 which is in close agreement with the chemical formulation of the biomineral
HA [35].
 
Figure 4. SEM images of (a) An, (b) PCL (c) PCL with 2 wt % TiO2 (d) PCL with 5 wt % TiO2 and (e)
PCL with 7 wt % TiO2 after immersing in SBF for 21 days. (f) EDS analysis results for the newly formed
calcium and phosphate of PCL with 5 wt % TiO2.
3.5. Cytotoxicity-MTT Assay
With the intention of using the PCL/TiO2 scaffolds in bone tissue engineering application,
the influence of the prepared composites on the growth and viability with hFOB cell lines were
investigated for day 1 and day 3 and presented in Figure 5. PCL has widely demonstrated polymer
for bone tissue engineering application for its slow degradation kinetics and biocompatibility [42].
In vitro cell culture experiments in the current research manifested the importance of PCL as a function
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of the TiO2 content. In fact, the presence of PCL has enhanced cell proliferation as a function of
the TiO2 amount. The addition of TiO2 nanoparticles at low concentration (2 wt % and 5 wt %)
to polymeric PCL scaffolds has favoured the proliferation of hFOB cells. Compared to cpTi and
PCL fiber mat, initial attachment and proliferation of PCL/2TiO2 and PCL/5TiO2 nanocomposites
supported the growth of the cells and mediated their proliferation by approximately 20% and 38%
respectively. The results demonstrate the substantial and time-dependent growth in cell viability of
TiO2 at lower concentrations.
 
Figure 5. hFOB Cell viability on An, Pure PCL coated, PCL/2TiO2 coated, PCL/5TiO2 coated and
PCL/7TiO2 coated cpTi samples cultured for day 1 and day 3 (p < 0.05).
However, a noticeable reduction in the cell viabilities is being observed in the PCL/7TiO2 sample
for both day 1 and day 3. At a higher content of TiO2, the TiO2 nanoparticles have fetched a significant
cytotoxic effect with viabilities of 53 ± 4% and 35 ± 5% as observed on day 1 and day 3 respectively.
As we know, the cellular behaviour particle cytotoxicity of TiO2 nanoparticles relay on numerous
aspects which includes particle shape/size, chemical stability, and mechanical stimulation. Many
studies conclusively showed that the effect of TiO2 nanoparticles concentrations on cellular behaviour
at higher concentrations [25,43]. From the above analysis, it can be implied that the incorporation of
TiO2 nanoparticles have a positive impact and suggests that PCL/5TiO2 can be considered as best
suitable biocompatible material that can be employed as a tissue scaffold for the orthopedic application.
3.6. Cell Morphology (Cell Adhesion and Proliferation) Studies
Cell morphology (cell adhesion and proliferation) of An, PCL and PCL/TiO2 (2, 5 and 7 wt %)
scaffolds were carried out using hFOB, a human osteoblast-like cell lines were presented in Figure 6a–j.
Integration of TiO2 nanoparticles into PCL, thereby surface coatings on cpTi has significantly increased
cell adhesion on day 1 as hFOB cells spread well over the surface and showed the normal morphology
of phenotype. Form the SEM analysis, when compared to An (Figure 6a–b) and PCL (Figure 6c–d), it is
evident that higher cell proliferation is been observed on the scaffolds containing TiO2 nanoparticles.
This early interaction of biomolecules and cells with the material is strongly dependent on the
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PCL/TiO2 surface properties, among which hydrophilicity is a key factor. After just 3 days of culture,
hFOB cells on PCL/5TiO2 nanocomposites showed an excellent homogeneous structure with a clear
evidence of cells penetrating into the scaffolds through their pores (Figure 6g–h). The results are well
in connection with the wettability studies (Section 3.3). It is evident that the added TiO2 nanoparticles
increase the surface area and surface hydrophilicity, thus by favoring cell adhesion on day 1 and cell
proliferation on day 3.
 
Figure 6. SEM images of hFOB cells seeded on various substrates after day 1, and day 3.
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Interestingly, when compared to other scaffolds, cell behavior to higher TiO2 content i.e., with
7 wt % demonstrated little attachment and proliferation (Figure 6i–j). This is probably due to some
leachables and an inhomogeneous mixture of TiO2 nanoparticles (Figure 1e). Also, it has been stated
in many reports that higher TiO2 content leads to toxicity into the substrates [25,43,44]. As found
in this study, for a given PCL concentration, depending on type of cells used, seeding densities and
cell viability test method, it must be definite and established that at given polymeric concentration,
the amount of TiO2 nanoparticles in scaffolds should not surpass a higher activation level, which should
be of the order of 5 wt % in the present case. However, optimized TiO2 nanoparticle concentration
(5 wt %) will help to engineer the PCL/TiO2 based scaffold favoring new tissue formation with an
antimicrobial property.
3.7. Antibacterial Activity
Due to the significant toxicity and minimal cell proliferation, the sample with 7% TiO2 was
eliminated as a candidate from further studies. Amongst the remaining samples, annealed sample
with no coating was taken as the control. The electrospun PCL fiber mat shows a relative increase
in the bacterial count compared to the control (Figure 7). This is attributed to the fibrous nature of
the interface which provides ample opportunities for cellular attachment. This attachment promoting
behaviour is also seen in previous studies where the increased surface area contributes to the increase
in hFOB proliferation and attachment to electrospun PCL mat and PCL mat containing 2% TiO2.
This factor proves to be advantageous for bone growth and repair as observed from the study with
mammalian cells. However, it may also cause problems due to increased adhesion of bacterial cells.
So, it is advisable to use an antimicrobial agent blended with PCL to retard and offset the bacterial
growth. TiO2 has proven to be such an agent. The antimicrobial properties of TiO2 are well known.
Figure 7. Antibacterial activity on different substrates against S.aureus.
As presented in Figure 8, several fundamental mechanisms for cell killing and bacterial growth
inhibition by the TiO2 photocatalytic processes were presented in the literature [45,46]. As a result
the blend of PCL and 2% TiO2 was initially tested against S.aureus. However, there is no significant
difference between the PCL fiber mat and the PCL fibers containing 2% TiO2. This implies that this
concentration of TiO2 is not enough to bring about a photocatalytic effect that reduces the bacterial
count. On increasing the TiO2 concentration to 5%, significant reduction is seen in the bacterial colony
count compared to plain annealed sample (control). Thus 5% TiO2 also seems to be the minimal
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concentration necessary to be incorporated with PCL to achieve antibacterial activity. It also appears
to be the optimal concentration of TiO2 necessary for to give an antibacterial action without significant
toxicity. This nanocomposite thus proves to be an efficient approach to achieving bioactivity and
improving integration of the titanium implants.
 
Figure 8. Schematic illustration for the mechanism of degradation bacteria by TiO2 nanoparticles under
UV radiation and cellular activity of PCL/TiO2 nanocomposites.
4. Conclusions
We report the fabrication of functional PCL-TiO2 coatings by means of the electrospinning
technique and coated on cpTi substrates for bone tissue engineering. A range of electrospun
nanocomposite scaffolds were fabricated with a novel and simple material consisting of biodegradable
polymer PCL (8 wt %) and TiO2 (2, 5 and 7 wt %). When subjected to SBF, the enrichment of a PCL
scaffolds was observed when TiO2 nanoparticles were incorporated into it. The TiO2 nanoparticles
serves as a basis of inorganic phosphate to enhance bone cell mineralization, demonstrating the
bioactive features of the hybrid scaffolds. The results obtained by hybrid PCL/TiO2 coatings have
a cell viability more than the uncoated one and pure PCL suggesting the effect of nanoparticles.
On the contrary, uncoated cpTi and PCL/7TiO2 appears to be less biocompatible mainly due to
minimum contact between the cells-substrate and toxic effect of higher TiO2 content respectively.
The synthesized nanocomposite PCL/TiO2 fibers possess the capacity to replicate surface chemical
properties of bone and also acts as an antibacterial surface with greater efficacy and performance
under strong UV radiation. In particular, PCL/5TiO2 coatings mimic the excellent biological response
with respectable antibacterial activity. Because of the effective antibacterial property, no additional
covering of the wound for infection prevention is required. The obtained coatings thus can be
successfully used to change the surface of cpTi implants to improve their biological properties and
antibacterial performance.
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Abstract: Traditional wound dressings require frequent replacement, are prone to bacterial
growth and cause a lot of environmental pollution. Therefore, biodegradable and antibacterial
dressings are eagerly desired. In this paper, gelatin/ZnO fibers were first prepared by side-by-side
electrospinning for potential wound dressing materials. The morphology, composition, cytotoxicity
and antibacterial activity were characterized by using Fourier transform infrared spectroscopy
(FTIR), X-ray diffractometry (XRD), particle size analyzer (DLS), scanning electron microscopy (SEM),
energy dispersive X-ray spectroscopy (EDX), thermogravimetry (TGA) and Incucyte™ Zoom system.
The results show that ZnO particles are uniformly dispersed on the surface of gelatin fibers and have
no cytotoxicity. In addition, the gelatin/ZnO fibers exhibit excellent antibacterial activity against
Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) with a significant reduction of bacteria
to more than 90%. Therefore, such a biodegradable, nontoxic and antibacterial fiber has excellent
application prospects in wound dressing.
Keywords: gelatin fibers; ZnO particles; antibacterial activity
1. Introduction
Skin, as the human body’s largest organ, exerts a vital role in protecting the human body from
external harm. Skin damage can lead to microbial invasion of the human body, resulting in a threat
to human health [1–3]. Medical dressing is a kind of medical equipment which can cover damaged
skin and form a microenvironment conducive to wound healing, thus playing an effective role in
wound care and treatment. At present, most medical dressings still use traditional cotton gauze.
Nevertheless, traditional cotton gauze needs to be replaced frequently, and easily adheres to the
wound, which can easily lead to secondary tissue trauma and bacterial breeding [4–6]. Moreover,
huge dressing wastes cause great harm to the environment. Therefore, it is urgent to design new
biodegradable and biocompatible dressing materials with good antimicrobial activity.
Gelatin, as a kind of natural material, is hydrolyzed from collagen in animals, which has many
advantages, such as good accessibility, a wide source of raw materials and low cost. Its amino
acid composition is similar to collagen and has good biocompatibility, biodegradability and low
immunogenicity [7–9]. Especially in the past decades, with the development of electrospinning
technology, gelatin fibers can be prepared simply and quickly. Furthermore, there are many small
secondary structures on the surface of gelatin fibers, which is similar to the structure of extracellular
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matrix (ECM) and closer to the structural size of organisms. Therefore, it plays an important
part in cell attachment, growth, migration and differentiation, as well as the formation of new
tissues [10–12]. Meanwhile, gelatin fibers have strong adsorption, good filtration, barriers, adhesion
and hygroscopicity [13–16]. Therefore, the gelatin 3D nanostructures prepared by electrospinning can
be widely used in the biomedical materials, which receives more and more attention. In addition, in
recent years nano-inorganic ions and nano-metal oxides have been found to have extensive antibacterial
properties, which caused widespread concern [17–19]. Among them, ZnO particles were generally
recognized as a safe (GRAS) material by the Food and Drug Administration (FDA) [20]. It has excellent
antibacterial properties and minimal effect on human cells, which is extensively used in biomedicine
and health products [21–23].
Recently, the blending of ZnO particles with gelatin has been used in the research of antimicrobial
materials. Liu et al. prepared gelatin/ethyl cellulose/ZnO nanofibers by electrospinning. The results
showed that the nanofibers had a good inhibitory effect on Escherichia coli (E. coli) and Staphylococcus
aureus (S. aureus) [24]. Chhabra et al. synthesized ZnO doped gelatin and poly-methyl vinyl
ether-alt-maleic anhydride (PMVE/MA) composite electrospun scaffolds, which can inhibit bacterial
activity and have no cytotoxicity to mammalian cells [25]. Münchow et al. prepared ZnO loaded
gelatin/polycaprolactone (PCL) composite nanofibers by electrospinning technique [26]. At present,
the current preparation of ZnO/gelatin fibers is usually carried out in the form of blending spinning.
Nevertheless, ZnO particles are hard to fully exert efficient antibacterial activity when encapsulated
in gelatin fibers. Consequently, it is necessary to increase the content of ZnO particles to achieve
better antibacterial effects [27]. However, with that, excess ZnO particles cause waste of materials,
and even more seriously excess ZnO particles may lead to cytotoxic effects and affect the growth of the
tissue [28–30].
In this paper, unlike the traditional blending method, ZnO particles were dispersed in ethanol,
so that ZnO particles can follow the solvent to be sprayed on gelatin fibers by using the side-by-side
spray nozzles in the electrospinning process. With the volatilization of ethanol solvent, ZnO particles
can be uniform spread only on the surface of gelatin fibers (as shown in Figure 1), so as to achieve the
best antibacterial effect with the minimum content of ZnO particles.
Figure 1. Schematic illustration of the fabrication of gelatin/ZnO fibers by side-by-side electrospinning.
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2. Materials and Methods
2.1. Materials
Gelatin (type B, basic-processed, prepared by bones, with a molecular weight of 100,000,
viscosity value of 4.9 MPa·s−1) was obtained from Dongbao Bio-Tech Co., Ltd. (Baotou,
China). 2,2,2-trifluoroethanol, formaldehyde solution (37–40 wt %), zinc acetate dihydrate
(Zn(CH3COO)2·2H2O), diethylene glycol and ethanol absolute were purchased from Titan Scientific
Co., Ltd. (Shanghai, China). The human lung fibroblast cell lines (MRC-5) were purchased from the
Cell Bank of Chinese Academy of Sciences (Shanghai, China). Staphylococcus aureus (S. aureus) and
Escherichia coli (E. coli) were obtained from the China General Microbiological Culture Collection Center
(Beijing, China). The deionized water had a resistivity of 18.2 MΩ·cm in the process of the experiments.
All chemical reagents were of analytical grade and required no post-treatment.
2.2. Preparation of ZnO Particles
For preparation of ZnO particles [31], 878 mg (0.004 mol) Zn(CH3COO)2·2H2O was added into
40 mL diethylene glycol with continued ultrasonic until dissolved completely, followed by transferring
into a teflon-lined stainless steel autoclave (45 mL). Then, the autoclave was heated to 160 ◦C from
room temperature in an oven and maintained for 5 h. After the reaction, the white power was obtained
by centrifugation. Then, the power was washed with ethanol and water in turn, and finally dried in
the oven at 100 ◦C for 5 h.
2.3. Preparation of Gelatin/ZnO Fibers
For preparation of gelatin/ZnO fibers, gelatin (12.5%, w/v) was added into 2,2,2-trifluoroethanol
with constant stirring at 45 ◦C until it was completely dissolved. Then, ZnO particles (0%, 0.10%,
0.25%, respectively) were evenly dispersed in the ethanol solution by ultrasonic. In the electrospinning
process, gelatin solution and ZnO particles solution were added into 50 mL syringes respectively,
in which the diameter of the syringe needle containing gelatin was 1.25 mm and that containing
ZnO particles was 0.80 mm. The distance from the drum collector to the needle tip was 15 cm,
and the applied voltage was 17 kV. The gelatin fibers and ZnO particles were spun with a flow rate
of 5 and 2 mL·h−1, respectively. In addition, the speed of reciprocating motion platform and drum
collector were 55 and 70 r·min−1, respectively. After electrospinning, the fibers were placed on the
porous ceramic shelf of the desiccator, and the ethanol solution containing 1% formaldehyde solution
was added at the bottom. Then, the desiccator was put into the oven at 25 ◦C for 48 h. After that,
the cross-linked fibers were put into the oven at 40 ◦C for 24 h to remove excess formaldehyde. GZ0’,
GZ1’ and GZ2’ represent the gelatin/ZnO fibers, in which the concentration of ZnO particles solution
is 0%, 0.1% and 0.25% in the electrospinning process, respectively. GZ0, GZ1 and GZ2 represent GZ0’,
GZ1’ and GZ2’ after cross-linking.
2.4. Characterization
The microstructure and chemical composition of the gelatin/ZnO fibers were characterized
by a S-4300 scanning electron microscope (SEM, Hitachi, Tokyo, Japan) and energy dispersive X-ray
spectroscopy (EDX, Hitachi, Tokyo, Japan). The size of ZnO particles was analyzed by the dynamic light
scattering (DLS) method (litesizerTM 500, Anton Paar GmbH, Graz, Austria). Samples were dispersed in
the ethanol, the concentration of the sample was 1 mg·mL−1, and the pH value was 6.5. The functional
groups in the fibers were characterized by Fourier transform infrared spectroscopy (FTIR) (Bruker
Tensor II, Karlsruhe, Germany), and the scanning range of the samples was 4000–400 cm−1. The crystal
structures of the samples were determined by X-ray diffraction (XRD, ARL XTRA, Zurich, Switzerland).
The scanning rate was 0.1 s·step−1 and the scanning range was 10–80◦. The thermal stability of the
samples was analyzed by thermogravimetry (TGA, NETZSCH, Selb, Germany) in nitrogen atmosphere,
and the heating rate was 10 ◦C·min−1. The IncucyteTM Zoom system (EssenBio, Ann Arbor, MI, USA)
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was used to observe effect of the extraction on MRC-5 cells in real time. The extraction and 10% FBS
were placed in 96-well plates. Each well was inoculated with 2000 cells and cultured in an atmosphere
of 5% CO2 at 37 ◦C for seven days. Phase contrast images were acquired every 3 h.
2.5. Stability of GZ2 in Aqueous Solutions
The stability of cross-linked fibers in aqueous solution was studied by taking GZ2 as an example.
Specifically, GZ2 was cut into a 2 × 0.5 × 0.2 cm3 shape (20 mg) and placed in a bottle containing
10 mL phosphate buffer saline (PBS, 0.01 M, pH = 7.2–7.4). Then, the bottles were placed in the oven at
37 ◦C and recorded every 24 h. The experiment was done in triplicate.
2.6. Cell Culture and Proliferation
MRC-5 cells were used to assess the cell culture and proliferation. The cells were cultured in a
humidified chamber containing 5% CO2 at 37 ◦C using Dulbecco’s modified eagle’s medium/F-12
(DME/F-12) containing 10% fetal bovine serum. Extraction experiment was carried out according to
the instruction of ISO 10993-12: 2002. Serum free cell culture medium (DME/F-12) was used to obtain
the extraction media of the GZ0, GZ1 and GZ2. The extraction ratio (the ratio of sample quality to
extraction medium) was 0.1 g·mL−1. GZ0, GZ1 and GZ2 soaked in the medium were incubated in a
humidified atmosphere with 5% CO2 at 37 ◦C for 24 h. Cell culture medium (DME/F-12) was used as
a negative control.
2.7. Antibacterial Evaluation
E. coli and S. aureus were chosen to explore the antibacterial properties of gelatin/ZnO fibers by
using the viable colony count method. Tryptic Soy Broth (TSB) and Trypticase Soy Agar (TSA) were
used as culturing nutrient sources. Specifically, E. coli and S. aureus were aseptically inoculated in TSB
and then cultured in a shaker at 37 ◦C for 16 h. Each of the cultured broths were continually cultured
in new TBS in a shaker at 37 ◦C for another 3 h, and then each of the cultured broths were centrifuged
and washed twice with sterile PBS (0.01 M, pH = 7.2–7.4). Finally, the bacterial PBS suspension with
the concentration of 1 × 106 colony forming units per milliliter (CFU·mL−1) was obtained by the
gradient dispersion method. The sterile gelatin/ZnO fibers (GZ0, GZ1 and GZ2) were cut into the
shape of 2 × 2 cm2 (30 mg) and then placed into tube containing 10 mL sterile PBS. One group of tubes
was irradiated for 1 h under ultraviolet light (UV, 365 nm, 50 w), the other group was not irradiated.
After the pretreatment, 0.1 mL of each bacterial suspension was added, and incubated in the shaker at
37 ◦C for 3 h. After that, a 10 μL solution was taken and serially diluted in sterile PBS. Then, 30 μL of
each diluent was taken and spread onto a TSA plate, and then all plates were incubated for 16 h at
37 ◦C. The numbers of the suitable colonies that formed were counted. In addition, medium with only
inoculum was used as negative control, and pure ZnO particles (30 mg) were used as positive control.
All experiments were performed in triplicate.
2.8. Statistical Analysis
The data were expressed as mean ± standard deviation. Statistically significant differences of the
samples were assessed using a Student’s t-test. p < 0.05 was considered to be statistically significant.
3. Results and Discussion
3.1. Morphologies of Gelatin/ZnO Fibers
3.1.1. Characterization of ZnO Particles
The characterization data of the ZnO particles are shown in Figure 2. Specifically, Figure 2a
represents the SEM images of ZnO particles. It indicates that the ZnO particles have a regular spherical
shape and are uniformly dispersed without agglomeration. The DLS measurements show that average
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hydrodynamic diameter is about 589.3 nm (Figure 2b). Figure 2c illustrates the FTIR spectrum of
the ZnO particles. The single peak at 407 cm−1 can be assigned to stretching mode of the Zn-O
bond [32]. To further determine the composition of the resulting particles, XRD was carried out.
As shown in Figure 2d, the diffraction peaks at 2θ values of 31.8◦, 34.5◦, 36.3◦, 47.8◦, 56.3◦, 63.2◦, 68.0◦






























































Figure 2. Characterization of ZnO particles (a) scanning electron microscopy (SEM) image, (b) particle
size distribution by intensity, (c) Fourier transform infrared spectroscopy (FTIR) spectrum and (d)
X-ray diffractometry (XRD) spectrum.
3.1.2. Characterization of Gelatin/ZnO Fibers
SEM measurements were performed to study morphology of the fibers before and after
crosslinking. As shown in Figure 3a–c, GZ0’, GZ1’ and GZ2’ represent the gelatin/ZnO fibers,
in which the concentration of ZnO particles solution is 0%, 0.1% and 0.25% in the electrospinning
process, respectively. The average diameters of GZ0’, GZ1’ and GZ2’ are about 6.22, 5.67 and 7.32 μM.
The pure gelatin fiber (GZ0’) exhibits a uniform smooth surface, and the fiber thickness is consistent.
With the addition of ZnO particles in electrospinning process, ZnO particles can be evenly dispersed
on the surface of gelatin fibers (Figure 3b,c), but no particles are found inside GZ1’ and GZ2’ (indicated
by blue arrow in Figure 4). The morphology of the fibers remains basically unchanged. Furthermore,
as a potential wound dressing, gelatin/ZnO fibers need to have good physical and chemical stability
in aqueous solution. Thus, formaldehyde was chosen as the cross-linking agent. GZ0, GZ1 and GZ2
(Figure 3d–f) represent the GZ0’, GZ1’ and GZ2’ after crosslinking, respectively. Figure 5 shows the
degradation process of GZ2 in PBS at 37 ◦C. It can be seen that the degradation of GZ2 is basically
completed after five days, which indicates that GZ2 has good water resistance. In addition, Figure 3d–e
shows that the average diameter of the nanofibers increases after the cross-linking, and the fibers
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are curly (indicated by red arrow above). Meanwhile, the fibers become denser and fuse at some
intersection points (shown by yellow arrow above).
   
(a) (b) (c) 
   
(d) (e) (f) 
Figure 3. SEM images of (a) GZ0’, (b) GZ1’, (c) GZ2’, (d) GZ0, (e) GZ1 and (f) GZ2.
  
(a) (b) 
Figure 4. The cross sections SEM images of (a) GZ1’, (b) GZ2’.
 
Figure 5. Degradation process diagram of GZ2 in phosphate buffer saline (PBS) at 37 ◦C.
To ascertain the chemical structures of gelatin/ZnO fibers, FTIR was first tested. As shown in
Figure 6a, the spectra of GZ1 and GZ2 represent three characteristic peaks at 1629, 1531 and 1236 cm−1
corresponding to amide I, amide II and amide III, respectively. The amide I band is mainly attributed
148
Nanomaterials 2019, 9, 525
to the tensile vibration of -C=O, and the amide II and III bands are caused by the bending vibration of
-NH and the stretching vibration of -C-N, respectively [34]. A weak absorption peak at 407 cm−1 in
the GZ1 and GZ2 spectra is consistent with the characteristic absorption peak of ZnO (as mentioned
in Section 3.1.1), which belongs to the stretching vibration of the Zn-O bond. In addition, due to
the reaction between the aldehyde group of formaldehyde and the amino lysine residue of gelatin,
the stretching vibration peak of the imide group (-CH=N) appears at 1448 cm−1 [35]. Furthermore,
Figure 6b shows the XRD spectra of gelatin/Zn fibers as well as the ZnO particles. GZ0 has a broad
diffraction peak at 2θ = 20◦ [36]. Unfortunately, no ZnO peaks are found in the GZ1 and GZ2 spectra,
which may be due to the low content of ZnO particles on the surface of the gelatin [24]. In order to
determine the types of elements contained in gelatin/ZnO fibers, EDX was carried out. The selected
area for mapping is a part of GZ2, in which the ZnO particles are evenly loaded on the surface.
Figure 6c,d represent EDX analysis and element mapping of GZ2, respectively. GZ2 shows the
presence of C, N, O and Zn elements. The appearance of C and N elements is due to the presence of
these two elements in gelatin molecules. The Zn element is caused by the presence of the element in
ZnO particles. In addition, the O element exists both in gelatin molecules and ZnO particles. Moreover,















































































Figure 6. (a) FTIR spectra of ZnO particles, GZ0, GZ1 and GZ2, (b) XRD patterns of ZnO particles, GZ0,
GZ1 and GZ2, (c) energy dispersive X-ray spectroscopy (EDX) analysis of GZ2, and (d) EDX mapping
of GZ2.
TGA was carried out to study the thermal stability of gelatin/ZnO fibers. As shown in Figure 7,
TGA curve of ZnO particles shows 9.02% weight lost at 500 ◦C, caused by the evaporation of physically
adsorbed water and decomposition of residual acetate. Meanwhile, the TGA curves of GZ0, GZ1 and
GZ2 are basically consistent, and the thermal decomposition process is divided into two stages [37,38].
In the first stage (30–224 ◦C), the weight lost is approximately 8.97%, which is caused by the evaporation
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of physically adsorbed water. The second stage is related to the decomposition of gelatin, and with the
increase of ZnO content, the weight loss decreases gradually at the end of the decomposition process
(500 ◦C). Obviously, the presence of ZnO has little effect on the thermal decomposition process of
gelatin fibers, and the gelatin/ZnO fibers have good thermal stability below 224 ◦C.
 

















 ZnO                  9.02
 GZ0                 74.41
 GZ1                 74.38
 GZ2                 72.82
Second stageFirst stage
Figure 7. Thermogravimetric analysis (TGA) curve of ZnO, GZ0, GZ1 and GZ2.
3.2. Bioactivity Studies of Gelatin/ZnO Fibers
3.2.1. Cell Activity
The proliferation of GZ0, GZ1 and GZ2 were analyzed by real-time monitoring of MRC-5 cells
using an IncucyteTM Zoom microscope. In Figure 8, time-lapse imaging of the control exhibits a
standard growth curve up to 55.5% cell confluence level by day 7, and the GZ0, GZ1 and GZ2 reach
45.6, 43.1 and 41.8% cell confluence level by day 7, respectively. The growth curve trends for GZ0,
GZ1 and GZ2 are basically the same, and lower than that of the control. The results indicate that the
GZ0, GZ1 and GZ2 have certain inhibiting effects on cell proliferation. Relative growth rate (RGR, %)
was used to express the cytotoxicity. Table 1 shows that all the relative growth rates are more than 75%,
corresponding to the cytotoxicity level of 0 or 1 per the standard in Table 2. This indicates that the
gelatin/ZnO fibers (GZ0, GZ1 and GZ2) have no cytotoxicity. In addition, as shown in Figure 9, MRC-5
cells cultured in extraction from GZ0, GZ1 and GZ2 are marked by a green phase object mask via the
software of IncucyteTM Zoom. It can be seen that the cells display healthy spindle-like or star-like
shape, and the number of cells rose with the extension of culture time, which suggests that GZ1 and
GZ2 impose no suppression on the growth of cells.
 


























Figure 8. Real-time cell confluence study MRC-5 cells. The cell population was monitored for 168 h
using an Incucyte™ Zoom system in an incubator (5% CO2 and 37 ◦C).
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Table 1. The relative growth rate (RGR) and cytotoxicity level of GZ0, GZ1 and GZ1.
Day 1 Day 3 Day 5 Day 7
GZ0
RGR (%) 105.8 95.7 85.2 82.1
Cytotoxicity level 0 1 1 1
GZ1
RGR (%) 84.6 81.2 80.7 77.6
Cytotoxicity level 1 1 1 1
GZ2
RGR (%) 92.4 84.1 75.8 75.3
Cytotoxicity level 1 1 1 1
Table 2. The standard of cytotoxicity determined from RGR.
Cytotoxicity Level 0 1 2 3 4 5
RGR (%) >100 75–99 50–74 25–49 1–24 0
 Control GZ0 GZ1 GZ2 
day 
0 
    
 (a) (f) (k) (p) 
day 
1   
    
 (b) (g) (l) (q) 
day 
3 
    
 (c) (h) (m) (r) 
day 
5 
    
 (d) (i) (n) (s) 
day 
7 
    
 (e) (j) (o) (t) 
Figure 9. Cell morphology of (a–e) Control, (f–j) GZ0, (k–o) GZ1 and (p–t) GZ2 at point of day 0, 1, 3,
5 and 7, respectively. Scale bar: 500 μm.
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3.2.2. Antibacterial Activity
Figure 10 illustrates the antibacterial activity of the gelatin/ZnO fibers against E. coli and S. aureus
with and without UV light. The bacteria were determined by using the viable colony count method.
Figure 11 represents photographs showing the antibacterial activity of gelatin/ZnO fibers against
S. aureus and E. coli. Obviously, pure gelatin fibers (GZ0) have no toxic effect on the bacterial strains,
and pure ZnO, GZ1 and GZ2 have excellent bacteriostatic effects. In addition, GZ2 containing a higher
concentration of ZnO has stronger antibacterial activity than GZ1 containing a low concentration
of ZnO. According to the reported literature [39–41], the reason for the antibacterial activity of
gelatin/ZnO fibers is the superoxide radicals (·O2−) produced by ZnO particles. The superoxide
radicals can attack the bacterial cell wall and lead to cell wall leakage, resulting in the death of bacteria.
In addition, under UV irradiation, ZnO particles can produce a large number of superoxide radicals.
The obtained data (Figure 10) show that the antibacterial effect of gelatin/ZnO fibers irradiated by























































































Figure 10. The antibacterial activity of the gelatin/ZnO fibers against (a) Staphylococcus aureus and (b)




control ZnO GZ0 GZ1 GZ2 
E. coli  
     
 (a) (c) (e) (g) (i) 
S. 
aureus 
     
 (b) (d) (f) (h) (j) 
Figure 11. The photographs showing the antibacterial activity of (a,b) negative control, (c,d) ZnO
particles, (e,f) GZ0, (g,h) GZ1 and (i,j) GZ2 against S. aureus and E. coli, respectively.
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4. Conclusions
In summary, we first fabricated gelatin/ZnO fibers via side-by-side electrospinning technique
as a potential wound dressing. The data indicate that ZnO particles can be uniformly dispersed on
the surface of gelatin fibers. Although gelatin/ZnO fibers have some inhibitory effect on MRC-5 cells,
the corresponding cytotoxicity level is 0 or 1 per the standard, which indicates that fibers have no
cytotoxicity. Moreover, the gelatin/ZnO fibers show excellent antibacterial activity against E. coli and
S. aureus, which is caused by the superoxide radicals (·O2−) produced by ZnO particles. In addition,
the reductions of bacteria are all more than 90%. The experiments imply that gelatin/ZnO fibers have
excellent application prospects for wound dressing.
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Abstract: Hydroxyapatite (HAp), a major inorganic and essential component of normal bone and teeth,
is a promising biomaterial due to its excellent biocompatibility, bioactivity, and osteoconductivity.
Therefore, synthetic HAp has been widely used as a bone substitute, cell carrier, and delivery carrier
of therapeutic genes or drugs. Mesoporous materials have attracted considerable attention due to
their relatively high surface area, large pore volume, high porosity, and tunable pore size. Recently,
mesoporous HAp has also been successfully synthesized by the traditional template-based process
and has been demonstrated to possess better drug-loading and release efficiencies than traditional
HAp. It is widely accepted that cell adhesion and most cellular activities, including spreading,
migration, proliferation, gene expression, surface antigen display, and cytoskeletal functioning, are
sensitive to the topography and molecular composition of the matrix. The native extracellular
matrix is a porous, nanofibrous structure. The major focus of this study is the fabrication of
porous hydroxyapatite-CaO composite nanofibers (p-HApFs) and the investigation of its drug-release
property. In this study, nanofibers were prepared by the sol-gel route and an electrospinning technique
to mimic the three-dimensional structure of the natural extracellular matrix. We analyzed the
components of fibers using X-ray diffraction and determined the morphology of fibers using scanning
and transmission electron microscopy. The average diameter of the nanofibers was approximately
461 ± 186 nm. The N2 adsorption–desorption isotherms were type IV isotherms. Moreover, p-HApFs
had better drug-loading efficiency and could retard the burst release of tetracycline and maintain
antibacterial activity for a period of 7 days. Hence, p-HApFs have the potential to become a new
bone graft material.
Keywords: sol-gel; electrospinning; hydroxyapatite; nanofiber; antibacterial
1. Introduction
Bone is a natural inorganic–organic composite consisting of collagen fibrils containing well-arrayed
apatite nanocrystals. Hydroxyapatite [HAp, Ca10(PO4)6(OH)2] is chemically similar to the inorganic
component of the bone matrix, which has led to extensive research efforts to use this material as a bone
substitute in both orthopedic and dental fields. Recently, HAp has been used in range of biomedical
applications, such as matrices for drug release and bone tissue engineering scaffold materials.
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HAp can be synthesized through a variety of well-developed techniques, such as the sol-gel
process [1], the wet-chemical reaction [2], the solid-state reaction [3] and the chemical vapor
deposition [4]. The synthesis of HAp using the sol-gel method consists of the molecular-level mixing of
calcium and phosphorus precursors under significantly milder conditions. Hence, a sol-gel synthesis
of HAp has recently attracted considerable attention.
The sol-gel synthesis technique is also used in conjunction with various spinning techniques to
fabricate HAp fibers [5]. Electrospinning is an easy and simple method that utilizes electrical fields to
fabricate nano- to microfibers from a polymer solution. The topological structure of the electrospun
matrix closely mimics the dimensions of the natural extracellular matrix (ECM). The ECM plays a key
role in triggering intracellular signaling cascades for tissue regeneration. Thus, the development of
new ECM substitutes has attracted a wide attention as a scaffold for tissue engineering. Franco et al.
successfully fabricated HAp nanofibers by combining electrospinning and a non-alkoxide sol-gel
system [6]. Pasuri noted that electrospun HAp nanofibers do not activate macrophages in vitro and
can be resorbed by human osteoclasts [7].
Recently, much attention has been attracted by HAp as a drug delivery carrier for the loading
and delivery of therapeutic agents, such as proteins, growth factors, genes, and drugs [8–10].
Mesoporous HA nanoparticles possess a higher drug-loading capacity and drug-release efficiency
than HAp nanoparticles as a result of their large surface areas and high pore volumes [11]. The
synthesis of mesoporous HAp nanoparticles using template reagents, such as Pluronic P123 [12],
cetyltrimethylammonium bromide (CTAB) [13], and Pluronic F127 [14], is the most well-known
method. In the synthesis of mesoporous HAp, the self-assembly of inorganic HAp phases and template
reagents followed by template removal can produce the mesoporous structure.
Münchow [15] incorporated CaO nanoparticles into electrospun matrices and demonstrated
improved cell viability and osteogenic differentiation. Hence, the aims of this study were to fabricate
and characterize a nanofibrous structure of porous hydroxyapatite-CaO (p-HApFs) by utilizing
an electrospinning process based on a sol-gel precursor and to evaluate the release profiles and
antibacterial activity of tetracycline from p-HApFs.
2. Materials and Methods
2.1. Synthesis and Characterization of Porous Hydroxyapatite Nanofibers
Mesoporous hydroxyapatite nanofibers were synthesized using poly(ethylene glycol)-block-poly
(propylene glycol)-block-poly(ethylene glycol) (P123, Sigma-Aldrich, St. Louis, MO, USA) as the
structure-directing agent. Briefly, 1.0 g of P123 and 6.172 mL of triethyl phosphite (TEP, Merck,
Germany) were mixed in a 10 mL ethanol aqueous solution (50% v/v), which was then continuously
stirred to form a clear solution. Ca(NO3)2 (14 g, Sigma-Aldrich, St. Louis, MO, USA) was dissolved
in 10 mL of absolute ethanol under magnetic stirring at room temperature. The calcium nitrate
solution was slowly added under stirring to the above P123/TEP solution to form a precursor solution.
The precursor solution was tightly capped and placed in an oven at 60 ◦C for 12 h. Then, 1.5 g
poly(vinyl pyrrolidone) (PVP, Sigma-Aldrich, St. Louis, MO, USA), 0.45 g P123 and 7 mL absolute
ethanol were prepared and incorporated into the 3 mL precursor solution to obtain a transparent
mixture solution. The mixture solution was placed inside a plastic syringe fitted with a stainless needle
(18 G, inner diameter = 0.838 mm) and then inserted into a syringe pump to supply a steady flow
rate (1.27 mL/h). An electrical field (1.3 kV/cm) was applied between the needle and an aluminum
substrate (grounded collector) using a high-voltage power supply (SL 60, Spellman, New York, NY,
USA). The polymer solution, which formed a Taylor cone upon exit, was collected on an aluminum
substrate in the form of nonwoven nanofiber structures and was then calcined at different temperatures
(600 ◦C, 800 ◦C and 1000 ◦C) and environments (air and nitrogen) to obtain the calcined p-HApFs
nonwoven structures.
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2.2. Characterization of the p-HApF
The p-HApFs morphology was observed using scanning electron microscopy (SEM, Hitachi
S-4800, Tokyo, Japan), which operated at an accelerating voltage of 15 kV The average fiber diameter
of the p-HApFs was analyzed by image analysis software (Image-Pro Express Version 6.0, Media
Cybernetics, Rockville, MD, USA) based on the SEM images. Moreover, the p-HApFs pore structure
was observed using transmission electron microscopy (TEM, JEOL JEM-2100, Tokyo, Japan) at an
accelerating voltage of 100 kV. Nitrogen adsorption–desorption measurements were used to obtain the
Brunauer-Emmett-Teller (BET) specific surface area, and the pore size was also analyzed (Micromeritic
ASAP 2020 instrument, Norcross, GA, USA). The phase of p-HApFs was characterized by X-ray
diffraction (XRD, Bruker D2-Phaser, Madison, WI, USA) with a copper target. Powder diffraction
patterns were acquired over 2-theta, ranging from 20 to 60◦ with a step size of 0.04◦. The functional
groups of p-HApFs were analysed with Fourier transitioned infrared spectroscopy (FTIR, Bruker
tensor II, Madison, WI, USA). The spectra were recorded from 4000 to 400 cm−1 wave number with a
resolution of 2 cm−1.
2.3. In Vitro Study of Drug Loading and Release
Tetracycline (TC) was selected as the model drug for the evaluation of drug loading and release.
p-HApFs (10 mg) was added to a TC aqueous solution (5 mg/mL, 10 mL) and stirred for 24 h. After
the loading procedure, the amount of TC adsorbed onto p-HApFs, which calcined at N2 atmosphere
800 ◦C, was calculated by determining the difference in the TC concentration before and after loading.
The TC concentration was analyzed at a wavelength of 360 nm using a UV-Vis spectrophotometer
(Ultrospec 1100 Pro, Amersham Biosciences, Piscataway, NJ, USA).
The drug contents and loading efficiency were calculated according to the following formulas:
Drug content (w/w) = weight of the TC in the p-HApFs/weight of the p-HApFs
Loading efficiency (%) = (weight of the TC in the p-HApFs/initial weight of the p-HApFs) × 100%
After loading, the p-HApFs were dried using a lyophilization process. TC-loaded p-HApFs
(20 mg) were added to a phosphate-buffered saline (PBS) solution (2 mL) and agitated in a horizontally
shaking bath at 37 ◦C. The release medium was withdrawn and replaced with fresh PBS at each
measurement. The mechanism of drug release was analyzed by fitting the experimental data to
equations describing different kinetic orders. Linear regression analyses were performed for zero-order
[Mt/M0 = K0·t] and first-order [ln(M0 − Mt) = K1·t] kinetics, as well as the Higuchi [Mt/M0 = KH·t1/2]
model, where K is the kinetic constant and Mt/M0 is the fraction of TC released at time t. The best-fitted
model was assessed on the basis of the correlation coefficient (r2). The drug release data were further
analyzed with the Ritger-Peppas equation [Mt/M∞ = kr·tn], where Mt is the amount of drug released
at time t, M∞ is the amount of drug released at time ∞, and kr and n represent the release rate constant
and release exponent, respectively.
2.4. Antibiotic Activity against Staphylococcus aureus and Pseudomonas aeruginosa
The antibiotic activity of TC in the in vitro release study was assessed against a Gram-positive
bacterial strain, Staphylococcus aureus, and a Gram-negative bacterial strain, Pseudomonas aeruginosa,
using the antibiotic elution samples from a turbidity assay. TC (500 μL) eluated during the in vitro
release study or from PBS (as the control group) was added to the inoculum containing 500 μL of the 2×
nutrient broth solution and 100 μL of bacteria in 5-mL test tubes. After 24 h of incubation, the optical
density (OD) of the culture medium was measured using a spectrophotometer at a wavelength of
600 nm. The relative antibacterial activity (R%) was calculated as follows:
R% = [(ODgrowth medium − ODreleased tetracycline)/ODgrowth medium] × 100%
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3. Results and Discussions
All of the electrospun nanofibers were calcined at three different temperatures, namely, 600, 800
and 1000 ◦C, to study the crystal phase structure. Figure 1 shows the XRD pattern for the nanofibers
calcined at different temperatures. The electrospun fibers were mostly crystalline calcium carbonate at
600 ◦C. The amount of CaO increased when the calcination temperature increased, which was due to
the breakdown of calcium carbonate that formed calcium oxide, accompanied by the evolution of CO2.
The HAp phase formed at 800 ◦C.
Figure 1. XRD pattern of the fibers calcined at different temperatures under an air atmosphere.
( : CaO, PDF 70-4068; : hydroxyapatite, PDF 84-1998; : CaCO3, PDF 85-1108).
Figure 2 shows the XRD pattern for the nanofibers calcined under air and nitrogen atmosphere
at 800 ◦C. The main crystal phase comprised HAp and CaO. However, the amount of HAp was
higher under the nitrogen than under the air atmosphere. The amount of dissolved ambient CO2
can be limited by performing the reaction under a nitrogen atmosphere [16]. Hatzistavrou [17]
fabricated hydroxyapatite-CaO composites using the sol-gel method and found that the presence of
CaO accelerated the formation of carbonate hydroxyapatite in simulated body fluid. This was due to
the dissolution of the CaO phase that rapidly formed carbonate hydroxyapatite. Hence, HAp/CaO
composites have been used as scaffolds with tuneable properties by varying the composition.
Figure 2. XRD pattern of the fibers calcined at 800 ◦C under various calcination atmospheres. ( : CaO,
PDF 70-4068; : hydroxyapatite, PDF 84-1998; : CaCO3, PDF 85-1108).
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Figure 3 shows a Fourier transform infrared (FTIR) characteristic spectrum for the nanofibers
that were calcined at 800 ◦C under a nitrogen atmosphere. Peaks at approximately 566 and 609 cm−1
are due to the bending vibration of the P-O bond in PO43− [18]. The bands at approximately 960
and 1000~1100 cm−1 are associated with the stretching modes of the PO43− bonds in Hap [19].
The characteristic bands at approximately 873 and 1440~1470 cm−1 are attributable to the CO3−2
group. Taherian et al. [20] pointed out CO32− ions may form due to the incomplete pyrolysis of organic
compounds, or the absorption of CO2 from the atmosphere. Bilton et al. [21] pointed out that the
evaporation of unreacted triethyl phosphite from the sol or gel could constitute to the presence of
CaCO3. CaCO3 decomposes to CaO after calcination at 800 ◦C
Figure 3. FTIR spectra of the fibers calcined at 800 ◦C under an N2 atmosphere.
The dissolution of CO2 from the atmosphere occurs by the following reaction:
CO2 (g) + 2 OH− (aq) → CO32− (aq) + H2O (l)
The characteristic peaks observed at 632 and 3571 cm−1 are attributable to the respective hydroxyl
functional group (-OH) deformation vibration and stretching vibrations of HAp [22]. Additionally,
a sharp peak was observed at 3642 cm−1, which confirms the formation of the CaO phase [23].
The morphology and structure of the p-HApFs were observed under SEM and TEM. Figure 4a
shows the SEM image of the p-HApFs. The average diameter of the p-HApFs was 461 ± 186 nm.
Figure 4b shows the TEM image of the p-HApFs. The TEM image showed that the nanofiber was
composed of a number of nanocrystals and clearly revealed the existence of mesopores within the
nanocrystals. The p-HApFs did not exhibit an ordered orientation of the mesopores, which generally
had a random arrangement.
The nitrogen adsorption–desorption isotherms of the p-HApFs were type IV hysteresis loops,
which are typical for mesoporous materials (shown in Figure 5a). The specific surface areas of the
p-HApFs calculated from the BET equation were 7.2 m2/g. The pore size distribution was plotted
according to the BJH nitrogen desorption model as shown in Figure 5b. The average pore size of the
p-HApFs calculated from the BJH equation was approximately 28 nm. Figure 5b shows a broad peak
ranging from 10 to 130 nm, centered at approximately 50 nm, which suggests that most pores had a
size of approximately 50 nm; however, the pore sizes were not uniform.
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Figure 4. (a) SEM and (b) TEM micrographs of the nanofibers after heat treatment at 800 ◦C under an
N2 atmosphere. (c) an enlarged graph in red square of (b). The red arrows in (c) indicates mesopores
within the nanocrystals.
 
Figure 5. (a) N2 adsorption–desorption isotherm and (b) pore size distribution curve of p-HApFs.
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The amount of TC loaded within the p-HApFs was 8.83 ± 0.09 mg/10 mg (TC/p-HApFs).
The loading efficiency of TC was 88.34 ± 0.89% (w/w). The cumulative drug-release curve as a
function of time for TC release from the TC-loaded p-HApFs was analyzed in triplicate (shown in
Figure 6). The drug-release data indicated that a no-burst release phenomenon occurred at the initial
step. The TC release from the TC-loaded p-HApFs was steady and slow over a period of 14 days.
The drug-release data were analyzed using different kinetic models: zero-order, first-order, Higuchi,
and Korsmeyer-Peppas. The best fit with the highest correlation coefficient (r2) was obtained using the
first-order equation (r2 = 0.996), followed by the Higuchi model (r2 = 0.941), and zero-order equation
(r2 = 0.983). The diffusion exponent n-value of the Korsmeyer–Peppas model was 0.75, which indicates
anomalous diffusion or both diffusion- and erosion-controlled drug release [24].
Figure 6. In vitro cumulative tetracycline (TC) release from TC-loaded p-HApFs.
To clarify the antibacterial activity of TC released from the TC-loaded p-HApFs, the release
solution was used to cultivate bacterial strains. As shown in Figure 7, the release solution had a strong
ability to inhibit bacterial growth, even on day 7.
Figure 7. Susceptibility trend of the released tetracycline against Staphylococcus aureus and Pseudomonas
aeruginosa.
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4. Conclusions
A mesoporous hydroxyapatite nanofibrous matrix to mimic the three-dimensional structure of
the natural extracellular matrix was successfully fabricated by an electrospinning process based on a
sol-gel precursor. p-HApFs exhibited a high drug-loading efficiency and could retard the burst release
of TC, as well as maintain antibacterial activity over a period of 7 days. Hence, it is anticipated that
p-HApFs have the potential to be used as drug delivery carriers and as bone graft substitutes.
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2. Cüneyt Taş, A.; Korkusuz, F.; Timuçin, M.; Akkaş, N. An investigation of the chemical synthesis and
high-temperature sintering behaviour of calcium hydroxyapatite (HA) and tricalcium phosphate (TCP)
bioceramics. J. Mater. Sci. Mater. Med. 1997, 8, 91–96. [CrossRef] [PubMed]
3. Rao, R.R.; Roopa, H.N.; Kannan, T.S. Solid state synthesis and thermal stability of HAP and HAP—beta-TCP
composite ceramic powders. J. Mater. Sci. Mater. Med. 1997, 8, 511–518. [CrossRef] [PubMed]
4. Li, H.; Zhang, N.; Wang, X.; Geng, X.; Yang, X.; Wang, H.; Li, B.; Liang, C. Synthesis and cytotoxicity of carbon
nanotube/hydroxyapatite in situ composite powders prepared by chemical vapour deposition. Mater. Res.
Innov. 2014, 18, 338–343. [CrossRef]
5. Ramanan, S.R.; Venkatesh, R. A study of hydroxyapatite fibers prepared via sol-gel route. Mater. Lett. 2004,
58, 3320–3323. [CrossRef]
6. Franco, P.Q.; João, C.F.C.; Silva, J.C.; Borges, J.P. Electrospun hydroxyapatite fibers from a simple sol–gel
system. Mater. Lett. 2012, 67, 233–236. [CrossRef]
7. Pasuri, J.; Holopainen, J.; Kokkonen, H.; Persson, M.; Kauppinen, K.; Lehenkari, P.; Santala, E.; Ritala, M.;
Tuukkanen, J. Osteoclasts in the interface with electrospun hydroxyapatite. Colloids Surf. B Biointerfaces 2015,
135, 774–783. [CrossRef] [PubMed]
8. Zhang, W.; Chai, Y.; Xu, X.; Wang, Y.; Cao, N. Rod-shaped hydroxyapatite with mesoporous structure as
drug carriers for proteins. Appl. Surf. Sci. 2014, 322, 71–77. [CrossRef]
9. Li, D.; Huang, X.; Wu, Y.; Li, J.; Cheng, W.; He, J.; Tian, H.; Huang, Y. Preparation of pH-responsive
mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
Biomater. Sci. 2016, 4, 272–280. [CrossRef] [PubMed]
10. Pistone, A.; Iannazzo, D.; Espro, C.; Galvagno, S.; Tampieri, A.; Montesi, M.; Panseri, S.; Sandri, M.
Tethering of Gly-Arg-Gly-Asp-Ser-Pro-Lys Peptides on Mg-Doped Hydroxyapatite. Engineering 2017, 3,
55–59. [CrossRef]
11. Gu, L.; He, X.; Wu, Z. Mesoporous hydroxyapatite: Preparation, drug adsorption, and release properties.
Mater. Chem. Phys. 2014, 148, 153–158. [CrossRef]
12. Cheah, W.K.; Ooi, C.W.; Othman, R.; Yeoh, F.Y. Synthesis of mesoporous hydroxyapatite through a soft
template route using non-ionic surfactant. ASEAN Eng. J. Part B 2012, 1, 57–69.
13. Yao, J.; Tjandra, W.; Chen, Y.Z.; Tam, K.C.; Ma, J.; Soh, B. Hydroxyapatite nanostructure material derived
using cationic surfactant as a template. J. Mater. Chem. 2013, 13, 3053–3057. [CrossRef]
14. Zhao, Y.F.; Ma, J.; Tan, G. Synthesis of mesoporous hydroxyapatite through neutral templating. Int. J. Nanosci.
2006, 5, 499–503. [CrossRef]
15. Münchow, E.A.; Pankajakshan, D.; Albuquerque, M.T.; Kamocki, K.; Piva, E.; Gregory, R.L.; Bottino, M.C.
Synthesis and characterization of CaO-loaded electrospun matrices for bone tissue engineering. Clin. Oral
Investig. 2016, 20, 1921–1933. [CrossRef] [PubMed]
164
Nanomaterials 2018, 8, 570
16. Nazeer, M.A.; Yilgor, E.; Yagci, M.B.; Unal, U.; Yilgor, I. Effect of reaction solvent on hydroxyapatite synthesis
in sol-gel process. R. Soc. Open Sci. 2017, 4, 171098. [CrossRef] [PubMed]
17. Hatzistavrou, E.; Chatzistavrou, X.; Papadopoulou, L.; Kantiranis, N.; Chrissafis, K.; Boccaccini, A.R.;
Paraskevopoulos, K.M. Sol-gel hydroxyapatite-CaO composites: Fabrication and bioactivity studies. Key Eng.
Mater. 2009, 396–398, 99–102. [CrossRef]
18. Baddiel, C.B.; Berry, E.E. Spectra structure correlations in hydroxy and fluorapatite. Spectrochim. Acta 1966,
22, 1407–1416. [CrossRef]
19. Wang, H.; Zhang, P.; Ma, X.; Jiang, S.; Huang, Y.; Zhai, L.; Jiang, S. Preparation, characterization of electrospun
meso-hydroxylapatite nanofibers and their sorptions on Co(II). J. Hazard Mater. 2014, 265, 158–165. [CrossRef]
[PubMed]
20. Taherian, M.; Rojaee, R.; Fathi, M.; Tamizifar, M. Effect of different sol–gel synthesis processes on
microstructural and morphological characteristics of hydroxyapatite-bioactive glass composite nanopowders.
J. Adv. Ceram. 2014, 3, 207–214. [CrossRef]
21. Bilton, M.; Milne, S.J.; Brown, A.P. Comparison of hydrothermal and sol-gel synthesis of nano-particulate
hydroxyapatite by characterisation at the bulk and particle level. Open J. Inorg. Non-Met. Mater. 2012, 2, 1–10.
[CrossRef]
22. Russell, S.W.; Luptak, K.A.; Suchicital, C.T.A.; Alford, T.L.; Pizziconi, V.B. Chemical and structural evolution
of sol-gel-derived hydroxyapatite thin films under rapid thermal processing. J. Am. Ceram. Soc. 1996, 79,
837–842. [CrossRef]
23. Hatzistavrou, E.; Chatzistavrou, X.; Papadopoulou, L.; Kantiranis, N.; Kontonasaki, E.; Boccaccini, A.R.;
Paraskevopoulos, K.M. Characterization of the bioactive behaviour of sol-gel hydroxyapatite-CaO and
Hydroxyapatite-CaO-bioactive glass composites. Mater. Sci. Eng. C 2010, 30, 497–502. [CrossRef]
24. Dash, S.; Murthy, P.N.; Nath, L.; Chowdhury, P. Kinetic modeling on drug release from controlled drug
delivery systems. Acta Pol. Pharm. 2010, 67, 217–223. [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution





Physical Properties and In Vitro Biocompatible
Evaluation of Silicone-Modified Polyurethane
Nanofibers and Films
Chuan Yin 1, Sélène Rozet 1, Rino Okamoto 1, Mikihisa Kondo 1, Yasushi Tamada 1,
Toshihisa Tanaka 1,*, Hatsuhiko Hattori 2, Masaki Tanaka 2, Hiromasa Sato 3 and Shota Iino 3
1 Interdisciplinary Graduate School of Science and Technology, Shinshu University, 3-15-1, Tokida, Ueda-shi,
Nagano 386-8567, Japan; yinkawa@outlook.com (C.Y.); selene.rozet@gmail.com (S.R.);
j3992a1953m@gmail.com (R.O.); Kondo.mikihisa@exc.epson.co.jp (M.K.); ytamada@shinshu-u.ac.jp (Y.T.)
2 Silicone-Electronics Materials Research Center, Shin-Etsu Chemical Co., 1-10, Hitomi, Matsuida-Machi,
Annaka-Shi, Gunma 379-0224, Japan; hhattori@shinetsu.jp (H.H.); m.tanaka@shinetsu.jp (M.T.)
3 Dainichiseika Color & Chemicals Mfg. Co., 1-4-3, Ukima, Kita-ku, Tokyo 115-8622, Japan;
hrsato@daicolor.co.jp (H.S.); iino@daicolor.co.jp (S.I.)
* Correspondence: tanakat@shinshu-u.ac.jp
Received: 29 January 2019; Accepted: 22 February 2019; Published: 5 March 2019
	

Abstract: In this study, the physical properties and the biocompatibility of electrospun
silicone-modified polyurethane (PUSX) nanofibers were discussed and compared with PUSX films.
To investigate the effects of different structures on the physical properties, tensile strength, elongation
at break, Young’s modulus, water retention, water contact angle (WCA) and thermal conductivity
measurements were performed. To prove the in vitro biocompatibility of the materials, cell adhesion,
cell proliferation, and cytotoxicity were studied by NIH3T3 mouse embryonic fibroblasts cells
following by lactate dehydrogenase (LDH) analysis. As a conclusion, the mechanical properties,
water retention, and WCA were proven to be able to be controlled and improved by adjusting the
structure of PUSX. A higher hydrophobicity and lower thermal conductivity were found in PUSX
nanofibers compared with polyurethane (PU) nanofibers and films. An in vitro biocompatibility
evaluation shows that the cell proliferation can be performed on both PUSX nanofibers and films.
However, within a short period, cells prefer to attach and entangle on PUSX nanofibers rather than
PUSX films. PUSX nanofibers were proven to be a nontoxic alternative for PU nano-membranes or
films in the biomedical field, because of the controllable physical properties and the biocompatibility.
Keywords: silicone modified polyurethane nanofibers; physical properties; cell attachment;
cell proliferation; cytotoxicity
1. Introduction
Electrospun nanofibers have been used in various fields such as filtration, catalysis, clothing, and
biomedical applications, because of their submicron size and high surface area, along with their porous
architecture [1,2]. Especially for biomedical applications, electrospun mats provide the lightness in
weight, porosity, flexibility in technique, as well as a good support for cells to attach and grow. Their
capacity to exchange nutrients and gases makes them suitable for tissue engineering, wound dressing,
drug delivery, health care, etc. [3]. A non-woven matrix composed of nanofibers is easily produced via
electrospinning, and it is architecturally similar to the nanofibrous structure of extracellular matrix [4].
If necessary, the nanofibers can be further functionalized via the incorporation of bioactive species
(e.g. enzymes, DNAs, and growth factors) to better control the proliferation and differentiation of cells
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seeded on the scaffolds [5]. These attributes make electrospun nanofibers well-suited as scaffolds for
tissue engineering.
Among various kinds of nanofibers, polyurethane nanofibers were selected as one of the
most suitable choices for biomedical applications, thanks to the unique properties of polyurethane.
Electrospun polyurethane nanofibers have been successfully used in wound dressing, due to an
excellent oxygen permeability and barrier properties [6]. Water permeability is also important, as it
keeps the wound moist and prevents the accumulation of fluid around the wound and on its cover.
These covers perform a preventive function against infection with microorganisms, to absorb blood
and wound fluids to contribute to the healing process, and in some cases, to apply medical treatment
to the wound [7–9].
However, there are still several limitations and disadvantages of polyurethane nanofibers to be
applied in the biomedical field, such as poor thermal capability, poor weatherability, and flammability.
In order to improve the properties of polyurethane nanofibers, silicone groups were introduced into
polyurethane polymer chains to fabricate silicone-modified polyurethane (PUSX) and to optimize the
electrospinning parameters. In this study, PUSX nanofibers were evaluated by physical properties and
cell culture studies, and they were compared with the films. The advantages of polyurethane, silicone,
and nanofibers are very attractive for this work. This new material is expected to be applied in many
fields as an improved alternative for polyurethane nanofibers, such as wound dressing and tissue
engineering, due to the biocompatibility of silicone. Before going for the in vitro cell attachment and
proliferation applications, all of the prepared nanofibers were analyzed in detail by various methods,
and compared with films. To investigate the effects of different structure (block and graft type), chain
lengths, and silicone concentration, evaluation of the physical properties was performed. Tensile tests
were performed to investigate mechanical properties such as tensile strength, elongation at break,
and Young’s modulus. The water contact angle (WCA) measurement and water retention tests were
carried out to determine the hydrophobicity of the PUSX material. The thermal conductivity was
analyzed in order to discuss the heat retention ability of the PUSX nanofibers and films. In order to
reveal the potential for cell adhesion and proliferation, NIH3T3 mouse embryonic fibroblasts cells
were cultured on all the samples, followed by lactate dehydrogenase (LDH) activity. The toxicity of the
PUSX nanofibers and films were evaluated by using direct contact based on ISO 10993-5. Therefore,
as the purpose of our research, the influence of PUSX structures on the physical properties and
biocompatibility is investigated. PUSX nanofibers might be expected as an ideal alternative for PU
nanofibrous membranes or films in the biomedical fields.
2. Experimental Section
2.1. Materials
The 12 kinds of PUSX solutions and films were kindly synthesized and provided by Shin-Etsu
Chemical Co., Ltd., and Dainichiseika Color & Chemicals Mfg. Co., Ltd. These synthesized PUSX
solutions in N,N-dimethylformamide/ ethyl methyl ketone (DMF/MEK) standardized a solid content
of 30 wt%. The structures of two types of PUSX are shown in Figure 1. PUSX with different silicone
concentrations and chain lengths are listed in Table 1. Solvents such as N,N-dimethylformamide (DMF)
and ethyl methyl ketone (MEK) were purchased from Wako Pure Chemical Industries., Ltd., and used
as received.
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Figure 1. Structures of block-type silicone-modified polyurethane (PUSX) (a) and graft-type PUSX (b).
Table 1. Polyurethane (PU) samples and silicone modified polyurethane (PUSX) samples of block type
and graft type.
Sample PU Si01 Si02 Si03 Si04 Si01-20 Si01-40 Si01-59 Si05 Si06 Si07 Si08
Molecular Structure × Block Type Graft Type
Mw (×105) 1.48 1.69 1.39 1.59 1.66 1.74 2.01 2.33 1.56 1.61 1.57 1.62
Mn (×105) 0.75 0.87 0.73 0.79 0.75 0.88 1.02 1.11 0.71 0.70 0.72 0.78
Silicone
Concentration (wt%) 0 10 10 10 10 20 40 59 10 10 10 10
Silicone Chain
Length (n) × 20 10 30 50 20 20 20 10 25 30 120
2.2. Electrospinning Method of PUSX Nanofibers
All the electrospinning solutions were prepared by diluting the PUSX solutions (30 wt%) in
DMF/MEK mixed solvent (v/v = 64:36), and stirring at room temperature for 48 h in order to obtain
homogeneous solutions. All electrospinning experiments were performed at room temperature
(22 ◦C) under the optimized parameters of our previous study [10], and the deposited nanofibers
were collected on a moving metallic collector. A 10–20 kV voltage was applied while the needle
tip-to-collector distance was 10 cm with an irradiation angle of 30◦, and the air flow rate in the spinning
environment was 0.1 mL/min.
The surface morphology of the nanofibers was investigated by scanning electron microscope
(SEM, JSM-6010LA JEOL, Tokyo, Japan) at an accelerating voltage of 10 kV. Before SEM analysis,
the prepared samples were coated by using a platinum sputter coater (Ion sputter JFC-1600 JEOL,
Ltd, Tokyo, Japan) under 30 mA for 60 s. The diameters of the nanofibers were measured by ImageJ
(National Institutes of Health, Bethesda, MD, USA). The average fiber diameters were calculated from
data of at least 50 measurements per sample.
2.3. Physical Properties
Tensile tests were performed by a compact tabletop universal tensile tester (EZTest/EZ-S,
Shimadzu Corporation, Kyoto, Japan) for samples 10 mm long and 5 mm wide, at a crosshead
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speed of 10 mm/min. At least 10 specimens were tested for each sample. To compare the mechanical
properties of the PUSX nanofibers with PUSX films, the same tests were performed on the PUSX films.
Thermal conductivities were determined by a KES-F7 Thermal LaboIIB precision rapid thermal
property measurement unit (KES-F7 Thermal Labo, Kato Tech Co., Ltd, Kyoto, Japan). The temperature
of the water box was set to room temperature. Samples (5 × 5 cm2) were then placed on the water box,
and the heat plate of the bottom temperature box (B. T. box) was placed on the upper surface of the
samples. After reaching a constant value, the heat flow loss W (watts) of the B.T. was recorded using a
panel meter. Steady heat flow lost was calculated as the following equation:
W = K·A·T/D
where D is the thickness of the samples (cm), A is the area of the B.T. heat plate (cm2), T is the
temperature difference of sample (◦C), and K is the thermal conductivity. The thermal conductivity K
was calculated by the following equation:
K = W·D/AT (W/cm ◦C) = 100 W·D/AT(W/mK).
While taking measurements with the B. T. Box, the applied pressure could be adjusted. The
standard value was set as 6 g/cm2. The temperature of the B. T. Box heat plate was controlled with an
error of less than 0.1 ◦C.
Water retention tests were performed based on JIS L 1913 6.9.2. The electrospun PUSX nanofibers,
and films of dimensions 100 × 100 mm2 were incubated in distilled water for a period of 15 min, and
then weighed. Water retention capacity was determined as the increase in the weight of the fibers. The
percentage of water absorption was calculated as in the following equation:
m = (m2 − m1)/m1 × 100%
where m2 and m1 are the weights of the samples in wet and dry environments, respectively.
WCA is an easy measurement for determining the wettability of the materials by a liquid. The
static contact angle of pure water for the surfaces of the PUSX samples was measured by an automated
contact angle meter (DM-501Hi, Kyowa Interface Science Co., Ltd, Saitama, Japan) after randomly
dripping 2 μL of purified water on the surfaces of the samples. The droplets on the samples were
captured after 1000 ms through an image analyzer, and the WCA, θ, was calculated by the software
through analyzing the shape of the drop. When depositing a droplet onto the material, the water
will form a droplet shape. The point where the surface, the water, and the vapor meet, is called the
three-face point, and it determines the contact angle. The relationship between the contact angle, the
surface free energy, the liquid surface tension, and the interfacial tension between solid and liquid is
defined by the Young equation:
γS = γL cosθ + γSL,
where θ is the contact angle, γL is the surface free energy of the solid, and γSL is the interfacial tension
between the solid and liquid.
Usually, when the WCA is less than 90◦, the material can be considered to be hydrophilic while
the material is hydrophobic. It is worth mentioning that if the WCA is between 150◦ and 180◦, it shows
the high water-repellency of the material.
2.4. In Vitro Biocompatible Evaluation
2.4.1. Cell Culture Studies
Before using the samples for in vitro cell culture, it is essential to remove the DMF/MEK mixed
solvents because of the possible cytotoxicity. All of the samples were washed with distilled water for
48 h and dried in oven at 80 ◦C overnight. Then, the nanofibers and films were cut into round shapes
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with a diameter of 10 mm, with three replicates per sample prepared. Sterilization was performed by
deeply soaking the samples in 70% ethanol aqueous solution in a multi-well tissue culture polystyrene
(TCPS) dish for 1 h, followed by rinsing three times in phosphate buffer saline (PBS) to remove all
traces of ethanol.
NIH3T3 mouse embryonic fibroblasts were used to measure the cell adhesion and proliferation.
For the cell adhesion test, 50,000 cells (in 1 mL of medium) were mixed well into the sample. After 3 h,
the cells were harvested in 1 mL of 0.5% Triton X-100/PBS solution, and evaluated by LDH assay for
adhesion evaluation of the cells.
The cell proliferation test was a quantitative investigation of the capacity for the cells to grow on
the electrospun nanofibers and films. At the seeding step of the proliferation culture, 5000 cells were
added into the sample. The experiment lasted for a total of seven days, and the results of the first,
third, fifth, and seventh days were compared.
The LDH activity was immediately measured by ultraviolet absorption at a wavelength of 340 nm,
using the Thermo Scientific Multiskan FC microplate photometer (Thermo Fisher Scientific Inc.,
Waltham, MA, USA) with a recorder. The enzyme activity of LDH can be measure from chemical
reaction of LDH, when it is released into the cells’ medium from the damaged or dead cells, due to cell
membrane damage. LDH converts lactate using NAD as a coenzyme, and produces pyruvic acid and
NADH. The number of cells was calculated from the calibration curve obtained by the relation between
the known number of cells, and the absorbance value at 340 nm of NADH in the assay supernatant.
The shape of the cells was observed by SEM to qualitatively investigate the cell reactions when
in contact with the electrospun nanofibers. After each incubation period, the sample was fixed with
paraformaldehyde (PFA) as a cross-linking fixation agent, to stop the proliferation of cells, and to
preserve their shapes. The sample was further dehydrated by serially using ethanol gradient solutions
of 50, 70, 95, and 99.5% for 30 min each, over a continuous process. Then, the sample was coated with
platinum for SEM analysis.
2.4.2. Toxicity Evaluation
The toxicities of the PUSX nanofibers and films were evaluated by using direct contact based on
ISO 10993-5. Briefly, cells were seeded evenly over the surface of each plate and incubated at 37 ◦C
until the cells covered the whole surface. The samples were then placed on the cell layers in the center
of the plates, and the culture medium was replaced. In order to determine the toxicity in accordance
with Grade 0 (nontoxic) to Grade 4 (severe toxic) evaluation, Trypan blue was added after 24 h in each
plate, and observed by morphological changes. This is the most obvious and direct way to reflect the
impact of testing the materials on the cell [11].
2.5. Statistical Analysis
Significance in vitro biocompatibility and physical properties were statistically analyzed by a
one-way analysis of variance (ANOVA) using R free software. Statistical significance was set at p < 0.05
to identify which groups were significantly different from the other groups.
3. Results and Discussions
3.1. Morphology of PUSX Nanofibers Prepared for Physical and Biocompatability Evaluations
In the previous study [10], we successfully prepared 12 kinds of PUSX nanofibers under the
optimized conditions, and investigated the effects of solvents and solution concentrations on the
as-spun nanofibers, along with the morphological appearance.
Representative SEM images of PUSX nanofibers are shown in Table 2. It can be seen that the
surface morphology of the block-type PUSX was smooth and continuous, with fiber diameters ranging
from 400 nm to 720 nm. The mean diameters decreased with the increase of both the chain lengths of
silicone, and the silicone concentration. The surface morphology of graft-type PUSX nanofibers was
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also fine and continuous, with the mean diameters ranging from 460 nm to 560 nm. Compared with
block-type PUSX, graft-type PUSX nanofibers did not show a clear influence of the chain length on the
electrospinning parameters. Compared with the PU nanofibers, the PUSX nanofibers showed a more
uniform surface with a smaller diameter, due to the hydrophobicity of the silicone group. In this study,
the physical properties and biocompatibilities of the prepared samples are discussed.
Table 2. Scanning electron microscope (SEM) morphologies and average diameters of the PUSX
nanofibers under the optimized electrospinning parameters (magnification: 2000×) [10].
Sample PU Si01 Si02 Si03
SEM
Average Diameter (nm) 720 636 690 548
Sample Si04 Si01-20 Si01-40 Si01-59
SEM
Average Diameter (nm) 440 531 402 471
Sample Si05 Si06 Si07 Si08
SEM
Average Diameter (nm) 564 544 456 456
3.2. Mechanical Properties
3.2.1. Tensile Strength
Figure 2a–c shows the graphs of the trend of tensile strength, and a comparison of all the samples.
Referring to all three graphs, the PUSX films had better tensile strength than the nanofibers, because
of the porosity and the fiber orientation of the nanofibers. Due to the porosity of the nanofibers,
the cross-sectional area was apparent, compared to the cross-sectional area of the films, which
made the tensile strength supposedly higher than the results obtained. Pure PU nanofibers had
the highest strength because of the high mechanical properties of PU. Figure 2a,b show that for
block-type PUSX nanofibers, the tensile strength increased with an increase of silicone chain length,
and Si04 samples with the longest silicone chain length (n = 50) showed the highest tensile strength of
5.9 MPa. Samples with longer silicone chain lengths showed smaller diameters and a more improved
orientation of the molecular chains while being prepared under the optimized parameters, which
contributed to the higher tensile strength. Meanwhile, the tensile strength decreased with the increase
of silicone concentration, because of the low cohesive force of the silicone structure, and the decreasing
concentration of PU.
When the silicone concentration increased, the low cohesive force changed the tensile strength of
the material. On the other hand, the increase of silicone concentration caused the decrease of the ratio
of PU in the polymer, and the weight percent of PU as well, which means there was a lack of the higher
mechanical structure (PU). The tensile strengths of the films did not show much statistical significance
because of the random orientation of the molecular chains.
In the graph of graft-type PUSX nanofibers and films (Figure 2c), Si08 nanofibers showed the
highest tensile strength, at 6.8 MPa, with the Si05 sample showing the lowest result of 6.1 MPa. There
was almost no difference in the observed trends, because the results were in the same range.
172
Nanomaterials 2019, 9, 367
In this case, the silicone groups on the side chain were not able to influence the properties much,
because the tensile strength was mainly determined by the high mechanical properties of PU in the
main chain.
Figure 2. Comparison of tensile strength (MPa). “*” was statistically significant (p < 0.05) between each
pair of samples. (a) Block-type PUSX nanofibers and films with various chain lengths, (b) Block-type
PUSX nanofibers and films with various silicone concentrations, (c) Graft-type PUSX nanofibers and
films with various chain lengths.
The tensile stress–strain curves of the electrospun PUSX nanofibers and the PUSX films are shown
in Figure 3. Typical curves, each from a different structure of PUSX, were plotted for an obvious
comparison. From Figure 3a, the differences before and after silicone modification could be easily
observed. Si01-59 samples, with the highest silicone concentration in the block structure, show the
lowest mechanical performances out of the fiber membranes, because of the low cohesive force of
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silicone. Instead, the tensile stress–strain curves of PUSX films showed very similar trends and much
better mechanical performances, because of the random orientation of the molecular chains.
Figure 3. Comparison of stress–strain curves. (a) Stress–strain curves of the PUSX nanofibers,
(b) Stress–strain curves of the PUSX films.
3.2.2. Elongation at Break
Referring to Figure 4, the elongation at break decreased with the increase of both silicone chain
length and silicone concentration in block-type PUSX nanofibers. For the PUSX nanofibers with
different silicone chain length, the increase of silicone chain length caused a decrease in fiber diameters
under optimized conditions, which lead to the increase of entanglement and frictional resistance in
the nanofibers. For PUSX nanofibers with different silicone concentrations, the increase of silicone
concentration resulted in the decrease of polyurethane concentration in the molecular chains, and the
high elongation property of polyurethane became difficult to observe. Meanwhile, the elongation at
break of the graft-type PUSX nanofibers showed very similar results to each other for the same reason
as with the tensile strength. As for the graft type, the elongation at break did not show an obvious
trend, as the silicone groups on the side chains are not able to influence the nanofiber properties
because the ratio of polyurethane and silicone in the molecular chain do not change with an increase
of chain length. PUSX films have better tensile strengths than nanofibers, because of the porosity and
fiber orientation of the nanofibers.
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(c) 
Figure 4. Comparison of elongation at break (%). “*” was statistically significant (p < 0.05) between each
pair of samples. (a) Block-type PUSX nanofibers and films with various chain lengths, (b) Block-type
PUSX nanofibers and films with various silicone concentrations, (c) Graft-type PUSX nanofibers and
films with various chain lengths.
3.2.3. Young’s Modulus
Referring to Figure 5, the Young’s modulus increased with the increase of both the chain length
and the silicone concentration in block-type PUSX nanofibers. As the silicone chain lengths and
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concentrations increased, the concentration of PU became lower and lower, and the characteristics of
PU (with a high elongation at break) became difficult to observe, which meant that the samples were
more elastic. Moreover, the existence of silicone also made it more difficult to change the shapes of
the samples.
For both block- and graft-type PUSX nanofibers, all of the tensile test results showed that PUSX
films have higher tensile strengths than nanofibers. This phenomenon can be explained by the
orientation of the polymer chain, and the different structures of the nanofibers and films (porosity
and density).
Figure 5. Comparison of Young’s modulus (MPa). “*” was statistically significant (p < 0.05)
between each pair of samples. (a) Block-type PUSX nanofibers and films with various chain lengths,
(b) Block-type PUSX nanofibers and films with various silicone concentrations, (c) Graft-type PUSX
nanofibers and films with various chain lengths.
176
Nanomaterials 2019, 9, 367
3.3. Thermal Conductivity
Figure 6 shows the comparison of the thermal conductivity between block-type PUSX nanofibers
and films and graft-type PUSX nanofibers and films. For the thermal conductivity analysis, there
was no obvious trend of varying chemical structures such as varying silicone chain lengths, varying
silicone concentrations and block or graft structures of PUSX. The thermal conductivity was influenced
mostly by the shapes of the samples. Both block- and graft-type PUSX nanofibers have much lower
conductivity than films, because of the pores keeping the air inside. The heat insulating property is
proved here. This result can be explained by the heat-retaining property of nanofibers because of the
high porosity.
Figure 6. Comparison of the thermal conductivity (W/mK). (a) Block-type PUSX nanofibers and
films with various chain lengths, (b) Block-type PUSX nanofibers and films with various silicone
concentrations, (c) Graft-type PUSX nanofibers and films with various chain lengths.
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It is worth mentioning that in solid objects, heat is transferred via conduction. For electrospun
structures, much of the volume is made of empty spaces between fibers. Usually, the conduction along
the fiber as part of the whole volume is negligible. But if the fibers becomes too compact, the packing
density will be increased beyond an optimum standard, heat transfer via conduction through the
solid fiber becomes significant, and the overall insulation property will be decreased. The insulation
properties of the electrospun nanofibers are made more controllable due to their packing density
compared to the films, to meet the demands of the market. As an ideal alternative to PUSX films, PUSX
nanofibers provides good heat insulating properties and lightness in weight.
3.4. Water Retention and Water Contact Angle
3.4.1. Water Retention
In Table 3, there is a huge gap between the pure PU and PUSX nanofibers where the PU nanofibers
showed the highest water retention of 280%, with statistical significance (p < 0.05).
Block-type PUSX nanofibers showed a decreasing trend in water retention with the increase of
both silicone chain length and silicone concentration, because of the hydrophobicity of silicone. This
also means that the water repellency of the PU nanofibers are able to be improved by introducing the
silicone groups into the main chain. Meanwhile, compared with films, since nanofibers have a high
porosity for holding water, the water retentions of the nanofibers are higher than films. Both the PU
nanofibers and films have the highest water retentions. Higher hydrophobicity of silicone structure
and moisture permeability were proven.
Meanwhile, for graft-type PUSX nanofibers, the silicone groups on the side-chain are not able to
increase the hydrophobicity of the material, so that the water retention did not show any difference
between the PU nanofibers and the graft-type PUSX nanofibers.
Table 3. Comparisons of water retention.
Block-Type PUSX with Different
Silicone Chain Lengths
PU Si02 Si01 Si03 Si04
Nanofiber Water Retention (%) 280.0 ± 40.0 27.0 ± 11.0 19.0 ± 8.1 11.0 ± 4.1 12.0 ± 2.5
Film Water Retention (%) 2.3 ± 1.5 2.7 ± 1.1 1.5 ± 0.2 5.8 ± 5.0 3.7 ± 1.1
Block-type PUSX with Different
Silicone Concentrations PU Si01 Si01-20 Si01-40 Si01-59
Nanofiber Water Retention (%) 280.0 ± 40.0 19.0 ± 8.1 4.7 ± 3.1 2.7 ± 0.9 6.9 ± 6.0
Film Water Retention (%) 2.3 ± 1.5 1.5 ± 0.2 3.7 ± 0.7 2.7 ± 1.0 2.9 ± 2.3
Graft-Type PUSX PU Si05 Si06 Si07 Si08
Nanofiber Water Retention (%) 280.0 ± 40.0 169.0 ± 23.3 196.0 ± 28.8 165.0 ± 55.0 200.0 ± 13.5
Film Water Retention (%) 2.3 ± 1.5 2.3 ± 2.6 6.6 ± 7.5 6.8 ± 3.8 1.7 ± 0.9
3.4.2. Water Contact Angle
Figure 7 shows that the water contact angles of PU were much lower than PUSX for both the
nanofibers and films. This phenomenon might be caused by the high hydrophobicity of the silicone
structure. It also proved the results of water retention when comparing PU and PUSX materials.
The PUSX nanofibers showed higher WCA than the films, because the surface of the nonwoven
nanofiber membrane was much rougher than the films. The pores of the nanofibers make the surface
microstructure similar to the lotus structure of Cassie’s state (Figure 7h).
It is worth mentioning that for graft-type PUSX nanofibers, the water retention appeared to be
higher compared with the block-type PUSX nanofibers, but the results of the water contact angle were
similar. This might be caused by the different surfaces of the block-type and graft-type nanofibers. It is
supposed that the silicone groups were distributed differently on the graft-type PUSX nanofibers than
on the block-type PUSX nanofibers.
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Figure 7. Comparison of water contact angle (WCA, degrees). (a) Block-type PUSX nanofibers and
films with various chain lengths, (b) Block-type PUSX nanofibers and films with various silicone
concentrations (c). WCA images of (d) PU nanofibers, (e) PUSX Si08 nanofibers, (f) PU films, (g) PUSX
Si08 films, and (h) the Lotus microstructure (Cassie’s state).
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3.5. Cell Culture Studies
3.5.1. Cell Attachment and Cell Proliferation
To investigate the in vitro biocompatibility of the blended nanofibers, NIH3T3 cells were
cultivated on to PUSX nanofibers and films of different structures. Cell attachment results were
obtained and calculated after 3 h, and are showed in Figure 8. As the result, the number of adhered
cells on block-type PUSX nanofibers became higher with the increase of silicone chain length. The
reason for the increase of the fibroblast cells might be due to NIH3T3 cells being easily grown on the
surface, which has a higher water repellency and hydrophobic surface characteristics. As discussed in
Section 3.4, a higher water repellency is found with the increase of silicone chain length in block-type
PUSX nanofibers. The cell attachment results of the PUSX films were not shown, due to the very low
numbers after 3 h. Cells take a shorter time to adhere on nanofibers than on films, because of the
porosity of the electrospun nanofibers. For cell attachment, PUSX nanofibers turned out to be more
suitable than films.
Figure 9 represents the SEM images of the NIH3T3 fibroblast cells cultured for three days on
different PUSX nanofibers and films with different structures. It can be seen that after three days of
culture, there were more cells on the films than on the nanofibers, but the entanglement of the cells was
totally different. The cells attached in the pores of the nanofibrous membranes with rough surfaces
were much easier to manage as a scaffold for tissue engineering. Their stability was much higher
than the cells attached onto the surfaces of the films. The reason might be that nanofibers have a fiber
diameter of 400–700 nm, mimicking the extracellular matrix (ECM), as well as pores that help the cells
to stay stable in the membranes. This work suggested that the PUSX nanofibers have an important
advantage of being able to physically biomimic the natural ECM for tissue engineering applications,
and cell ingrowth and cell encapsulation in the nanofibrous scaffolds are equally important. The
architecture of a scaffold and the material used to play an important role in modulating tissue growth
and response behavior of the cells that have been cultured onto the scaffold. In this regard, the scaffold
should not only work as a substrate for cell attachment, growth, and proliferation, but also facilitate
cell migration, ingrowth, and assembly into a stereo-structure. Referring to the SEM morphologies,
the cells could attach onto PUSX nanofibers better than onto films, because the porosity makes the
nanofibers more stereo than in films.
Figure 10 shows the cell proliferation results after one day, three days, five days, and seven days,
respectively. The doubling time of NIH3T3 in the normal cell culture condition was between 20 to 26 h,
which means that it requires 30 h to produce 10,000 cells. However, the conditions of the nanofibers can
slow the processes down, because the structure allows less space for the cell to adhere as quickly as on
the normal substrate. From the results, all 12 kinds of PUSX nanofibers were proven to be appropriate
for cell proliferation, with a maximum cell number of around more than 10,000 on the fifth day. PUSX
nanofibers can be applied in the biomedical field as a better alternative to PU nanofibers, and with
controllable physical properties, as seen in the similar results of the cell proliferation test. As a result,
this study, it was confirmed that biomedical materials of desired physical properties are able to be
prepared by changing the structure without losing the same level of biocompatibility.
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Figure 8. The attachment of NIH3T3 cells, (a) Block-type PUSX nanofibers with various chain lengths,
(b) Block-type PUSX nanofibers with various silicone concentrations, (c) Graft-type PUSX nanofibers
after cells have attached for three hours. “*” was statistically significant (p < 0.05) between each pair
of samples.
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Figure 9. SEM images of NIH3T3 cells after culturing for three days on each sample. Cell attachment
morphologies on PU nanofibers (a) and films (b), Si01 nanofibers (c) and films (d), Si01-59 nanofibers
(e) and films (f), Si04 nanofibers (g) and films (h), Si08 nanofibers (i) and films (j). (Magnification of
nanofibers 1000×, films: 500×).
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Figure 10. The proliferation of NIH3T3 cells on block-type PUSX nanofibers with various chain lengths,
block-type PUSX nanofibers with various silicone concentrations, and graft-type PUSX nanofibers after
cells were cultured for 1, 3, 5, and 7 days, respectively. “*” was statistically significant (p < 0.05) for
each sample between 1 day and 3, 5, and 7 days.
3.5.2. Toxicity Evaluation
The results as displayed in Figure 11 showed that both the PUSX films and nanofibers caused
less toxicity when they were in contact with cells. The cells were able to keep a spreading shape, and
discrete intra-cytoplasmic granules with no cell lysis, which can be considered as a survival mechanism
compared with the positive control (cells became round and layers were completely destroyed). The
morphological grade of the cytotoxicity is supposed to be 0.
There was no obvious difference between the PUSX and PU materials, because of the
biocompatibility of silicone. To the best of our knowledge, silicone has been extensively used in
medical areas, in several products such as breast implants, contact lenses, lubricants, sealers, artificial
cardiac tubes and valves, urethral and venous catheters, membranes for blood oxygenation, dialysis
tubes, orthopedic applications, and facial reconstructions, because of its high biocompatibility [12,13].
The existence of the silicone group does not change the biocompatibility of the material. From these
results, the PUSX materials showed a suitable biocompatibility for use as biomedical materials, such
as waterproof bandages or scaffolds for tissue engineering.
Therefore, our novel nanofibrous membranes favored fibroblast cell attachment and growth
by providing a stereo-structure environment that mimics the ECM, and which is considered to be
biofriendly after toxicity evaluation. Indeed, there are a large amount of studies for developing
biomedical materials for wound dressing and tissue engineering. For instance, Fenghua Xu et al.
suggested tannic acid/chitosan/pullulan composite nanofibers, which showed synergistic antibacterial
activity and the potential for deep and intricate wound healing. Compared with these materials, PUSX
nanofibers show the controllable tensile strength of PU, which suggests potential applications for
long-term tissue engineering, and hydrophobicity that is influenced by the silicone groups. As
we know, wound infection is one of the main areas of concern in the management of the wound
environment. Infection complicates treatment, and it impedes the healing process by damaging tissue,
reducing wound tensile strength and inducing an undesirable inflammatory response [14–16]. PUSX
nanofiber wound dressing may provide a hydrophobic effect, which helps to control bacteria by
adsorbing bacteria onto the dressing surface. These results provide insight for the potential use of
PUSX nanofibers for wound healing and tissue engineering into clinical practice in the future.
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(a)    (b) 
(c)    (d) 
(e)    (f) 
(g)    (h) 
(i)    (j) 
(k)    (l) 
Figure 11. The toxicity evaluation of PU and PUSX samples. PU nanofibers (a) and films (b), Si01
nanofibers (c) and films (d), Si01-59 nanofibers (e) and films (f), Si04 nanofibers (g) and films (h),
Si08 nanofibers (i) and films (j), compared to the negative control (k) and the positive control (l).
(Magnification: 40×).
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In the present study, the physical properties and biocompatible properties of PUSX nanofibers
were investigated and compared with films. As a conclusion, for all of the analyses, physical properties,
mechanical properties, water retention, and water contact angle (WCA) can be controlled and improved
by adjusting the structure. Unfortunately, the graft-type PUSX did not show obvious changes in
mechanical strength, because the side chains of silicone could not have as much influence as the main
chain of PU does. Conversely, the graft-type PUSX nanofibers were the most similar alternatives to PU
nanofibers in terms of mechanical properties, but with better water repellency according to the water
contact angle results. Higher hydrophobicity and lower thermal conductivity were also found in the
PUSX nanofibers, due to the unique advantages of nanofibers compared with films. This material can
be expected to be applied in various fields. For instance, by controlling the silicone chain length and
the concentration of block-type PUSX nanofibers, it can be applied in the medical field as bandages
or scaffolds, the apparel field as outdoor goods and sportswear, and it can also be used for air or
water filters.
In vitro biocompatible evaluation shows that cell proliferation can be performed on both the
PUSX nanofibers and films. However, for cell attachment, the cells are not able to attach onto the
PUSX films in a short time, nor entangle in the material, PUSX nanofibers were proven to be more
appropriate for cell culture study. As we know, PU nanofibers have been developed as biomedical
materials for several years. For instance, Lakshmi R. Lakshman et al. [17] and Afeesh R.Unnithan
et al. [18] reported wound-dressing materials with antibacterial activity, which provided a basic
understanding of the design for efficient PU nanofiber-based antibacterial wound dressing materials.
Chang Hun Lee et al. [19] and Rui Chen et al. [20] demonstrated that electrospun PU nanofibers had
the characteristics of a native extracellular matrix, and they may be used effectively as an alternative
material for tissue engineering and functional biomaterials.
4. Conclusions
In this research, the physical properties and the biocompatibility of PUSX nanofibers were
discussed and compared with PUSX films. Tensile strength increased with the increase of silicone chain
length, and decreased with the increase of silicone concentration. The elongation at break decreased
with the increase of both the silicone chain length and the silicone concentration in block-type PUSX
nanofibers, while the Young’s modulus showed the entirely opposite trend. Higher hydrophobicity
and lower thermal conductivity were found in PUSX nanofibers, compared with PU nanofibers and
films. An in vitro biocompatible evaluation shows that PUSX nanofibers are able to be applied in the
cell culture field, and that it shows very little toxicity. Compared with films, PUSX nanofibers shows
better cell attachment over a short period of time. Therefore, electrospun PUSX nanofibers with highly
controllable physical properties can be expected as ideal alternatives to PU membranes applications of
the biomedical field, such as for wound dressings and tissue engineering.
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Abstract: The limitations of conventional therapeutic drugs necessitate the importance of developing
novel therapeutics to treat diverse diseases. Conventional drugs have poor blood circulation time and
are not stable or compatible with the biological system. Nanomaterials, with their exceptional
structural properties, have gained significance as promising materials for the development of
novel therapeutics. Nanofibers with unique physiochemical and biological properties have gained
significant attention in the field of health care and biomedical research. The choice of a wide
variety of materials for nanofiber fabrication, along with the release of therapeutic payload in
sustained and controlled release patterns, make nanofibers an ideal material for drug delivery
research. Electrospinning is the conventional method for fabricating nanofibers with different
morphologies and is often used for the mass production of nanofibers. This review highlights the
recent advancements in the use of nanofibers for the delivery of therapeutic drugs, nucleic acids
and growth factors. A detailed mechanism for fabricating different types of nanofiber produced
from electrospinning, and factors influencing nanofiber generation, are discussed. The insights from
this review can provide a thorough understanding of the precise selection of materials used for
fabricating nanofibers for specific therapeutic applications and also the importance of nanofibers for
drug delivery applications.
Keywords: electrospinning; nanofibers; fabrication; therapeutics; biomedical applications
1. Introduction
Nanotechnology—the use of nanomaterials for biomedical applications—is an emerging and
promising paradigm in biomedical research. Nanomaterials with exceptional physiochemical
properties, biocompatibility and minimal biological toxicity, can sense local biological environments
and initiate cellular level reprogramming to achieve the desired therapeutic efficacy. Diverse
zero dimensional (quantum dots, carbon dots, graphene quantum dots), one-dimensional
(nanorods, nanowires, nanotubes, nanofibers) and two-dimensional (graphene oxide, transition metal
dichalcogenides, transition metal oxide, MXens, etc.) nanomaterials along with nanosized particles are
currently used for diagnosis, imaging and therapy [1–3]. Nanofibers are fiber shaped nanostructures,
typically with two of their dimensions in nanoscale. Nanofibers have a high surface area-to-volume
ratio with tunable porosity and can easily be functionalized with biological molecules. The choice of a
wide variety of materials, such as natural and synthetic polymers, inorganic nanomaterials, composites
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and biomolecules as drugs for nanofiber fabrication makes them a robust and attractive candidate for
many advanced biomedical applications [4–12]. These remarkable characteristics make nanofibers
an ideal nanomaterial for energy generation and storage, water and environmental treatment, and
healthcare and biomedical engineering applications.
Electrospinning is a unique and versatile technique that depends on the electrostatic repulsion
between surface charges to constantly draw nanofibers from viscoelastic fluids. Polymers, ceramics,
small molecules and their combinations are used as rich materials for the production of nanofibers.
In addition to solid nanofibers, a secondary structure of nanofibers—including porous, hollow or
core-sheath structures—has been manufactured and the surface of the structure can be functionalized
with different molecular moieties, during or after the electrospinning process [13]. Electrospinning is
the main method of choice for the large scale production of nanofibers due to its controllable diameter,
easy handling, minimum consumption of solution and cost effectiveness. Electrospun nanofibers have
various biomedical applications, such as wound dressings, drug and gene delivery tools, sensors and
catalysts [14]. In this review, our focus is on addressing the application of electrospun nanofibers
in therapeutics (drug/gene) delivery. Various therapeutics delivery systems have been investigated
for efficient loading, releasing and accumulation of the therapeutics into the target site. However,
electrospinning exhibits great flexibility for selecting diverse materials, drugs and genes (DNA, RNA
etc.) for therapeutic applications [15].
We have reviewed the most efficient and recent therapeutic applications of electrospun based
nanofibers and their future perspectives. Different electrospinning techniques are described here,
along with their biomedical applications and suitability. Nanofibers are generally natural or synthetic
polymers and they have vast therapeutic applications even though only a limited number reach
clinical trials. The application of nanofibers as drug delivery carriers—especially for cancer drugs,
antibacterial drugs, nonsteroidal anti-inflammatory drugs, cardiovascular agents, gastrointestinal
drugs, antihistamine drugs, contraceptive drugs and palliative drugs delivery—is described here.
Nanofibers have promising therapeutic applications for DNA, RNA and growth factors, for example,
protein and steroid hormones delivery, which are included in this review. The current scenario for
nanofiber based materials is mostly promising for wound dressing, sensor technology and for the
catalysis of various reaction pathways in the laboratory [14]. The therapeutic application of nanofibers
to drug or gene delivery is limited due to proper functionality, controlling capacity, toxicity and
large-scale production limitations. However, the development of nanofiber based delivery systems
is growing rapidly and many of them have shown excellent characteristics for future therapeutic
delivery applications [15]. This review depicts the whole scenario around current therapeutic delivery
systems based on nanofibers and their useful biomedical applications, as well as suggesting future
perspectives for nanofiber based delivery systems, and provides relevant literature for researchers
working in this area.
2. Electrospinning Techniques
Electrospinning is considered a promising, highly productive and simple method for fabricating
the nanofibers of polymers, composites, and inorganic materials, including carbides, oxides, nitrides
and hybrid composites. In the electrospinning technique, electrostatic forces are utilized to produce
nanofibers from a polymer solution [16]. In general, the electrospinning setup consists of three
main compartments, namely: (i) high voltage power supply; (ii) a spinneret; and (iii) a conductive
collector, as shown in Figure 1. In the electrospinning process, a potential (kV) is applied between
the spinneret and the collector. These parts conduct electricity and are separated at an optimum
distance. When the applied electric field overcomes the surface tension of the droplet, a charged
jet of polymer solution can be ejected from the tip of the needle. The jet grows longer and thinner,
with an increasing high diameter loop, which results in the solidification of the polymer due to
solvent evaporation. The solidified nanofibers are then collected on the target. In general, electrospun
nanofibers are categorized in two ways; namely, random and aligned nanofibers [16]. Random
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nanofibers can be produced using a simple plate collector, while aligned nanofiber mats or uni-axial
fiber bundles can be produced using a disc or cylinder, rotating at a high speed, as the collector,
along the direction of rotation. The unique physical characteristics of electrospun nanofibers, such as
high surface-to-volume ratio, controllable fiber diameters and surface morphologies (dense, hollow,
and porous) and fibrous structures, can be altered by modulating parameters, for example: (i) the
molecular weight of polymers and polymer solution properties (viscosity, conductivity, dielectric
constant, and surface tension) [17,18]; (ii) The processing parameters (such as the electric potential,
flow rate, feeding rate, distance between the capillary and collection, as well as using coaxial or
triaxial needles for hollow, core–shell or multi-sheathed structures); and (iii) controlled post processing
parameters (such as heating rates and heating temperatures, especially for inorganic materials) [19].
Figure 1. Schematic representation of a traditional electrospinning process and various healthcare and
biomedical applications of nanofibers.
3. Types of Electrospinning
Although fibers produced by different electrospinning methods have attracted increasing attention
in the field of biomedical applications, challenges persist for the selection of an appropriate method,
as well as for optimizing multiple parameters to generate robust cargo loaded nanofibers [20].
Electrospinning techniques can be classified into five categories: (i) blend electrospinning; (ii) coaxial
electrospinning; (iii) emulsion electrospinning; (iv) melt electrospinning; and (v) gas jet electrospinning.
Blend electrospinning can be used to develop nanofibers with burst release, while co-axial and
emulsion electrospinning can be used to generate core-shell nanofibers that can assist in sustained
drug release [21]. Melt electrospinning is a cleaner fabrication method that has been used extensively
to produce highly ordered electrospun nanofibers. However, melt electrospinning results in the
generation of fibers with a larger diameter [22]. The basic mechanism of each electrospinning setup
and the process parameters affecting the fiber morphology are discussed below.
3.1. Blend Electrospinning
Blend electrospinning is the conventional electrospinning technique, in which the
drug/biomolecules are dispersed or dissolved in the polymer solution, resulting in the development of
nanofibers with drugs/biomolecules dispersed throughout the fibers [23]. Although this method is
simple in contrast with other electrospinning methods, the solvents used for the dispersion of bioactive
molecules can lead to protein denaturation or loss of biological activity. In addition, the inherent
charge of the biomolecules can often result in their migration on the jet surface and thereby result in
their distribution on the surface of the nanofibers rather than the encapsulation of biomaterials within
the fibers. The surface dispersion can be associated with the burst release of the biomolecules [24].
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3.2. Co-Axial Electrospinning
Co-axial electrospinning is an improvement on conventional blend electrospinning, in which
two nozzles are connected to the high voltage source rather than one nozzle. Two different
solutions are loaded within each nozzle and are pumped out to generate nanofibers with core-shell
morphologies [25]. Both synthetic and natural polymers can be used to develop core-shell nanofibers
with improved physiochemical and biological properties. This method is advantageous over
the blend electrospinning method, as they can protect as well as overcome the denaturation of
drugs/biomolecules in the biological system [26]. In co-axial electrospinning, the biomolecules
or drugs are situated in the inner jet and are co-spun with the polymers present in the outer jet.
This results in protection of the cargo, as well as assisting their being sustained in the biological
environments [27,28]. For example, Merkle et al. used polyvinyl alcohol (PVA) and gelatin for the
fabrication of core-shell nanofibers [29]. The mechanical strength of the core PVA phase was improved
by increasing the amount of gelatin in the shell. The authors have claimed that the gelatin shell
augmented cell adhesion and fibroblast adhesion onto the surface of the PVA/gelatin fibers, compared
to the PVA fibers. In addition, coaxial fibers can be surface-modified with biomolecules to improve
their biofunctionality and enhance cell-surface interactions [30]. Apart from the design complexity,
the viscoelasticity and interfacial tension of the core and shell polymers must be thoroughly monitored
to generate core-shell nanofibers from co-axial electrospinning.
3.3. Emulsion Electrospinning
Emulsion electrospinning requires a setup similar to that of blend electrospinning, in which two
immiscible solvents are simultaneously spun to generate core-shell nanofibers. Here, active bioactive
molecules, along with surfactants, are initially allowed to form W/O emulsions and are later mixed
with the polymer matrix solution [25]. During the fiber trajectory, the emulsion droplets are stretched
into elliptical shape. Furthermore, the continuous phase solvent is swiftly evaporated, resulting in
the viscosity gradient as well as droplet enrichment in the axial region [31]. This viscosity gradient
between the polymer matrix and elliptical droplet guides the core material to settle within the fiber
matrix rather than on the polymer surface. This method is relatively simple compared to co-axial
electrospinning and also offers sustained release of the loaded cargo materials [32]. Applied voltage
has a significant effect on the nanofiber diameters. Higher applied voltage ensues in the generation of
nanofibers with a reduced diameter. In addition, other parameters like flowrate and spinning distance
can also affect fiber morphology [33]. However, the interface tension between the organic and aqueous
phases of the emulsion can damage the bioactive molecules loaded within the emulsion electrospun
fibers [34].
3.4. Melt Electrospinning
Melt electrospinning has gained more attention in the electrospinning field, where toxicity and
solvent accumulation is a concern. In this process, polymer melt is used instead of a solution, which
is transformed from liquid to solid to achieve the desired product on cooling, rather than through
solvent evaporation [22]. The polymer melt flow rate and homogeneous polymer melt conditions
must be controlled to produce high quality fibers of uniform morphology, but with a broad range
diameter. Polymer blends [35] and additives [36] have been used to reduce the average diameter of the
fibers. The effect of the melt temperature can affect the structure and function of drugs, proteins and
bioactive molecules loaded in the fibers [37]. The flow rate and melt viscosity of melt electrospinning
can influence the characteristics of the resulting fibers. The surface wettability of melt electrospun
fibers has improved through the formation of hydroxyl or peroxyl and N-containing functional groups,
respectively, by using oxygen and ammonia plasma [35,38].
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3.5. Gas Jet Electrospinning
Gas jet electrospinning is an improvement on the conventional melt electrospinning technique,
in which the conventional electrospinning setup is additionally equipped with a gas jet device. The
major limitation of melt electrospinning is that it requires definite control over the temperatures
and therefore multiple heating zones must be placed to maintain the polymer melt. This results
in generation of thicker nanofibers compared to the solutions. In this technique, the co-axial jet is
surrounded by a tube feeding the heated gas, which can provide sufficient heat near the nozzle
and delay the process of polymer solidification. For example, Zhmayev et al. spun polylactic acid
(PLA) and showed a decrease in the diameter of the nanofibers obtained by gas jet electrospinning
compared to normal electrospinning. Interestingly, the heated gas flow-rate had a significant effect
on the diameter of the nanofiber. The increased gas flow rate can offer additional drag force to the jet
surface which can result in the development of thinner nanofibers. Zhmayev et al.’s result showed a
significant decrease in the diameter of the nanofiber, from 350 nm to 183 nm, when the gas flow rate
was increased from 5.0 L/m to 15.0 L/m [39,40].
4. Therapeutics Delivery Systems
Most conventional drugs are hydrophobic and suffer from poor bio-distribution, solubility and
stability in the biological system. Moreover, these drugs do not have the desired active targeting
capabilities, which can result in non-specific systemic toxicity or faster elimination from the body,
without achieving the desired therapeutic efficacy. Drug delivery systems (DDS) are approaches,
formulations and technologies for transporting therapeutic agents to the targeted therapeutic site in
the body [41]. The developed DDS technologies not only encapsulate the target drug/biomolecule
but also attune their absorption, distribution, release and elimination with higher loading efficacy
and safety. The drug release from DDS carriers depends on diffusion, degradation, swelling and
affinity-based mechanisms [42]. As mentioned above, electrospun nanofibers are gaining significant
attention as promising therapeutic nanocarriers. In addition, their impressive characteristics, including
biocompatibility, biodegradability, and high therapeutic payload capacity, meet the prerequisites for a
good therapeutic delivery candidate [13]. Employing electrospun nanofiber scaffolds as a therapeutic
nanocarrier, different routes of administration (ROA) are being investigated. Drugs/therapeutics can
be administered to any region/organ in the body by way of common routes, such as oral, parenteral
(subcutaneous, intramuscular, intravenous, and intrathecal), sublingual/buccal, rectal, vaginal, ocular,
nasal, inhalation, and transdermal, using electrospun nanofibers (Figure 2). Here, we present the
common routes of drug administration by electrospun nanofiber [43].
 
Figure 2. Types of electrospinning, different therapeutics-loaded nanofibers and their route
of administrations.
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4.1. Oral
Of all delivery routes, the oral route is considered the most preferable and convenient route of
administration, which can overcome the problems associated with other routes of administration [44].
However, to achieve successful administration of therapeutics targeting the oral route of administration
is a difficult task. Before designing a successful oral delivery system, scientists should consider
the major key challenges, including the presence of acidic gastric juice in the stomach, along with
proteases, mucosal barriers and intestinal retention, which can hamper the absorption of drug delivery
systems into the body [45]. Electrospun nanofiber scaffolds offer a great opportunity to load and
deliver both micro and macromolecules, targeting the oral route [46]. Some of the common features of
electrospun nanofiber in oral drug delivery systems include targeted delivery of therapeutics, sustained
release properties, high transfection efficiency, rapid onset of action and fascinating pharmacokinetic
profiles. Another promising advantage of using electrospun nanofibers is that researchers can
design any desirable release properties such as fast [47], controlled [48], biphasic [49] or delayed [50]
releases of the drug. Various polymers are used for designing oral drug delivery systems utilizing
electrospun nanofibers such as poly (lactic-co-glycolic acid) (PLGA), polyvinylpyrrolidone (PVP),
poly(ethyleneoxide) (PEO), PVP/cyclodextrin, polyvinyl alcohol (PVA), polycaprolactone (PCL),
PVP/ethyl cellulose, PVP/zein, Cellulose acetate, Eudragit L, hydroxypropyl methylcellulose (HPMC),
Eudragit S, Eudragit S/Eudragit RS, and shellac [50].
4.2. Sublingual/Buccal
The oral mucosa has its own subdivisions according to its different regions, namely, buccal,
sublingual and gingival. A few years ago, researchers were also interested in designing nanofiber
based drug delivery systems for sublingual (under the tongue) or buccal (between the gums and teeth)
routes of administration. The sublingual or buccal delivery systems usually allow the drug-loaded
electrospun nanofibers to dissolve in the presence of mucus so that the drug can directly penetrate
into the small blood vessels. Interestingly, these oromucosal routes of administration are the most
studied sites for nanofiber-based therapeutics, offering versatile and multifunctional drugs, DNA,
RNA, protein, peptide, growth factors or vaccine delivery platforms [51].
4.3. Rectal
Pediatric patients (aged under 6 months) usually cannot swallow any drug or food supplement.
Under such circumstances, the rectal route could be the best alternative to oral drug delivery systems.
In addition, the rectal route is also effective in cases of unconscious or vomiting patients. An electrospun
nanofiber-based rectal drug delivery system is continually gaining popularity. In the treatment of
post-operative peritoneal effusion following rectal/pelvic surgery, electrospun nanofibers could be
considered a safe potential biocompatible, and biodegradable sealing fiber. The first clinical trial on
the safety and sealing properties of electrospun nanofibers in lymphorrhea following pelvic surgery
was published in 2014 [52]. The authors used a synthetic material (PuraMatrix) that consists of
sixteen amino acid peptides to fabricate self-assembled nanofibers. A total of 20 colorectal cancer
patients participated in the clinical trial. After a 2–3 month follow-up period, a significant reduction in
post-operative drainage volumes was apparent in the experimental group compared with the control
group. In another study, Modgill and co-workers investigated the permeability of penicillin from an
extremely thin nanofiber scaffold through different biological membranes. The authors used PVA
to fabricate ciprofloxacin-loaded ultra-thin nanofibers. In vitro permeability studies exhibited the
potency of electrospun nanofibers compared with the plain drug. The PVA nanofibers revealed the
highest ciprofloxacin permeability in the rectal mucosal membrane. The drug release study showed the
controlled release behavior of ciprofloxacin from nanofibers in the rectal mucosal membrane, whereas
the control group showed a high degree of fluctuations [53].
192
Nanomaterials 2019, 9, 532
4.4. Vaginal
Electrospun nanofiber scaffolds targeting vaginal routes have recently been investigated. However,
the acidic condition of vaginal mucosa (~pH 4) should be considered before designing vaginal drug
delivery systems using nanofibers. For example, Brako et al. fabricated progesterone-encapsulated
nanofibers targeting the vaginal route of administration. The authors used a mucoadhesive
molecule (carboxymethylcellulose) for the fabrication of electrospun nanofibers. As-synthesized
progesterone/carboxymethylcellulose electrospun nanofibers exhibited sustained release
properties [54,55]. Another example of nanofiber-based vaginal drug delivery would be a study
involving the anti-HIV drug (maraviroc), in which the authors spun maraviroc either with PVP or
PEO and demonstrated fast drug dissolving properties upon contact with moisture [56].
4.5. Nasal
Currently, supramolecular peptides are used to fabricate electrospun nanofiber scaffolds.
Electrospun supramolecular peptide nanofibers have proven their potential for intranasal vaccine
delivery. For example, Si and coworkers developed intranasal administrated influenza vaccine using
peptide nanofibers consisting of virus polymerase. This self-assembled nanofiber could elicit both
humoral and cell mediated immune responses against the influenza virus. To be specific, nasal
administrated nanofiber vaccine particles were initially ingested by antigen presenting cells in
lung-draining mediastinal lymph nodes and activated both Th1 Th2 to produce the antibody against
the given antigen. Furthermore, a high immune response was elicited without any use of vaccine
adjuvant [57].
4.6. Ocular
Generally, various drops or ointments are used for ocular infection or inflammation. In these cases,
those drugs are easily excreted from the eye very quickly. Therefore, to improve therapeutic efficacy
and overcome the repetitive administration of an established ocular dosage, nanofiber-based ocular
inserts have been considered and compared with eye drops or similar methods of dosage. Drug-loaded
nanofiber scaffolds that allow the controlled release of incorporated drugs can be placed into the
ocular mucosa. For example, the use of brimonidine tartrate (BT)-loaded electrospun nanofibers as
ocular inserts were used to treat ocular infection and inflammation, which is described in detail in
Section 5.1.9 [58].
4.7. Transdermal
Transdermal drug delivery systems (TDDS) deliver a drug locally, avoiding undesired drug
distribution and possessing excellent skin permeability. Due to high solubility, great morphology
and sustained drug release kinetics, electrospun nanofibers have been developed into TDDS. It has
been reported that electrospun nanofibers could enhance solubility and form a transdermal patch
for the biopharmaceutics classification systems II drugs with a high therapeutic efficiency and no
cytotoxicity. Hydrophilic polymers with great permeation are the strength of TDDS, and several
in vitro and in vivo evaluations suggest the possibility of using drug-loaded electrospun nanofibers in
establishing TDDS [59].
5. Applications of Nanofibers in Therapeutics Delivery
Producing nanofibers with excellent physico-biochemical characteristics using an electrostatic
spinning technique is considered to be an efficient multipurpose drug delivery strategy for delivering
various therapeutic agents ranging from nanomedicines to macromolecules, including proteins and
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nucleic acids. Nanofibers can overcome several key challenges such as low solubility, loading efficiency,
short circulation and the plasma half-life of drugs and are effective at improving the bioavailability of
drug growth factors, DNA, RNA, and so forth. [60]. Using various biocompatible and biodegradable
polymers (natural and synthetic or their hybrid combinations) in nanofiber production may overcome
problems relating to the necessity of a second surgery to remove implants. In this section, we review
the biomedical applications of electrospun nanofibers and delineate novel strategies employed to
deliver drugs, biomolecules and nucleic acids by way of the electrospun nanofibers.
5.1. Nanofibers in Drug Delivery
5.1.1. Anticancer Agents
Discovering a new potential treatment strategy against cancer is very difficult due to several
drawbacks of anticancer therapeutics such as imperfect solubility, impermanence in the circulatory
bloodstream, poor accumulation in cancer cells, highly toxic to normal cells, low working efficiency
in solid tumors and excess elimination profile [61]. To surpass such limitations, the nanofiber-based
targeted drug delivery of anticancer therapeutics could be a promising strategy in the field of
cancer nanomedicine. Electrospun nanofiber scaffolds have superior drug loading and transferring
capabilities which not only amplify the therapeutic efficacy and potency of loaded drugs but also
decrease undesirable side effects by ensuring high cellular accumulation of loaded drugs at the target
site. These versatile drug carriers have proven to overcome the major limitations of traditional drug
carriers that face anticancer drugs delivery, including poor therapeutic-loading capacity, non-targeted
delivery, objectionable drug release and so on [62]. In addition, their sustained release properties
downregulate the repetitive administration of drugs, thus improving patient compliance.
Recently, electrospun nanofibers have been widely used to ameliorate the solubility of anticancer
drugs (Figure 3a). In this system, the drug-loaded nanofibers can circumscribe and crystallize the
anticancer agents within the fiber, resulting in improvement of their dissolution rate in the biological
system. For instance, water-insoluble anti-cancer drug Paclitaxel was loaded with surface modified
mesoporous hollow stannic oxide nanofiber (SFNFP) in order to study whether electrospun nanofibers
can improve the dissolution rate of Paclitaxel. The in vitro dissolution study results show that SFNFP
exhibited an 8.34 times higher dissolution rate compared to naked Paclitaxel, over a period of 5 minutes.
While the cumulative release rate of pure Paclitaxel was only 16.77 ± 2.00% after 1h, a high dissolution
rate of 80.00 ± 2.64% was observed from SFNFP [63]. The release profiles of Paclitaxel from the SFNFP
followed Noyes-Whitney’s drug release profiles. Extreme-sleazy shells functionalized nanofibers as
core-shell structure were synthesized using the coaxial electrospinning method to load and enhance
the dissolution rate of water-insoluble drugs Quercetin and/or Tamoxifen Citrate, as another example.
The core of the nanofibers was composed of PVP-K90 or PCL while Quercetin/Tamoxifen Citrate along
with surfactant SDS and PVP-10 as hydrophilic moieties were used to form the shell. The in vitro
results suggested a faster release of insoluble drugs from nanofibers in dissolution media within
a 1 min period. To be specific, 16.14% and 15.15% of pristine Quercetin and TC were released in
0.5 h respectively, while drug loaded nanofibers released Quercetin/TC either immediately or in
1 min [64]. The reason for a fast release could be due to the uniform distribution of the model drug in
the extremely thin (100 nm in diameter) outer layer of the core-shell nanofiber scaffolds, allowing a
large contact surface area and a short diffusion distance. Therefore, multifunctional nanofibers are able
to dramatically increase the release profile of poorly water-soluble anticancer drugs regardless of the
drug’s characteristics.
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Figure 3. (a) The cytotoxicity effects of anticancer drug-loaded electrospun nanofibers targeting
various deadly cancers. (Here, the numerical numbers 1, 2, 3, and 4 on the diagram represent the
usages of nanofibers in lung, liver, gastric and colon cancer respectively.); (b) tumor dimension
after treating with indicated patches (DXM-PLA); (c) quantitative tumor volume of mice treated
with indicated scaffold/film/drug/control; (d) change of body weight of mice as a function of time
upon treatment with indicated patch (Figure 3b–d reproduced from ref. [65] with permission from
ACS Publication, 2019).
Even though polymeric nanoparticles (NPs) are used as a drug carrier to load anticancer drugs
like Paclitaxel, the poor drug-loading efficiency of these systems minimizes the applications in
the biological system [66]. On the other hand, nanofiber scaffolds using electrospinning facilitate
higher drug loading because of large space and stereological honeycombed composition. Moreover,
the choice of fabrication method for developing electrospun nanofibers, such as the coaxial process,
emulsion methods, surface modification and blending, can tune/regulate the drug loading capacities
of the nanofibers. For example, Xu and co-workers fabricated self assembleed Paclitaxel- Succinic
Acid (PTX-SA) conjugate into supramolecular nanofibers. The loading efficiency of PTX in the
as-synthesized nanoconstruct was more than 89%, which is considered the highest loading efficiency
of PTX ever reported [67]. In addition, the controlled release of PTX from this nanoconjugate inhibited
the proliferation of human lung adenocarcinoma cells in both in vitro and in vivo animal models.
Compared to the burst release, the sustained release properties of cancer drug-loaded nanofiber
scaffolds has great cytotoxic effects on tumor tissues. To understand these findings, Kumar et al. (2019)
fabricated the anticancer drug dexamethasone (DXM)-loaded PLA nanofibers (DXM-PLA) in the form
of a patch and applied it to a melanoma tumor in an experimental mice model. The sustained release
properties of DXM from the as-synthesized nanopatch led to cytotoxic effects on cancer cells up to 85%
within 3 days. Compared to the control groups, which resulted in 300% tumor growth, the DXM-PLA
significantly prevented melanoma tumor cell proliferation and maintained the bodyweights of the
animals (Figure 3b–d) [65].
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Various reported scientific validations narrate that the circulation and plasma half-life of a drug
nanocarrier highly depends on its size and shape. Geng et al. showed that uniquely shaped filomicelles
like nanofibers can circulate in biological conditions for up to 7 days, which was 10 times greater than
any type of polymeric nanoparticles, with which the drug can be eliminated from the bloodstream
within 2 days. In addition, these filomicelles can selectively deliver the anticancer agent to the tumor
tissues [68]. Furthermore, a versatile and scalable electrostatic spinning technique was employed to
fabricate fiber rods with various sizes and shapes in order to confirm whether the shape and size of
nanofibers can enhance the half-life, cancer tissue accumulation, cellular uptake, and tumor toxicity
profiles of the anitcancer drug-loaded fiber rods. In this study, the electrospun fibers were treated
under ultrasonication to fabricate fiber rods, where the lengths of the fiber rods were regulated by
adding different volumes of sodium chloride (NaCl) void-precursors to the electrospun scaffolds.
The experimental results revealed that when anticancer drug Doxorubicin was incorporated into fiber
rods using PELA (RDDOX, 500 nm) and these nanocomposites were injected into a tumor-bearing mice
model, it showed 4 times more accumulation in the cancer site and was 3 times more stable in plasma
level compared with microspheres. However, small length nanofibers of 2 micrometers in diameter
exhibited the most powerful cancer cell apoptosis and necrosis activities with the highest resistance to
metastasis [69].
To reduce the undesirable side effects and toxicity of anticancer drugs for normal tissues,
electrospun nanofibers are considered for targeted and pH-mediated drug delivery to tumors.
The surface modification of electrospun nanofibers with ligands that can target specific receptors
overexpressed on the tumor, along with pH-dependent tunable drug release, can be optimal for
targeted drug delivery. For example, a chitosan/PLA solution was used to encapsulate graphene oxide
(GO), titanium dioxide (TiO2) and a chemotherapy medication doxorubicin (Dox, C27H29NO11) into
nanocomplexes through electrospinning. As-prepared chitosan/PLA/GO/TiO2/Dox fiber scaffolds
showed an increased release of Dox in the acidic pH of a tumor microenvironment rather than in
the physiological pH of 7.4 during a 200 h experiment. This characteristic would be imposed due to
protonation of –NH2 in Doxorubicin that can disintegrate the –H bond between doxorubicin and
nanofibrous scaffolds resulting in higher drug release in cancerous tissues [70]. The in vitro cytotoxicity
studies revealed that chitosan/PLA/GO/TiO2/Dox fibers were biocompatible and did not expose
any toxicity to normal cell lines. This research also evidenced that the cytotoxicity of nanofibers to
tumor cells depends on the concentration of nanofibers—a higher concentration of nanofibers can
increase both targetability and cytotoxicity to cancerous cells. A higher concentration of doxorubicin
even appeared in the presence of an external magnetic field. As mentioned earlier, electrospun
nanofibers can be developed with negligible toxicity towards normal cells by actively targeting the
cancer cells. Heat shock protein (HSP 90) is highly overexpressed on lung cancer cell lines in humans.
Researchers have developed novel stratgies by targeting HSP 90 to deliver anticancer drugs into
tumor tissues of the lung [71]. Drugs like 17-DMAG (17-dimethylaminoethylamino-17-dimethoxy
geldanamycin) can target both cancerous cells and the ATP-binding site of HSP 90, thus increasing the
inhibition of both cancer cell proliferation in the lungs, and chaperoning the activities of HSP 90 and
telomerase activity, respectively. Nevertheless, the unwanted side effects and extreme hepatotoxicity
had minimized the use of 17-DMAG as a novel anticancer drug in lung cancer treatment [72].
To overcome such major problems, Mellatyar, and co-workers designed and developed 17-DMAG
encapsulated PCL/PEG nanofibers via an electrospinning process. Their drug release profile revealed
that about 96% 17-DMAG can release from PCL/PEG/17-DMAG fiber scaffolds after 6 h. In addition,
the IC50 values and MTT assay results proved the potency of PCL/PEG/17-DMAG nanofibers over
17-DMAG in A549 cells cytotoxicity. After 3 days, the free 17-DMAG can reduce the HSP 90 expression
level and telomerase activity up to 48% and 71% respectively whereas the percentages of inhibition by
PCL/PEG/17-DMAG nanofibers were 79% and 83%, respectively [73]. These promising characteristics
of PCL/PEG/17-DMAG nanofibers are connected with its controlled release properties over an
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extended period of time. Nevertheless, nanofiber scaffolds are able to easily target and enter into
cancer cells due to the irregular vascular composition of tumor tissues.
5.1.2. Antibiotics
Since Alexander Fleming discovered and developed a true antibiotic named penicillin, antibiotics
have been the most commonly prescribed and used pharmaceutical agents to treat various bacterial
infections. Despite all the favorable characteristics of antibiotics, their appropriate delivery routes,
toxicological profile, poor water solubility and, most importantly, microbial resistance are major
limitations to their therapeutic efficiency. Although several delivery approaches have been proposed
over the past few decades, issues associated with poor antibiotic loading efficiency, systemic toxicity
and drug release profile limited their translation into clinical settings. In this scenario, electrospun
nanofibers are considered as an alternative for antibiotic delivery because the large surface area and
tunable pore size offer maximum antibiotic loading capacity and encapsulation efficiency. In addition,
the current generation of nano-based fibers can also regulate the sustained and controlled release
activities of antibiotics, maximize the dissolution rate of poor water-soluble antimicrobial agents
and minimize systemic toxicity Antibacterial drugs which are encapsulated into nanofibers usually
exhibit antimicrobial actions by inhibiting cell wall synthesis, protein synthesis, DNA/RNA synthesis,
mycolic-acid synthesis, and folic acid synthesis. Penicillin has been widely studied as a model
antibiotic to load within nanofibers for testing antimicrobial actions. For instance, an aminopenicillin
drug like amoxicillin (AMX) was initially loaded into nanomicelle as a hydrophobic antibacterial
drug via a film dispersion hydration method and later coaxial electrospining was performed to load
AMX-loaded nanomicelle into the core/shell nanofiber (AMX/NM/NF). Antibacterial assays showed
that AMX/NM/NF can create an inhibition zone of 9.2 mm and 7.3 mm against E. coli and S. aureus
respectively [74].
The first criteria for developing an effective delivery system is to ensure the excess release of the
encapsulated drug into the physiological environment. Khorshidi et al. developed an electrospun
scaffold for loading a second generation fluoroquinolone antibiotic (ciprofloxacin), which can result in
ultrasound-assisted drug release. These alginate-emanated nanofibers revealed 3 times more drug
release properties with ultrasonic stimuli at 15 W/cm2 intensity and endowed higher percentages
of bacterial DNA synthesis inhibition in both in E. coli and S. aureus [75]. The in vitro and in vivo
studies further suggested that electrospun nanofiber scaffolds can enhance both the bactericidal and
bacteriostatic activities of antibiotics. The use of metal ions and compounds, nanoparticles and salts
are receiving burgeoning interest as antimicrobial agents. For example, iron oxide, silver, titanium
dioxide, and zinc oxide either alone or in combination with other salts or ions are used as a core
for generating antimicrobial nanofibers with bactericidal and/or bacteriostatic action. Among them,
silver is considered the most potent antimicrobial agent due to its unique property of accumulating
on the microbial cell wall and assisting in the arrest of the cell cycle and the denaturation of bacterial
DNA [76]. Recently, Jatoi and co-workers proposed a new method to evaluate the antibacterial
activities of silver nanoparticles and titanium dioxide by preparing cellulose acetate nanofibers,
where TiO2 was first bound with DOPA followed by the introduction of AgNPs to form TiO2/AgNP.
Finally, a TiO2/AgNP-loaded cellulose acetate nanofiber scaffold (CA/TiO2/AgNP) was fabricated
with the electrospinning method. Their antimicrobial assays demonstrated that the as-synthesized
CA/TiO2/AgNP nanoparticles (10 wt.% of TiO2/AgNP) showed almost 100% antibacterial activities
against both E. coli and S. aureus for up to 3 days. In addition, CA/TiO2/AgNP nanoparticles can
overcome severe adverse effects (argyria or argyrosis) that are commonly associated with silver
nanoparticles-based antimicrobial therapy [77]. Moreover, bacteria usually lose the integrity of their
cell wall when they come into contact with highly charged nanofibers like cationic chitosan, thus
resulting in cell lysis. This non-release antimicrobial system is a promising strategy because of their
substantially prolonged activities outside of drug resistance [76].
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The amount of antibiotic release and the effectiveness of its therapeutic window for effective
treatment and preclusion of bacterial infections depend on the antibiotic loading efficiency in the
carriers. In this regard, nanofiber-based drug delivery systems have gained more consideration for
controlled drug release. This decreased and sustained dosing frequency of antibiotics can result in fewer
side effects, high patient compliance, minimized fluctuation of antibiotics level in the bloodstream and
overcome dose-dependent toxicity. In the traditional strategy of nanofiber-based drug delivery systems,
the electrospinning process fabricates antibiotic-loaded nanofiber scaffolds either by making a solution
of drug/nanofiber before electrospinning or by loading the antibiotic onto the large surface of the
nanofibers through physical or chemical modifications as shown in Figure 4a. Both of these strategies
can proficiently control the antibiotic release. One such example would be aminopenicillin (AMX)
loaded PEGylated PLGA electrospun nanofibers, where AMX powder was blended with PEG-modified
PLGA, followed by the fabrication of nanofiber scaffolds (AMX/PLGA-PEG) via electrospinning.
The in vitro release profile exerted about 51.5% and 90.7% of AMX release within 2 and 48 h respectively
from 1% AMX/PLGA-PEG nanofiber, and the drug releasing activities continued for more than 10 days.
Due to the improvement of hydrophilicity in the AMX/PLGA-PEG nanofiber, faster and prolonged
drug release properties were achieved. In addition, 1% AMX/PLGA-PEG nanofiber scaffolds can
inhibit approximately 95.9% growth of penicillin resistance gram-positive Streptococcus aureus at an
AMX concentration of 60 μg/mL. The hemolysis and anticoagulant in vitro experiments revealed that
they have great hemocompatibility and cytocompatibility [78]. In another study, RuO4 (ruthenium
tetroxide) oxidized herringbone graphite carbon nanofibers (hGCNF) was prepared for surface labeling
of antibiotics. The higher carboxylic acid groups of RuO4-Oxidized hGCNF served as the binding site
of antibiotics during the acyl substitution reaction. Finally, as-synthesized nanofiber scaffolds were
covalently functionalized with tobramycin, amikacin, and ciprofloxacillin and this antibiotic-labeled
RuO4-oxidized hGCNF possessed magnificent antibacterial action versus Pseudomonas aeruginosa [79].
To control the antibacterial drug release pattern from the nanofiber-based carrier, another
important method has recently been investigated in the fabrication of both multidrug loaded or
core-shell electrospun nanofibers. Although both emulsion and coaxial electrospinning processes are
generally used, coaxial electrospun core-shell nanofibers are more commonly used to regulate the
sustained release profiles of the loaded drug (Figure 4b). Mainly, the drug molecules are encapsulated
into the core region of this advanced core-shell structure of electrospun nanofibers whereas the outer
shells act as a protector and also manage the release behaviors of the incorporated antibacterial
drugs. Thus, the core portion and shell portion of a core-shell electrospun nanofiber scaffold can
sustain the release profiles of the antibiotics. Due to the protective and biocompatible nature of
the outer shell of antibacterial nanocarriers, the sensitive antimicrobial drug is more stable in blood
plasma. This can further prolong its release characteristics and facilitate long term antibacterial
activities without dose repetition. Apart from protecting the core region of the antibacterial drug,
the shell membranes can function as an antibacterial agent that can generate bacterial resistance
in biological environments. A shape memory polyurethane (core-shell) antibacterial nanofiber was
synthesized with a coaxial electrospinning method in which a polycaprolactone-assisted shape memory
polyurethane core was shelled with a pyridine presenting polyurethane. The results demonstrated
that the developed core-shell nanofibers displayed enhanced antibacterial properties in both gram
positive and gram negative bacteria [80]. On the other hand, the emulsion electrospinning process
has also gained the attention of many researchers, in which the use of a single nozzle fabricated
core-shell nanofiber scaffold is more simple and more advantageous over the coaxial electrospinning
method. In addition, the production of biocompatible, prolonged release, and low toxic core-shell
nanofibers with foaming free facilities allows researchers to employ emulsion electrospinning to
develop nanofibers. For example, Chai and coworkers for the first time proposed antimicrobial
core-shell nanofiber scaffolds that hold a colloidal particles emulsion by electrospinning. In their
core-shell nanofibers (Van/OA-MION-PLA), the antibacterial drug vancomycin was in the core portion
as a water phase and the polylactic acid solution served as the oil phase, while oleic acid coated
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magnetic iron oxide nanoparticles were used as an emulsifier. The in vitro vancomycin release study
depicts that about 10% of burst redemption appeared within 5 h. Surprisingly, a prolonged release
of vancomycin up to 25 days with approximately 57% of cumulative deliverance was observed from
Van/OA-MION-PLA [81].
 
Figure 4. Drug loading strategies to nanofibers: (a) basic antibacterial delivery systems, (b) advanced
antibacterial delivery systems (core–shell structure, nanoparticle decorated and multidrug loaded),
and (c) smart delivery systems (stimuli responsive). (Reproduced from ref no [76] with permission
from “Taylor and Francis Group”, Ref: AF/IEDC/P19/0117).
Furthermore, in the smart antibiotic delivery system, electrospun nanofiber scaffolds are
commonly used to control the release of drugs in response to various biological parameters
including pH factor, temperature or UV-light sensitivity (Figure 4c). Recently Fakhri and coworkers
investigated the UV-light and pH-responsive photocatalytic activity of Tungsten disulfide (TDS),
TDS-chitosan and TDS-polycaprolactone nanofibers with respect to the degradation of the antimicrobial
Neomycin. The antibacterial drug Neomycin conjugated with TDS-chitosan and TDS-polycaprolactone
nanofibers revealed a comparatively good decomposition rate of Neomycin as well as an antimicrobial
performance at pH 3 [82]. In other research, the pH-dependent antibiotic release Eudragit nanofiber
mesh was fabricated via a coaxial electrospinning process. The drug release study indicated that the
release rate of Tetracycline from a Tetracycline-loaded Eudragit nanofiber mesh depended on both
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the physiological pH value and the molar ratio of pure Eudragit and Eudragit L100 in an Eudragit
nanofiber mesh. At pH 6 the Tetracycline release was much faster from the as-fabricated nanofiber
mesh, but at pH 2 the release rate was very slow. In addition, at the high molar ratio of the Eudragit
nanofiber mesh, Tetracycline release was optimum in both pH values [83]. In comparison with other
drug nanocarriers, nanofiber scaffolds present more potential applications for antibacterial drug
delivery with sustained release properties.
5.1.3. NSAIDs
Nonsteroidal anti-inflammatory drugs (NSAIDS) distinguish themselves from steroids and are
popular worldwide due to their anti-inflammatory actions. In addition, they are a frequently prescribed
medication as they are widely known to have pain relieving, anti-pyretic, and blood clotting activities.
NSAIDs usually reduce the synthesis of prostaglandins by inhibiting the actions of biological enzymes
cyclooxygenase-1 and cyclooxygenase-2. However, these drugs are not free from side and adverse
effects. The severe side effects associated with NSAIDs include GI ulcers, heart attack and kidney
disorders [84,85].
The amount of poorly water-soluble NSAIDs is increasing daily in the pharmaceutical industry.
To achieve the desired goal and for improving treatment with NSAIDs, electrospinning techniques have
already been introduced in this sector. Ibuprofen is a class of NSAIDs, generally suggested for pain,
fever, inflammation, migraines, arthritis, and painful menstruation. In one study, Potrč and co-workers
showed that ibuprofen-loaded PCL nanofibers can enhance the dissolution rate of this loaded drug in
a biological environment where almost 100% ibuprofen was released from as-synthesized nanofibers
within 4 h [41]. Naproxen sodium is another cyclooxygenase inhibitor of the NSAIDs class which
is used to treat inflammation including fever and rheumatoid arthritis, pain and menstrual cramps.
Naproxen is also used in combination with sumatriptan succinate (a member of the triptans family)
to treat migraines or with proton pump inhibitors (i.e., esomeprazole) to avoid NSAIDs-assisted
acidity. A few years ago, naproxen and its salt (naproxen sodium) had been electrospun with various
hydrophilic (chitosan, PVA and polyacrylic acid) and hydrophobic (PCL) polymers with very good
drug loading capacity for achieving rapid onset of action, avoiding hepatic fast pass metabolism and
readily accessible through the sublingual route of administration. All developed nanofibers provided
the burst release of naproxen in which almost 90% of the released drug from all nanofiber scaffolds was
dissolved within 10 min in the acceptor phase. In addition, under the same conditions, no significant
differences had been observed between the release profiles of naproxen and its salted form (naproxen
sodium). Somehow, the hydrophobic PCL fiber mat exhibited a very quick release of naproxen [86].
Electrospinning techniques are not only applicable to fast releasing, dissolving and complete
absorbtion of drugs but also these methods are used for easy swallowing and taste masking of various
drugs in case of oral administration. Meloxicam is such a type of NSAID, which is used to treat
inflammation in rheumatoid arthritis and osteoarthritis as well as pain. However, its bitter taste,
difficulty to swallow, and low bioavailability due to incomplete absorption after peroral administration
limited its usage, especially in children [87]. To improve these demerits, an oral dissolving formulation
was developed employing the electrospinning process. The incorporation of a cyclic oligosaccharide
(cyclodextrin) into PVP nanofibers improved the physical stability of mats whereas the addition of
sweeteners avoided the bitter taste of meloxicam. The meloxicam-encapsulated PVP/cyclodextrin
fiber mats were a nanometer in size with suitable tensile strength. Interestingly, the nanofiber mats
released 100% of the meloxicam in the artificial saliva pH 6.8 within 120 min of administration whereas
the tablet and powder dosage forms of meloxicam (marketed product) released only 30% in the same
environment. These studies indicate that the developed oral formulation was capable of increasing
the solubility, disintegration time, release, bioavailability, and palatability of the encapsulated drug.
However, the nanofiber mats disintegrated within 1 min on contact with mouth saliva and, after that,
the disintegrated fiber mats continuously released the drug in the gastrointestinal tract [88]. Thus,
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electrospun nanofiber scaffolds have their own potential to overcome the problem related to keeping
the nanofiber mats in the oral cavity for a long time to complete release of the drug.
5.1.4. Cardiovascular Agents
Disorders related to heart and blood vessels are categorized as various cardiovascular diseases
such as stroke, heart attack, hypertension, cardiomyopathy, heart arrhythmia, carditis, aortic
aneurysms, peripheral artery disease, thromboembolic disease, venous thrombosis and rheumatic,
valvular and congenital heart disease [89]. Among these disorders, coronary artery diseases like angina
and myocardial infarction are the most common cardiovascular disorders. Nicorandil is widely used
against angina or angina pectoris due to its agonistic properties to both ATP-sensitive K+ channel and
a polyatomic ion, nitrate, channel [90]. The low bioavailability and slow onset of activities and the
major side effects including excess turnover rate and mucosal ulceration have limited the usage of
nicorandil as an anti-anginal agent. To overcome these limitations, nicorandil had been electrospun
with polymeric nanofibers composed of riboflavin, hyaluronic acid, and PVA to prepare a sublingual
dosage for treating angina pectoris. It was expected that the presence of riboflavin in the nanofiber
scaffolds would cure mucosal ulceration whereas hyaluronic acid would ensure the quick recovery of
inflammation in damaged tissue by reducing the amount of pro-inflammatory cytokines. However,
this nano-sized drug-loaded fiber mat was able to sustain the controlled release of nicorandil over a
prolonged period of time. The pharmacokinetic study revealed the maintenance of a therapeutic level
over a longer period of time and about 4 times more biological half-life of the developed formulation
in comparison with marketed nicorandil. Moreover, no mucosal ulceration had been evidenced by the
histopathological study at the site of administration for the developed formulation [91].
Carvedilol is another cardiovascular drug that binds and blocks both alpha and beta-adrenergic
receptors in an attempt to treat congestive heart failure. Potrč et al. (2015) researched electrospun PCL
nanofiber scaffolds as a delivery carrier for the oral administration of poorly water-soluble carvedilol.
It was observed that the average size of a drug-loaded PCL nanofiber is directly proportional to
the amount of loaded drug and the crystallinity of the carvedilol decreased after encapsulation
into the PCL nanofiber. The encapsulated drug was partly molecularly interspersed in the PCL
nanofiber and in the formation of dispersed nanocrystals to a certain extent. It had been reported
that up to 77% of carvedilol was released from the PCL electrospun nanofibers within only 4 h which
indicated a significant improvement of the dissolution rate of this poorly water-soluble drug [41].
Hence, electrostatic spinning is a novel nanotechnology-based strategy especially for improving the
dissolution rate of water-insoluble drugs.
5.1.5. Gastrointestinal Drugs
Drugs that are used against various gastrointestinal tract or gut or digestive system disorders
or ailments to cure or prevent many severe symptoms of the esophagus, stomach, intestines
(both small and large), rectum, and anus, are known as GIT drugs. GIT drugs include antidiarrheal,
antiemetic, anti-ulcer agents, cathartics, cholagogues and choleretics, emetics, laxative, lipotropic
agents, antibacterial and many other types which are frequently prescribed to control gastric
juice, regulate gut motility, water flow and improve the digestion of patients [90]. Unfortunately,
the inability of GIT drugs as a curative therapy may lead to surgery in the case of serious complications.
Hence, finding a new method to improve the pharmacological action of GIT in human physiology is
crucial, especially for serious diseases such as inflammatory bowel syndrome-assisted Crohn’s disease,
gastroesophageal reflux disease or acid reflux disease, irritable bowel syndrome, and peptic ulcer
disease that can lead to stomach cancer.
Metoclopramide (4-amino-5-chloro-N-[2-(diethylamino) ethyl]-2-methoxybenzamide) is an
antidopaminergic benzamide, pharmacologically used as a serotonin receptor agonist. Its inhibitory
action on acetylcholinesterase exerts its prokinetic and anti-emetic effect due to its actions on
contractility of colonic smooth muscle. Recently, Jaber and co-workers fabricated a core/shell nanofiber
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using PVA/PCL to load metoclopramide hydrochloride [92]. The release profile indicated an initial
burst release of the loaded drug (about 55% of total release). The reason behind the initial burst release
of metoclopramide may indicate the presence of micron or nano-sized pores in the PCL shell.
Designing the control release behavior of hydrophilic molecules such as protein, peptide, nucleic
acid or even a drug is a very difficult task. Tiwari et al. proposed a new method by controlling the
partition release of two-layer fiber matrix using a core-shell electrospun strategy where the polymer will
serve as an outer layer and the encapsulated drug will be in the core. The authors used metoclopramide
to represent a hydrophilic drug and loaded it into various monolithic fibers (PCL, PLLA, PLGA, and
PVA) as well as core-shell nanofibers such as PVA/PCL, PVA/PLLA, and PVA/PLGA to investigate
the control release behavior of metoclopramide loaded as-synthesized nanofibers. The drug release
profile data suggested that the controlled release of hydrophilic entities is possible by using core/shell
nanofibers and by verifying the physicochemical properties of core/shell solutions. The result also
showed a clear difference according to the release characteristics between the monolithic fibers, which
are made of hydrophilic and hydrophobic polymers, and core/shell fibers using PCL, PLLA, and
PLGA 80/20 shell polymers. The monolithic fibers cannot control the initial burst release of the
hydrophilic drug metoclopramide hydrochloride but core/shell electrospun nanofibers can easily
regulate the controlled release of incorporated drugs. Thus, electrospun nanofibers would be a
promising gastrointestinal drug carrier to achieve controlled release behavior and protect sensitive
drugs in a biological pH [93].
5.1.6. Antihistamines
Antihistamine generally works by blocking the physiological activities of histamine, thus,
antihistamines are used in the treatment of nasal congestion, sneezing, hives, seasonal hay fever
and especially, to relieve the symptoms of various allergies such as dust allergy, cold allergy, allergic
rhinitis, indoor and food allergies. For the time being, electrostatic nanofiber scaffolds are being used
as a carrier of various antihistamine drugs. One experimental study was designed to incorporate the
first-generation antihistamine (H1 receptor antagonist) chlorpheniramine maleate into glutinous rice
starch combining polyvinyl alcohol (GRS/PVA) electrospun nanofibers to investigate a drug delivery
carrier concept and control release properties of the nanofibers [94]. The hybrid nanofibers (GRS/PVA)
offered a biphasic release of loaded-antihistamine in which 60% of initial release had taken place
within first 10 min and reached the highest release at about 90% within 120 min of administration.
The authors suggested this GRS/PVA nanofiber scaffold as a novel oral antihistamine drug carrier.
Development of fast dissolving delivery systems of therapeutics (FDDST) is an excellent and
unique concept especially for those patients who have difficulties swallowing pharmaceutical solid
dosage forms. FDDST offers very fast-dissolving solid oral dosage forms that take a few minutes
for absorption in the patient’s mouth. Thus, FDDST facilitates high drug bioavailability, therapeutic
window and exemption of hepatic first-pass elimination. Previously, the electrospinning method was
employed to design, develop and evaluate FDDST in which one study proved more than 80% of
total ibuprofen release within 20 s [95] whereas another study showed the co-release of caffeine and
vitamin B12 at about 100% and 40% respectively within 1 min [96]. However, Loratadine is another
effective peripheral histamine H1 receptor inverse agonist and responsible for anti-allergic effects.
Nevertheless, its low water solubility, bioavailability and rapid first-pass hepatic effect with mainly
CYP3A4 and CYP2D6 (isoforms of cytochrome P450) metabolism systems reduce their usages. In this
respect, electrospinning nanofiber-based Loratadine delivery would be the best solution. A few years
ago, Akhgari et al. described the impact of few parameters such as the concentration of polymer and
antihistamine, and the amount of feed ratio and the voltage on the first dissolving delivery systems for
Loratadine. The authors prepared a Loratadine-encapsulated PVP nanofiber scaffold by way of the
electrospinning technique and observed a lower feed ratio and low concentration of the polymeric
solution with high voltage application produce nano-sized nanofibers with excellent uniformity.
The results of this study showed that, to achieve quick solubility and release of antihistamine from
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as-prepared nanofibers, the fiber should be a nanometer in size and the antihistamine amount should
be smaller [97].
Another example of an antihistamine is Diphenhydramine, a member of the ethanolamine
class of histamine H1 receptor antagonists, which is mainly used to treat allergies, nausea, motion
sickness, extrapyramidal symptoms and symptoms of a common cold by reversing the effects of
histamine on capillaries. It is also used in parkinsonism due to its ability to act as a muscarinic
acetylcholine receptor reverse agonist by crossing the blood-brain barrier. In addition, its usage as
a sodium channel blocker introduced it as a local anesthetic [90]. However, to produce porous and
fast-disintegrating nanofiber scaffolds targeting oral administration, diphenhydramine-incorporated
nanofibers were directly electrospun onto a polymeric backing film of hydroxypropylmethylcellulose
and glycerol [98]. The physicomechanical characterization data revealed the potency of nanofiber
scaffolds in a nanofiber-based oral antihistamine delivery system with the following configurations:
high encapsulation efficiency and very short disintegration times (12.8 s). This very short integration
time may indicate the large surface area of PVA nanofibers, which were loaded with diphenhydramine.
5.1.7. Contraceptives
For the first time, a composite electrospun nanofiber was fabricated by free-surface electrospinning
with various microscale geometries as a carrier of physicochemical diverse medicines including the
contraceptive drug progestin levonorgestrel [99]. The as-fabricated PVA nanofibers were capable of
encapsulating more than 80% of all matrix formulations except interwoven matrix where an artifact of
the processing led to a calculated >150% encapsulation efficiencies for levonorgestrel. The authors
checked the solid dispersion of levonorgestrel in the electrospun nanofibers by employing various
differential scanning calorimetry analyses. After encapsulation of levonorgestrel, the thermograms of
the PVA fabrics did not dramatically change even with high loading of levonorgestrel (17 wt.%).
The in vitro release kinetics demonstrated slow and controlled release of levonorgestrel due to its highly
hydrophobic nature, where levonorgestrel took 4 h to achieve 100% release from the as-synthesized
composite microarchitectures. The idea is that these contraceptive-loaded nanofibers would be inserted
into the vaginal mucosal environment to prevent unplanned pregnancy by releasing the appropriate
dose of contraceptives into the local cells.
5.1.8. Palliative Drugs
Palliative treatment—also known as comfort or supportive care—aimed to relieve, reduce or
control symptoms, side effects and adverse effects such as pain and sickness at any stage of serious
diseases, thus enhancing the life expectancy and comfort of a patient even during the last stages of
an illness.
Nagy et al. used lower molecular weight poly(vinyl alcohol) to fabricate the non-woven
tissues of a nanofiber with a large surface area for developing an oral fast-dissolving dosage form
by applying electrostatic spinning. After loading highly water-soluble Donepezil HCl (which is
used to treat dementia-related Alzheimer’s disease) into as-prepared nanofibers, the diameter of the
electrospun nanofiber was 100–300 nm even when the polymer-drug ratio was 33 w/w%. Interestingly,
in comparison with the release rate of the commercially available Aricept tablet (brand name of
Donepezil HCl), the drug-loaded nanofiber took less than 30 s to release whereas the Aricept tablet
took ≥30 min. This might be due to the availability of the nanofiber’s large surface area which is directly
proportional to the dissolution rate, corresponding to the Noyes and Whitney equation [100]. Hence,
it can be said that organic solvent free electrospinning could be a promising option for manufacturing
highly oral dissolving dosage forms for achieving instant drug release and quick onset action with
high patient compliance, which is a basic requirement for palliative care policies.
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5.1.9. Miscellaneous
Among various miscellaneous drugs, caffeine is the most used agent worldwide that binds to
adenosine receptors by mimicking natural adenosine, affecting various body functions. At present,
electrospinning techniques are being widely used to fabricate caffeine loaded nanofibers as a FDDST
facilitating a high surface area and high porosity of nanofibers that can lead to fast-wetting features of
the nanofiber surface to ensure quick release properties of incorporated drugs. In these respects, drugs
are usually encapsulated into nanofibers either in amorphous or nanocrystal format, ensuring high
solubility, dissolution, rapid onset of action and bioavailability of loaded drugs. A study was designed
by electrospinning using PVA as the drug nanocarriers of caffeine (CA) and riboflavin (RFN) in which
the dissolution time and wetting time were 1.5 s and 4.5 s respectively for both PVA-CA and PVA-RFN.
In addition, the release percentages of CA and RFN from PVA filament-forming nanofibers were
100 and 40 respectively within 1 min [96]. In another study, paracetamol and caffeine-loaded PVP
electrospun nanofiber scaffolds were fabricated as a FDDST model with more than 90% drug loading
capacity in which both loaded drugs remained intact even after electrospinning. This study indicated
a high disintegration rate of the drug-loaded nanofiber scaffolds within 0.5 s whereas it took less than
150 s to reach 100% dissolution rate. The drug-loaded nanofiber matrix revealed its potency over
the pure standard drugs (caffeine and paracetamol individually) [101]. Moreover, it was evidenced
that electrostatic spinning has the potential to fabricate such nanofibers that can ensure the ultrafast
drug delivery and dissolution of water-insoluble miscellaneous drugs even through the oral route of
administration [102].
Discovering an effective and potential ophthalmic drug delivery system (ODDS) is still a
challenge due to the quick elimination of ocular drugs like eye drops. Thus, rapid peroneal losses
of eye drops, even with the high volume of administration resulting in low bioavailability and very
short half-life of applied drugs and a lower amount of ophthalmic drugs (1–3% of total volume),
can reach into intraocular tissues via penetration through the cornea. To address these problems,
Gagandeep et al. (2014), developed a nanopatch using PVA and PCL via electrostatic spinning to
load and deliver a combination of timolol maleate and dorzolamide hydrochloride as a model drug
against glaucoma. As-developed drug-loaded nanopatches were 200–400 d·nm with almost 100% drug
entrapment efficiency—no interaction has been found between polymers and encapsulated drugs.
Furthermore, the in vitro drug release experiment alluded an initial burst release of incorporated drug
from nanopatches followed by controlled release behavior for up to 24 h [103]. The overall results
reveal the efficiency of electrospun nanopatches in ocular drug delivery.
Drug enrichment on the surface of the polymer is only possible if the drug is blended with the
polymer solution before electrostatic spinning. This system facilitates an initial burst release of the
loaded-drug resulting in rapid onset of action, but it also decreases the potential lifetime of delivery
carriers. Hence, to obtain desired results such as sustained therapy, local and controlled release,
enhanced activity and retrenchment of side and adverse effects, core-shell nanofibers would be the best
option. One study was designed to load brimonidine tartrate (BT) into a first dissolving dendrimer
nanofibers (DNF) against glaucoma (Figure 5a). The in vivo intraocular pressure (IOP) was evaluated
as an efficacy parameter for both BT and BT-DNF (Figure 5b). As shown in Figure 5c, the single
dose responses of BT and BT-DNF were almost similar to each other regarding the therapeutic effects.
Nevertheless, after daily treatment with BT and BT-DNF over a period of 3 weeks, BT-DNF was more
effective in comparison with BT for reducing IOP (Figure 5d) [58]. In another study, a novel method
was established, combining both coaxial electrospinning and emulsion electrospinning to fabricate a
core/shell fiber matrix. As-proposed PLGA coaxial-emulsion electrospun fibers were loaded with an
anticonvulsant class of drug—Levetiracetam—and the aim was to implant them in the brain to treat
various seizures in adult patients and children with epilepsy. The constant and linear release kinetics of
the incorporated lower molecular weight drug Levetiracetam from fiber scaffolds was noticed during
480 h of the study [104].
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Figure 5. (a) An illustrative diagram of nanofiber-based ophthalmic drug delivery system; (b) Ocular
deposition of dendrimer nanofibers (DNF). Brown Norway rats (BNR) (n = 3) received a DNF-FITC mat
topically in the right eye (experimental eye), whereas the left eye received no treatment (contralateral
eye); (c) In vivo single dose response. BNR (n = 4) received a single dose of brimonidine tartrate (BT)
topically via saline eye drops or DNF; (d) In vivo 3-week daily dose response. Brown Norway rats
(n = 4) received a daily dose of BT via saline eye drops or DNF for 3 weeks. (Here in, Figure 5b–d
reproduced from ref. [58] with permission from ACS Publication, 2017).
5.2. DNA and RNA Delivery
The delivery of nucleic acid molecules such as DNA or interfering RNA, into a target cell to
knockout/ knockdown mutated gene expressions, either by gene editing or impeding the mechanism
of the mutated gene, has proven its novelty in the field of regenerative disease treatment. In this case,
when a gene misbehaves in a protein, gene therapy is able to introduce the new copy of that specific
gene for recuperating the function of that protein by adjusting the signal transduction pathway [105].
To date, the nucleic acid delivery system depends on the carriers and can be folded into two groups; a
viral and a non-viral vector. As nucleic acid directly implanted into the cell does not work, researchers
use vectors as their carrier. In viral vectors, useful viruses are genetically modified with a specific
nucleic acid so that they can enter into the target cell and introduce new genetic material in the place
of missing or faulty genes. However, viral vectors are very specific such as their delivery strategy
depends on the type of tissues and gene, even they can carry a very small size of a gene that may
sometime cause mutation. In comparison with a viral vector, non-viral vectors are more appreciable
among scientists owing to their manageable toxicity, ability to carry various size of genes, large surface
area, and large porosity [106]. Among all types of non-viral vectors, nanofiber scaffolds are widely used
even though problems associated with electrospun nanofiber scaffolds, such as inappropriate nucleic
acid encapsulation and transfection efficiency, are still unsolved. To overcome these limitations, several
attempts have been introduced, for example, core/shell, surface modification, coating, encapsulation,
incorporation, or interfacing electrostatic interaction, to protect the nucleic acid [107–132].
However, the encapsulation of a nucleic acid/polymer complex in the core of core/shell nanofiber
scaffolds can protect the encapsulated DNA or interfering RNA from biological degradation and
denaturation, as well as prolong their release up to several months by controlling it. For instance,
non-knitted, membraneous nanofiber scaffolds were fabricated via the electrospinning procedure
as a gene delivery carrier, containing plasmid DNA encapsulated with poly(lactide-co-glycolide)
and poly(D,L-lactide)–poly(ethylene glycol) type biodegradable synthetic copolymers [107]. These
promising nanofiber scaffolds can control the release behavior of plasmid DNA over 20 h of the study,
whereas the burst release of plasmid DNA appeared within 2 h of the study. In addition, the cumulative
release profile indicated up to 80% of plasmid DNA was released from nanofiber scaffolds. The
released plasmid DNA had a high cellular transfection efficiency with specific protein encoding
properties. In another study, various fiber mesh scaffolds were designed and prepared through the
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coaxial electrospinning method containing the plasmid DNA and non-viral gene delivery vector poly
(ethyleneimine)-hyaluronic acid within the core and sheath polymer of poly(ethylene) glycol and
poly(ε-caprolactone), respectively. The cumulative releases of plasmid DNA and the non-viral gene
delivery vector from the core and sheath of fiber mesh scaffolds over a time period of almost 2 months
showed a dramatic increase in transfection efficiency compared to the control group [108]. Though
variously modified nanofiber scaffolds are used today to protect and encapsulate plasmid DNA-like
genetic materials, the blending of plasmid DNA with an electrospun solution does not facilitate proper
encapsulation and protection of biotherapeutics. In this case, the incorporated plasmid DNA is not
uniformly distributed throughout the nanofiber scaffolds, which may hamper their release profile.
Hence, surface modification with a cationic polymer could solve these issues. Kim et al. designed
DNA-loaded surface modified nanofibers for epidermal gene delivery with a matrix metalloproteinases
(MMPs) responsive control release behavior. Here, a MMPs-cleavable linker was used for surface
modification of as-synthesized poly(ethylene) glycol/poly(ε-caprolactone) nanofiber meshes with
linear polyethyleneimine (LPEI) so that the external MMPs can breakdown the MMPs-linker and
facilitate the MMPs-responsive control release of the DNA-loaded polymer [119]. The release studies
revealed that more than 80% DNA and almost 80% LPEI can release from the proposed nanofiber
mashes over a 72 h time period whereas the transfection efficiency mainly depended on the charge
ratio between DNA and LPEI rather than the amount of release.
To date, various natural and synthetic polymers have been used to fabricate electrospun nanofibers
in order to allow the successful delivery of genetic materials to the target site. In addition, the hybrid
blending of natural and synthetic polymers has also been introduced for the same purpose. In Table 1
we illustrate the usages, designs and advances of various nanofibers as delivery platforms for DNA
and RNA, respectively.
Table 1. Electrospun nanofiber-based DNA/RNA delivery.
Design
Strategy




Prevent DNA degradation. Protect the
bioactivity of DNA during electrospinning.
Controlled and sustained release of DNA.
High Transfection efficiency.
[126]
pDNA encoding pCMV-EGFP PEI-HA, PEG, PECL
Extended-release properties (>120 d).
High transfection efficiency. Controllable
release kinetics. High Expression of EGFP.
[108]
AV encoding-gene for GFP PECL, PEG
Controlled and porogen-assisted release
behavior. High and localized transgene
expression. Very low proliferation rate.
Controlled virus exposure. The lower level of




Sustained the controlled release. High
Transfection efficiency. Promising cell viability.
Highly controlled spatiotemporal gene
expression. Promote tissue regeneration.
[128]
pDNA (pbFGF and pVEGF) PELA, PEI
Sustain release properties (>28 d). Enhance cell
attachment, viability and protein expression.
Higher cellular transfection. Ensure
extracellular secretion of collagen IV and
laminin. Downregulate inflammation.






PEG-b-P4VP Offers tetrasome like pathway for DNAdelivery. Ensure highly controllable kinetics. [130]
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Stable bioactivity of BMP-2 plasmid. Enhance
Cell attachment ability. Low toxicity and
immunological effects. Controlled release
profile and bone regeneration capability.








GAPDH siRNA PCL, PEG
Control release of siRNA (>28 d). High cellular
transfection. Up to 81% of GAPDH gene
silencing efficiency. Local delivery of siRNA.





Sustained the controlled release of siRNA
(>28 d). More than 97% release kinetics profile.
Prominently induced the desired gene
silencing.
[111]
EGFP-specific siRNA duplexes PLGA, Chitosan Excellent release properties. Prolonged andefficient gene silencing [112]
GADPH siRNA Zein
Offers proper encapsulation with intact
bioactivity of siRNA. High loading efficiency.
Ensure the sufficient release of siRNA. High
cellular attachment and transfection efficiency.
More significant gene knockdown.
[113]
REST siRNA (siREST) PCL
Controlled REST knockdown of specific
neuronal cells. Prominently induced the







High cultivation period (>5 d). Large
surface-to-volume ratio and highly flexible.
Manageable transgene expression.
[115]
pDNA (Plasmid EGFP-N2) HAp, PDLLA
Facilitate > 95% of the accumulated release
(>14 d). High cell viability and density.
High GFP expression.
[116]
pDNA (pEGFP-N1) PEG/PECL with LPEI High transfection efficiency. MMp-responsivecontrol release. [119]
siRNA PEG-PECL with LPEI
MMP-2 responsive siRNA release. Excellence
gene silencing effects. Facilitates neo-collagen
accumulation at the wound sites. Wound
recovery can restore to normal levels. Improve
the prognosis of diabetic ulcers. Low toxicity.
[117]
REST siRNA (siREST) PECL
High loading efficiency. Prevent initial burst
release. Enhance gene knockdown efficiency.
Increase neuronal markers expressions. Reduce
glial cell commitment.
[118]
hTERT siRNA ZnGa2O4: Cr
Increase the siRNA concentration in-situ.
High cellular transfection efficiency. Enhance
gene silencing effects.
[120]




Prolonged the availability of siRNA (≥30 d).







Up to 80% of intact released of pDNA (>20 d).
Capable of cell transfection and bioactivity.
Able of tissue regeneration. Capable to deliver




Provide localized targeted gene delivery.
Ensure intracellular uptake. Enhance siRNA
residence time in the brain region. Successfully
downregulate the specific gene expression and








Therapeutics Polymer Facilities Ref
DCEF pDNA (pEGFP-C3) Alginate/PCL
Improve gene immobilization. Enhance cell
adhesion, viability, and proliferation.









Localized and sustained delivery (>28 d).
High loading efficiency. Downregulates
COL1A1 both in vitro and in vivo. Enhance
cellular uptake. Prominently induced the
desired gene silencing.
[125]
pDNA: plasmid DNA, PEG: polyethylene glycol, PLA: poly(lactide), PDLLA: poly(D,L-lactide), PLGA: poly(lactide-co-glycolide),
PEI: poly (ethyleneimine), HA: hyaluronic acid, PCL: poly(caprolactone), PECL: poly(ε-caprolactone), PELA:
poly(DL-lactide)–poly(ethylene glycol), Hap: hydroxyapetite, P4VP: poly(4-vinyl pyridine), LPEI: linear polyethyleneimine,
ELP: elastin-like polypeptides, siRNA: short interfering RNA, PEG: polyethylene glycol, PLGA: poly(lactide-co-glycolide),
PCL: poly(caprolactone), PECL: poly(ε-caprolactone), LPEI: linear polyethyleneimine, PCLEEP: poly(ε-caprolactone-co-ethyl
ethylene phosphate), ZnGa2O4:Cr: chromium-doped zinc gallate.
Nanofiber-based siRNA delivery is also in the spotlight due to its promising mechanism for
silencing specific gene expression, targeting various diseases. Those genes have the ability to develop
genetic mutations and block the secretion of inhibitory factors resulting in excess cell proliferation
that may lead to cancer. To date, various electrospun nanofiber scaffolds have been used as a siRNA
nanocarrier to deliver siRNA into the physiological system. Among them, PCL is the most used
nanofiber scaffold that facilitates high siRNA loading efficiency, local delivery of siRNA, control
release behavior, higher cellular transfection, manageable toxicity and maximum gene silencing
properties [114].
However, the hydrophobic nature and slow degradation properties of PCL are responsible for the
slow release properties of encapsulated siRNA [110,121]. To overcome this issue, surface modification,
the formation of the block polymer and the polydopamine coating of PCL types strategies are taken into
consideration which are briefly described in Table 1. Peptide-based nanofiber scaffolds have also been
introduced as an siRNA nanocarrier targeting neurodegenerative disease. Their unique characteristics
facilitate targetwise siRNA release and accumulation, a high residence period of siRNA in the
brain region, a promising gene silencing profile, and ensure genetic intervention [123]. In addition,
for the first time, scientists proposed a zein nanofiber-inspired siRNA delivery system that ensures
proper siRNA encapsulation and the sufficient release of siRNA, high loading efficiency, cellular
attachment, and transfection of siRNA. This zein-based electrospun nanofiber successfully preserves
the efficiency of siRNA [113]. Various nanoparticles, except for PCL, such as PEG (polyethylene
glycol), PCLEEP (poly(ε-caprolactone-co-ethyl ethylene phosphate)), ZnGa2O4:Cr (chromium-doped
zinc gallate), P-G3A3KRK (Palmitoyl-GGGAAAKRK peptide), Zein, PECL (poly(ε-caprolactone)),
PEG-b-P4VP ((Poly(ethylene glycol)-b-poly(4-vinylpyridine)), PLGA (poly(lactide-co-glycolide)), LPEI
(linear polyethyleneimine), ELP (elastin-like polypeptides), PDLLA (poly(D,L-lactide)), and many
more are used as a nucleic acid carrier [111–113,120,122,123,125] and are summarized in Table 1.
5.3. Growth Factor
Growth factors are naturally occurring endogenous signaling molecules (i.e., proteins or steroid
hormones) which are efficient for inciting cellular development, differentiation, regeneration and
proliferation by binding to cellular receptors. Recently, marked progress has been made in preparing
several types of ultrathin electrospun nanofiber scaffolds to successfully load and deliver several
growth factors (Figure 6a) as well as regenerative medicines, owing to the unique characteristics
of nanofibers such as large surface area, porous formation, high loading capacity, easy access, and
cost-effectiveness [133]. Notably, the large surface area to volume ratio of electrospun nanofibers
facilitates cell adhesion, loading, storage and release of growth factors [134]. Those parameters
are required for guiding cellular behaviors and transmitting signals that regulate proliferation,
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differentiation, metabolism, and apoptosis of cells, including extracellular matrix deposition in
tissue engineering.
The quick inactivation and very short biological half-life of growth factors are the most important
factors hindering their effectual delivery. In addition, it has been noted that the growth factors’
carrier should have slow and sequential releasing properties. The establishment of growth factors into
nanofiber scaffolds play very crucial roles in repairing and regenerating damaged tissues by mimicking
signal transduction from cell to cell, or from cell to its extracellular matrix [135]. Either electrospinning
procedures alone (for example, bending, emulsion, and coaxial electrospinning) or in combination
with other traditional methods such as hydrogel (electrospinning) are ranked at the top among all
nanofiber fabrication techniques for their controlled and sustained release properties. On the other
hand, surface modified nanofibers promote high loading efficiency, protection of incorporated growth
factors and the binding of growth factors to cell receptors. Those surface modified nanofibers exhibit
biochemical and morphological uniformity to natural tissues.
Recently, the polysaccharide matrix is being used as a superior nanofiber material to fabricate a
growth factor carrier owing to their low toxicity, biocompatibility, and extracellular matrix mimicking
capability. However, introducing the sulfation state to the alginate scaffolds ensures the appointed
binding and loading of growth factor into the polymer backbone, as well as maintenance of its
control release properties. For instance, Mohammadi S, et al. fabricated electrospun scaffolds by
blending alginate sulfate and polyvinyl alcohol to load and deliver transforming growth factor-beta1
(TGF-β1) for tissue engineering applications. For the first time, this research revealed that more
successful binding, encapsulation and sustain release of heparin-like proteins from electrospun
scaffolds could be achieved by the addition of an affinity site to the alginate [134]. A part of mammalian
polysaccharides—glycosaminoglycans (heparin-like substance)—would be another example of an
excellent nanofiber matrix because of its efficiency in conjugating with GFs by successfully interacting
with its (GFs) anionic sulfated backbones and mimicking a pathway similar to ECM.
Figure 6. Schematic of the synthesis of growth factor loaded electrospun nanofiber with the controlled
release properties (a), and VEGF (vascular endothelial growth factor) release profile with respect to time
from PCL nanofibers (Reproduced from ref no [123] with permission from ACS Publications, 2018) (b).
Usually, the traditional nanofiber scaffolds-based GFs delivery methods such as dip coating
and covalent binding are associated with low entrapment efficiency and primary burst release
properties. Currently, researchers are looking for new, innovative and stable strategies by focusing on
controlled and sustained release properties. To control the release properties of encapsulated GFs,
the usage of gelatin particles in nanofiber fabrication is becoming popular. Generally, the in vitro
degradation time of gelatin particles is about 240 h, so researchers tend to use gelatin particle-mediated
nanofiber scaffolds as a promising GF nanocarrier. The basic advantages of using gelatin particles
are their slow degradation and controlled release properties in a biological environment because of
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introducing cross-linking treatment during fabrication. An example would be the work of Jiang
and co-workers who prepared PCL fibrous scaffolds containing vascular endothelial growth factor
(VEGF)-incorporated gelatin particles which were able to exhibit both diffusion and degradation
mediated release for a long period of time (Figure 6b), differentiate mesenchymal stem cells from
endothelial cells, sustain the durability of the tubular composition, and form new blood vessels
among endothelial cells [136]. The integration of various sustained release characteristics within
nanofiber scaffolds protects the encapsulated GFs from biological degradation, generates cellular
signal transduction as well as repairs and regenerates damage.
Biocompatible and biodegradable polymeric nanoparticles and biomimetic hydrogel have gained
more attention for encapsulating various types of growth factors and confirming their controlled and
prolonged releasing [133]. VEGF and bone morphogenetic protein 2 (BMP2) were incorporated and
injected to improve the angiogenesis and regeneration of bone in rabbits [133]. Another preclinical
study suggested that VEGF-loaded and hMSC (human bone marrow stroma cells)-seeded PDLA
nanofiber scaffolds are able to regenerate blood vessels and enhance bone growth [137]. Interestingly, to
achieve dual actions from two separate GFs at a time, core/shell nanofibers or emulsion electrospinning
methods are widely used in tissue engineering applications. Liu et al. prepared bicomponent
scaffolds with the emulsion electrospinning method for delivering two GFs at the same time in nerve
tissue engineering. In this study, the nerve growth factor was encapsulated in poly(D,L-lactic acid)
(PDLLA) nanofiber scaffolds whereas the glial cell line-derived neurotrophic factor was incorporated in
poly(lactic-co-glycolic acid) (PLGA) electrospun scaffolds [138]. This dual factor core/shell electrospun
nanofiber scaffold not only revealed its sustained release and degradation-dependent weight loss
properties over 42 days but also ensured the high entrapment efficiency and the intact bioactivity of
GFs. Apart from degradation-based controlled release behavior of electrospun scaffolds, providing
the affinity sites and/or covalent binding of heparin to the surface of nanofibers is also established.
The covalent binding of heparin-like proteoglycans on the surface of the nanofibers preserves the
biological integrity of GFs and promotes the sustained release properties of the scaffolds. The aminated
PLGA was immobilized with VEGF in the presence of heparin via EDC/NHS coupling to facilitate
the sustained release properties of the encapsulated growth factor [139]. The presence of hydroxyl
(–OH) and carboxylic acid (–COOH) groups on the surface of the heparin simplifies its modification
with both GFs and nanofiber scaffolds. Heparin also increased the binding capacity of VEGF to VEGF
receptors on the cell surface.
The time period of sustained release of GFs from its carrier should be proportional to
the time period of GFs capability to preserve the nanofiber scaffolds; therefore, this important
factor is considered during the design of nanofiber-mediated GFs delivery. Employing several
electrospinning techniques, the preservation of GFs’ bioactivity is achieved for the proliferation
and migration of specific cells. The heterogeneous electrospun matrix made of biocompatible
poly(L-lactide-co-caprolactone) and poly(2-ethyl-2-oxazoline) was able to protect the bioactivity of
dual angiogenic basic fibroblast growth factor and vascular endothelial growth factor during and
after their physical blending. It is also capable of mimicking the topography and chemical cues
of native cardiac tissue structures [140]. The structural integrity and bioactivity of encapsulated
GFs remained the same over the total period of sustained release in comparison with the pure GFs.
In another study, for the first time, Naskar et al. reported the anteriority of using natural polymer silk
protein fibroin reinforced synthetic carbon nanofiber scaffolds for preserving bioactivity and controlling
the sustained release kinetics of BMP-2 and TGF-β1 GFs over a prolonged period of 50 days [141].
The primary attachment of GFs and the regeneration, excess proliferation, and differentiation of
both osteoblastic cells and MSC proved the structural integrity of encapsulated GFs in the nanofiber
scaffolds. Moreover, a few linear polysaccharides (i.e., chitosan) are very popular for encapsulating GFs
(transforming growth factor beta-1). The major challenge associated with the polysaccharide-based GFs
delivery system is their short biological half-life. Hence, they are further composited with nanofiber
scaffolds in order to improve the long term presence of GFs in stem cells through maintaining their
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sustained release from electrospun scaffolds [142]. Previously reported data proved the efficiency of
electrospinning methods to load and achieve the sustained release properties of two different GFs
at the same time in tissue engineering applications, but now it is also possible to accomplish the
distinct release kinetics and spatiotemporal delivery of two different GFs from the same scaffolds with
various layered configurations by applying several electrospinning techniques. The combination of
emulsion, sequential, high speed and double-sourced double power electrospinning were employed to
fabricate tri and tetra layered nanofiber scaffolds using poly(lactic-co-glycolic acid) and poly(D,L-lactic
acid) [135]. This glial cell line-derived growth factor and nerve growth factor incorporated multilayer
electrospun nanofibers was able to maintain various release actions of these GFs due to aligned fiber
coating in each layer with a controlled thickness. The cumulative release studies of encapsulated-GFs
indicated distinct release properties from different sites of tri-layered and tetra-layered nanofiber
scaffolds over a period of 42 days.
6. Conclusions and Future Outlook
Electrospinning is a promising technology for manufacturing nanofibers from the laboratory
to industrial level. Nanomaterials possess a large surface area and enhanced porosity, which are
advantages for drug delivery and many other biomedical applications. Nanofibers can be formed
using three different techniques: electrospinning, self-assembly, and phase separation. Electrospinning
is the most widely used technique because of its promising results. Electrospun nanofibers have
attracted much attention due to their biocompatibility, adhesiveness, sterile nature and their efficiency
in diverse applications. Currently, nanofibers are considered suitable candidates for scaffold materials,
wound dressing materials, drug delivery systems, filtration membranes, catalysts for reduction and
so on. Nanofibers are used for medical applications, batteries and fuel cells as a new material.
Though the application of nanofibers is versatile, still more development and research is required
for the proper use of nanofibers, especially for biomedical therapeutic delivery. The application of
nanofibers in drug delivery, medical implants or tissue engineering is still very limited and most of
the materials cannot reach the stage of clinical trials. A thorough investigation on the scaling up of
nanofiber technology is required, to make it widely available.
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Abstract: Polymeric nanofibers (NFs) have been extensively reported as a biocompatible scaffold to
be specifically applied in several researching fields, including biomedical applications. The principal
researching lines cover the encapsulation of antitumor drugs for controlled drug delivery applications,
scaffolds structures for tissue engineering and regenerative medicine, as well as magnetic or plasmonic
hyperthermia to be applied in the reduction of cancer tumors. This makes NFs useful as therapeutic
implantable patches or mats to be implemented in numerous biomedical researching fields. In this
context, several biocompatible polymers with excellent biocompatibility and biodegradability
including poly lactic-co-glycolic acid (PLGA), poly butylcyanoacrylate (PBCA), poly ethylenglycol
(PEG), poly (ε-caprolactone) (PCL) or poly lactic acid (PLA) have been widely used for the synthesis of
NFs using the electrospun technique. Indeed, other types of polymers with stimuli-responsive
capabilities has have recently reported for the fabrication of polymeric NFs scaffolds with
relevant biomedical applications. Importantly, colloidal nanoparticles used as nanocarriers and
non-biodegradable structures have been also incorporated by electrospinning into polymeric NFs for
drug delivery applications and cancer treatments. In this review, we focus on the incorporation of
drugs into polymeric NFs for drug delivery and cancer treatment applications. However, the principal
novelty compared with previously reported publications is that we also focus on recent investigations
concerning new strategies that increase drug delivery and cancer treatments efficiencies, such as the
incorporation of colloidal nanoparticles into polymeric NFs, the possibility to fabricate NFs with
the capability to respond to external environments, and finally, the synthesis of hybrid polymeric
NFs containing carbon nanotubes, magnetic and gold nanoparticles, with magnetic and plasmonic
hyperthermia applicability.
Keywords: electrospun nanofibers; cancer treatment; drug release; nanomedicine; biocompatible
polymers; hyperthermia
1. Polymeric Nanofibers in Biomedicine: General Overview
The improvement of chemotherapeutic treatments in cancer patients is seriously limited by the
difficulty of increasing the ability of drugs to specifically target tumor cells, thus reducing their toxicity
in healthy cells. However, these antitumor molecules cannot increase their therapeutic response,
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which leads to poor prognosis and results in serious health problems, due to the prevalence of these
several pathologies. Consequently, further research is needed to find new therapeutic approaches that
improve the prognosis of patients affected by several types of cancers, thus decreasing the possible
mortality rate. In this context, new strategies are appearing concerning the development of systems with
the capability to encapsulate chemotherapeutic drugs and act as vehicles to be delivered in a specific
area in a higher extension, thus avoiding the previously mentioned limitations and improving their
efficiency, specifically in tumor cells [1,2]. According to the data from the World Health Organization,
cancer caused 9.6 million deaths in 2018, and is one of the leading causes of death worldwide. The most
common tumors are lung, breast and colorectal cancer [3]. For this reason, it is important to develop
new nanoformulations that allow the improvement of cancer treatments and therefore the survival of
these patients.
In general, drug delivery systems are nanostructures that can be loaded with small molecules
or macromolecules, thus acting as vehicles of specific compounds to be used in a pharmaceutical
administration process. Nowadays they represent one of the most promising challenges in the
improvements of biomedical investigations [4]. Such materials are able to transport a chemotherapeutic
molecule to a desired area, thus increasing the drug concentration, to be subsequently released in
a controlled manner. Among a great number of nanoformulations, such as liposomes [5], micelles [6],
Pickering emulsions [7], dendrimers [8] or nanoemulsions [9], polymeric nanoparticles (NPs) have
been extensively reported as drug delivery systems to be applied in, for example, the chemotherapeutic
treatment of solid tumors [9]. These NPs can be composed by synthetic polymers such as polylactic acid
(PLA), poly lactic-co-glycolic acid (PLGA) or polyethylene glycol (PEG) [10,11], which in principle can
be administered as colloidal systems and dispersed in a solution by means of intravenous administration.
However, during the last years, apart from colloidal structures, polymeric nanofibers (NFs) have been
reported as a scaffold with the ability to encapsulate antitumor drugs for biomedical investigations,
including drug delivery and cancer treatments [12,13]. Among various techniques available for NFs
fabrication, electrospinning is simple and produces NFs with high interconnected pores in the nanoscale
range [14], having also a large surface area-to-volume ratio, high interfiber porosity, low hindrance for
mass transfer, flexible handling, adjustable morphology, and high mechanical strength, which make
NFs useful as therapeutic patches or mats for biomedical applications [15,16], indeed they are used in
the fabrication of non-woven fibers with diameters ranging from a few nanometers to microns.
In the electrospun technique, when a strong electrostatic field is applied to a polymer solution held
in a syringe, the pendent droplet of the polymer solution is deformed into a Taylor cone [17]. When the
electric force overcomes the surface tension of the droplet, one or multiple charged jets are ejected
from the tip of the droplet. As the jet moves towards a collecting metal screen, the solvent evaporates,
and a nonwoven fabric mat is formed on the screen. This technique is able to fabricate fibers with
diameter in the order of nanometers. During the last years, by using this technique, a great number
of polymers have been used for the generation of biocompatible NFs scaffolds [18]. Biodegradable
synthetic polymers such as PCL or PLGA, as well PEG and PLA can be used as substrates for the
fabrication of NFs by using electrospun approaches [19]. Importantly, during the last few years,
other types of polymers with stimuli-responsive behavior have been investigated as NFs scaffolds [20].
Two examples are poly(N-Isopropylacrylamide) (pNIPAM) and poly(4-vinylpyridine), which are
the most investigated thermo- and pH-responsive polymers, respectively. By using this technique,
the fiber diameter can be modulated by several polymer solution properties as viscosity, elasticity,
polymer concentration and conductivity, the electric field strength, the distance between the injector
and the metal collector, or other external parameters as temperature and humidity. Importantly,
these NFs can incorporate and accumulate chemotherapeutic molecules by means of two main
approaches [21]; (i) Blend electrospinning, which is based on mixing a drug with a polymeric solution
prior to electrospinning process or (ii) Coaxial electrospinning, which is basically a simultaneous
co-spinning of two polymeric liquids. The general system for this “core/shell” electrospinning is based
on two needles, structured in a coaxial manner Indeed, drugs can be incorporated into the NFs through
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physical adsorption (involving electrostatic interactions) [22] or covalent bond [23], as well as the
aforementioned co-axial electrospinning or mixing with the polymer solution. By applying some of
the previously mentioned approaches, electrospinning also offers the possibility to fabricate hybrid
composites NFs. These composites structures are produced by the incorporation of other systems with
specific properties into the polymeric NFs as CNTs, magnetic nanoparticles or metal nanoparticles.
Among several reported reviews concerning the fabrication of polymeric NFs by electrospinning
for drug delivery purposes [24–26], the principal novelty of this review is that we include recent
advances for the fabrication and application of polymeric NFs by electrospinning not only focused
in polymeric NFs. We also include recent investigation in 3 major items: (i) the incorporation of
particles as nanocarriers into the NFs (vesicles, micelles or silica particles), which are able to increase
drug accumulations, (ii) the fabrication of polymeric NFs with the capability to respond to external
environments, and (iii) the generation of hybrid systems structured as polymeric NFs containing CNTs,
magnetic and gold nanoparticles for hyperthermia applicability.
2. Electrospun Nanofibers for Drug Delivery Application
2.1. Free drug-Loaded Nanofibers
As was previously mentioned, coaxial electrospinning is based on co-spinning two liquids in
a core/shell structure. Figure 1 shows a typical coaxial electrospinning setup used for the fabrication
of core/shell NFs. As can be observed, it is composed by 2 syringe pumps. In this particular case,
the injector is formed by a coaxial needle where the inner part contains a paclitaxel (PTX) solution
and the outer part contains the polymer [27]. This technique has been applied for the incorporation of
PTX into poly(L-lactic acid-co-ε-caprolactone), P(LLA-CL) (75:25)NFs, thus resulting in PTX loaded
P(LLA-CL) NFs. Paclitaxel is a chemotherapeutic drug which is extensively used in breast, ovarian,
lung, bladder and prostate cancer. Huang et al. [27] prepared a PTX solution by dissolving this
chemotherapeutic drug in 2,2,2-trifluoroethanol. Then, co-axial electrospinning was used to directly
introduce the PTX solution into a polymeric P(LLA-CL) shell. They prepared various core/shell NFs
with tunable diameter, which was controlled by the polymer concentration and flow rate between the
2 solutions. Drug delivery investigations exhibited a short burst of PTX during 24 h followed by a very
slow release for the following 60 days. Indeed, these PTX-IN-P(LLA-CL) NFs also inhibited the activity
of HeLa cells. Paclitaxel was also introduced into PLGA nNFs mats fabricated by blend electrospinning
for controlled drug delivery [28]. In this case, the drug release investigation was performed for
the in vitro treatment of C6 glioma. The polymer fiber diameter was controlled by using different
polymer concentrations, as well as different amounts of an organic salt named tetrabutylammonium
tetraphenylborate (TATPB). They obtained NFs with dimension from several tens nanometers to 10 mm,
and after the addition of organic salts, the NFs diameter were decreased up to 30 nm. For PTX-IN-
PLGA NFs the encapsulation efficiency was higher that 90%. In vitro release profiles confirmed
a sustained PTX release for more than 60 days. Their results also indicated that the density of C6
glioma cells was much lower after administration of different concentrations of PTX-IN-PLGA NFs,
as compared to the control and blank PLGA NFs after 72 h.
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Figure 1. Schematic representation of the coaxial electrospinning setup. In this example the core solution
is composed by the PTX dissolved in 2,2,2-trifluoroethanol and the shell solution is the poly(L-lactic
acid-co-ε-caprolactone) polymer. Reprinted with permission from reference [27]. Copyright Wiley
Online Library, 2009.
Low-water soluble molecules as PTX are not the only option that has been introduced into
NFs. A hydrophilic antibiotic drug, as MefoxinR, has also been incorporated into polymeric NFs by
using PLGA and a mixture of PLGA/PEG-b-PLA/PLA (80:15:5) through blend electrospinning [29].
These authors demonstrated that the morphology and density of the prepared NFs depended on the
drug concentration, which is basically produced by the different conductivity provided by the ionic salt
during the electrospinning process. They obtained interesting antimicrobial effects on Staphylococcus
aureus cultures when reaching a maximum dosage after 1 h. Indeed, when the amphiphilic block
copolymer (PEG-b-PLA) with a ratio of 85:15 was used during electrospinning, the fabricated NFs
were able to reduce the cumulative amount of the released drug at shorter times, and prolonged the
drug release rate at longer times (up to a 1-week period). Blend electrospinning was also used for the
encapsulation of three chemotherapeutic drugs into poly(L-lactide)(PLLA) NFs: PTX, doxorubicin
(DOX) and DOX hydrochloride [30]. In this case, the influence of solubility and compatibility of drugs
with the polymer was investigated, and it was associated with the drug delivery behavior. In these
scaffolds, after drug incorporation, the degradation of PLLA fibers was monitored in the presence
of the enzyme proteinase K, following a drug release with a nearly zero-order kinetics. Cisplatin is
another compound that is used in chemotherapy for the treatment of liver cancer, although it has little
effectiveness. Zhang et al. [16] used an electrospun system that consisted of five layers composed of
PLA and the drug interleaved in layers. The drug was located in the even, second and fourth layers,
while the PLA was located in the odd, first, third and fifth layers. In this study, fruitful results were
obtained for in vivo investigations since the layered structure allows a continuous release of the drug.
Consequently, a reduction in the toxicity during the treatment and a longer half-life of the mice was
obtained. NFs can be also used for attenuating the side effects of the used drug. This is the case of the
study of Singh et al. [31] These authors introduced Docetaxel (DOC) into polyvinyl alcohol (PVA) fiber
using the electrospinning method. The aim of the study was to prevent inflammation, extravasation
and other side effects of chemotherapy in the treatment of oral cancer. Because of that, they designed
a mucoadhesive nano-carrier DOC-PVA and made in vitro studies with positive results, showing that
anticancer drugs can be successfully used for local administration with polymeric NF.
Apart from chemotherapeutic drugs and antibiotics, Lovastain, a commonly used drug that
reduces the cholesterol level and the risk of heart attack, has been incorporated into biocompatible NFs
for drug delivery purposes. Zhu et al. [32] used blend electrospinning to introduce these biomedical
properties of lovastatin into biodegradable and biocompatible PLLA NFs with drug delivery capability.
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Lovastatin was fully dissolved with PLLA by using hexafluoro-isopropanol as a solvent and at weight
percentages of lovastatin in PLLA of 0%, 5%, and 10%. Interestingly, authors found that lovastatin
values of 5 wt% or 10 wt% improved the NFs properties for alignment and surface smoothness,
while also enhancing the NFs diameter. These Lovastain-IN-PLLA NFs reached high drug entrapment
efficiency, ranging from 72% to 82%. The in vitro drug delivery investigations confirmed a release
behavior in two stages. Initially, fast release was produced during the first day, and a slower release was
measured that reached a plateau after 7 days. By using a cylinder collector during the electrospinning,
they also fabricated PLLA films. These authors compared the drug delivery capabilities of PLLA NFs
with PLLA films, and they found a higher release rate for fibers compared with films.
2.2. Nanocarriers-IN-Nanofibers
Nanocarriers have gained attention in drug delivery due to their ability to act as vehicles in the
transport and delivery of different drugs. It is important to remark that nanocarriers are not only
interesting in terms of vehiculization, they are also relevant because after introducing the drug into the
nanocarrier, the amount of chemotherapeutic molecule to be delivered is considerably increased. It is
accepted that a colloidal system is formed by a complex fluid where a certain substance (disperse phase)
remains immersed in another substance (solvent). Accordingly, a colloidal system is formed by
a disperse phase containing solid particles that are dispersed in a liquid. In this context, vesicles,
micelles, microgels, or emulsions are colloidal structures where the disperse phase is a solid particle
which is dispersed into a certain solvent. The possibility to introduce chemotherapeutic drugs into
these colloidal particles has been extensively exploited in drug delivery applications and cancer
treatments. Importantly, as these particles are in the range of nanometers, they can be incorporated
into the human body by intravenous administration. However, it is important to mention that the
simple introduction of drugs into some nanocarriers normally leads to inevitable burst drug release.
To overcome this limitation, some improvements have been found, for example, by the incorporation
of these nanocarriers into polymeric NFs, which improves drug delivery and the applicability of
cancer treatments.
2.2.1. Vesicles and Micelles as Nanocarriers
Vesicles and micelles have been used as drug nanocarriers to be incorporated into polymeric
NFs. An important advantage of this type of colloidal particles is the fact that they possess in
their structure two different environments (hydrophobic or hydrophilic) that can be exploited
in, for example, the incorporation of two different drugs, thus performing dual drug delivery.
Li et al. [33] investigated a dual drug delivery approach by using two types of drugs, 5-FU and
paenolum. 5-Fluorouracil is a hydrophilic chemotherapeutic drug principally used in colon cancer
treatment, and paenolum is a hydrophobic molecule used to prevent blood platelet clotting, thus
having anti-inflammatory properties. Initially, the vesicles were fabricated by mixing two surfactants,
cetyltrimethylammonium bromide (CTAB) and sodium dodecylbenenesulfonate (SDBS), which were
able to trap the aforementioned drugs. As is represented in Figure 2A, hydrophilic 5-FU were
encapsulated within the aqueous inner part of the vesicle, and the hydrophobic paenolum was situated
into the external bilayer of the vesicle. Then, after nanocarriers fabrication and drug encapsulation,
they were mixed with a PEO solution, and blend electrospinning was performed to obtain a core/shell
scaffold, with the drug-loaded vesicles as core introduced into PEO NFs, Figure 2B. The release
investigations concluded that the hydrophilic drug was released in an increased manner when the
molar ratio of CTAB/SDBS was higher. In contrast, the hydrophobic drug showed a decrease in the
release capability as the molar ratio of surfactants was increased. Figure 2A,B shows a schematic
representation for the incorporation of dual drug-loaded vesicles into PEO NFs. The vesicle is initially
introduced into the mixture of drugs, and then electrospinning is used to form the vesicle-IN-PEO
NFs scaffolds. More recently, the same authors fabricated three different vesicles that were used as
nanocapsules systems introduced into polymeric NFs for drug delivery purposes. These vesicles
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were composed of didodecyldimethylammonium bromide, cetyl trimethyl ammonium bromide
(CTAB)/sodium dodecyl benzene sulfonate (SDBS) (7/3) and CTAB/SDBS (3/7). After that, these vesicles
were introduced into nanocapsules fabricated by a mixture of sodium alginate and chitosan. PEO NFs
were obtained by blend electrospinning, and they were composed by PEO, containing a mixture of
chitosan/sodium alginate with the vesicles as a template. In this work 5-FU was chosen as a model
chemotherapeutic molecule to be incorporated during vesicles fabrication. The drug release behavior
was followed by UV-visible spectroscopy. As was expected, the different drug-delivery systems showed
different release rates and pH-responsive behaviors.
Figure 2. Schematic representation of the preparation of hydrophilic/hydrophobic electrospun
composite fibers. (A) Accumulation of the drug mixture into the vesicle and (B) incorporation into the
NF by electrospinning and drug release. Reprinted with permission from reference [33]. Copyright
American Chemical Society, 2015.
Other types of linear polymer, as pluronic F127, were also used for release investigations, along with
with tissue regeneration. Electrospinning was chosen for the fabrication of a scaffold containing high
molecular weight PCL NFs containing pluronic (F127) vesicles, which were delivered by exploiting
the slow dissolution of PCL into glacial acetic acid. The vesicles were fabricated by pluronic F127
self-assembled with low-molecular weight PCL in a tetrahydrofuran-water mixture [34]. The authors
were able to tune the vesicle size from 1 to 10 μm in diameter. Time-dependent stability of the vesicles
in glacial acetic acid was determined before the electrospinning process. The electrospun membrane
was found to be composed of pluronic F127/PCL vesicles within a PCL mat with a fiber diameter
between 50–300 nm. Authors proposed that the most probable condition for the vesicles generation
is the non-solubility driven self-assembly and stabilization of PCL and F127 into bilayers in the
tetrahydrofuran (THF)-water mixture. By using this method, the amphiphilic polymer is dissolved in
a water miscible organic solvent and mixed at a high speed with water, leading to the rapid precipitation
of polymers into nanoscale particles. Drug delivery of a model molecule as rhodamine-B (introduced
into the polymer network) for this composite pluronic F127-IN-PCL showed an important reduction
in the release rate of this molecule, when it was compared to the free vesicles. Indeed, the systems
containing vesicles in the membrane presented an enhanced hydrophilicity compared to the control
PCL membrane. Apart from drug delivery behavior, this increased surface hydrophilicity was exploited
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for increasing the cell viability of L929 cells on the membrane [34]. Another study with PCL was
carried out by Yohe et al. [35] using the N-38 anticancer drug for the colorectal cancer cell line HT-29.
They electrospun a mesh using 10% of a hydrophobic poly(glycerolmonostearate-co-ε-caprolactone)
(PGC-C18) and 90% of PCL loaded with the N-38, showing promising results in the cytotoxicity of the
cell line.
Micelles introduced into polymeric NFs have been also used for dual drug delivery. Hu et al. [36]
fabricated colloidal structures formed by a block co-polymer composed by methoxypoly(ethylene
glycol)-block-poly(L-lactide). Into these colloidal particles, a water soluble chemotherapeutic drug
(5-FU) and a lipophilic drug as cefradine (an antibiotic active against Gram positive bacteria) were
introduced. The external shell of the NFs was fabricated by a mixture of chitosan and PEO, and the
micelles loading drugs were introduced into NFs by blend electrospinning. The NFs without micelles
were uniform and smooth, with diameters in the range of 100–500 nm. However, after drug-loaded
micelles incorporation within the NFs, the surface of the NFs was relatively rough, with diameters in
the range of 200–800 nm, with some black spheres with diameters of approximately 150 nm in the NFs.
By using this drug loaded nanocarrier-IN-NFs, they performed release investigations that revealed
a low burst release tendency of 5-FU and Cefradin. Indeed, this system was able to reduce the activity
of HepG-2 cells with good cell viability after 3 days of incubation. Zhang et al. [37] fabricated micelles
composed by triblock copolymers as poly(L-glutamic acid)-b-poly(propyleneoxide)-b-poly(L-glutamic
acid) which were able to deliver low water-soluble drugs, such as PTX, at clinically relevant doses.
These micelles containing PTX were used as drug loaded nanocarrier which were grafted onto NFs
scaffolds of (poly(L-lactide-co-ε-caprolactone) (PLCL):fibrinogen; 2:1 (w/w)) by blend electrospinning.
Yang et al. [38] fabricated an implantable device structured as drug-loaded micelles-IN-NFs for
controlled drug delivery. In this case authors used DOX introduced into micelles composed by
PCL-PEG copolymer. The implantable devices were fabricated by coaxial electrospinning, with the
core composed by the DOX-loaded PCL-PEG micelles introduced into a PVA solution dissolved in
distillated water. The outer shell layer of the NFs was composed by genipin cross-linked gelatin.
Importantly, these authors also functionalized the micelles with folic acid to specifically target tumor
cells. The drug release investigations demonstrated that the implantable device reduced the drug dose,
the frequency of administration and side effect of chemotherapeutic drugs while maintaining highly
therapeutic efficacy against solid tumors.
2.2.2. Silica Particles as Nanocarriers
Dual drug delivery has been also performed by using two different types of colloidal nanoparticles
as mesoporous silica nanoparticles (MSNs) and hydroxyapatite nanoparticles. These colloidal systems
were used as nanocarriers for the incorporation of DOX HCl and the topoisomerase inhibitor
hydroxycamptothecin [39]. Initially, the mixture of mesoporous silica particles and hydroxyapatite
nanoparticles individually containing both chemotherapeutic drugs was a mixture within a polymer
solution of PLGA to be introduced into NFs as a core/shell structure by electrospinning. This dual
anticancer biocompatible system improved the mechanical capacity as well as the thermal stability
of the NFs. In addition, when in vitro investigation was performed, the dual micelle-IN-NFs system
provided a sustained and controlled drug release and an improved capacity for inhibiting HeLa
cells growth. Using a similar approach, Qiu et al. [40] fabricated a drug-loaded implantable device
for the treatment of a tissue defect after tumor resection. They used MSNs as nanocarriers for
the incorporation of the anticancer drug DOX hydrochloride. These MSNs colloidal systems with
incorporated chemotherapeutic drugs (DOX@MSNs) were introduced into PLLA NFs generated
by electrospinning, thus obtaining a drug-loaded NFs scaffold DOX@MSNs-IN-NFs. Initially they
confirmed the successful introduction of DOX-loaded MSNs into the PLLA NFs by UV-vis spectroscopy,
and then several nanocomposite systems with different MSNs and DOX contents were fabricated.
Figure 3 shows the schematic representation for the fabrication of DOX-loaded MSNs-IN-PLLA NFs.
Optimal results concerning particles distribution that also improved thermal stability were found by
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using PLLA/1.0% DOX and 10% MSNs NFs. These authors investigated the in vitro antitumor efficacy
against HeLa cells, and they found high DOX-loading capacities. Due to this fact, the drug was released
in a sustained and prolonged manner, with a higher in vitro antitumor efficacy compared with free
MSNs particles. Thus, these fabricated composite NFs mats are highly promising as a local implantable
device for potential postsurgical cancer treatment. Yuan et al. [41] propose a drug delivery system
which can release anti-tumor drugs in two phases. They designed a NFs scaffold for breast-conserving
therapy after breast cancer by using DOX-loaded MSNs into an electrospun PLLA nanofibrous scaffold.
In vivo results (mice) showed a significantly inhibition in the tumor growth, making its use promising
in a coadjuvant therapy against this tumor type.
 
Figure 3. Schematic illustration for the process of fabrication of DOX@MSNs-IN-NFs electrospun
composite NFs and the location of DOX in the fiber [40].
2.2.3. Gelatin Nanoparticles as Nanocarriers
Song et al. [42] used gelatin nanospheres (GNs) as colloidal systems to improve the antibacterial
effects of silk NFs membranes. They prepared two types of GNs by adding different amounts of
glutaraldehyde into the suspension during the synthesis of GNs. The size and distribution of the GNs
into the NFs, fabricated by electrospinning and using a mixture of PEO and silk fibroin, was monitored
by fluorescent labeling. Positively charged drugs as vancomycin and colistin were used as a model
for controlled drug delivery investigations. Vancomycin is an antibacterial compound that inhibits
the synthesis of the bacterial cell wall, and colistin is an apolypeptide that is effective against most
of the Gram-negative bacilli. These authors used both blend and coaxial electrospinning to fabricate
GNs-IN-PEO/silk NFs, and they examined the antibacterial effect by introducing the mentioned
antibacterial drugs. By using the NGs synthesized with the highest amount of glutaraldehyde,
the fabricated NFs supplied a more sustained release of vancomycin compared with pure GNs. Indeed,
apart from being totally cytocompatible, the NFs showed excellent and sustained antibacterial effects
against Staphylococcus aureus. Lai et al. [43] fabricated collagen (Col) and hyaluronic acid (HA) NFs
with the aim to release a series of growth factors directly embedded in the NFs or encapsulated in the
gelatin nanoparticles (GNs) by using electrospinning technology. The fabricated GNs-IN-Col/HA NFs
showed mechanical properties that mimicked human natural skin. The designed GNs-IN-Col/HA
NFs were able to release growth factors in a slow controlled manner for up to 1 month. From the
above, the electrospun Col-HA-GN composite nanofibrous skin substitute with a stage-wise release
pattern of multiple angiogenic factors could be a promising bioengineered construct for chronic wound
healing in skin tissue regeneration. They also used several release patterns for GNs-IN-Col/HA
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NFs with 4 different growth factors and demonstrated their potential capability to deliver multiple
bioactive molecules.
Electrospun PLGA and PLGA/gelatin NFs embedded with MSNs were synthesized, obtaining
MSNs distributed in the core of the fiber. PLGA and MSNs contributed to increase the hydrophobicity
of electrospun NFs and the gelatin contributed to increase the mechanical properties of this scaffold.
With a final size of approximately 267 nm, these nanoformulations are synthesized to provide
a very suitable microenvironment for the adhesion, growth and migration of stem cells involved in
nervous tissue regeneration [44,45]. Aytac et al. [46] synthesized electrospun gelatin NFs to vehiculate
ciprofloxacin (CIP) and hydroxypropyl-beta-cyclodextrin (HPβCD)-inclusion complex (IC), which is
normally used to improve the physico-chemical properties of some drugs as well as their bioavailability.
This IC achieved an increase of the solubility and wettability of the nanoformulations, leading to
their fast dissolution and therefore to a fast release of CIP transported in gelatin NFs, which can be
an important property in certain situations where a rapid release of drugs is required. With this type of
gelatin-based scaffolds, in addition to drug transport and use for tissue engineering, the migration
of certain cells can also be induced or favored. This is the case in the study of Piran et al. [47] that
synthesized electrospun three-layered scaffold with plasma enriched with growth factor to promote the
migration and growth of fibroblast, which is a very important aspect in the regeneration of wounds.
2.2.4. Stimuli-Responsive Nanoparticles as Nanocarriers
Some stimuli-responsive colloidal particles have been used as nanocarriers to be introduced into
polymeric NFs for drug delivery applications. For example, Gong el al. [48] introduced redox-responsive
nanoparticles into a polymeric scaffold to be incorporated into the body with the aim to deliver a growth
factor (morphogenic protein BMP-2) used of bone regeneration. The strategy to fabricate redox-sensitive
NFs with a core/shell structure consisted of a blend of PCL and redox responsive c-6A PEG-PCL nanogel
with –S–S– bond on the outer shell. This redox-sensitive shell was able to respond to the change of the
glutathione concentration and thus regulate the BMP-2 release for in vitro and in vivo investigations.
Light-responsive nanoparticles, as TiO2 and incorporated into a polyacrylonitrile (PAN)/multiwalled
carbon nanotube composite NFs have been reported for the photocatalytic degradation of
pharmaceutical molecules as Ibuprofen, Cetirizine, and Naproxen [49]. Visible light (0.1 W/cm2)
irradiation was employed to investigate the drug degradation. The photocatalytic degradation of
molecules using TiO2-IN-PAC/MWCNT NFs was higher compared with TiO2-IN-PAC NFs under
visible light irradiation. A total degradation of drugs molecules was performed at 200, 50, and 90 min,
respectively under visible light.
Another interesting strategy was developed by Elashnikov et al. [50]. They were able to release
antimicrobial molecules from thermos-responsive microgels introduced into PLLA NFs. Crystal violet
(CV) was incorporated within the polymer network of temperature-responsive PNIPAM microgels used
as nanocarriers. Then, blend electrospinning was performed using PLLA as a biocompatible polymer,
thus resulting in composite PLLA NFs with incorporated pNIPAM particles containing antimicrobial CV.
They investigated the controlled drug delivery behavior of these core/shell NFs by UV-vis spectroscopy,
which was produced after modification of the external temperature below and above the lower
critical solution temperature (LCST). The antibacterial activity was investigated against gram-negative
Escherichia coli (E. coli) and gram-positive Staphylococcus epidermidis (S. epidermidis). Authors
demonstrated that the temperature-responsive release of antibacterial CV possessed remarkable
antibacterial activity. This activity showed higher inhibition zones at temperatures above the LCST,
with its size dependent on the polymers ratio and temperature.
2.3. Stimuli-Responsive Nanofibers
As was mentioned, synthetic polymers have been extensively used as scaffolds in the synthesis
of NFs for drug delivery investigations. However, during the last years, important researching efforts
have been focused on the use of stimuli-responsive systems [20]. These structures can undergo
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changes in response to external stimulus, as temperature, pH, ion strength, or solvent nature [51–53].
Most of the recent studies in the area of switchable drug release have been dedicated to the
creation of systems for drug encapsulation based on two types of polymer [54]: pH-responsive
and thermo-responsive polymers.
2.3.1. pH-Responsive Nanofibers
The acidic environment found in tumor tissues can be employed as a way to specifically target the
release of antitumor drugs at the tumor in response to a change in pH by the use of nanoformulations
sensitive to pH changes [55]. Illangakoon et al. [56] used ES100, which is an anionic co-polymer
constituted by metacrylic acid and methylmethacrylate, for the fabrication of pH-responsive nanofiber
for the delivery investigation of 5-FU. Co-axial electrospinning was carried out with a core composed
of poly(vinylpirrolidone), ethyl cellulose (EC) and the 5-FU drug, and the shell was formed from
pH-responsive ES100. The drug release investigation demonstrated a controlled drug release developed
at pH 1, reaching a maximum of 80% drug release after 2 h, produced by the diffusion of 5-FU through the
pores of the ES100 polymer. At this pH, the polymeric fibers were fragmented, supplying an increased
5-FU delivery. Indeed, these authors fabricated NFs with a core/shell structure made of ES100
for the shell and Eudragit L100 (EL100) for the core to allow the controlled release at certain pH
conditions, and controlled this release using the cover thickness [57]. Tran et al. [58] introduced
ibuprofen into pH- and thermo-responsive polymers for controlled drug delivery investigations.
Ibuprofen was initially mixed with a polymeric solution of PCL as the control experiment and also into
poly(Nisopropylacrylamide-co-methacrylic acid) (pNIPAM-co-MAA) to fabricate stimuli-responsive
NFs by blend electrospinning. As comparative results, when PCL NFs were investigated as a drug
delivery system for ibuprofen, the fabricated NFs did not show significant drug release behavior at
temperatures between 22–40 ◦C or pH from 1.7–7.4. However, NFs generated from pNIPAM-co-MAA
were able to diffuse ibuprofen in a linear and controllable manner when the temperature was above the
lower critical solution temperature (LCST) of pNIPAM-co-MAA (33 ◦C), as well as at pH lower that
the pKa of carboxylic acids (pH 2). However, when the drug delivery experiments were performed at
room temperature, the release rate was radically increased by closely ten times, compared to the release
behavior at higher temperature and lower pH. NFs of cationic chitosan and poly(acrylic acid) (PAA) were
synthetized with different levels of Cs deacetylation, showing that the mechanical properties of these
NFs are determined by both the pH and the level of deacetylation, which could be useful in biomedical
applications such as the transport and release of drugs [59]. Gelatin and poly(lactide-co-ε-caprolactone)
(PLCL) were used to synthetize NFs that were loaded with ciprofloxacin and sodium bicarbonate
with a response to low pH of gelatin/sodium bicarbonate fibers, whereas the hydrophobic PLCL had
no sensitivity to pH [60]. These NFs not only showed good biocompatibility in fibroblasts (L929),
they were also able to stimulate cell growth compared to untreated cells. Functionalized electrospun
PCL scaffolds sensitive to pH changes, were loaded with DOX and tested at different pH levels (from 7.4
to 2.5) finding the highest drug release (90%–95%) at the lowest pH levels [61]. This was observed
in the human embryonic kidney cells (HEK) treated with these scaffolds with a cell viability at pH 6
lower than those obtained at pH 7.2.
Thixotropic silk NFs hydrogels were loaded with DOX and it was designed to release the drug
in the tumor site due to their thixotropy capability [62]. This allows the hydrogel inoculation that
then solidifies at the specific site and releases the drug in response to certain pH conditions. In the
in vitro studies carried out on the human breast cancer cell line MDA-MB-231, it could be observed
that the DOX-loaded hydrogels were more suitable for a long treatment, since even after 10 days they
continued to inhibit cell growth, in contrast with free DOX. In the in vivo studies in breast tumors
bearing BALB/c nude mice, it was observed that after the inoculation of the liquid hydrogel it solidified
around the tumor, finding remains of the hydrogel even 5 weeks after the inoculation. In a similar
way, in the in vivo studies after the inoculation, the decrease in tumor volume was similar with the
treatment of free DOX and DOX transported by the hydrogels in the first weeks. However, at the
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fifth week, significant differences were observed in the volume and weight of the tumor treated with
DOX-loaded hydrogels compared to free DOX, reaching reductions of approximately 1.5 times for
both parameters, see Figure 4.
 
Figure 4. Stimuli-responsive NFs. Once NFs are synthesized by the electrospinning process and loaded
with the antitumor drug, treatment may be applied in an experimental mouse model that carries
a specific type of tumor. Once the treatment has been inoculated, an internal stimulus, such as the low
pH present in the tumor tissues, or an external stimulus such as a temperature rise, stimulate the release
of the drug at the specific site of the tumor, thus applying the treatment on tumor cells. Reprinted with
permission from reference [62]. Copyright American Chemical Society, 2016.
2.3.2. Thermo-Responsive Nanofibers
In general, there are various protocols for synthesizing nanoformulations sensitive to temperature
that are suitable for their possible use in biomedicine, because they can be administered by injection
and may be degraded. These properties are useful in the transport of drugs for cancer targeting
and controlled release such as degradable NFs fabricated by an electrospinning technique [63].
Slemming-Adamsen et al. [64] presented a novel approach to introduce DOX into thermoresponsive
pNIPAM-NHS/gelatin NFs by cross-linking with 1-ethyl-3-(3-dimethyl-aminopropyl)-1-carbodiimide
hydrochloride (EDC) and N-hydroxysuccinimide (NHS). This strategy consisted of a mixture with
a solution of pNIPAM-NHS/gelatin acting as a shell with another mixture of EDC and NHS in the
presence of DOX. By using this approach, EDC initiates the conjugation by bonding with a carboxyl
group of the polymer. Then, the EDC-polymer conjugate is able to react with a primary amine,
or, NHS, replacing EDC with the amine ester linkage. Finally, NHS can be replaced by a primary
amine, linking the carboxyl-polymer with the amine-polymer. This mixture was electrospun to obtain
cross-linked pNIPAM/gelatin NFs containing an anticancer drug that can be released in a controlled
manner. The DOX-IN-pNIPAM NFs showed thermo-responsive swelling/deswelling properties.
Indeed, the fabricated cross-linked NFs were able to release DOX when the temperature was raised
above the LCST and were able to reduce the viability of human cervical cancer cells [64].
Zhang et al. [65] fabricated a core/shell structure formed by polylactic acid PLA as a core using
electrospinning, and then a thermoresponsive pNIPAM shell was incorporated by UV photo-polymerization.
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Initially, biodegradable PLA NFs were fabricated by electrospinning in the presence of Combretastatin
A4 (CA4), a tubulin polymerization inhibitor which was used as the model drug was produced.
These fabricated PLA NFs were introduced into a pNIPAM solution in presence of the crosslinker
(N,N′-methylenbisacrylamide). After exposed to UV radiation, the drug-loaded PLA core was coated
and cross-linked with a pNIPAM shell. The composite NFs exhibited different wettability confirmed
by water contact angle measurements at temperatures below or above the lower critical solution
temperature (LCST) of pNIPAM. Most importantly, in vitro drug release investigations demonstrated
a difference drug release when the temperature was at 25 or 40 ◦C. For example, the pNIPAM shell
could limit the release rate of CA4 below the LCST, however, above the LCST, the rate of drug
release increased significantly. Cicotte et al. [66] used thermos-responsive pNIPAM films fabricated
by electrospinning to exploit a rapid reversible adhesion of mammalian cells, thus performing cell
attachment and detachment using pNIPAM scaffolds. These authors modified various parameters
during the electrospinning process such as the needle gauge, collection time, and molecular weight
of the polymer. Two types of cells were investigated for reversible attachment of pNIPAM mats that
provided potential results by seeding mammalian cells from standard cell lines (MC3T3-E1) as well
as cancerous tumor (EMT6) cells. Once attached, the temperature of the cells and mats was changed
to ~25 ◦C, resulting in the extremely rapid swelling of the pNIPAM NFs. The authors found that
pNIPAM mats fabricated using small and dense fibers fabricated from high molecular weight pNIPAM
polymers are extremely appropriate as a rapid release method for cell sheet harvesting. Recently,
new nanoformulations that allow the release of drugs in a dual way in response to both temperature
and pH stimuli have been designed. This is the case of poly(N-isopropylacrylamide-co-acrylic acid)
NFs in a passive thermoplastic polyurethane (TPU) which are sensitive to pH and temperature.
Consequently, by varying these two parameters, the movement in terms of direction and size can be
modulated, which could be interesting in several biomedical applications, such as drug release [67].
In another study, a thermo-sensitive polymer, PNIPAAm and a pH-sensitive polymer, Eudragit®
L100-55 (EL100-55), were synthetized and made NFs by electrospinning [68]. These NFs showed
sensibility to pH and temperature and a release of ketaprofen that are dependent on these parameters
without toxicity against fibroblast, even at high concentrations. Another example is a fiber mixture of
poly(N-vinylcaprolactam) and ethyl cellulose (EC) in the case of temperature-dependent release and
EL100 fibers for pH-dependent release, synthesized by twin-jet electrospinning [69]. This mixture of
fibers showed a sustained release of the non-steroidal anti-inflammatory drug ketoprofen in response
to pH and changes in temperature, also showing a very good biocompatibility in fibroblasts. The study
of biocompatibility of these NFs is noteworthy because it is an essential property that nanomaterials
which are intended for therapeutic use must comply with. For this purpose, fibroblasts (L929) were
seeded on cover slips that were previously sterilized and where fibers were directly slectrospun. After 1,
3 and 5 days of exposure, cytotoxicity is determined by the MTT assay. NFs are inclined to show good
biocompatibility, but some types may be more appropriate than others, such as thermosensitive fibers
made of poly(di(ethylene glycol) methyl ether methacrylate) (PDEGMA) synthesized and electrospun
into fibers using EC, which showed great biocompatibility even after 5 days of exposure and better
in vitro biocompatibility than other nanoformulations such as EC/NIPAM [70,71]. Another type
of stimuli-responsive NFs that could be used for the transport of antitumor drugs is electrospun
self-immolative polymer (SIP)/polyacrylonitrile (PAN) fibers [72], which depolymerize surprisingly
rapidly in response to an external stimulus, producing an instantaneous release of the transported
molecules at the right time.
2.4. Hybrid Nanofibers
2.4.1. CNTs/Nanofibers
Carbon nanotubes have been used as platforms to improve mechanical, structural and drug delivery
properties in NFs synthesized by electropun. In a recent investigation carried out by Qi et al. [73],
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DOX was chemically incorporated onto the surface of MWCNTs. After being optimized, the drug
encapsulated up to 83.7% and the dispersion of MWCNTS@DOX particles was mixed with a PLGA
polymer solution at 3 different amounts of DOX, relative to PLGA, to fabricate a composite NF by
electrospinning. Importantly, the incorporation of MWCNTs into PLGA NFs did not alter the structure
of the PLGA NFs, instead it improved their mechanical properties. In vitro viability assay demonstrated
that the developed DOX-loaded MWCNTs-IN-PLGA composite NFs were totally cytocompatible with
L929 cells. The drug delivery investigation confirmed that this composite system was able to reduce
burst DOX release, and it also allowed a continued DOX release over 42 days. This composite structure
structured as CNTs-IN-NFs was also used for Yu el al. for the incorporation of DOX HCl thus creating
a hybrid NFs mat by blend electrospinning. In this case CNTs were also used as carriers of DOX and
they were introduced within PLGA NFs by electrospinning, thus creating a composite nanofibrous
mat. In this investigation, authors modified the amount of CNTs in the final mixture polymer-CNTs
during electrospinning. The in vitro antitumor efficacy against HeLa cells was investigated, resulting
in a DOX release by a sustained and prolonged manner, which effectively inhibited growth of HeLa
cells. Figure 5 shows a schematic representation for the fabrication of DOX-loaded CNTs-IN-PLGA
NFs by blend electrospinning.
 
Figure 5. Schematic illustration for the fabrication process of PLGA/DOX-IN-CNTs electrospun
composite NFs. The morphology and diameter distributions of PLGA and PLGA/DOX@CNTs composite
NFs [74].
Zhang et al. [75] fabricated a new class of highly porous NFs by using PLA as the principal
polymer scaffold and PEO as a porogen. Different concentrations of CNTs were incorporated onto the
fibers to allow self-sealing behavior, which was carried out by photothermal conversion after light
irradiation. Basically, they developed a strategy to fabricate porous PLA/CNT fibers with controlled
pore sizes. Indeed, CNTs were used in the current study to perform the pore self-closure through their
photothermal conversion ability. Zhang et al. investigated several ratio polymer/CNTs during the
electrospinning process and they found that the fibers containing 0.4 mg/mL of CNTs showed the
optimum encapsulation efficiency of model biomacromolecules such as dextran, bovine serum albumin,
and nucleic acid. The pores of the surface were reversibly reopened by PLA degradation, reaching
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a stable release of biomacromolecules after encapsulation. They showed morphological changes of
PLA/CNT fibers with 0, 0.2, 0.4, and 0.8 mg/mL CNT concentrations. At a CNT concentration of
0.2 mg/mL, only a small amount of CNTs could be seen on the fibers surface. As the concentration was
increased to 0.4 mg/mL, much more CNTs were observed, which seemed to be dispersed homogeneously
around the nanopores on the fibers. Nevertheless, with further increase of the CNT concentration to
0.8 mg/mL, significant agglomeration was observed. After trapping the drug molecules, a controlled
and sustained release from the fibers over extended periods of time was investigated. An extended
release of the molecules for over the period of 15 days was achieved, with a relatively low initial
burst release within the first 24 h. Indeed, in these structures the amount of CNT introduced into the
nanofiber was relevant to control parameters as morphology, structure, thermal/mechanical capability,
degradation, and cell viability.
It is well-known that CNTs have the capacity to acts as thermal generators by absorbing
near-infrared radiation (NIR). Zhang et al. [76] combined MWCNTs and DOX in a methanol/chloroform
solution with PLLA dispersed in CHCl3 to fabricate NFs by the electrospinning technique. Without
NIR irradiation, DOX release was extremely restricted. However, when NIR irradiation (2 W/cm2) was
applied on DOX-loaded MWCNTs-IN-PLLA NFs burst release of the loaded DOX was observed at
the time of 2 h with an amount of ~20% during the 30 min irradiation period. Indeed, these authors
demonstrated that after NIR radiation, the temperature of the tumor area in contact with the
NFs was significantly increased. Apart from that, these multifunctional NFs showed increased
cytotoxicity both in vitro and in vivo for Hela cancer cells through the combination of photothermal
induced hyperthermia and drug delivery. Barzegar et al. [77] introduced graphene into PVA NFs
by electrospinning, thus creating grapheme/PVA hybrid NFs. Figure 6 shows scanning electron
microscope (SEM) images where uniform hollow PVA NFs containing graphene dispersion within the
NFs can be appreciated. The synthesized polymer reinforced NFs have potential biomedical materials
for drug delivery.
 
Figure 6. SEM micrographs of PVA/(graphene foam and expanded graphite) NFs at 2 kV operating
voltage for (A) solution with 0.02 g GF concentration, (B) solution with 0.08 g GF concentration,
(C) solution with 0.02 g EG concentration and (D) solution with 0.08 g EG. Reprinted with permission
from reference [77]. Copyright Elsevier, 2015.
In recent years, there has been an increase in the number of investigations related to the use
of electrospun NFs combined with conductive nanomaterials, as biosensors, due to their promising
applications [78]. Electrospun NFs in combination with CNTs have also been investigated as biosensors
for the detection of early stages of pancreatic cancer by the use of the biomarker CA19-9. Electrospun
NFs made of poly(allylamine hydrochloride) and polyamide 6 were covered with MWCNTs, and CA19-9
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detection were determined by electrochemical impedance spectroscopy [79]. This biosensor showed
a good sensitivity for the antigen without the rest of the blood components could suppose interference
in the detection. This high sensitivity was achieved through antibody-antigen irreversible adsorption.
In addition, this system was able to distinguish between patients with higher levels of the biomarker
in blood and those who had it in lower concentration.
However, concerning toxicology studies, it has been reported that CNTs produce some adverse
effects, due principally to the incorporation of catalytic metal impurities during their fabrication [80].
For this reason, a general use of CNTs in the biomedical field has generated some doubts about their
security and possible toxicity. For example, long-term accumulations of CNTs were produced in
lungs and liver of mice after exposure during 90 days [81]. Some reported investigations detailed the
negative effects of these CNTs in biological systems. An alternative to reduce toxicity is the use of
surface functionalized CNTs. Specifically, a recent investigation showed that pure CNTs had negative
effect on the systemic immunity, producing more inflammation and immunosuppression as compared
to some surface modified CNTs, such as PEG-modified CNTs [82].
2.4.2. Magnetic Nanoparticles/Nanofibers
Magnetic nanoparticles are another type of colloidal particles widely used in biomedical
applications. The systems, in the range of nanometers, are able to respond to external magnetic
fields. This property has been extensively exploited in the biomedical field for localized drug delivery,
because they can be transported to a specific area by the application of an external magnetic field.
Apart from conventional drug delivery systems used in nanomedicine for the reduction of solid
tumors, magnetic hyperthermia treatments [83–85], in which magnetic or magnetic-derived NPs are
administered to tumors, and then a local heat is supplied under alternating magnetic field (AMF)
application, have attracted an ever increasing interest due to their improved precision for cancer
therapy [86–88]. The basis of using hyperthermia as a treatment modality for cancer is the high
sensitivity of cancer cells to temperatures in the range from 41 to 45 ◦C, in contrast to normal cells.
However, the use of free magnetic nanoparticles has certain limitations such as poor tumor targetability,
high variability in the amount of magnetic nanoparticles administered to the tumor, as well as the
transfer of magnetic nanoparticles into the healthy tissues close to the tumor. To overcome this
disadvantage, magnetic NPs have been also used in electrospinning to fabricate hybrid NFs for drug
delivery and cancer treatment purposes.
It is important to mention that a significant advantage of magnetic nanoparticles is that they
present a reduced toxicity, while also being accepted by the human body. Indeed, once they are placed
into the cells they degraded reasonably quickly [89]. The degradation of magnetic nanoparticles
into iron and oxygen is performed inside the lysosomes of macrophages, and it is influenced by
several parameters as the presence of hydrolytic enzymes, a low pH, as well as proteins related with
the iron metabolism. In particular, iron oxides nanoparticles are able to degrade in vivo by iron
mobilization and some other published routes [90]. Most importantly, magnetite is an iron oxides
derivative approved by FDA for in vivo investigation [91].
Feng et al. [92] prepared a mixture of Fe3O4 NP and graphene oxide sheets containing functional
groups to be introduced into PAN NFs for guiding cellular application. They used blend electrospinning
to fabricate a hybrid GO/Fe3O4-IN-PAN as short-fibers (SFs). These synthesized NFs films were cut into
small pieces, and after being dispersed in tert-butanol solution, they demonstrated a strong magnetic
capability. As guiding cellular behavior, breast cancer cells were cultured on the surface of these
magnetic SFs, and due to the external GO on the surface of SFs they promoted adhesion of cell membrane
proteins and good biocompatibility. Indeed, guided cellular behavior by magnetic actuation with the
help of magnetic SFs was performed. Huang et al. [93] introduced 50 nm iron oxide nanoparticles
into polystyrene (PS) NFs scaffolds. Fe3O4 NPs were initially dispersed and ultrasonicated in THF,
this dispersion was a mixture with a PS solution to proceed with blend electrospinning. Upon applying
an AMF on these hybrid Fe3O4-IN-PS NFs, an important heating process occurred due to the high
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loading capacity of the fibers. Using this hybrid structure, the fabricated magnetic fibers can be
heated several times without loss of heating capacity or releasing magnetic nanoparticles. Indeed,
these authors functionalized the surface of the hybrid NFs structure with collagen in order to increase
cell attachment. In vivo investigations were performed by using Human SKOV-3 ovarian cancer cells,
which were incorporated onto the fibers. After the application of an AMF during 10 min to the mats,
the cancer cells deposited on the Fe3O4-in-fibers were eliminated. This methodology possesses two
important advantages to be implemented for in vivo investigations, as the fibers can be loaded with
magnetic nanoparticles in a controlled manner and the composite scaffolds can be localized in the body
by magnetic resonance imaging (MRI). Sasikala et al. [94] fabricated an implantable hybrid magnetic
NFs device to be applied in both magnetic hyperthermia, upon an AMF, and cancer cell-specific
drug release, to perform a synergistically cancer therapy. A borate-containing anticancer drug was
investigated known as bortezomib (BTZ), a protease inhibitor frequently used in chemotherapeutic
administration. This device was fabricated by blend electrospinning, by a mixture that initially was
a Fe3O4 NPs dispersion and a PLGA solution. Then, a shell of polydopamine was grown through
a simple immersion method to be used as a shell-mimicking mussel adhesive. The mussel-inspired
magnetic NFs with numerous catechol moieties were able to bind and release borate-containing
anti-cancer drugs. Figure 7 includes transmission electron microscopy (TEM) image of free Fe3O4
NPs as well as field emission scanning electron microscopy (FESEM) and TEM images of electrospun
PLGA NFs. The FESEM images confirmed that hybrid NFs shows good fiber morphology and some
aggregation of the Fe3O4 NPs inside of the NFs. They investigated the effect of repeated hyperthermia
application in murine breast cancer (4T1) cell lines by using the BTZ-loaded Fe3O4-IN-PLGA NFs.
After three hyperthermia cycles (15 min/24 h) were applied to the BTZ-loaded Fe3O4-IN-PLGA NFs,
an improved antitumor efficacy was obtained.
 
Figure 7. (A) TEM image of the iron oxide NPs (the inset shows the corresponding selected-area
electron diffraction pattern), (B,C) FESEM images of electrospun PLGA (poly lactic-co-glycolic acid)
NFs and magnetic NF matrix, respectively, (D) TEM image of MNF. Reprinted with permission from
reference [94]. Copyright Elsevier, 2016.
In other reported cases, polyurethane NFs combined with superparamagnetic iron nanoparticles
(γ-Fe2O3) have been synthesized for cancer treatment by hyperthermia, which were able to reach
a temperature increase of up to 43 ◦C in 70s by the application of an AMF. This promising result was
achieved by making the electrospinning process much more precise with the addition of a conical
aluminum auxiliary electrode [95]. Radmansouri et al. [96] designed DOX hydrochloride-loaded
electrospun chitosan/cobalt ferrite/titanium oxide NFs to treat melanoma cells (B16F10) by means of
chemotherapy and hyperthermia at the same time. NFs were made of chitosan by the electrospinning
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process and were combined with cobalt ferrite nanoparticles and titanium oxide nanoparticles
(used to modulate the temperature increase). Higher cell death was observed when hyperthermia and
chemotherapy were combined, achieving a synergistic effect, which enhances the cytotoxic effect and
allows a reduction of side effects.
2.4.3. Gold Nanoparticles/Nanofibers
It is well-known that some non-spherical gold nanoparticles (Au NPs) display large near infrared
(NIR) resonances that can be used to induce both hyperthermia and drug delivery when they are
irradiated with the appropriate wavelength [97]. As non-invasive therapy, NIR radiation is crucial for
biomedical uses because it penetrates tissue more deeply, but it is absorbed less than other types of
radiation. NIR hyperthermia is a minimally-invasive oncological treatment strategy in which photon
energy is selectively administered and converted into sufficient heat to induce cellular injury [98–100].
An important property concerning Au NPs is that by varying their size and shape, the surface plasmon
absorption can be tuned from ultraviolet (UV) to infrared (IR) wavelengths. Recently, the potential
uses of gold nanoparticles in NIR-hyperthermia have been reported using a variety of noble metal
nanostructures, including gold nanoshells [99,101], gold nanorods [102–104], and recently, gold
nanocages [105]. The potential toxic impact of AuNPs has been discussed. The particles size, surface
chemistry and the presence of functional groups may play a relevant role in cell toxic effects [106].
Some studies have reported that cationic Au NPs are toxic while anionic AuNPs are non-toxic for
cells [107]. The toxicity is caused by the electrostatic interaction of Au NPs with the negatively
charged bilayer of the cellular membrane. Several investigations have also confirmed that some
modified Au NPs (as PEG-modified Au NPs) are non-toxic at the dose that is effective for in vivo
drug delivery [108]. Recently, the synthetic toxicity of AuNPs capped with polyethylenimine (PEI)
and PEGylated anisamide has been tested for in vivo investigations, obtaining changes in blood cells
by hemocytometer. These results demonstrated nonsignificant differences between hematological
toxicity of these modified NPs and controls (saline serum) In addition, an extensive analysis of the
tissue injury was carried out using gold nanoparticles prepared with PEG and DOX. In this case, Au3
treatment did not induce histopathologically observable differences in mice (including among others,
heart, lung, stomach, intestine, liver, pancreas, kidney, spleen, skeletal muscle, brain, spinal cord) from
those treated with saline serum, thus indicating no systemic toxicity [109].
In this context, Zhang et al. [97] incorporated gold nanorods (AuNRs) into pNIPAM NFs in order to
create a hybrid composite with fast thermal/optical response and structural integrity by electrospinning.
They prepared a mixture of the pNIPAM polymer at 12 wt% and AuNRs in THF, then electrospinning
was performed to achieve the hybrid AuNRs-IN-pNIPAM NFs. The photothermal property of these
metal nanoparticles and the thermo-responsive property of pNIPAM were demonstrated. They obtained
a NFs heating from room temperature to 34.5 ◦C after 1 s of laser application, and a further increase to
60 ◦C in 5 s of irradiation. Figure 8 shows TEM images of both the AuNRs dispersion and the hybrid
NFs where the metal nanoparticles are incorporated onto the pNIPAM surface, a photograph of the
hybrid composite is also included.
Poly (ε-caprolactone diol) based polyurethane solutions were used to synthesize NFs by
electrospinning and they were combined with gold nanoparticles [110]. This nanoformulation was
loaded with temolozolamide and was designed as a potential implant that allows a continued release
of the antitumor drug for the treatment of glioblastoma multiforme. In fact, in U-87 MG human
glioblastoma cell line this nanoformulation achieves a greater cell death overtime in contrast with free
temozolamide (25% more) that practically does not modify the percentage of cell proliferation. In the
same way as with electrospun NFs made of poly(allylamine hydrochloride) and polyamide 6 covered
with MWCNTs, these NFs were also covered with gold nanoparticles for the detection of the pancreatic
cancer biomarker CA19-9. In this case, lower biomarker detection thresholds were obtained with the
use of gold nanoparticles (1.57 U mL−1) compared with the use of MWCNTs (1.84 U mL−1) [79].
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Figure 8. TEM images of (A) Au nanorods (AuNRs), (B) AuNRs/PNIPAM electrospun fibers and
(C) photograph of AuNRs/PNIPAM composite film immersed in water. Reprinted with permission
from reference [97]. Copyright ACS Publications, 2017.
3. Conclusions
Electrospinning is a technique used worldwide that allows the fabrication of polymeric NFs in the
range of micro- and nanometers. Biocompatible and biodegradable synthetic polymers are essential
structures that have improved chemotherapeutic treatments in the biomedical field. During the last
years they have been extensively and specifically reported as systems with important benefits in
important fields, including drug delivery and cancer treatments. In this review we have summarized
recent advantage for the fabrication of NFs by electrospinning focused on drug delivery applications
and cancer treatments (magnetic and plasmonic hyperthermia). Two methods are principally used
for the fabrication of NFs by electrospinning: blend and coaxial electrospinning. Based on these
methodologies, we reported recent approaches for the fabrication of drugs-IN-NFs with drug delivery
and cancer treatment applications. We not only included a direct introduction of the drug dissolved
within the polymer, nowadays, a very useful strategy is the incorporation of colloidal particles used
as vehicles into the NFs during electrospinning. These particles are able to increase the amount of
drug into the NFs to be released in a constant and controlled manner. In this sense, in this review
we have also included polymers with stimuli-responsive behavior, obtaining NFs with the ability
to increase the drug delivery capability in the function of an external stimulus (temperature or pH).
Indeed, electrospinning also offers the possibility to fabricate hybrid NFs, structured as polymeric NFs
with systems such as CNTs, graphene oxide, or even magnetic or metallic nanoparticles. Consequently,
we also pointed out in the relevance of hybrid NFs in drug delivery improvements as well as in the
reduction of solid tumors through magnetic and plasmonic hyperthermia.
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Abstract: Electrospinning has gained wide attention recently in biomedical applications. Electrospun
biocompatible scaffolds are well-known for biomedical applications such as drug delivery, wound
dressing, and tissue engineering applications. In this review, the synthesis of polymer-based fiber
composites using an electrospinning technique is discussed. Formerly, metal particles were then
deposited on the surface of electrospun fibers using sputtering technology. Key nanometals for
biomedical applications including silver and copper nanoparticles are discussed throughout this
review. The formulated scaffolds were found to be suitable candidates for biomedical uses such as
antibacterial coatings, surface modification for improving biocompatibility, and tissue engineering.
This review briefly mentions the characteristics of the nanostructures while focusing on how
nanostructures hold potential for a wide range of biomedical applications.
Keywords: electrospinning; sputtering; drug delivery; wound dressing; biocompatibility; tissue
engineering
1. Introduction
In the last 20 years, the emergence of nanotechnology has drawn much attention to the
electrospinning process. This process is used for the preparation of polymer Nano-micro fibers, and it
has great importance in the biomedical industry due to its cost-effectiveness, scalability, versatility,
and simplicity. The process was developed in 1901 by JF Cooley and WJ Morton, but had slower
development over the subsequent 100 years. In more recent years, Reneker [1] developed fiber
preparation from an organic polymer, which created a new field of science for the formulation of fiber
diameter ranging between 1 × 10−9 and 1 × 10−6 m.
Electrospinning devices include four main components (Figure 1): high power supply, syringe
pump, syringe needle with solutions, and a collector for fiber deposition. The electric field is applied
between the needle and the collector, where the positive electrode is connected to the needle and the
negative electrode to the collector. Hence, when voltage is applied, the repulsive charge accumulates
at the tip of the needle, which is shaped in the form of a hemisphere [2]. When the repulsive charge
overcomes the surface tension, it leads to the formation of a Taylor cone. This directs the polymer
solution to the negative electrode, as the collector, and produces fibers. The solvent from the polymer
solution is evaporated, and the polymer solution is deposited on the collector as dry fibers ranging in
size from nanometers to micrometers [3].
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Figure 1. Schematic representation of electrospinning apparatus with a rotating collector. Reproduced
with permission from [Coatings]. Copyright MDPI, 2014.
1.1. Electrospinning Parameters
There are many parameters controlling the electrospinning process. These include solution
parameters and processing parameters. The solution parameters include the concentration of the
polymer solution, molecular weight, viscosity, surface tension, solvents, and conductivity/surface
charge density. Additionally, processing parameters such as voltage, collector/needle distance,
flow rate and the diameter of the syringe, along with ambient parameters like humidity and
temperature, also play a major role in the fabrication of nanofibers for electrospinning process [4].
Customized electrospun fibers are produced by changing the parameters above [5]. Understanding
these parameters is necessary in order to optimize the fiber structure.
1.1.1. Solution Parameters
The solution parameters are important criteria for the production of uniform fibers. Of these,
concentration is the most powerful tool for governing the morphology of the electrospun nanofibers.
Electrospraying occurs when the concentration of the solution is too low, resulting in the development
of micro- or nanoparticles [6]. However, smooth fibers are established when the concentration is
increased [7]. However, increase in the concentration beyond a certain point will lead to the formation
of a ribbon-like morphology. Simultaneously, higher molecular weight also leads to the ribbon-like
structure for the nanofibers, even at a lower concentration of fibers [8]. Surface tension is also an
important parameter, and depends on solvent composition. It has been noted that a reduction in the
surface tension of the solution can lead to smooth fibers at a fixed concentration due to a smaller
electric field being required to overcome the surface tension for the formation of uniform Taylor
cones [9,10]. Concurrently, viscosity also performs a critical role in the electrospinning process.
A lower-viscosity polymeric solution cannot be electrospun, but higher-viscosity solutions also cause
problematic ejection jets in the solution. Therefore, viscosity adjustment is also an important factor for
continuous and uniform fiber formation with continuous Taylor cones [11]. Additionally, conductivity
also plays an important role in fiber formation. Conductivity depends on the type of polymers, solvents,
and addition of salts. It has been found in the literature that, the increment in the conductivity leads to
thinner and more uniform fiber formation [12]. All solution parameters are linked with one another [13].
It follows that solution optimization is an important step for the design of uniform and continuous
fiber morphologies in the electrospinning process.
1.1.2. Processing Parameters
Processing parameters are also an important factor in the electrospinning process. These include
voltage, tip–collector distance, flow rate, type of collector, and electric field. Voltage influences
244
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the anatomical morphology of the nanofibers due to the dependency on fluid flow dynamics [14].
Many authors have found a non-linear relationship between fiber diameters and voltage [15].
The level of impact of voltage on the fiber diameter is known; however, polymer concentration
and tip-to-collector distance play a more significant role than voltage [16]. Tip-to-collector distance
has shown direct proportionality with fiber diameter due to solvent evaporation at larger distances
exhibiting thinner fibers, and vice versa [17]. Furthermore, flow rate also plays a key role in fiber
morphology. As the flow rate increases, the fiber diameter increases directly with thicker beads [13].
The type of collector also influences the fiber morphology. There are different types of collectors,
including pins [13], girded bars, and rotating rods/wheels [18]. It has been noted that a smaller
collection area shows a negative effect on fiber morphology with respect to the formation of beads [19].
The electric field plays a very important role in the electrospinning process. The electric field can be
approximated as the voltage divided by the distance between the needle and the collector [20–22].
1.1.3. Ambient Parameters
Environmental conditions also affect the morphology of the electrospun fibers. For instance,
temperature, pressure, and humidity play a unique role. For example, electrospinning under high
vacuum may lead to higher electric fields, and thus the formation of larger fiber diameters [23]. On the
other hand, Supaphol et al. observed thinner fiber of polyamide-6 at 60 ◦C than at 30 ◦C [24], suggesting
that an increase in temperature leads to a reduction in fiber diameter [24]. In addition, surface pores
became apparent when electrospinning in an atmosphere with relative humidity higher than 30% [25].
The purpose of this review is to highlight the benefits of employing electrospun and sputtered
electrospun polymer nanofibers in current biomedical applications connected to electrospinning
and sputtering technologies. Furthermore, a novel approach is discussed for the processing
of fibrous materials for different biomedical applications by combining electrospinning and
sputtering technologies.
2. Biomedical Applications of Polymer-Based Electrospun Nanofibers
It is worth noting that polymer-based composites are widely used in a variety of different
applications [26–37]. The fibers prepared by the electrospinning process have a high surface-to-volume
ratio, adjustable porosity, tailored composition, and other favorable properties. To take advantage
of this, a wide variety of polymers can be electrospun, including natural polymers, synthetic
polymers, and biodegradable polymers. These micro/nanofibrous polymers have several advantages,
including the fact that the fiber scaffold mimics the extracellular matrix, thereby enhancing cell
adhesion, proliferation, migration, and differentiation. On the other hand, the pore size of electrospun
membranes is too small to house cells inside the pores, and the cells spread out on the surface of the
material [38]. This makes possible the release of biofactors such as drugs, proteins, and genes, as well
as promoting nutrient and oxygen diffusion and waste removal. Also, the morphology of electrospun
nanofibers—including core/shell, hollow, nanowire-micro tubers, and three-dimensional fiber scaffold
morphologies—can be modified by changing the parameters of the electrospinning process. Thus,
these beneficial factors make electrospun nanofibers suitable for biomedical applications such as drug
delivery, tissue engineering, and wound healing.
2.1. Drug Delivery
The idea of drug delivery emerged in the 1970s for the controlled release of drug for treatment [39].
The high surface area and porosity of polymer fibers has attracted great attention in recent years for
use as a drug carrier. The use of the electrospinning technique can modify polymer fiber morphology
and bulk properties. In this process, polymer nanofibers loaded with drugs are synthesized for drug
delivery. Drugs ranging from antibiotic and anticancer agents to proteins, aptamer, DNA [40] and
RNA [41] have been incorporated into nanofibers. The release mechanism of drugs in polymer fibers
can be altered by changing the type of drug loadings employed, which include co-axial electrospinning,
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emulsion electrospinning, multiple layers, blended electrospinning, co-electrospinning, etc. However,
co-axial electrospinning and multi-layered electrospun fibers have shown great application in drug
delivery due to a sustained release of the drug, rather than an initial burst release of drug from
the fiber scaffolds. Therefore, recent advancement in the field of electrospinning for drug delivery
will be discussed in the proceeding paragraphs. The discussion of electrospinning in drug delivery
will be broken down into categories of drug loading types, drug loading materials, types of drugs,
and mathematical modeling of drug delivery systems, as explained in detail below.
2.1.1. Drug Loading Types
Electrospinning has different drug loading types, which determine the diverse structure and
drug release kinetics. The drug loading procedure in electrospinning can be executed in different
ways, including co-electrospinning, multi electrospinning, side-by-side electrospinning, co-axial,
surface immobilization and emulsion electrospinning (Figure 2). In co-electrospinning, the drug
molecules are mixed with the polymer solution before electrospinning. These electrospun fibers
provide a uniform distribution of drugs/biomolecules and high drug/biomolecule loading. However,
the biomolecule properties can be negatively affected when they are directly exposed to high voltage.
On the other hand, blend electrospinning and side-by-side electrospinning help to solve the issue of
drug and molecule solubility in common solvents. Moreover, multi-jets with more than two spinnerets
represent a way of protecting the bioactivity of the drug. In addition, surface immobilization is another
method, in which drug molecules are covalently bonded with the scaffolds via chemical or physical
immobilization methods. In these chemical methods, the surfaces of the nanofibers are changed
by introducing amines, carboxyl, hydroxyl or thiol; the physical methods involve the incorporation
of Van der Waals, electrostatic and hydrophobic interactions. These methods of immobilization
retain biomolecular activity, but the drug molecules in all electrospinning processes exhibit burst
release kinetics. To overcome this, co-axial and emulsion electrospinning processes were introduced.
Co-axial and emulsion electrospinning processes have been gaining increasing interest recently due
to their promising ability to shield the biomolecules with the core and to minimize the drawback of
the initial burst. They provide sustained release of the drug by minimizing the initial burst release
by controlling the thickness and composition of the shells. The core/shell structure is generated
utilizing a single-nozzle electrospinning unit employing emulsion input, commonly named emulsion
electrospinning [42]. Another means of drug loading for sustained release of a drug is layer by layer,
via the addition of drug in between the electrospun scaffolds; controlled release is promoted by the
shield provided by the layer of polymer scaffolds. Therefore, co-axial electrospinning and multilayer
electrospinning drug loading types provide a more sustained and controlled release of the drug.
Figure 2. Schematic representation of different types of electrospinning processes. Reproduced with
permission from [42]. Royal Society of Chemistry, 2015.
246
Nanomaterials 2019, 9, 77
2.1.2. Multiple Layered Fiber Mats
Multilayered fiber mats provide controlled release of a drug through the layer-by-layer stacking
of a nanofiber sandwich, with drug loaded in between. This type of design is straightforward,
easily controllable, and with a simple fabrication process as compared to the core/shell design.
The drug release mechanism of multilayer fibrous mats can be controlled by adjusting the thickness
of the outer layer, the amount of drug loaded, the porosity of the scaffolds, etc. The design of a
core/shell structure is a complicated process, in one sense, due to the diverse electrical and rheological
properties, such as conductivity and surface tension, of the core and shell polymer materials [43].
Hence, due to the difficulty of fabricating a core/shell design, electrospun fiber mats are not able to
achieve sustained repeatability; additionally, controlled release of drug from the structure is difficult to
be investigated efficiently. GeunHyung Kim [44] prepared polycaprolactone (PCL)-PEO-PCL layered
fiber mats, and drug delivery was examined with various thicknesses of PCL outer layer. It was
shown that burst release can be avoided by increasing the thickness of the PCL layer, as well as by
incorporating antimicrobial peptide HPA3NT3, which does not lose its biological activities (Figure 3).
On the other hand, sustained release of the drug haloperidol was investigated by changing the
hydrophobicity of the scaffolds. Therein, polyvinyl alcohol (PVA)-methylated b-cyclodextrin was
incorporated with PLA and PLGA. The addition of b-cyclodextrin reduced the fiber degradation rate
of PVA [45]. It was noted that when the hydrophobicity of the scaffold was increased, the release of the
hydrophilic drug was sustained in a controlled manner, while polyester polymers released the drug by
means of hydrolysis. The blending of the hydrophobic and hydrophilic drug will minimize the toxicity
caused by the burst release of the drug. This type of combination can be applied for hydrophobic and
heat-sensitive drugs, due to the simplicity of the process.
Figure 3. Schematic of the new drug release system consisting of two different electrospun mats.
The inner and outer parts of the mat were PEO/rhodamine and PCL fibers, respectively. The red
color shows that the rhodamine was well embedded in the PEO/rhodamine mat. Reproduced with
permission from [44]. Springer Nature, 2010.
The drug delivery of ibuprofen from sandwich-layered fiber mats was studied, and its
mathematical modeling was elaborated by using applying the power law, the Higuchi equation,
and Fick’s second law [46]. The mathematical modeling suggests that the thickness of the fiber
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mats have a greater impact on drug delivery than the concentration of the loaded drug. Here,
PLA was successfully electrospun by incorporating ibuprofen drug in between the two layers of
PLA. Finally, according to the type of treatment, the drug loading can be changed by altering the
thickness of the layers for controlled release of the drug. Dave Wei-Chih Chen et al. [47] studied
drug delivery of vancomycin, gentamicin, and lidocaine for wound-healing applications. In their
research, they successfully mixed PLGA/collagen on the outer layer and PLGA loaded with a drug
in the middle layer. The drugs vancomycin and gentamicin were released in high concentrations
from the biodegradable polymer scaffold. However, lidocaine showed a release time of up to 3 weeks.
The bioactivities of the drug were shown to exhibit 40–100% efficiency, and it was concluded that this
scaffold was suitable for boosting the wound-healing process in the initial stage of the wound.
2.1.3. Drug Loading Materials
Varieties of polymers can be electrospun into diverse designs for drug delivery applications,
taking account of polymer–drug compatibility and their ability to be molded to fit a range of
delivery routes. When designing an optimized drug delivery system, there are many polymer
factors to be considered. For instance, biocompatibility, biodegradability, mechanical properties
and hydrophilicity [48]. There are many polymer varieties, such as natural and synthetic polymers,
that are used for designing drug delivery systems [49,50]. A diverse range of drugs have been loaded
into delivery systems, including growth factors, DNA, proteins, inhibitors, and antibiotics [33–35].
Electrospinning processes can be applied to synthetic polymers easily and with great flexibility.
However, synthetic polymers affect cell affinity due to their hydrophobic nature and the smooth
surfaces of their cell recognition sites. On the other hand, natural polymers show enhanced
biocompatibility, and some exhibit antibacterial properties and better clinical functionality.
The group of natural polymers includes cellulose, chitosan, chitin, dextrose, collagen, silk, gelatin,
etc. [51]. Lee et al. investigated the features of different polysaccharides upon electrospinning, as well as
their biomedical applications, such as drug delivery, wound dressings and enzyme immobilization [52].
The studied polysaccharidses included cellulose, chitosan, alginate, chitin, starch, hyaluronic acid,
dextran, and heparin. Chitosan polymer had anticancer properties due to its polycationic nature.
The quartininized form of chitosan is well known for its improved in vitro anticancer ability
against Hep3B, HeLa and SW480 cells [53]. However, natural polymers lack mechanical strength,
and have a relatively sudden degradation rate due to their hydrophilic nature, inhibiting their use in
long-term drug delivery process. In addition, the disadvantages of immunogenicity, batch-to-batch
differences, limited availability, expensive production and vulnerability to cross-contamination all
limit their clinical application [54].
On the other hand, the limitations of natural polymers could be overcome in application through
the use of synthetic polymers, which mainly include biodegradable polymers such as PCL, PVA,
polylactic acid (PLA) and Polyglycolic acid (PLGA). These synthetic polymers can be degraded via
enzymolysis or hydrolysis. These materials are therefore of great importance in drug delivery, as drug
delivery for the tissue regeneration process can take time; also, tissue regeneration can occur [55].
The rate of degradation depends on the sustained release of the drug, such that the degradation rate
can be controlled by changing parameters such as the ratio of amorphous to crystalline segments of
polymers and polymer blend compositions [41,42]. Synthetic polymers have many advantages in
comparison to natural polymers, as they are inexpensive, have excellent mechanical properties and
tunable degradation, as well as exhibiting great durability. However, they also have disadvantages,
such as lack of cell-specific recognition sites due to their smooth and hydrophobic surfaces.
The production of novel composite fibers through the combination of synthetic and natural
polymers could reduce the disadvantages [56,57]. The combination of natural and synthetic polymers
would help in the formation of a fiber that was the same as the extracellular matrix, with outstanding
mechanical properties and adjustable biodegradability. For example, PLGA-gelatin was fabricated by
blending electrospinning for the drug delivery of fenbufen (FBF) [58]. These blended scaffolds have
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optimized mechanical properties, degradation rates and bioactivites. However, the drug release profile
could be controlled by increasing the volume of PLGA in the blend. This would make the scaffolds
more hydrophobic, resulting in a slower degradation rate. In another paper, composite scaffolds were
prepared through a combination of PCL-gelatin, resulting, because PCL is a hydrophobic polymer,
in tunable hydrophobicity, degradation rate, and mechanical properties.
Simultaneously, gelatin provided cellular attachment and adhesion of bone marrow derived
from human mesenchymal stem cells (hMSCs). Thus, these types of tunable properties could
result in promising scaffolds for drug delivery applications and tissue engineering systems [59].
While designing a system for the sustained release of a drug, many factors contribute to the efficient
release of drug from the polymer scaffolds. These elements include the degradation and wettability of
the polymer scaffolds, the type of drug and the drug loading type.
For the sustained release of the drug, the most important factor is the drug loading type. There are
many types of loading, including co-axial electrospinning and multilayer electrospinning, which shows
a controlled release of the drug over a longer term. The sustained release of the drug depends on
the following factors in coaxial electrospinning: the thickness of the shell layer, porosity, degradation
rate of the shell fiber, the hydrophobicity of the scaffolds, etc. On the other hand, in multilayered
electrospinning, the drug release kinetics depends on the scaffold porosity, the thickness of the outer
layer, the hydrophilicity of the scaffold, etc. The following sections describe co-axial electrospinning
and multilayered electrospun scaffolds prepared by PVA hydrophilic and PCL hydrophobic polymers
incroporating various drugs.
Polycaprolactone (PCL)
Polycaprolactone (PCL) is a hydrophobic polyester polymer widely studied in electrospinning.
PCL has wide biomedical applications due to its biocompatibility, biodegradability, mechanical
properties, non-toxicity, low cost, and low melting point. Commercially available PCL has a molecular
weight ranging between 3000 and 85,000 g/mol. PCL is a hydrophobic molecule. Hence, it dissolves
in solvents like chloroform, acetone, acetic acid, dichloromethane, toluene, methanol, benzene and
tetrachloride [10]. The properties of PCL, including biodegradability, cytotoxicity and degradation rate,
have been studied elaborately with respect to short- and long-duration implants [60,61]. Degradation
of PCL is non-enzymatic, and occurs by means of hydrolysis. PCL fibers have been widely studied as
a drug carrier in drug delivery.
Polyvinyl Alcohol (PVA)
Polyvinyl alcohol (PVA) is a semicrystalline hydrophilic polymer that is easily soluble in water.
The solubility in water gives PVA wide applicability in drug delivery [62,63]. PVA is a biocompatible,
biodegradable and easily electrospinnable polymer. PVA has been used as a sacrificing template for
the preparation of non-electrospinnable polymers. However, PVA alone cannot be used for drug
delivery due to its water solubility. PVA was fused with chitosan to improve its biocompatibility and
cell attachment [47,48]. Gelatin electrospun with PVA was used as a template for improved gelatin
fibers [64]. However, PVA has poor mechanical properties. Therefore, many scientists have tried to
study composite materials that might enhance the mechanical properties of PVA [64]. To avoid the burst
release of drugs, Zupančič et al. synthesized core/shell nanofibers with a poly(methylmethacrylate)
(PMMA) shell and a monolithic PVA core, or novel core/shell nanofibers with a blended PMMA/PVA
core loaded with ciprofloxacin hydrochloride (CIP) [65]. The combination of PVA with PCL polymer
has gained much attention recently, because the addition of PCL might enhance its mechanical
characteristics. Therefore, the study of PCL/PVA as a multilayer scaffolds for the sustained and
controlled release of drug is described below.
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Combined PCL/PVA
Multilayered structures have gained much attention due to their versatility and controlled release
of drugs. The drug was studied as a middle layer, and the outer layer requires the controlled release
of antibiotics. For instance, Liu et al. [66] prepared a novel scaffold by integrating a 3D bioprinting
platform and electrospinning in order to study multiple drug delivery. Here, PVA blended with
gentamicin sulfate and co-axial PVA-DFO/PCL was fused layer by layer to form a 3D scaffold
for osteointegration and sustained drug release. Burst release was noted for gentamicin sulfate,
but the sustained and controlled release of DFO due to the presence of a vertical gradient of sodium
alginate/gelatin in the scaffold give the DFO a gradient mode of release. Therefore, a combination of
3D bioprinting and electrospinning can be used to prepare functional gradient scaffolds. In another
study, the release of the model drugs tetracycline hydrochloride (TC-HCL) and phenytoin sodium from
PVA-PCL-PVA multilayered electrospun nanofibers was reported [67]. Hydrophilic and hydrophobic
polymers were prepared layer by layer by incorporating multiple drugs such as PHT-Na with OVA
and TC-HCL with PCL, respectively. 87% of the TC-HCL was released from a single fiber, and only
47% was released from the multilayer scaffolds. The release kinetics mechanism was Fickian diffusion,
and the release profile corresponded to the Korsmeyer-Peppas equation. These materials had great
application in wound dressing mats. Multilayered electrospun fiber scaffolds have great importance in
drug delivery.
2.1.4. Types of Applied Drugs
Antibiotics and Antibacterial Agents
Antibiotics and antibacterial agents have been incorporated for the enhancement of scaffold
properties. Ignatova et al. studied the use of several antibiotics in electrospun scaffolds and
their application for wound dressings [68]. The antibiotics included tetracycline hydrochloride,
ciprofloxacin, moxifloxacin, levofloxacin and antibacterial agents (for example, 8-hydroquioline
derivatives, benzalkonium chloride, itraconazole, fusidic acid, and silver nanoparticles (Ag NPs)).
Gentamicin sulfate-loaded PLGA and gelatin were also studied for the continuous release of drugs [69].
The results showed that 70/30 PLGA/gelatin nanofiber scaffolds exhibited a gradual release of the
drug over the first 15 h, rather than a burst release effect, indicating that this is a promising scaffold
for wound healing applications. On the other hand, the drug release profile was studied for a
polyethylene covinyl acetate and PLA blend scaffold in which tetracycline hydrochloride was the
model drug [70]. The drug delivery release profile depends on the type of fiber and percentage of drug
content. The 50/50 blend provided about 5% release of tetracycline hydrochloride within 5 h, with a
regulated and smooth release thereafter. Additionally, 25 wt% exhibited a more rapid release than
5 wt% due to the surface segregation of tetracycline, which dissolves quickly.
Zhang et al. [71] electrospun nylon 6 nanofibers and electrosprayed TiO2 NPs onto them to
fabricate highly porous photocatalytic TiO2 NP-decorated nanofibers with excellent antibacterial
behaviors. Moreover, they also prepared solution-blown soy protein nanofibers decorated with Ag
NPs. Another type of antibacterial electrospun nanofiber prepared from sodium alginate (SA)/PVA
was discussed by Shalumon et al. [72]. Incorporating ZnO NPs increased the diameter of the prepared
fibers. Antibacterial examinations confirmed that the processed mats displayed inhibition of both
bacterial strains for all contents of ZnO NPs, and that the inhibition increased with an increase in the
ZnO NP content [72].
Unnithan et al. prepared uniform nanofibers of polyurethane–dextran loaded with ciprofloxacin
drug. The cell attachment and viability were improved after adding dextran to the polyurethane.
The nanofibers displayed a good antibacterial activity for both Gram-positive and Gram-negative
bacteria [73]. In addition, a biocompatible composite based on chitosan/collagen exhibited high liquid
absorption and good antibacterial activity [74].
250
Nanomaterials 2019, 9, 77
Anticancer Agents
Not only antibiotics, but also many other types of drugs, such as anticancer drugs, have been
applied to the scaffolds of electrospun mats for chemotherapy. Diverse anticancer drugs, such as
doxorubicin (Dox), paclitaxel (PTX), dichloroacetate and platinum complexes have been incorporated
into the electrospun fibers for localized postoperative chemotherapy sessions. For instance, Xu et al.
fabricated PEG-PLLA-loaded electrospun fibers via an water-in-oil emulsion method in which
the aqueous phase was the hydrophilic drug, and the oily phase was the chloroform solution of
PEG-PLLA [75]. The drug was well and uniformly dispersed in the PEG-PLLA fibers by using the
electrospinning technique. In the same way, they successfully incorporated hydrophobic Paclitaxel
(PTX) and DOX, which were simultaneously added to the nanofiber scaffolds via the emulsion
electrospinning method; subsequently, multiple drug delivery was studied [76]. In contrast, Xe et al.
prepared an electrospun scaffold of (30/70) PLA/PLGA blended fiber with the addition of cisplatin,
and the results showed a 90% encapsulation efficiency; the sustained release of drug was noted for
75 days in the in vitro treatment of glioma [77].
Protein, DNA, RNA and Other Growth Factors
Over time, electrospinning has improved, thereby propagating many new and innovative
ideas for biomedical applications. Blend electrospinning and co-axial electrospinning have been
developed with the combination of protein, DNA, RNA and growth factors with the electrospun
fiber mats for biomedical applications. The main challenge faced in this type of design is the loss
in the bioactivity of the drug incorporated. Therefore, it is mandatory to optimize the material and
electrospinning parameters for efficient results. Hence, the processes of blend electrospinning and
co-axial electrospinning have drawn more interest towards this specific type of drug addition. Co-axial
electrospinning is more efficient for protecting the bioactivity of the drug than blend electrospinning.
Chew et al. encapsulated the human nerve growth factor, with BSA as a carrier, in polymers such as
PCL and poly(ethyl ethylene phosphate) [78]. The results showed that there was a partial bioactive
retention of the hNGF when the PC12 cell line was introduced to the scaffolds. There was a consistent
release of hNGF for around three months, without burst release. The same group studied the
release of small interfering RNA (snRNA) and transfection reagent (TKO) on electrospun fibers
of copolymer caprolactone and ethyl ethylene phosphate (PCLEEP) [79]. The results showed a
sustained release of siRNA for around 28 days. The copolymerization of ethyl ethylene phosphate
with PCL led to improvements in the delivery rate of siRNA, as well as in gene knockdown efficiency,
when compared to PCL alone. In co-axial electrospinning, the bioactive components are incorporated
inside the core and are protected by the shell polymer. Hence, bioactivity can be protected from
the electrospinning environment and the biological environment. Saraf and co-workers studied the
incorporation of plasmid DNA (pDNA) into the core and shell polymers with non-viral gene carrier
poly(ethleamine)-hyalouric acid (PEI-HA) [80]. The gene release was observed to last around 60 days
by altering parameters such as the concentration of pDNA and the molecular weight of the core in
order to control the transfer efficiency of the pDNA. The bioactivity of the drug could be controlled
by the new design suggested by Mickova et al. [81]. They proposed the addition of liposomes to the
core, which are able to hold the bioactive ingredients and protect their activity for effective action by
shielding the lipid sphere from the electrospinning process.
2.1.5. Mechanisms of Drug Release
The release of drug from the scaffolds takes place via three mechanisms: desorption from the
surface, diffusion through the fibers, and fiber degradation [82]. These three processes can occur
simultaneously, which impacts the release kinetics throughout the entire process. Figure 4 provides a
schematic representation of the drug release behavior of different types of drug loading. When the
fiber is immersed in the aqueous media, the desorption mechanism occurs for drug on the surface of,
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as well as drug present inside of, the nanopores of the nanofibers [83]. Of these three mechanisms,
desorption is undergone by drug on the surface of the polymer; therefore, burst release is observed.
This burst release is due to the direct interaction of the medium with the polymer surface. Because
burst release of a drug is not useful, surface modification is carried out, which is the main physical
modification implemented for the controlled and sustained release of the drug to the environment.
For example, Srikar et al. [84] embedded Rhodamine 610 chloride fluorescent dye in PCL/PMMA
nanofibers to investigate the release of water-soluble compounds from electrospun polymer nanofibers.
Furthermore, Gandhi et al. examined the release of serum albumin (BSA) and an anti-integrin antibody
(Al) from electrospun PCL nanofibers [85]. The mechanism of release was observed to be dominated
by desorption from the PCL surface. The two-stage desorption-controlled release of fluorescent
dye Rhodamine B and vitamin B2 (riboflavin) from solution-blown and electrospun poly(ethylene
terephthalate) (PET) nanofibers containing porogens was reported by Khansari et al. [86].
The second type of kinetics is the diffusion mechanism, whereby the concentration gradient causes
the release of the drug into the medium. Herein, the diffusion process reduces the initial burst release
and promotes a controlled and sustained release of the drug. Co-axial and emulsion electrospinning
methods can exhibit this type of release kinetics. In emulsion electrospinning, drug droplets are
well dispersed in the polymer solution before electrospinning [87]. A core/shell fibrous morphology
comprises a core consisting of macromolecule aggregates in the aqueous phase, and a shell consisting
of the polymers [87].
Finally, the third type of release mechanism is the degradation of the outer surface. For instance,
using a low-degradability polymer as the shell will result in the sustained release of the drug due to the
low degradation rate. In this sense, the mechanism of drug release kinetics can be optimized depending
on the polymer incorporated and the type of electrospinning process. PCL is a low-biodegradability
polymer; however, PVA is a highly biodegradable polymer. Therefore, a combination of these two
polymers could provide a better drug release profile.
Figure 4. Drug loading and release (desorption and diffusion) from polymeric micro/nanofibers
fabricated by (a) surface modification; (b) blending; (c) coaxial; and (d) emulsion electrospinning.
The green color stands for the polymer, blue for drugs, and maroon for the surfactant. The red arrows
represent the direction of the drug release. Reproduced with permission from [87]. Elsevier, 2017.
252
Nanomaterials 2019, 9, 77
2.2. Tissue Engineering
Electrospinning techniques have received much consideration in tissue engineering.
The electrospun fiber structure possesses many characters suitable for tissue engineering, including
favorable mechanical properties, high surface-to-volume ratio, and adjustable porosity. Tissue
engineering is an advanced field of science which merges applied engineering and bioscience in
order to construct biomaterials that recover, sustain or improve the biological activities of injured
tissues [88]. For efficient tissue engineering processes, three parameters need to be considered: seeding
and attachments of cells, biomaterial scaffolds, and the addition of cell signaling factors. Of these,
the biomaterial scaffold is a major parameter, and should mimic natural extracellular matrix with
having sufficient mechanical properties, biocompatibility, biodegradability, high surface area, and high
interpore connectivity. These criteria contribute to cell proliferation, differentiation, and migration.
To this end, electrospun fibers can be prepared efficiently and cost-effectively to produce suitable
candidate scaffolds for tissue engineering. Nowadays, several electrospun fiber mats are being
prepared and studied for tissue engineering—with and without the addition of biological agents or
growth factors—for wound healing, bond construction, and nerve tissue regeneration.
2.2.1. Skin Tissue Engineering/Wound Healing
In recent years, wound healing and skin tissue engineering have frequently been researched.
Acute wounds normally heal in a very orderly and efficient process characterized by four distinct,
but overlapping phases: hemostasis, inflammation, proliferation, and remodeling [89]. In the first
phase, wound healing is stabilized by different cells, growth factors, and cytokines. The host cells and
bacteria are removed by macrophages in the inflammation step. Then, fibroblasts migrate in to begin
the proliferative phase and deposit new extracellular matrix. The new collagen matrix then becomes
cross-linked and organized during the final remodeling phase. Therefore, effective wound dressing
material is mandatory for proper treatment of wounds. Wound healing scaffolds should have good
biocompatibility, mechanical properties and the capacity to prevent fluid evaporation from the injured
site. Furthermore, it should provide a site for cell epithelization and inhibit infection [90].
Hence, the ability of cell attachment to electrospun fiber scaffolds plays an important role in
the efficiency of engineered wound dressing scaffolds. The material and manufacturing process is
important for the preparation of ideal wound dressings mats. Electrospinning is an ideal manufacturing
process for wound dressing mats due to the above-mentioned advantages, such as biocompatibility,
biodegradability, hydrophilic surface, porosity, and so on. Moreover, nanofiber scaffolds offer
better clearing of exudates from the injured site, and manage both the loss of water from and the
diffusion of oxygen in and out of the wound site [91]. There are natural (like collagen, gelatin,
chitosan) and synthetic biodegradable polymers (PCL, PLGA, PGA, PLA, PVA, etc.) that can
be molded together to form scaffolds. An electrospun scaffold is prepared in combinations of
different natural and synthetic biodegradable polymers loaded with antibacterial and wound healing
factors. The polymers can employ co-electrospinning, as well as blended, co-axial and multilayer
electrospinning. Syed Mahdi Saeed [92] prepared a multilayered fiber mat loaded with curcumin as an
active antibacterial component with novel PCL-PVA-PCL multilayered electrospun fibers. The results
showed that multilayered PCL-PVA-curcumin-PCL illustrated better exudate absorbance than a
pristine dressing at the incision. In the same vein, it indicates that 16% loaded curcumin displays
antibacterial activity without killing the cell viability. Antibacterial properties can be built up in the
scaffold with the addition of antibacterial agents or antibiotics. Silver is a well-known antibacterial
agent, because it can mitigate the DNA replication of bacteria [93]. Khodkar and Ebrahimi [94]
successfully prepared PVA/PCL core/shell fibers loaded with Ag NPs in the core for wound dressing
applications. Fibers loaded with silver showed lower porosity, as well as an improved water vapor
transmission rate (WVTR) and greater angle of contact. These scaffolds are suitable for long-term
antibacterial activity (Escherichia coli and Staphylococcus aureus) because of the sustained and controlled
release of the Ag NPs in the core/shell structure. On the other hand, PCL/PVA has been co-electrospun
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by loading silver sulfadiazine (SSD) as a drug for wound dressing mats [93]. PCL and PVA loaded
with SSD were prepared successfully. The effect of different weight % of SSD on cell toxicity and
mechanical and antibacterial properties was studied. Higher SSD concentrations were correlated
with improved antibacterial ability, and cellular attachment, as well as proliferation, were observed.
Fibronectin coatings can improve the biocompatibility of scaffolds loaded with SSD. Therefore, 5 wt%
SSD-loaded co-electrospun PVA/PCL showed better antibacterial and reasonable cell proliferation
and differentiation. Recently, Online et al. fabricated PVA merged with monodispersed Ag NPs
and PCL loaded with Ascorbyl palmitate (AP) by dual-spinneret electrospinning [95]. The NIH-3T3
fibroblast cells were seeded on the scaffold mats, and it was shown that AP inhibits the toxic effects of
Ag NPs on cell proliferation. It should also be noted that antibacterial tests confirmed the inhibition
of gram-negative and gram-positive Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus),
respectively. Wound healing tests and histological observation concluded that this material provided
a promising candidate for future biomedical applications [96]. Porosity and surface wettability are
important parameters which determine the healing process. Xin Liu has electrospun PVA, PCL, PAN,
and PVDF-HFP incorporating wool protein and Ag for wound dressing mats. Hydrophilic membranes
have been shown to be an efficient remedy for wounds in comparison to hydrophobic membranes.
Porosity, for the purpose of oxygen diffusion, also leads to an improved wound healing process.
However, the wound healing process for diabetic ulcers is time-consuming due to the lack of efficient
blood supply resulting from the higher amount of sugar in the blood. These processes lead to a long
inflammatory stage, defective angiogenesis and blocked fibroblast proliferation.
Recently, Wang et al. [97] fabricated silk fibroin (SF)/GO nanofibers for wound healing
applications. It was emphasized that graphene oxide enhanced the biocompatibility and antibacterial
properties of SF composite nanofibers [97].
2.2.2. Bone Tissue Engineering Applications
Bone is a strong rigid organ that plays an essential role in our body. It protects our vital interior
organs, movements, manufactures white blood cells and red blood cells, and also stores minerals [98].
Bone extracellular matrix mainly consists of organic and inorganic components, such as collagen
and hydroxyapatite (HAp). Incorporation of these components results in suitable scaffolds for bone
tissue engineering applications. The architecture of the electrospun scaffolds, including microstructure,
porosity and surface properties, plays an essential role in successful bone regeneration [99]. Electrospun
fibers should offer better mechanical properties to support the structure, and provide space for
osteochondral adhesion, proliferation, and differentiation. Hence, the development of an ideal scaffold
for tissue regeneration could be achieved by using a porous ceramic material, lamellar material and a
fiber matrix material for imrpoved biological and physical properties. Subramanian Uma Maheshwari
developed a scaffold comprised of a polymer–ceramic combination in a PCL/PVA bilayer scaffold
blended with HAp NPs [100]. (PVA-PCL)-HAp has an improved porosity of around 64%, as well as
hydrophilicity of around 141%. Also, MTT assay studies with MG-63 osteoblast cells had better cell
adhesion and proliferation, which indicates promise for application in tissue regeneration. However,
the incorporation of growth factors (GFs) or drug to the scaffold is also crucial for enhancing the
regrowth of broken bones. Many GFs, including bone morphogenetic protein-2 (BMP-2) and VEGF,
have been added to electrospun scaffolds in order to achieve long-lasting sustained release of GFs to
mimic the natural healing process. For instance, co-axial electrospun of collagen-PCL incorporating
BMP-2 and dexamethasone (DEX) have shown a more controlled release of GFs, thereby encouraging
the osteogenic expression of human mesenchymal stromal cells (hMSCs) [101]. In this design, the shell
layer was loaded with DEX, and the core incorporated BMP-2. Dual drug release was exhibited,
in which DEX showed a fast release. However, BMP-2 demonstrated a sustained release over 22 days.
This scaffold provides an efficient healing process, as well as osteogeneration.
On the other hand, incorporation of stem cells into the biomaterials is also a novel approach
for tissue regeneration of the cells. For instance, Abbas Shafie has studied, in vitro and in vivo,
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cartilage tissue regeneration from rabbit bone marrow mesenchymal stem cells (BM-MSC) seeded
on the electrospun scaffold of PVA/PCL nanofibers [102]. In vitro, the MTT assay showed that the
scaffolds supported the chondrogenic differentiation of MSC. In vivo, the scaffold with and without
MSC loading was implanted in rabbit full-thickness cartilage defects. To study cartilage regeneration,
histological and semi-quantitative grading was executed. The results showed that scaffold seeded
with MSC enhanced the healing process in comparison to non-seeded scaffolds. These results indicate
that PVA/PCL scaffold seeded with MSC is suitable for grafts for articular cartilage repair.
Recently, the effect of polyacrylonitrile/MoS2 nanofibers on the growth behavior of bone marrow
mesenchymal stem cells (BMSCs) was discussed by Wu et al. [103]. The nanofibers were realized
to enhance the contact of BMSCs with each other, to enhance cellular behavior, and also to provide
positive promotion of regulation of cellular proliferation [103]. In addition, for guided spinal fusion,
an injectable and thermosensitive hydrogel made of collagen/n-HA/BMP-2@PCEC/PECE enclosed in
poly(D,L-lactide) (PDLLA) nanofibrous membranes was made by Qu et al. [104]. This system restricted
the escape factor in order to maintain osteogenesis in the desired position [104].
2.2.3. Skeletal Muscle Regeneration
Skeletal muscle makes up around 40% of the human body. Skeletal muscle is made of various
fibers, with diameters ranging from 10 to 80 μm [105]. These fibers are unidirectional and produce
an enormous amount of force during contraction [106]. If a muscle cell gets injured or wounded,
it will not be possible to contract, and satellite cells are switched on in order to perform their muscle
cell regeneration activities. However, this healing process can create scar tissue and block muscle
function [106]. Many efforts have been made to study the initial steps of muscle regeneration, such as
autologous muscle transplant, satellite cells, exogenousmyogenic cells, and myoblasts, but these
methods have met with limited success [107]. Therefore, long-term denervation and severe injuries
can lead to the loss of skeletal muscle function.
Muscle tissue engineering materials require better contraction ability and mechanical
properties [108]. Muscle cell adhesion and proliferation have been studied using both mechanical
properties and electric stimulus in cell culture. Mckeon-Fischer K D prepared co-axial electrospun
fibers with a PCL core and a modified outser shell layer comprising multiwalled carbon nanotubes
(MWCNT) and a blend of (83/17, 60/40, 50/50, and 40/60) poly(acrylic acid/poly(vinyl alcohol)
(PAA/PVA) [109]. All four components were electrically conductive, although the scaffold was not
actuated when an electric field was applied. The best results occurred at 20 V. MTA assay in soleus
and vastus lateralis (VL) muscles extracted from rats showed that 0%, 0.14% and 0.7% concentrations
of MWCNT in the scaffold were non-toxic for cells over a four-week period. Based on the different
percentages of blend solutions, 40/60 PAA/PVA in the outer layer illustrated a higher number cells
than other scaffolds. The scaffold has tensile properties that are higher than those of skeletal muscle.
Further modification of these scaffolds for contraction, rather than bending, could lead to promising
scaffolds for artificial muscle applications.
2.2.4. Nerve Tissue Engineering
Electro-conducting polymers such as polypyrrole (PPy), polyaniline (PANI), polythiophene (PT),
poly(3,4-ethylene dioxythiophene) (PEDOT)) show attractive electrical and optical phenomena. Thus,
they have been researched in the past few decades for various applications such as microelectronics,
actuators and polymer batteries [110]. Electro-conducting polymers that possess the advantages
of biocompatibility and good conductivity can be applied as biosensors and tissue engineering
scaffolds [111]. Electrospun electro-conductive polymers are an excellent tool for electrically
stimulating neurons and for nerve tissue engineering, as well as for application in neural prostheses for
therapeutical function [88,89,112]. Schmidt et al. first studied PC12 cells using the polypyrrole (PPy)
electroconductive polymer, recognizing the growth of PC12 cells on the PPy thin film, they enhanced
the neurite outgrowth from the cells; these results suggest significant application of these type of
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scaffolds for nerve tissue regeneration [113]. Many studies have proposed the improvement of the
electro-conducting polymer for nerve tissue regeneration applications by adding cell adhesive [114],
neurotrophins [115], and topographical features [116]. Jae Y Lee prepared electrospun nanofibers
coated with the conductive polymer PPy for nerve tissue engineering applications [117]. PPy-PLGA
showed improved growth of rat pheochromocytoma 12 PC12 cells and hippocampal neurons compared
to non-coated PLGA as a control. This suggests that PPy-PLGA could be used for nerve tissue
engineering applications. Simultaneously, electrical stimulus studies on the scaffold indicated that
a stimulus of 10 mV/cm improved the neurites such that they were 40–50% longer, as well as
exhibiting 40–90% greater neuron formation, compared to the same scaffolds with no stimulus.
Moreover, aligned scaffolds show greater neurite elongation and formation than randomly oriented
PPy-PLGA fiber scaffolds. The good results for electric stimulus suggest that biocompatible polymers
prepared by electrospinning have significant advantages in biomedical applications such as nerve
tissue engineering.
3. Combination of Electrospinning and Sputtering Technologies for Biomedical Applications
3.1. Setup—Operating Principles of Sputtering Technology
Sputtering is the ejection of atoms by the bombardment of a liquid or solid target by energetic
particles, typically ions [118]. These ejected atoms are then deposited on the substrate [118]. Figure 5
presents a schematic representation of sputtering technology. Argon gas is commonly used as a
sputtering gas. The ejected fragments are accumulated on the substrate by adjusting the distance
between the target and substrate. The number of atoms excited from the surface per incident ion is
known as sputtering yield, ‘S’. The value of S depends on many parameters, including target material
composition, experimental geometry, binding energy, and the properties of incident ions. In addition,
there are also experimental parameters, such as voltage and current. In a conventional sputtering
machine, the cathode is connected to the target and the anode is connected to the substrate, with the
plasma in between them.
Figure 5. Schematic representation of sputtering technology [119].
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The direct current (DC) and radio frequency (RF) sputtering processes differ mainly with respect
to the power supply installed. In the DC sputtering process, metals are only used as a target for
coating. However, in the case of RF, insulators are used as a target for coating purposes. This is mainly
achieved by providing the RF potential to the target. In practice, when insulators are used as the target,
their charges are accumulated on the surface of the target after striking positive ions. This would
make the target surface inaccessible for the further bombardment of ions. Therefore, to inhibit this
process, both positive ions and electrons are bombarded directly onto the insulator target [120]. This is
achieved by applying a RF power supply, which gives enough energy for the oscillating electron
in the presence of an alternating field to originate ionizing collision, and a self-preserved discharge
is maintained. However, the incorporation of magnetron sputtering into DC/RF sputtering could
increase the sputtering yield by applying a strong magnetic field along the sputtering target to confine
the plasma to the nearby target surface, on which the electric field
→
E and the magnetic field
→
B are used
for electronic motion. Electrons experience the well-known Lorentz force in the magnetic field, and the
electric field force in the electric field, leading to the circular motion of electrons close to the target
material, enhancing the collision with the target, and improving the sputtering yield. The sputtering
process is accomplished under vacuum to avoid oxygen or other gas contamination that might cause
impurities to form on the substrate surface. The Factors affecting the plasma sputtering process are
depicted in Figure 6.
Figure 6. Factors affecting the plasma sputtering technique.
3.2. Biomedical Applications of Sputtered Electrospun Polymer-Based Nanofibers
Plasma technology can be used to improve the surface properties of polymers without changing
their bulk characters. Plasma-treated polymers have found wide application in diverse fields, such as
the automobile, microelectronics, chemical and biomedical industries [121]. Polymer surface properties
such as hydrophobicity, roughness, chemical structure, conductivity, etc. can be modified for various
applications. Plasma treatment can affect the polymer surfaces through micro-etching, organic
contamination, cross-linking, surface chemistry modification, and surface coating with a specific target
material [122]. The biomaterials should possess good mechanical and surface characteristics that are
appropriate for the biological environment. For instance, for cell adhesion, the polymer surface should
have low surface free energy, surface roughness, and hydrophilicity. Plasma treatment via magnetron
sputtering technology has been implemented to coat the surfaces of polymers to form biomaterials
suitable for biomedical applications such as antibacterial, biocompatibility, and tissue engineering.
257
Nanomaterials 2019, 9, 77
Plasma sputtering technology includes both thermal and non-thermal deposition processes.
However, non-thermal deposition processes are highly recommended for polymers, because they do
not damage the bulk properties of the polymer. Magnetron sputtering is the technique used for coating
the polymer surface. Magnetron sputtering is a technology that was developed during the 1970s, and it
is a high-speed and low-temperature technique for preparing a strong and uniform adhesion film on the
surface of polymers, ceramics and composite materials [123]. However, argon gas is commonly used,
because it does not damage the target due to its nobility. The full process is quick and requires only a
low temperature, while offering a high film forming rate and strong film adhesion [124]. For instance,
composite microfibers of Poly(methyl methacrylate)/organically modified montmorillonite (O-MMT)
were manufactured by electrospinning with the incorporation of emulsion polymerization [125]. Here,
the prepared composite microfibers of PMMA-O-MMT were magnetron sputter-coated with Titanium
dioxide (TiO2). The results showed that the deposited anatase-TiO2 and rutile-TiO2 exhibited better
surface wettability without damaging the PMMA-O-MMT compound. These composite fibers have a
UV absorption of 254 nm. Therefore, it induces the photocatalytic degradation of the model compound
methylene blue. Thus, these materials provide a promising application in dye wastewater treatment.
Polymer microspheres [126], thin films [127], and fibers [128] have been coated with
Ag [107,108,129], Cu [130], Ti [131], TiO2 [132], gold (Au) [133], hydroxyapatite (HAP), tricalcium
phosphate (TCP) [134], amorphous calcium pyrophosphate (CPP) [134], and dicalcium phosphate
dihydrate (DCPD) [134] for different biomedical applications.
3.2.1. Antibacterial Coatings
The attachment of bacteria to the surface of a polymer can lead to the formation of biofilm.
Therefore, biofilm-resistant polymers are an essential factor for the medical field. Biofilm resistance
could be imbued in the polymer through the addition of antibacterial agents on the surface of the
polymer to prevent bacterial adhesion. Materials such as medical textiles, wound dressings, prostheses
and implant materials should display antibacterial activity for efficient biological activity. Antibacterial
properties are an essential parameter to take into account for wound dressing. Antibacterial activities
are promoted through the addition of some antibacterial components to the fabrics. There are many
components, including both inorganic and organic (drugs), as well as metals. Inorganic agents include
TiO2, carbon nanotubes, and Ag, Zn, ZnO2, Cu, Ga, and Au NPs [135]. Organic agents such as
Triclosan inhibit the development of micro-organisms using electrochemical activity to disrupt their
cell walls [136].
Among the inorganic antibacterial components, Ag NPs have been well studied [137].
Ag NPs were added to electrospun fibers via Ag ions through the wetting process [138,139],
silver sulfaazide [93], etc. The wetting process for the addition of Ag to the matrix has many
disadvantages, such as uneven distribution of NPs, use of reducing agents that are toxic, and the
difficulty of controlling the size of NPs—depending on the strong and weak reducing agents used [140].
However, the most efficient way of introducing NPs to the surface of polymers or fabrics is by using
plasma technology. Plasma technology provides more uniform deposition, less use of resources, and a
simpler process for the coating of antibacterial material such as Ag, Si, Cu, etc., onto the surface of
the polymer than the wetting process. Sputtering, known as physical vapor deposition, has been
used effectively in the coating of a number of thin films for electronics applications. Therefore,
sputter-coating of metals to enhance antibacterial properties can be performed with the addition
of many target materials, including Ag, Ag/Si, Cu, Ti, etc. Therefore, more studies are required to
compare the antibacterial properties of various materials incorporated in bioresorbable polymers.
Silver (Ag)
Silver is a transition metal in the periodic table. Silver-related compounds or NPs have a biocidal
effect on around 16 species of bacteria, because of its toxic effect on microorganisms [119,120,141,142].
Thus, silver is coated on medical devices for antibacterial applications [143]. At low concentrations,
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Ag NPs show good antibacterial efficiency [144]. Moreover, the lack of toxic effect of Ag NPs on human
monocytes cell lines indicates the possible application of Ag in the fabrication of medical devices.
The mechanism of antibacterial activity of Ag on microorganisms has not yet been well studied.
It has been shown that, in E. coli, AgNP-treated bacteria exhibit some pits on the cell wall and
an accumulation of Ag in the cellular membrane. This type of membrane exhibits an increase in
permeability. Bacterial DNA loses its replication ability and cellular proteins and becomes denatured
by binding Ag ions or NPs to the functional group of the protein [145]. On the other hand, some authors
have reported that Ag NPs would denature the cellular proteins required for cellular nutrient transport
and damage the cell membrane or cell wall, enhancing cell permeability and ultimately leading to cell
death [142]. It has also been noted that the antibacterial efficiency of Ag depends on its shape. Ag NPs
with a {111} lattice basal plane (representing the cubic structure lattice pattern) display more robust
antibacterial action than spherical and rod-shaped NPs and silver ions [146].
Silver has excellent antibacterial properties. Silver treatment is well known for its application
in wound dressing materials. The silver is incorporated as Ag NPs by introduction through AgNO3
using a reducing agent. However, this type of silver incorporation leads to burst release of silver from
the material, resulting in a very high concentration of Ag in the wound. This is followed by the sudden
reduction in silver because of both bacterial consumption and reaction with other compounds present
in the wound beds, such as phosphates, chlorine, and proteins. Therefore, silver release in the wound
should take place in a controlled manner. Also, the silver nitrate present is a hypotonic; hence, it can
cause a strong electrolyte imbalance, which could damage the wound site and produce gross systemic
inequality, which could kill patients with extensive burns who require large doses of silver. However,
silver sulfaazide was developed in order to minimize the side effects of using silver nitrate. However,
the removal of silver sulfaazide cream from the wound surface is performed by scraping, and this
could result in a highly painful dressing procedure for the patients. Moreover, sulfaazide does not
show any hypotonic effect. Therefore, it is necessary to develop a better process for delivering silver
that is efficient, involves introduction over a prolonged period, acts against many ranges of bacteria,
requires only a few changes of the wound dressing, and never interferes with the wound healing
process. With this in mind, sputtering is a new field of surface coating of wound dressing materials
for extended release of silver with potent antibacterial properties. The optimization of the sputtering
process is an essential criterion for better antibacterial properties.
It is also noted that silver is the best candidate for wound curing applications, because it reduces
inflammation [147], impedes contraction, and improves cell epithelialization [148]. Ag NPs exhibit cellular
toxicity, and this leads to a decrease the biocompatibility of the scaffolds [149]. However, the amount of
Ag in the scaffolds can be used to optimize the antibacterial effect and cellular toxicity of the Ag.
Antibacterial coatings on medical textiles are an important tool for avoiding infections during
the surgical process [150]. Silver is coated onto textiles via different techniques. Silver-coated textiles
are limited in application because of their reduced durability. Therefore, strong adhesion of silver on
fabrics can be obtained by using the sputter-coating technique [150]. Cotton fabric with antibacterial
properties could have a variety of applications. Silver is the most commonly used material for
enhancing the antibacterial properties of cellulosic fibers [150]. Wet and dry methods can be used to
incorporate silver particles. The wet method changes the bulk properties of textiles and also has a
negative impact on the environment. However, dry processes such as sputter-coating are eco-friendly
processes than only change the surface of the matrix. Therefore, Ag was incorporated into cotton
matrixes of various thicknesses in order to study the antibacterial properties, the release of the Ag in
water, etc. The results suggested that Ag shows antibacterial activity against Staphylococcus aureus,
Escherichia coli and Candida albicans [150]. In addition, sputter-coating also improved the water contact
angle of the cotton fabrics. Thus, antibacterial properties could be added to the nanofibers using the
sputtering technique. Simultaneously, Chen et al. sputtered PET fabrics using high-power impulse
magnetron sputtering, which provides a highly concentrated plasma, so that these fabrics will support
adhered films [151]. Examination of antimicrobial activity revealed that a silver film that is deposited
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for more than 1 min displays excellent bactericidal (>0) and bacteriostatic (>2.0) effects, based on JIS
standards. Furthermore, the coated fabrics showed the capacity to retain antibacterial properties over
20 cycles of washing, indicating the long-term durability for the materials.
The wound dressing mats of polymer sheet and electrospun fiber scaffolds were sputter-coated
with Ag and their antibacterial properties studied. Liu et al. examined the influence of magnetron
sputter-coating of nanosilver on polyetheretherketone (PEEK) and investigated the resulting
cytotoxicity and antibacterial properties [152]. PEEKs were sputter-coated with Ag 3 nm, 6 nm,
9 nm and 12 nm NPs (Figure 7). The antibacterial properties and bacterial adhesion to the surface were
studied. Homogeneous nanosilver was coated on the surface; an increase in the water contact angle
was observed, and there was no cytotoxicity for the CCK-8. In addition, the coating also provided
excellent adhesion of bacteria to the PEEK and improved antibacterial activity towards Streptococcus
mutans and Staphylococcus aureus.
Figure 7. (a) Schematic representation of PEEK film coated with nanosilver via sputter-coating; (b) SEM
images of PEEK at different thicknesses of Ag (3, 6, 9, 12 nm); (c) Water contact angle of the coated
thin film; (d) Antibacterial activity of the PEEK/Ag composite material. Reproduced with permission
from [152]. Elsevier, 2017.
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The combination of electrospinning and sputtering technology can result in many novel composite
fibers with diverse applications in the biomedical field, such as for wound dressing mats with excellent
biocompatibility and antibacterial properties. The electrospun microfibers were coated with Ag by DC
magnetron sputtering [129]. The electrospun scaffolds of poly(glycerol sebacate)/poly(3-caprolactone)
(PGS/PCL) were coated with Ag, and their antibacterial properties and silver release behavior were
studied. PGS/PCL showed good mechanical and thermal behavior due to the increase in fiber
diameter and the decrease in fiber pore size when sputter-coated with Ag. The fiber scaffolds
demonstrated a gradual release of Ag, contributing to antibacterial activity. Therefore, this material
could find appropriate application in wound dressing and bandages. Moreover, prosthetic implants
also require antibacterial properties in order to avoid infection after surgery. With the objective of
avoiding abdominal infections after implanting prostheses for hernia repair, Muzio et al. [153] prepared
polypropylene prostheses coated with a silver-silica composite (Ag/SiO2) layer. The prepared mesh
hernia prostheses (CMC) consisted of two layers of microporous light mesh and a thin transparent
film of polypropylene. The Ag/SiO2 composite was sputter-coated onto the CMC meshes and the
microporous mesh layer alone. The sputtering process was optimized via addition in order to test
biocompatibility and antibacterial properties. In addition, it is noted that sputter-coating with CMC
improved the antibacterial properties, but reduced biocompatibility. However, the sputter-coated
meshes alone showed good antibacterial properties and biocompatibility. In addition, fiber meshes
coated with Ag/SiO2 enhanced the growth of seeded fibroblast without causing apoptosis or necrosis
of the fibroblast; in addition, the meshes also exhibited good antibacterial properties.
Copper (Cu)
In addition to Ag, electrospun scaffolds have been sputter-coated with Cu to improve their
antibacterial properties [132,133]. Cu is cheaper than Ag; therefore, Cu coating can provide economical
wound dressing mats [154,155]. A PLA scaffold was DC magnetron sputter-coated with copper
(Cu) [130]. The PLLA scaffold had increased hydrophobicity, proportional to plasma treatment time.
Antibacterial testing concluded that the modified composite scaffold had a bacteriostatic effect in
which bacteria were reduced by 30% and 50% [130]. In addition, it was also found that copper has a
stronger antibacterial impact than copper oxide. Therefore, this type of composite material could be
used for economical wound dressing mats with antibacterial effect.
Eichornia crassipes, commonly known as water hyacinth, is a natural fiber that has found significant
applications in recent years [156]. It was sputter-coated with copper (Cu) to study the antibacterial
properties. The results revealed that the Cu-coated fibers showed better bacterial inhibition towards
Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) compared to pure water hyacinth fibers.
In addition, the incorporation of the Cu coating improved the hydrophobicity of the fiber, thereby
enhancing the antibacterial activity.
Titanium Dioxide (TiO2)
Electrospun chitosan (Cs) nanofibers were sputtered with TiO2 particles by plasma-enhanced
chemical vapor deposition using a planar magnetron device [132]. The physiochemical interaction
of the Cs and Cs-TiO2 was studied computationally using the Gaussian software package, followed
by experimentally examining the antibacterial properties of the materials. The results revealed that
Cs-TiO2 behaves as a single composite unit by forming a C-O-C glycosidic bond in the glucose
ring. The Cs-TiO2 composite had an improved structure and reactivity because of the reduced
HUMO-LUMO energy gap, larger dipole moment, and lower ionization potential when compared
to pure Cs. Finally, the Cs-TiO2 composites exhibited antibacterial activity, with inhibition zones
approximately 11.5 mm in diameter.
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3.2.2. Surface Modification for Enhancing Biocompatibility
Surface modification via coating can improve the cell adhesion, proliferation, and differentiation;
this reduces the risk of thrombosis and imparts bactericidal properties to the stent. In the literature,
it has been shown that plasma surface treatment of L-PLA and PCL polymers improves the surface
roughness, as well as reducing the surface free energy for better cell attachment of diverse cells to the
surface of the polymer mesh [157]. Magnetron-sputtered polymer sheets offer reduced cytotoxicity
and better cell viability for biomedical applications. The surface characteristics have been studied
for polymer thin films, as well as for electrospun fiber scaffolds. For example, Staszek et al. [158]
reported the cytotoxicity of glycerin sputtered with different noble metals such as Au, Ag, palladium
(Pd) and platinum (Pt). The results suggested that they had prepared Au, Ag, Pd, and Pt NPs with
sizes of 6.1 ± 1.0 nm, 4.2 ± 0.9 nm, 2.5 ± 0.6 nm and 1.9 ± 0.4 nm, respectively. In addition, Pt and Pd
demonstrated great cytotoxicity for the 6 cells lines tested (human cells from hepatocarcinoma (HepG2),
human keratinocytes (HaCaT), mouse macrophages (RAW264.7), mouse embryonic fibroblasts (L929
and NIH3T3), and cells from Chinese hamster ovary (CHO-K1)), and lower cytotoxicity was noted for
Ag and Au after 24, 48 and 72 h.
Consequently, surface modification of hydrophobic polymers via plasma treatment can enhance
wettability. E.N. Bolbasov studied the surface modification of PLA and PCL bioresorbable polymers
via radio frequency thermal glow discharge plasma using hydroxyapatite as a target in the presence
of Ar+ as plasma [127]. The results indicated that the PLA and PCL surfaces showed enhanced
biocompatibility for cell line EA-hy926 attachment to the surface. Surface free energy and surface
roughness were improved by long exposure to plasma treatment. In addition, plasma sputtering
technology can enhance surface roughness, improving cell attachment onto the thin polymers
fibers [159]. The PLLA polymer thin film was RF magnetron-sputtered with hydroxyapatite target.
This coating led to an increase in biocompatibility with the cells of bone marrow multipotent
mesenchymal stromal cells. This was mainly due to the increase in the surface roughness of the PLLA
film resulting from the plasma coating, in addition to the enhancement of calcium and phosphorous
caused by the hydroxyapatite target. Surface modification of polymer films enhances biocompatibility
and reduces cell toxicity.
Furthermore, biodegradable PLA polymer was prepared via electrospinning, and surface
modification was implemented by RF magnetron sputtering. The electrospun PLA scaffold
was sputter-coated with hydroxyapatite (HAP), tricalcium phosphate (TCP), amorphous calcium
pyrophosphate (CPP) and dicalcium phosphate dihydrate (DCPD) [134]. It was found that all prepared
fibers showed cytotoxicity because of the production of a toxic compound on the fiber surface, as well
as the fact that the fiber surface had been devastated due to the extended plasma treatment.
On the other hand, the same team of scientists worked on PCL scaffold fibers that were magnetron
sputter-coated with titanium targets (Figure 8) [131]. They found that hydrophilicity improved with an
increase in plasma treatment time. In addition, increasing the number of pores on the fiber structure
did not affect the mean fiber diameter. As plasma treatment time was increased, the adhesion of cells
improved. Consequently, cell viability decreased when plasma treatment time reached 9 min.
In another study, poly (L-lactic) acid (PLLA) scaffold was sputter-coated with titanium target
under a nitrogen atmosphere [160]. The pure PLLA did not show any changes in its physiomechanical
properties. Biocompatibility testing in in vivo rat models indicated that there was no severe tissue
reaction after around three months for the implemented subcutaneous tissue. Finally, the replacement
of scaffolds from the recipient tissue depends on plasma treatment time.
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Figure 8. SEM images, fluorescent map of labeled cells (live green cells (acridine orange), orange
nucleus of dead cells (ethidium bromide) and wettability for PCL samples that were (a) untreated;
and treated in plasma for (b) 1 min; (c) 3 min; (d) 6 min; and (e) 9 min. Reproduced with permission
from [131]. Elsevier, 2016.
3.2.3. Tissue Engineering
Plasma technology has also emerged recently for use in tissue engineering applications such as
vascular grafting, stem cell therapy, and artificial muscle sputter-coated with conductive Au. For this
purpose, highly biocompatible polymers have provided a platform for cell adhesion, proliferation,
and differentiation. To this end, stem cells are added to the polymer scaffold to provide a better
tissue regeneration environment. Stem cell therapy is a new platform that may act as an alternative
to many complicated surgical procedures. Stems cell-loaded materials have gained much attention
recently [126]. Lee et al. [126] reported the use of PCL microspheres sputter-coated with Au as a
platform for differentiating cardiomyogenic cells from human embryonic stem cells. They sputtered
the PCL microspheres for 5 min, and then incorporated the human embryonic stem cells (hESCs).
It was noted that these composites showed a higher cardiac differentiation, because Au acted as the
mediator for gene expression on day 4 and day 14 [126].
Moreover, PLLA and PEG fibers were electrospun and sputter-coated with calcium phosphate for
bone tissue engineering applications. Here, simple combination of the electrospinning and sputtering
techniques is feasible for the fabrication of biopolymer scaffolds for biomedical applications [161].
Many novel composite materials have emerged due to the fusion of two valuable techniques,
such as the electrospinning and sputtering techniques [162]. Innovative materials have been studied
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for vascular tissue engineering. These composite materials were prepared using the electrospinning
and sputtering technique. To this end, PCL and PHBV were incorporated at a ratio of 1:2 (v/v) and
sputter-coated with Ti. Firstly, the sputtering process was optimized so that it would not damage the
macrostructure of the scaffolds. The biocompatibility of the prepared composite mats was studied with
hybridoma of the endothelial cells of the human umbilical vein and human lung carcinoma (EA.hy.926
cell line). The results showed that cell adhesion was improved for Ti-coated scaffolds, and that they
exhibited better proangiogenic activity.
Furthermore, a novel approach was applied to process fibrous scaffolds for artificial muscles
or human body smart devices by combining electrospinning and sputtering technologies [133].
A core/shell structure was made by first electrospinning the PMMA in optimized form to obtain
a uniform fiber; later, the PMMA was coated with Au to induce conductivity and obtain suitable
mechanical properties in the scaffolds. Subsequently, polyaniline (PANI) was coated onto the scaffolds
via in situ electrochemical polymerization, starting with aniline and using sulfuric acid as an oxidizing
agent (Figure 9). PANI-coated metalized fiber scaffolds in a structure similar to the core/shell structure
showed fascinating electrochromic properties, in which color changes occurred when the applied
voltage was switched from 0 to 1 V, and vice versa. In vitro biocompatibility testing revealed good
cell adhesion, with a better result shown when tested on human amniotic fluid stem cells than on
eukaryotic cells. Therefore, this type of web could be used to prepare smart artificial muscle devices
via a versatile and straightforward preparation technique using electrospinning and sputtering.
Figure 9. Schematic representation of electrospinning and sputtering for muscle tissue engineering
applications. Reproduced with permission from [133]. Elsevier, 2016.
4. Conclusions
Throughout this review, new insights for biomedical applications have been addressed, focusing
predominantly on the promising benefits of employing sputtered electrospun polymer-based
nanofibers. It is evident from the number of ineffective conventional treatments that there is a
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desperate necessity for distinct and unique therapies. As addressed extensively in this paper,
combining sputtering and electrospinning technologies has the potential to play a critical function in
different biomedical applications such as antibacterial coatings, surface modification for enhancing
biocompatibility, and tissue engineering. Investigated by means of various nanostructure studies,
the above-mentioned concepts can be used in an attempt to strengthen overall therapeutic behavior.
As represented through the numerous reports addressed, therapies including silver and copper
nanoparticles have the potential to be applied directly in different biomedical applications. Overall,
it is clear that the field of combined sputtering and electrospinning technologies is progressing at an
incredibly fast rate, providing promising behaviors for various biomedical applications.
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16. Yördem, O.S.; Papila, M.; Menceloǧlu, Y.Z. Effects of electrospinning parameters on polyacrylonitrile nanofiber
diameter: An investigation by response surface methodology. Mater. Des. 2008, 29, 34–44. [CrossRef]
17. Homayoni, H.; Ravandi, S.A.H.; Valizadeh, M. Electrospinning of chitosan nanofibers: Processing
optimization. Carbohydr. Polym. 2009, 77, 656–661. [CrossRef]
18. Xu, C.Y.; Inai, R.; Kotaki, M.; Ramakrishna, S. Aligned biodegradable nanofibrous structure: A potential
scaffold for blood vessel engineering. Biomaterials 2004, 25, 877–886. [CrossRef]
19. Um, I.C.; Fang, D.; Hsiao, B.S.; Okamoto, A.; Chu, B. Electro-Spinning and Electro-Blowing of Hyaluronic
Acid. Biomacromolecules 2004, 5, 1428–1436. [CrossRef]
20. Kong, C.S.; Lee, T.H.; Lee, S.H.; Kim, H.S. Nano-web formation by the electrospinning at various electric
fields. J. Mater. Sci. 2007, 42, 8106–8112. [CrossRef]
21. Yang, Y.; Jia, Z.; Liu, J.; Li, Q.; Hou, L.; Wang, L.; Guan, Z. Effect of electric field distribution uniformity on
electrospinning. J. Appl. Phys. 2008, 103, 104307. [CrossRef]
22. Samadian, H.; Mobasheri, H.; Hasanpour, S.; Faridi Majidi, R. Electrospinning of Polyacrylonitrile Nanofibers
and Simulation of Electric Field via Finite Element method. Nanomed. Res. J. 2017, 2, 87–92. [CrossRef]
23. Reneker, D.H.; Chun, I. Nanometre diameter fibres of polymer, produced by electrospinning. Nanotechnology
1996, 7, 216–223. [CrossRef]
24. Supaphol, P.; Mit-Uppatham, C.; Nithitanakul, M. Ultrafine electrospun polyamide-6 fibers: Effect of emitting
electrode polarity on morphology and average fiber diameter. J. Polym. Sci. Part B Polym. Phys. 2005, 43,
3699–3712. [CrossRef]
25. Casper, C.L.; Stephens, J.S.; Tassi, N.G.; Chase, D.B.; Rabolt, J.F. Controlling Surface Morphology of
Electrospun Polystyrene Fibers: Effect of Humidity and Molecular Weight in the Electrospinning Process.
Macromolecules 2004, 37, 573–578. [CrossRef]
26. Al-Marri, M.J.; Masoud, M.S.; Nassar, A.M.G.; Zagho, M.M.; Khader, M.M. Synthesis and Characterization
of Poly(vinyl alcohol): Cloisite® 20A Nanocomposites. J. Vinyl Addit. Technol. 2017, 23, 181–187. [CrossRef]
27. Kabalan, L.; Zagho, M.M.; Al-Marri, M.J.; Khader, M.M. Experimental and theoretical studies on the
mechanical and structural changes imposed by the variation of clay loading on poly(vinyl alcohol)/cloisite®
93A nanocomposites. J. Vinyl Addit. Technol. 2018. [CrossRef]
28. Hussein, E.A.; Zagho, M.M.; Nasrallah, G.K.; Elzatahry, A.A. Recent advances in functional nanostructures
as cancer photothermal therapy. Int. J. Nanomed. 2018, 13, 2897–2906. [CrossRef]
29. Zagho, M.M.; Khader, M.M. The Impact of Clay Loading on the Relative Intercalation of Poly (Vinyl
Alcohol)—Clay Composites. J. Mater. Sci. Chem. Eng. 2016, 4, 20–31. [CrossRef]
30. Zagho, M.M.; Al, M.; Almaadeed, A.; Majeed, K. Role of TiO2 and Carbon Nanotubes on Polyethylene, and
Effect of Accelerated Weathering on Photo Oxidation and Mechanical Properties. J. Vinyl Addit. Technol. 2018.
[CrossRef]
31. Zagho, M.M.; Elzatahry, A. Recent Trends in Electrospinning of Polymer Nanofibers and their Applications
as Templates for Metal Oxide Nanofibers Preparation. In Electrospinning—Material, Techniques, and Biomedical
Applications; Haider, S., Ed.; InTech: Rijeka, Croatia, 2016; pp. 3–24.
32. Majeed, K.; AlMaadeed, M.A.A.; Zagho, M.M. Comparison of the effect of carbon, halloysite and titania
nanotubes on the mechanical and thermal properties of LDPE based nanocomposite films. Chin. J. Chem. Eng.
2018, 26, 428–435. [CrossRef]
33. Zagho, M.M.; Hussein, E.A.; Elzatahry, A.A. Recent Overviews in Functional Polymer Composites for
Biomedical Applications. Polymers 2018, 10, 739. [CrossRef]
34. Khan, M.I.; Zagho, M.M.; Shakoor, R.A. A Brief Overview of Shape Memory Effect in Thermoplastic Polymers,
Smart Polymer Nanocomposites. In Smart Polymer Nanocomposites; Ponnamma, D., Sadasivuni, K.K.,
Cabibihan, J.-J., Al-Maadeed, M.A.A., Eds.; Springer Series on Polymer and Composite Materials; Springer
International Publishing: Cham, Switzerland, 2017; pp. 281–301, ISBN 978-3-319-50423-0.
35. Dawoud, H.D.; Altahtamouni, T.M.; Zagho, M.M.; Bensalah, N. A brief overview of flexible CNT/PANI
super capacitors. J. Mater. Sci. Nanotechnol. 2017, 1, 23–36.
36. Zagho, M.M.; AlMaadeed, M.A.A.; Majeed, K. Thermal Properties of TiO2 NP/CNT/LDPE Hybrid
Nanocomposite Films. Polymers 2018, 10, 1270. [CrossRef]
37. Al-Enizi, A.M.; Zagho, M.M.; Elzatahry, A.A. Polymer-Based Electrospun Nanofibers for Biomedical
Applications. Nanomaterials 2018, 8, 259. [CrossRef] [PubMed]
266
Nanomaterials 2019, 9, 77
38. Gómez-Tejedor, J.A.; Van Overberghe, N.; Rico, P.; Ribelles, J.L.G. Assessment of the parameters influencing
the fiber characteristics of electrospun poly(ethyl methacrylate) membranes. Eur. Polym. J. 2011, 47, 119–129.
[CrossRef]
39. Liu, M.; Duan, X.; Li, Y.; Yang, D.; Long, Y. Electrospun nano fi bers for wound healing. Mater. Sci. Eng.
C-Mater. 2017, 76, 1413–1423. [CrossRef] [PubMed]
40. Zhang, J.; Duan, Y.; Wei, D.; Wang, L.; Wang, H.; Gu, Z.; Kong, D. Co-electrospun fibrous scaffold–adsorbed
DNA for substrate-mediated gene delivery. J. Biomed. Mater. Res. Part A 2011, 96A, 212–220. [CrossRef] [PubMed]
41. Cao, H.; Jiang, X.; Chai, C.; Chew, S.Y. RNA interference by nanofiber-based siRNA delivery system. J. Control.
Release 2010, 144, 203–212. [CrossRef] [PubMed]
42. Balaji, A.; Vellayappan, M.V.; John, A.A.; Subramanian, A.P.; Jaganathan, S.K.; Supriyanto, E.; Razak, S.I.A.
An insight on electrospun-nanofibers-inspired modern drug delivery system in the treatment of deadly
cancers. RSC Adv. 2015, 5, 57984–58004. [CrossRef]
43. Kim, G.H.; Min, T.; Park, S.A.; Kim, W.D. Coaxially electrospun micro/nanofibrous poly(ε-caprolactone)/
eggshell-protein scaffold. Bioinspir. Biomim. 2008, 3, 016006. [CrossRef]
44. Kim, G.; Yoon, H.; Park, Y. Drug release from various thicknesses of layered mats consisting of electrospun
polycaprolactone and polyethylene oxide micro/nanofibers. Appl. Phys. A Mater. Sci. Process. 2010, 100,
1197–1204. [CrossRef]
45. Fathi-Azarbayjani, A.; Chan, S.Y. Single and multi-layered nanofibers for rapid and controlled drug delivery.
Chem. Pharm. Bull. 2010, 58, 143–146. [CrossRef]
46. Immich, A.P.S.; Arias, M.L.; Carreras, N.; Boemo, R.L.; Tornero, J.A. Drug delivery systems using sandwich
configurations of electrospun poly(lactic acid) nanofiber membranes and ibuprofen. Mater. Sci. Eng. C 2013,
33, 4002–4008. [CrossRef] [PubMed]
47. Chen, D.W.C.; Liao, J.Y.; Liu, S.J.; Chan, E.C. Novel biodegradable sandwich-structured nanofibrous
drug-eluting membranes for repair of infected wounds: An in vitro and in vivo study. Int. J. Nanomed.
2012, 7, 763–771. [CrossRef]
48. Ahlin Grabnar, P.; Kristl, J. The manufacturing techniques of drug-loaded polymeric nanoparticles from
preformed polymers. J. Microencapsul. 2011, 28, 323–335. [CrossRef] [PubMed]
49. Zamani, M.; Prabhakaran, M.P.; Ramakrishna, S. Advances in drug delivery via electrospun and
electrosprayed nanomaterials. Int. J. Nanomed. 2013, 8, 2997–3017. [CrossRef]
50. Chen, S.; Wang, G.; Wu, T.; Zhao, X.; Liu, S.; Li, G.; Cui, W.; Fan, C. Silver nanoparticles/ibuprofen-loaded
poly(L-lactide) fibrous membrane: Anti-infection and anti-adhesion effects. Int. J. Mol. Sci. 2014, 15,
14014–14025. [CrossRef] [PubMed]
51. Mele, E. Electrospinning of natural polymers for advanced wound care: Towards responsive and adaptive
dressings. J. Mater. Chem. B 2016, 4, 4801–4812. [CrossRef]
52. Lee, K.Y.; Jeong, L.; Kang, Y.O.; Lee, S.J.; Park, W.H. Electrospinning of polysaccharides for regenerative
medicine. Adv. Drug Deliv. Rev. 2009, 61, 1020–1032. [CrossRef]
53. Toshkova, R.; Manolova, N.; Gardeva, E.; Ignatova, M.; Yossifova, L.; Rashkov, I.; Alexandrov, M. Antitumor
activity of quaternized chitosan-based electrospun implants against Graffi myeloid tumor. Int. J. Pharm.
2010, 400, 221–233. [CrossRef]
54. Garg, T.; Rath, G.; Goyal, A.K. Biomaterials-based nanofiber scaffold: Targeted and controlled carrier for cell
and drug delivery. J. Drug Target. 2015, 23, 202–221. [CrossRef] [PubMed]
55. Gunn, J.; Zhang, M. Polyblend nanofibers for biomedical applications: Perspectives and challenges.
Trends Biotechnol. 2010, 28, 189–197. [CrossRef] [PubMed]
56. Kim, K.; Yu, M.; Zong, X.; Chiu, J.; Fang, D.; Seo, Y.-S.; Hsiao, B.S.; Chu, B.; Hadjiargyrou, M. Control
of degradation rate and hydrophilicity in electrospun non-woven poly(d,l-lactide) nanofiber scaffolds for
biomedical applications. Biomaterials 2003, 24, 4977–4985. [CrossRef]
57. Behrens, A.M.; Kim, J.; Hotaling, N.; Seppala, J.E.; Kofinas, P.; Tutak, W. Rapid fabrication of
poly(DL-lactide) nanofiber scaffolds with tunable degradation for tissue engineering applications by
air-brushing. Biomed. Mater. 2016, 11, 035001. [CrossRef] [PubMed]
58. Meng, Z.X.; Xu, X.X.; Zheng, W.; Zhou, H.M.; Li, L.; Zheng, Y.F.; Lou, X. Preparation and characterization of
electrospun PLGA/gelatin nanofibers as a potential drug delivery system. Colloids Surf. B 2011, 84, 97–102.
[CrossRef] [PubMed]
267
Nanomaterials 2019, 9, 77
59. Binulal, N.S.; Natarajan, A.; Menon, D.; Bhaskaran, V.K.; Mony, U.; Nair, S.V. PCL-gelatin composite
nanofibers electrospun using diluted acetic acid-ethyl acetate solvent system for stem cell-based bone tissue
engineering. J. Biomater. Sci. Polym. Ed. 2014, 25, 325–340. [CrossRef] [PubMed]
60. Zhu, X.; Ni, S.; Xia, T.; Yao, Q.; Li, H.; Wang, B.; Wang, J.; Li, X.; Su, W. Anti-neoplastic cytotoxicity of
SN-38-loaded PCL/Gelatin electrospun composite nanofiber scaffolds against human glioblastoma cells
in vitro. J. Pharm. Sci. 2015, 104, 4345–4354. [CrossRef] [PubMed]
61. Gomes, S.R.; Rodrigues, G.; Martins, G.G.; Roberto, M.A.; Mafra, M.; Henriques, C.M.R.; Silva, J.C. In vitro
and in vivo evaluation of electrospun nanofibers of PCL, chitosan and gelatin: A comparative study.
Mater. Sci. Eng. C 2015, 46, 348–358. [CrossRef]
62. Alhosseini, S.N.; Moztarzadeh, F.; Mozafari, M.; Asgari, S.; Dodel, M.; Samadikuchaksaraei, A.; Kargozar, S.;
Jalali, N. Synthesis and characterization of electrospun polyvinyl alcohol nanofibrous scaffolds modified by
blending with chitosan for neural tissue engineering. Int. J. Nanomed. 2012, 7, 25–34. [CrossRef]
63. Mojtaba, K.; Hamid, M. Electrospinning, mechanical properties, and cell behavior study of chitosan/PVA
nanofibers. J. Biomed. Mater. Res. Part A 2015, 103, 3081–3093. [CrossRef]
64. Ba, L.N.T.; Ki, M.Y.; Ho-Yeon, S.; Byong-Taek, L. Fabrication of polyvinyl alcohol/gelatin nanofiber
composites and evaluation of their material properties. J. Biomed. Mater. Res. Part B Appl. Biomater.
2010, 95B, 184–191. [CrossRef]
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Abstract: Innovative solutions using biopolymer-based materials made of several constituents seems
to be particularly attractive for packaging in biomedical and pharmaceutical applications. In this
direction, some progress has been made in extending use of the electrospinning process towards fiber
formation based on biopolymers and organic compounds for the preparation of novel packaging
materials. Electrospinning can be used to create nanofiber mats characterized by high purity of the
material, which can be used to create active and modern biomedical and pharmaceutical packaging.
Intelligent medical and biomedical packaging with the use of polymers is a broadly and rapidly
growing field of interest for industries and academia. Among various polymers, alginate has found
many applications in the food sector, biomedicine, and packaging. For example, in drug delivery
systems, a mesh made of nanofibres produced by the electrospinning method is highly desired.
Electrospinning for biomedicine is based on the use of biopolymers and natural substances, along with
the combination of drugs (such as naproxen, sulfikoxazol) and essential oils with antibacterial
properties (such as tocopherol, eugenol). This is a striking method due to the ability of producing
nanoscale materials and structures of exceptional quality, allowing the substances to be encapsulated
and the drugs/biologically active substances placed on polymer nanofibers. So, in this article we
briefly summarize the recent advances on electrospinning of biopolymers with particular emphasis
on usage of Alginate for biomedical and pharmaceutical applications.
Keywords: biopolymers; packaging; pharmaceutical; biomedical; electrospinning; alginate
1. Introduction
Modern packaging should protect products from external factors, extend the period of maintaining
the quality of the product and above all, minimize impact on the environment [1–6]. Figure 1
summarizes some of the properties desired in common packaging materials. Detailed properties
have been discussed in some excellent review articles, so we won’t be going into more detail [1,2,7–9].
In this direction, public awareness is rapidly growing and attracting greater attention to ecology, as well
as the use of natural substances for a range of applications from automotive to biomedical [10–16].
A tendency in the packaging industry to design innovative materials and introduce new solutions is
gaining greater attention [17,18]. Active and modern packaging frequently relies on natural substances
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such as natural polysaccharides [9]. It is imperative to preserve all aspects of environmental safety
during production, as well as the effectiveness and safety of use for patients [19–23]. Interestingly,
the cyclic olefin copolymer (COC) is most commonly used for tamper-resistant packaging and is a
remarkable alternative to a damped polyvinyl chloride (PVC).
Figure 1. General properties of commonly used packaging materials.
Packaging in medical and biomedical engineering is defined as a technique that enables the
closure of a pharmaceutical product from its production to its end use [24]. The role of pharmaceutical
packaging is to provide life-saving drugs, surgical devices, nutraceuticals, pills, powders and liquids,
to name a few [7,25]. Pharmaceutical packaging influences the isolation and ensures the safety, identity
and convenience of using the drug. The packaging must communicate well with the patient so that
there are no adverse effects on the health of the patient. The key issue in packaging is also the issue of
ecological safety [26,27]. Drug companies that pack drugs are among the industry leaders due to their
technological advances. Current trends in industrial research on such new materials are the result of
a continuous series of challenges being faced by the industry. The packaging industry is constantly
evolving and is an important factor in the development of the pharmaceutical industry and biomedical
sciences. Electrospinning of polymers/nanomaterials [28,29] is one of the potential methods in the
packaging process that allows for the use of biopolymers [30]/natural substances for the production
of medical packaging, dressings, biosensors, medical implants, and is a growing trend in biomedical
sciences [10,31–39]. Figure 2 illustrates the schematic of a coaxial electrospinning setup. The inset
shows an illustration of a coaxial jet under applied voltage [39]. Mercante et al in their excellent review
articles have also shown the number of publications that’s involved the use of electrospinning in sensor
applications and the number of these publications is increasing day by day [10].
Different types of electrospun fibers are being produced for biomedical applications [32]. However,
the electrospinning of biopolymers is a very challenging process. For example, in the case of chitosan,
its neutralization lead to the loss of chitosan traits by using unsuitable substances. In the production of
continuous filaments, suitable solvents should be used so that there is no interruption. In addition,
during chitosan nanofiber synthesis, the value of the electric field generated is also crucial. Too high of
an electric field causes repulsion between ionic groups of the polymer backbone, which disturbs the
formation of continuous filaments. The use of chitin and chitosan nanofibers in biomedical and other
applications has been recently reviewed [32–34]. Jayakumar et al, in their article, had primarily focused
on the properties, preparation and biomedical applications [32]. Electrospinning of silk has also been
reported [35]. It is used because of beneficial properties such as non-toxicity and biocompatibility.
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Due to its positive mechanical properties, it can be used in various temperature and humidity ranges.
However, in the case of silk, one of the protein components, sericin, should be removed before
biological application because it can cause allergic reactions, for example, in the case of medical
dressings [36–38].
Figure 2. Schematic of coaxial electrospinning setup. The inset shows an illustration of a coaxial jet
under applied voltage [39]. Reprinted with permission from Ref. [39]. Copyright American Chemical
Society, 2010.
One of the organisms that is produced as a structural component of silk protein is Bombyx
mori [40]. The protein it produces, silk fibroin, is a large crystalline macromolecule consisting
of repeating units of amino acids, mainly alanine (A), glycine (G) and serine (S). The fibers that
are formed with its participation exhibit good mechanical properties [41]. Researchers have also
demonstrated that electrospinning of biopolymer blends of chitin and silk fibroin is possible [42].
In this process, nanofibrous membranes of blended chitosan and silk fibroin were successfully prepared
using electrospinning in a HFIP/TFA spinning solvent. With the increment in the content of silk fibroin,
the typical diameter of the as-prepared nanofibers was found to increase. The incorporation of silk
fibroin was also found to contribute to the enhancement in the mechanical properties of nanofibrous
membranes. Furthermore, with the increment in the chitosan content, the antibacterial activity
became significantly suitable for wound dressings [42]. Electrospun collagen–chitosan nanofiber
having a typical fiber diameter of 434–691 nm was also prepared as a biomimetic extracellular matrix
(ECM) for endothelial cells and smooth muscle cells [43]. Different characterization techniques such
as FTIR spectra analysis, XRD analysis, DSC and tensile testing were carried out to analyse the
developed materials [43]. Double-network (DN) agarose/polyacrylamide nanofibers were prepared
by electrospinning [44]. The DN of agarose/polyacrylamide (PAAm) nano fibers developed using
simultaneous photo-polymerization and electrospinning. Different characterization techniques were
used to confirm the realization of a crosslinked double-network. In comparison to the pristine
agarose, the electrospun fibrous agarose/PAAm demonstrated 66.66% enhancement in the strength [44].
Similarly, electrospinning of alginate is being carried out for a number of applications [45]. Alginate is
an important biopolymer with vast potential [46].
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1.1. Synthetic Polymers
Different types of polymers ranging from natural to synthetic are rapidly becoming the most
interesting subject of research in the sector of the biomedical industry [47]. They are often used in
the packaging of medicines [48,49], as well as in the development of flexible ampoule/syringes that
are more easy to use. However, adsorption and migration of the bioactive substance to the polymer
changes in pH, permeability of oxygen, optical properties and the release of leached components
affect their use and should be taken into account [50,51]. Interaction of the different outer components
not only affects the drug but also the function of the polymeric container. Polyolefins, high-density
polyethylene (HDPE) or polypropylene (PP) are some of the most common polymers used for the
production of vials. Often, multilayer containers are developed to achieve such requirements as
inertia, oxygen or UV protection. Polycyclic and olefinic polymers and copolymers (Daikyo Crystal
Zeniths) have been used for filling polymer syringes [51,52]. Devices such as PVC tubes containing
di-2- ethylhexylphthalate (DEHP) plasticizer are used in dialysis for blood supply or extracorporeal
oxygenation. The bags containing the polymer are used to donate blood and store blood products.
Due to lipophilicity, the plasticizer is transferred from the polymer surface to lipids and red blood cell
membranes [53]. It has been found that the plasticizer in blood bags reduces haemolysis of red blood
cells by about 50% compared to blood stored in non-plastic containers, which improves the quality
of the blood product [50]. Tubes for extracorporeal circulation are often heparinized to reduce the
coagulation, which causes intense contact with PVC and increases thrombogenicity [54].
For the storage of red blood cells, an alternative plasticizer such as butyryl-trihexyl-citrate (BTHC)
or di-iso-nonyl-1, 2-cyclohexanedicarboxylate (DINCH) is used. Polyolefins as alternative polymers
are used to store platelets [55,56]. Polyethylene and polyurethanes are used to create tubes. Tubes
of positronic pumps are usually made of silicone [51]. Hemodialysis membranes are produced as
bundles of hollow fibers with a surface in contact with blood. The technical requirements concern
mainly the permeability for substances smaller than albumin, preventing the passage of impurities
from the dialysate to the blood, and the compatibility of the membrane with blood. Previously,
dialysis membranes were made of cellulose [51,57]. The hydroxyl groups were replaced with acetylene
derivatives or other modified additives, preventing the activation of the complement system and
the associated leukocyte activation and leukocyte sequestration in the lungs [51,57]. Synthetic
membranes consist of a hydrophobic base material and hydrophilic components. The polyaryl sulfone
co-precipitation membranes, polysulfone (PSf) and polyvinylprolidone (PVP) membranes are the
most popular for a number of applications [58]. In addition, other membrane materials such as
polyamide (PA), polycarbonate (PC) and polyacrylonitrile (PAN), PMMA, polyester polymer alloy
(PEPA), ethylene vinyl alcohol copolymer (EVAL), and molecular thin nanoporous silicon diaphragms
are also used. Poly (ethylene glycol) (PEG) is used in membranes to improve compatibility with
blood [59]. Polymer stents used in the upper sections of the ureter are designed to overcome the
problems of sperm infection. Silicone is the best biocompatible material with the lowest incrustation
tendency. Its use is limited by low mechanical stiffness and high resistance. Therefore, polyurethane
products with better mechanical properties than silicone were optimized [51,60]. The stents were
coated with glycosaminoglycans (GAGs, heparin or pentosan polysulfone), phosphorylcholine, which
increases the comfort of patients, reduces bacterial colonization and encrustation [51,60].
1.2. Biopolymers: Structure of Alginate
Recently, there has been a great thrust on the usage of biopolymers for a number of applications,
especially in the biomedical and pharmaceutical [61–65]. The functional efficiency of the biopolymer
molecules depends on the composition, physicochemical properties and structural features [66–68]. It is
possible to rationally design the composition and structure of the biopolymer to obtain the appropriate
functional attributes [23]. The internal structure of the polymer molecule determines many functional
characteristics such as permeability, chargeability and integrity [69]. The stability of the biopolymer
particles and their ability to aggregate is influenced by the electrical characteristics. Biopolymer
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particles with a high electric charge will repel and prevent aggregation. Molecules of biopolymers and
their electrical properties influence the interaction with other molecules present in the surrounding
environment [69]. Among natural biopolymers, alginate is one of the most popular and intensely
studied [70,71]. It is an anionic biopolymer consisting of units of mannuronic acid and guluronic acid
in irregular blocks [72]. Mannuronic acid and guluronic acid are linked by glycosidic linkages [73–75].
Mannuronic acid forms β (1 → 4) bonds and α bonds (1 → 4) with guluronic acid [76]. The stiffness of
molecular chains is ensured by the rigid and bent conformations of guluronic acid [77,78]. Hadas and
Simcha have recently reported their interesting work on the characterization of sodium alginate and
calcium alginate with particular emphasis on their structure [79]. Different properties and applications
of alginate have also been reviewed [80]. The properties of alginates used in biomedicine can be shaped
by modifying the availability of their hydroxyl and carboxyl groups [81]. It affects the properties of
alginates, such as solubility, hydrophobicity and their biological activity. Alginate hydrogels were
created by crosslinking polymer chains [82]. The chemical properties of alginate hydrogels were found
to depend on the cross-linking density of the chain [83]. One of the methods used in the design of
alginate hydrogels is intermolecular cross-linking, in which only the alginate guluron groups react with
the divalent cation most often the calcium used to gel the alginate [84]. Marguerite has summarized
the applications of alginate especially for packaging in an excellent review article, so we won’t go into
detail [85].
2. Electrospun Antioxidant/Antibacterial Materials for Medical Packaging
Electrospinning is one of the most prominent techniques currently being used in the development
of a number of products for biomedical applications, as discussed in the preceding section [86–88].
The electrospun creates ultrathin fibers collected in a random pattern. The mats produced in this way
are used as filters, catalytic carriers, dressings and drug delivery systems [89]. Currently, scientific
research focuses on the use of nanofiber properties and the focus on determining the parameters of
electrospinning of biopolymers for medical and pharmaceutical applications [90–92]. In this technique,
varying electrified fields are applied to produce polymer filaments, which can then be embedded
in various device platforms (briefed in introduction section). The basic device for electrospinning
consists of four parts: a syringe containing a polymer solution, a metallic needle, a power source and
a metal collector (with variable construction) [93]. The polymer solution is extruded through the tip
of the needle by forming a polymer stream that is leached out of the needle and expands as a result
of deflection and dissipation of the electric charge voltage of the solution surface. The basic set for
electrospun fibers is shown in Figure 3 [94]. Electrospinning of anisotropic fiber yarns (Biohybrid)
was carried out via the extraction of microfibrils from bacterial cellulose networks [94]. In the
equipment, a plastic syringe of 5 mL was used as the polymer reservoir in the continuous feed
system. An aluminum reservoir that was filled with water was used and the fibers were subsequently
collected on the surface of the water 120 mm from the needle tippet [94].
The polymeric solution stream flows towards the metal manifold with simultaneous evaporation
of the solvent and then the nanofibers are deposited on the collector surface. When nanoparticles are
deposited instead of nanofibers, the process takes place using electrospray [95,96]. Electrospinning
is a fiber production process with a diameter of 0.01 to 10 μm by using electrostatic forces. In the
electrospinning technique, a syringe filled with a polymer solution has a high potential source from 10
to 30 kV. The electrical voltage produces free electrons, ions or pairs of ions attracted to the electric
field [97]. One of the elements is Taylor’s cone, in which the polarity of the solution depends on the
generator’s voltage. The drive between similar charges in the electric space acts against the surface
tension and fluid elasticity in the polymer solution, distorting the drop to the shape of the cone
structure. In addition to the critical charge density, the Taylor taper becomes unstable and the liquid
stream is released from the tip of the cone. Then, in the presence of the electric field, the polymer
stream is formed, creating a light continuous form of the fiber. The fluid stream through continuous
stretching becomes unstable because the number of spiral paths accumulated on the collector electrode
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increases [98]. This area is called whipping region. Polarized electrospun nanofibers move down to
collision with less collector plate potential. The collector’s morphology affects the straightening of the
fiber. Different collectors are used, such as drum rotary collector, movable belt collector and straight
mesh collector. To produce nanofibers with controlled morphology, parameters such as molecular
weight of the polymer, surface tension, solution viscosity, solution conductivity, flow rate, temperature,
collector morphology and distance of the collector apex are optimized [99]. It has been found that the
diameter of the fibers increases with increasing concentration and viscosity. Increasing the molecular
weight reduces the risk of interference on fibers such as balls and drops. It was determined that
nanofibers can be formed with a variety of secondary structures. Thus, nanofibers with a core-shell
structure, with an empty interior or with a porous structure may be formed [99,100]. As a drug
delivery system, a mesh made of nanofibres produced by the electrospinning method offers a number
of advantages. This is an attractive method due to its ability to produce nanoscale materials and
structures of exceptional quality [101]. This allows substances to be encapsulated and drugs and
biologically active substances placed on polymer nanofibers [102]. Biologically active substances can
be attached to nanofibers like a mesh in the electrospinning process. In this way, antibacterial and
antioxidant materials are created for medical applications [103,104]. Coating materials containing
chitosan formulations with antioxidant and antifungal properties were also formed [88,105].
 
Figure 3. Electrospinning setup with a spinneret–water surface working distance of 120 mm and
a spool running at 15 rpm/min. The spool (hollow) was designed to collect fibers with minimal
spool–fiber yarn contact [94]. Reprinted with permission from Ref [94]. Copyright American Chemical
Society, 2010.
By choosing a base mesh polymer, it can be easily designed to have improved mechanical
properties, biocompatibility and cellular response, which makes mesh a good medical product in the
nanocomposite materials sector. The electrospinning creates a macroporous scaffolding containing
randomly oriented or aligned nanofibres on which the drug is placed. Electrospun nanofiber scaffolds
provide the optimal environment for vaccinated cells [88]. Therapeutic compounds such as lipophilic
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and hydrophilic drugs, proteins, antimicrobials, etc. can be incorporated into the polymer nanofiber
mesh by using monoaxial or coaxial electrospinning [106].
Nanofibers can help treat skin damage and can be considered a substitute for skin tissue [107].
The drug enclosed in the nanofiber mesh is released by various mechanisms when the nanofibrils
mesh is swollen, biodegradable or absorbed by the human body. As an effective dressing, it inhibits
bacterial growth during wound healing. The lower drug release rate allows for non-wound healing of
wounds from a few days to several weeks [100,105]. Polymer after electrospinning acts as a barrier
controlling the release of loaded molecules. The advantage of this method is the ability to close almost
all drugs (especially hydrophobic) in the core, regardless of the drug-polymer interaction. Drugs,
proteins, uptake factors and genes can be included in nanofibers [105].
Silver nanoparticles exhibit the capability to interact with bacteria. This allows the size of
silver nanoparticles 1–10 nm in diameter. The smaller size provides better antibacterial activity.
Scientific research has proven the antibacterial activity of electrospun nanofibers containing polylactic
acid and silver nanoparticles (AgNPs) against Staphylococcus aureus and Escherichia coli. Fibers
of silver nanoparticles and polyethylene oxide were mixed with polyurethane fibers exhibiting
antibacterial activity on Escherichia coli [103,105]. Antimicrobial efficacy increases with an increase in
the concentration of silver. The activity can also be increased by reducing silver nanoparticles. Smaller
silver nanoparticles have the ability to disperse the bacterial membrane and inhibit bacterial growth.
Antimicrobial activity of electrospun nanofibers results from the distribution of silver nanoparticles to
electrospun nanofibers. Increased access of silver nanoparticles to electrospun nanofibers increases
microbial capacity [108–110]. Polyacrylonitrile fibers combined with silver nanoparticles showed
antibacterial activity on gram positive Bacillus cereus and gram negative Escherichia coli. The fibers
formed from the combination of silver nanoparticles and Nylon 6 have an antibacterial effect on the
gram of negative Escherichia coli and gram positive on Staphylococcus aureus [111].
Antioxidative effects of electrospun nanofibers have also been proven by obtaining multifunctional
biomaterials, especially through the use of vitamin E and natural biopolymers [105]. Fibers resulting
from the combination of polylactic acid, silver nanoparticles and vit. E inhibited the growth of
Escherichia coli up to 100%. The release time of silver ions from nanofibres immersed in water lasted up
to 10 days. It was proved that the combination of polylactic acid nanofibres, silver nanoparticles and
vitamin E showed antioxidant activity in studies on fresh apple juice [112].
It has been proven that nanofibers act as a membrane that actively reduces polyphenol oxidase
activity. Such materials can be used for preservation in the food industry in fruit and juice
packaging [105,112]. Nanofibers can be coated with biocompatible polymers (hydrolysed collagen,
elastin, hyaluronic acid, chondroitin sulfate). In this way, the electrospun fibers are coated with
pure polyurethane to use the substance to improve the antibacterial effect of urinary catheters.
The membranes thus obtained, have good antimicrobial activity on Escherichia coli, Salmonella
typhimurium, Listeria monocytogenes [105].
Much research has been focused on the learning and operation of plant extracts using electrospun
fibers [113,114]. Researchers have managed to encapsulate with the use of electrospun fibers
several raw plant extracts such as Centella asiatica, baicalein, green tea, Garcinia mangostena,
Tecomella undulata, aloe vera, Grewia mollis, chamomille, grape seed, Calendula officinalis, Indigofera
aspalathoides, Azadirachta indica, Memecylon edule and Myristica andamanica [112]. Also, essential
oils such as linalool, pinene, eugenol and cymene are used [115–117]. Antibacterial action with essential
oils is determined by their hydrophobic nature. Bioactivity of essential oils combined using electrospun
fibers to create scaffolding of fibers with antibacterial properties and thermo-mechanically controlled
mobility. Electrospinning of chitosan nanoparticles and cinnamon essential oils in the ratio 1:1 has been
demonstrated [112]. Fibers with a diameter of 38-55 nm were formed. The fibers were prepared from
an aqueous solution containing 5% w/v acetic acid and various concentrations of essential oil (0.5 and
5.0% by volume). After fabrication, the fibers were cross-linked with glutaraldehyde to increase the
stability of their chemical properties. The activity of chitosan nanofibres and ether oil particles has
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been proven in action against P. aeruginosa, E. coli. Efficacy of the essential oil was demonstrated in
a study in which cellulose acetate was used as a polymer matrix [118]. Fibers containing essential
oils of peppermint and lemongrass were also analyzed. The generated scaffolds inhibited E. coli
proliferation and were non-toxic to fibroblasts and keratinocytes [116]. The Shikonin component of
Lithospermum erytrorhizon root dried was also used in the electrospinning technique [116]. It has
anticancer, antioxidant, anti-inflammatory and antibacterial effects. Shikonina was encapsulated and
placed on PCL/poly (trimethylene carbonate) fibers. Note that the drug was released in the first hour at
an increased rate and then for 48 h at a fixed dose. The shikonin-laden fibers showed a profound effect
against E. coli and S. aureus. The healing properties were also tested in combination with alkannins,
which are naturally occurring hydroxynaphthoquinone. The connection was used for the preparation
of topical and transdermal patches. Cellulose acetate, poly (lactic acid) (PLA) and two different poly
(lactic-glycol) mixtures were used as a matrix. Inclusion complexes of cyclodextrins (CD-IC) with
plant extracts and complexes with eugenol (EG) were also formed [119]. Eugenol has a bactericidal
effect and, in combination with inclusion cyclodextrins, has been used in electrospun fibers. The use
of cyclodextrins complexes, increases the solubility of natural extracts in water affects antioxidant
and antibacterial activity. Chitosan-based dressings were also developed for biomedical applications.
A mixture of chitosan, TiO2, poly (N-vinyl pyrrolidone) a synthetic polymer with good biocompatibility
was prepared [120]. The membrane thus formed showed high activity against the microorganisms
S. aureus, B. subtilis, E. coli, P. aeruginosa. The use of a membrane of chitosan, poly (N-vinylpyrrolidone)
and silver oxide showed a similar effect, but with the added advantage of film transparency, allowing
for observation of the wound [120].
Sodium alginate based nanofibers were also synthesized using polyethylene oxide (PEO) as
“carrier polymer” [121]. It was concluded from the study that the sodium alginate on its own could
not be electrospun. However, with the addition of a suitable polymer, it can be easily electrospun [121]
and the PEO–PEO interactions with high molecular-weight entangled PEO were the key to “carrying”
the alginate from the prepared solution to synthesise the fibers using electrospinning (Figure 4).
 
Figure 4. Schematic for the synthesis of alginate–polyethylene oxide blend nanofibers and the role of
the carrier polymer in electrospinning. Reprinted with permission from Ref [121]. Copyright American
Chemical Society, 2013.
In other studies, it was proved that nanofiber mats containing silver ions were more active
compared to nanofibre mats without silver nanoparticles [122,123]. To monitor the human breath,
smart fabrics were synthesized via electrospinning of the in situ assembly of well-dispersed Ag
nanoparticles [124]. In this work, lightweight and flexible Ag/alginate nanofiber sensor were
successfully developed that have the capability to sensitively monitor human breath (Figures 5 and 6).
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Figure 5 shows the schematic for the fabrication of Ag/alginate nanofibers and Figure 6 shows the
SEM images of different alginate nanofibers.
 
Figure 5. Schematic diagram illustrating the fabrication process of Ag/alginate nanofibers. (a)
Na-alginate nanofibers prepared by electrospinning. (b) Ion-exchange and in situ reduction processes.
Reprinted with permission from Ref. [124]. Copyright American Chemical Society, 2018.
 
Figure 6. SEM images of (a) as-electrospun Na-alginate nanofibers and (b–d) Ag/alginate nanofibers
obtained at different reduction times: (b) 10, (c) 20, and (d) 30 min. Reprinted with permission from
Ref. [124]. Copyright American Chemical Society, 2018.
Other synthetic polymers such as polyurethane, polyacrylonitrile, poly (acrylamide),
poly (nitrilesulfonic acid sodium salt, poly (sulphobetaine methacrylate) were also used to develop
wound dressings. Fluoroquinolones and norfloxacin were attached to polyphosphates by chemical
modification using amino acid esters (alanine, glycine, and phenylalanine) as chain extenders, and these
components were then used to create nanofibers by electrospinning [125].
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Antimicrobial biodegradable multilayer systems were developed using electrospinning, especially
the active multilayer structures based on natural polymers [126]. The system was developed in such a
way that it consisted of different layers; for example, alginate-based film as outer layer; using a PHBV8
film as outer layer or no outer layer. Different characterizations such as oxygen and water vapour
permeabilities, intermolecular arrangement, transparency and thermal properties were evaluated.
In addition the antimicrobial activity was also evaluated. Alginate based coatings for Food Packaging
Applications have been recently reviewed by Tugce et al. [127]. In this article, authors have summarized
the recent advances on the usage of alginate for recent edible coatings.
3. Biopolymers for Biomedical and Pharmaceutical Packaging
Active and modern packaging biomaterials contain natural substances that are abundantly
found in nature [1,11,128]. Biomaterials are often based on natural polysaccharides [129–133].
Among polysaccharides, Alginates have found applications in the food sector, water purification,
biomedicine and packaging [73,134–139]. Algae contain nutrients such as vitamins, salts, iodine
and sterols. Organisms containing large amounts of alginate in the cell walls are the brown algae
Phaeophyceae such as Fucus, Laminaria, and Aseophyllum. The amount of alginates obtained
generally depends on the species of algae and the extraction methods used [140]. They are linear
polymers composed of (1→4)-α-L-guluronic acid blocks (GG) β-D-mannuronic acid blocks (MM)
additionally, of heteropolymeric sequences of M and G (MG blocks) [74,80]. In biomedicine, alginates
are used for controlled drug release, encapsulation, scaffolds in ligaments, tissue engineering
and in dentistry for the preparation of forms in the presence of slow-release calcium salt [141].
The pharmaceutical industry uses purified alginates for dispersion or stabilization of substances.
In biomedicine, alginates are used for controlled drug release, encapsulation, scaffolds in ligaments,
tissue engineering and in dentistry for the preparation of forms in the presence of slow-release
calcium salt. Figure 7 shows the application areas of alginate hydrogels. The alginate produces edible
coatings with good barrier and mechanical properties allowing the protection of active ingredients by
encapsulation [3]. Garlic oil is often added as a natural antibacterial agent in such coatings. Alginate
is partially dusted with calcium and mixed with starch to obtain high water retention in the paper
coating. This is important in order to obtain a uniform mass and coating by pressing to improve
its rheology [85]. Alginates have found a number of applications in biomedical sciences as wound
dressing materials [142]. Especially sodium alginate used in the form of a hydrogel has stimulated
more and more scientific interest due to its physicochemical properties. Materials made of alginate
are considered to be friendly to humans due to tissue biocompatibility, which allows for their use in
biomedical engineering [135,140]. Highly absorbent dressing materials are formed by the production
of wet spinning fibers. With the addition of calcium and sodium, high-absorbency sodium and
calcium fibers were produced. Antimicrobial fibers were also formed by adding alginic acid or silver.
By adding zinc, the fibers that generate the immune system were created. Fibers for immobilizing
or supporting bioactive molecules were readily prepared [143]. Antimicrobial properties were
imparted to cotton fabrics employing alginate–quaternary ammonium complex nanoparticles [144].
Using the ionic gelation method, a new type of nanoparticle (average size of 99 nm) that was
composed of sodium alginate (SA) and 3-(trimethoxysilyl) propyl-octadecyldimethylammonium
chloride (TSA) was synthesized. Fibers exhibited an efficient antimicrobial activity that was even
maintained after 30 laundry cycles (non-leaching antimicrobial agent) [144]. Ionic gelation was used
to develop a new class of nanoparticles that consists of sodium alginate (SA) and 3-(trimethoxysilyl)
propyl-octadecyldimethylammonium chloride (TSA). The ratio of SA/TSA was found to exhibit a
significant effect on the average size of the SA–TSA nanoparticles. Nanoparticles having an average
size of 99 nm were selected for the study and, after using a pad-dry-cure method, were loaded
onto cotton fabrics. Different characterization techniques were used to analyse the treated fabrics.
It was concluded from the study that the SA–TSA nanoparticles exhibit high potential to be used as a
non-leaching agent imparting robust antimicrobial characteristics to the studied cotton fabrics [144].
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The new generation of medical textiles marks the field of expansion for scientists and researchers [145].
The current dressings are non-toxic, bacteriostatic, antiviral, non-allergic, hemostatic, highly absorbent
and, above all, biocompatible. It is possible to modify them so that they contain medicines with
some mechanical properties. Current textile materials in modern packaging are also highly diverse.
These include tapes, fabrics, non-woven fabrics, knitted fabrics, composite materials [16,146]. Lignin
and cellulose [147,148] are the most abundant natural polymers available as by-products of various
industries. Recent scientific reports show that lignin is increasingly used as an essential component of
hydrogels [149]. This allows for the creation of various types of materials, especially in the medical or
pharmaceutical sector [150]. It is also possible to add additives to dressings such as odor absorbing,
soothing pain and irritation.
 
Figure 7. Various applied applications of alginate based hydrogels [135]. Reprinted with permission
from Ref. [135]. Copyright Elsevier, 2018.
Nanofibres are being used in the treatment of wounds due to interesting properties such as fiber
diameter at the nanoscale, porosity, low weight. Polymers from various natural resources are attracting
the attention of more and more scientists for exploring their use in wide range of application [151–153].
Nanofibers of alginates were created by electrospinning in the presence of various synthetic
polymers and surfactants [154]. The electrospinning process has been used inexpensively by an
efficient technique for the production of nanofibers with the use of biopolymers and other organic
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substances used in medicine and pharmaceuticals [93,155]. This technique is used to create dressings,
drug delivery systems and scaffolds in tissue engineering. The electrospinning creates ultrathin fibers,
collected in a random set [156]. The mats that are created during this process are used as wound
dressings, catalytic carriers and nanocomposites with many applications [99]. The versatility of the
electrospinning technique is so developed that it allows for its use in drug delivery systems and
the creation of poly (lactide-co-glycolide) scaffolds, which allows the permanent release of the drug
from nanofibres while maintaining their structure and biological activity [86,157]. Nanofibres have
also been used in the chemical field as catalysts, sensors and chemical and physical adsorbents. Still,
most popular is the use of unique properties of nanofibers prepared using different biopolymers
via electrospinning [158]. Several materials have been commercialized under different trademarks
such as Coalgan from Brothier Laboratories (France), which is sold as an haemostatic fibers pad
for nosebleeds; Algosteril® or Sorban® are also non-woven dressing absorbing rapidly and retains
wound fluid resulting in haemostasis and accelerates wound healing. Alginate based hydrogels were
also synthesized and used as novel platform for in situ preparation of metal–organic framework
[MOF] [159]. In order to establish the feasibility of the synthesis technique, the Hong Kong University
of Science and Technology-1 [HKUST-1] –alginate composite was selected as a model system. Figure 8
shows the schematic for the preparation of the MOF–alginate composite and Figure 9 displays the
cross-section backscattered electron images. It was concluded from the study that MOF particles can
be incorporated into the alginate substrates and for in situ MOF growth, the metal ion cross-linked
alginate hydrogels provided outstanding templates.
 
Figure 8. (A) Schematic of the preparation of the MOF–alginate composite. Photographs of (B) alginate
hydrogels cross-linked by Cu2+ right after the addition of a sodium alginate aqueous solution to a
Cu2+ aqueous solution, (C) alginate hydrogels cross-linked by Cu2+ after being washed with water
and ethanol, and (D) HKUST-1–alginate hydrogels [159]. Reprinted with permission from Ref. [159].
Copyright American Chemical Society, 2016.
284
Nanomaterials 2019, 9, 404
 
Figure 9. Cross-section backscattered electron images of (A) HKUST-1– and (B) ZIF-67–alginate
composites and their corresponding EDX elemental maps (scale bar of 60 μm). (C) Chemical
composition of sodium alginate, HKUST-1, and ZIF-67. Schematic of the formation of (D) the
HKUST-1–alginate composite, (E) the ZIF-67–alginate composite, and (F) the “egg-box” model of
metal ion cross-linked alginate [159]. Reprinted with permission from Ref. [159]. Copyright American
Chemical Society, 2016.
Smart Biopolymers
Intelligent biopolymers are becoming more and more attractive in biotechnology and medicine,
as well as in packaging [160,161]. They are used in biomedicine and tissue engineering. Intelligent
biopolymers have been reported to play an important role in drug delivery [22,162,163]. They are easy
to produce, are a good carrier of nutrients and maintain the stability of the drug [150,164]. It is possible
to inject them in vitro as a liquid and they can form a gel at body temperature. Thermosensitive
polymers are used to solubilize hydrophobic drugs and are used in the production of preparations
with low solubility drugs as a drug carrier. The use of intelligent polymers for drug delivery is
promising in view of the mechanism of drug release observed [165]. External and internal stimuli that
affect the mechanism include temperature, light irradiation, electric current and intelligent hydrogels
that can immobilize enzymes have the ability to gel by phase transition [165]. The chemical signal
translates into a mechanical signal causing shrinking or swelling of the gel. This phenomenon is
used for the controlled release of the drug. The diffusion of the drug from the beads depends on the
condition of the gel [166]. The intelligent polymer is generally integrated with a wall microcapsule
or a liposome lipid bilayer. The conformational transition of the polymer affects the integrity of the
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microcapsule or liposome and allows controlled release of the drug incorporated into the microcapsule
or liposome [167].
Thanks to the use of drugs released in hydrogels, pharmaceutical aspects can increase productivity,
profitability and wide range of applications [70]. One example of an insulin delivery system is a
hydrogel comprising an insulin-containing reservoir within a poly (methacrylic acid-g-ethylene glycol)
copolymer in which glucose oxidase was immobilized [168,169]. Currently, there is a limited research
on fluorinated polymers as a drug carrier in drug delivery applications. Polymer membranes have
been used as passive materials for drug release due to their ability to be hydrophilic to hydrophobic
in surface wettability. The characteristics of the process are reversible and can go to the initial
state [170,171]. The use of lipid based biopolymers for cancer therapy has been recently reviewed [172].
In this article, authors have focused on the advantageous biologic and physicochemical characteristics
including controlled drug release, long circulatory half-lives and facile targeted therapy of the natural
and synthetic lipid.
4. Summary and Future Prospective
Packaging plays an imperative role in supply chain and has received great attention
in number of industries. However, the existing packaging systems are primarily based on
synthetic polymers/plastics from fossil resources. Seeing the issues associated with the synthetic
polymers/plastics, biomedical and pharmaceutical industries in particular all around the globe are
looking for new bio-based sustainable packaging materials that can extend the shelf life of these
materials due to the environmental and health issues associated with traditional packaging waste.
Increasing the use of sustainable polymeric materials in packaging could address such concerns.
The main goals of polymer researchers in the development of new medical and pharmaceutical
materials are associated with a reduction in the risk of disease transmission and the spread of infections.
The search for new effective antimicrobial dressing materials is constantly growing. Electrospinning
is being used in medicine for the production of non-woven structures at the nanoscale. In the
electrospinning process, the chemical and physical parameters of the obtained nanofibre mats can be
adjusted by dressing the appropriate materials and parameters of the process. The electrospinning
process is also influenced by nanoparticles of various natural materials and biopolymers. The addition
of natural nanomaterials affects the morphology and size of the electrospun fibre. Along with alginate,
the other biopolymers being used in the electrospinning technique include hyaluronic acid, cellulose,
silk, gelatin and collagen, to name a few. The mixture of biopolymers and synthetic polymers is
also used to create the novel biomaterials with specific properties such as mechanical resistance,
thermal stability and barrier resistance. Mixtures with natural polymers may also affect the structural,
morphological and subsequent degradation properties of the electrospun fibers
The treatment of disease states with the help of biologically active materials created with the
help of electrospun nanofibers is part of modern regenerative medicine. The use of natural materials
such as plant oils and extracts means that the nonwovens created in the electrospinning process find
many applications with safety of use. It is of great importance that it is possible to optimize process
conditions and create nanofibers that meet specific requirements. Among the various materials studied,
alginate has very high potential for packaging applications and is being seen as the future of packaging
materials. However, a very limited study has been carried out on the use of Alginate based electrospun
mats for packing application, and to realize its real potential an extensive study in this direction
is needed.
Author Contributions: Conceptualization, J.W-K., T.R., I.M-P., and V.K.T.; investigation, J.W-K., T.R., I.M-P.,
and V.K.T.; writing-original draft preparation, J.W-K., T.R., I.M-P., and V.K.T.; visualization, J.W-K., T.R., I.M-P.,
and V.K.T.
Funding: V.K.T. wish to acknowledge and thank the British Council for the support of this work through a UKIERI
grant (No. DST /INTUK/P-164/2017).
Conflicts of Interest: The authors declare no conflict of interest.
286
Nanomaterials 2019, 9, 404
References
1. Cazón, P.; Velazquez, G.; Ramírez, J.A.; Vázquez, M. Polysaccharide-based films and coatings for food
packaging: A review. Food Hydrocoll. 2017, 68, 136–148. [CrossRef]
2. Gomez-Estaca, J.; Gavara, R.; Catala, R.; Hernandez-Munoz, P. The Potential of Proteins for Producing Food
Packaging Materials: A Review. Packag. Technol. Sci. 2016, 29, 203–224. [CrossRef]
3. Hambleton, A.; Debeaufort, F.; Bonnotte, A.; Voilley, A. Influence of alginate emulsion-based films structure
on its barrier properties and on the protection of microencapsulated aroma compound. Food Hydrocoll. 2009,
23, 2116–2124. [CrossRef]
4. Khalil, H.P.S.A.; Davoudpour, Y.; Saurabh, C.K.; Hossain, M.S.; Adnan, A.S.; Dungani, R.; Paridah, M.T.;
Sarker, M.Z.I.; Fazita, M.R.N.; Syakir, M.I.; et al. A review on nanocellulosic fibres as new material for
sustainable packaging: Process and applications. Renew. Sustain. Energy Rev. 2016, 64, 823–836. [CrossRef]
5. da Silva, F.T.; da Cunha, K.F.; Fonseca, L.M.; Antunes, M.D.; Mello El Halal, S.L.; Fiorentini, A.M.;
da Rosa Zavareze, E.; Guerra Dias, A.R. Action of ginger essential oil (Zingiber officinale) encapsulated
in proteins ultrafine fibers on the antimicrobial control in situ. Int. J. Biol. Macromol. 2018, 118, 107–115.
[CrossRef] [PubMed]
6. Kuntzler, S.G.; Vieira Costa, J.A.; de Morais, M.G. Development of electrospun nanofibers containing
chitosan/PEO blend and phenolic compounds with antibacterial activity. Int. J. Biol. Macromol. 2018, 117,
800–806. [CrossRef] [PubMed]
7. Kwon, H.; Kim, D.; Lee, K.; Seo, J.; Lee, H.-J. The Effect of Coating Process and Additives on EVA Coated
Tyvek (R) for Gas Sterilizable Medical Packaging Applications. Packag. Technol. Sci. 2017, 30, 195–208.
[CrossRef]
8. Lauriano Souza, V.G.; Fernando, A.L. Nanoparticles in food packaging: Biodegradability and potential
migration to food—A review. Food Packag. Shelf Life 2016, 8, 63–70. [CrossRef]
9. Wróblewska-Krepsztul, J.; Rydzkowski, T.; Borowski, G.; Szczypiński, M.; Klepka, T.; Thakur, V.K.
Recent progress in biodegradable polymers and nanocomposite-based packaging materials for sustainable
environment. Int. J. Polym. Anal. Charact. 2018, 23, 383–395. [CrossRef]
10. Mercante, L.A.; Scagion, V.P.; Migliorini, F.L.; Mattoso, L.H.C.; Correa, D.S. Electrospinning-based
(bio)sensors for food and agricultural applications: A review. TrAC Trends Anal. Chem. 2017, 91, 91–103.
[CrossRef]
11. Thakur, S.; Chaudhary, J.; Sharma, B.; Verma, A.; Tamulevicius, S.; Thakur, V.K. Sustainability of bioplastics:
Opportunities and challenges. Curr. Opin. Green Sustain. Chem. 2018, 13, 68–75. [CrossRef]
12. Shao, P.; Niu, B.; Chen, H.; Sun, P. Fabrication and characterization of tea polyphenols loaded pullulan-CMC
electrospun nanofiber for fruit preservation. Int. J. Biol. Macromol. 2018, 107, 1908–1914. [CrossRef] [PubMed]
13. Ochoa, M.; Collazos, N.; Le, T.; Subramaniam, R.; Sanders, M.; Singh, R.P.; Depan, D. Nanocellulose-PE-
b-PEG copolymer nanohybrid shish-kebab structure via interfacial crystallization. Carbohydr. Polym. 2017,
159, 116–124. [CrossRef] [PubMed]
14. Depan, D.; Misra, R.D.K. Hybrid Nanoscale Architecture of Wound Dressing with Super Hydrophilic,
Antimicrobial, and Ultralow Fouling Attributes. J. Biomed. Nanotechnol. 2015, 11, 306–318. [CrossRef]
[PubMed]
15. Singha, A.S.; Thakur, V.K. Synthesis and Characterization of Pine Needles Reinforced RF Matrix Based
Biocomposites. J. Chem. 2008, 5, 1055–1062. [CrossRef]
16. Thakur, V.K.; Singha, A.S. Mechanical and Water Absorption Properties of Natural Fibers/Polymer
Biocomposites. Polym.-Plast. Technol. Eng. 2010, 49, 694–700. [CrossRef]
17. Antunes, M.D.; da Silva Dannenberg, G.; Fiorentini, A.M.; Pinto, V.Z.; Lim, L.-T.; da Rosa Zavareze, E.;
Guerra Dias, A.R. Antimicrobial electrospun ultrafine fibers from zein containing eucalyptus essential
oil/cyclodextrin inclusion complex. Int. J. Biol. Macromol. 2017, 104, 874–882. [CrossRef] [PubMed]
18. Kurd, F.; Fathi, M.; Shekarchizadeh, H. Basil seed mucilage as a new source for electrospinning: Production
and physicochemical characterization. Int. J. Biol. Macromol. 2017, 95, 689–695. [CrossRef] [PubMed]
19. Kohsari, I.; Shariatinia, Z.; Pourmortazavi, S.M. Antibacterial electrospun chitosan-polyethylene oxide
nanocomposite mats containing ZIF-8 nanoparticles. Int. J. Biol. Macromol. 2016, 91, 778–788. [CrossRef]
[PubMed]
287
Nanomaterials 2019, 9, 404
20. Miculescu, F.; Maidaniuc, A.; Voicu, S.I.; Thakur, V.K.; Stan, G.E.; Ciocan, L.T. Progress in Hydroxyapatite–
Starch Based Sustainable Biomaterials for Biomedical Bone Substitution Applications. ACS Sustain.
Chem. Eng. 2017, 5, 8491–8512. [CrossRef]
21. Pandele, A.M.; Comanici, F.E.; Carp, C.A.; Miculescu, F.; Voicu, S.I.; Thakur, V.K.; Serban, B.C. Synthesis
and characterization of cellulose acetate-hydroxyapatite micro and nano composites membranes for water
purification and biomedical applications. Vacuum 2017, 144, 599–605. [CrossRef]
22. Corobea, M.C.; Muhulet, O.; Miculescu, F.; Antoniac, I.V.; Vuluga, Z.; Florea, D.; Vuluga, D.M.; Butnaru, M.;
Ivanov, D.; Voicu, S.I.; et al. Novel nanocomposite membranes from cellulose acetate and clay-silica
nanowires. Polym. Adv. Technol. 2016, 27, 1586–1595. [CrossRef]
23. Pandele, A.M.; Neacsu, P.; Cimpean, A.; Staras, A.I.; Miculescu, F.; Iordache, A.; Voicu, S.I.; Thakur, V.K.;
Toader, O.D. Cellulose acetate membranes functionalized with resveratrol by covalent immobilization for
improved osseointegration. Appl. Surf. Sci. 2018, 438, 2–13. [CrossRef]
24. Van de Walle, E.; Van Nieuwenhove, I.; Vanderleyden, E.; Declercq, H.; Gellynck, K.; Schaubroeck, D.;
Ottevaere, H.; Thienpont, H.; De Vos, W.H.; Cornelissen, M.; et al. Polydopamine-Gelatin as Universal
Cell-Interactive Coating for Methacrylate-Based Medical Device Packaging Materials: When Surface
Chemistry Overrules Substrate Bulk Properties. Biomacromolecules 2016, 17, 56–68. [CrossRef] [PubMed]
25. Rogina-Car, B.; Grgac, S.F.; Katovic, D. Physicochemical Characterization of the Multiuse Medical Textiles in
Surgery and as Packaging Material in Medical Sterilization. Autex Res. J. 2017, 17, 206–212. [CrossRef]
26. Rowson, J.; Sangrar, A.; Rodriguez-Falcon, E.; Bell, A.F.; Walton, K.A.; Yoxall, A.; Kamat, S.R. Rating
Accessibility of Packaging: A Medical Packaging Example. Packag. Technol. Sci. 2016, 29, 607. [CrossRef]
27. Kale, R.D.; Gorade, V.G.; Madye, N.; Chaudhary, B.; Bangde, P.S.; Dandekar, P.P. Preparation and
characterization of biocomposite packaging film from poly(lactic acid) and acylated microcrystalline cellulose
using rice bran oil. Int. J. Biol. Macromol. 2018, 118, 1090–1102. [CrossRef] [PubMed]
28. Nasajpour, A.; Mandla, S.; Shree, S.; Mostafavi, E.; Sharifi, R.; Khalilpour, A.; Saghazadeh, S.; Hassan, S.;
Mitchell, M.J.; Leijten, J.; et al. Nanostructured Fibrous Membranes with Rose Spike-Like Architecture.
Nano Lett. 2017, 17, 6235–6240. [CrossRef] [PubMed]
29. Muhulet, A.; Miculescu, F.; Voicu, S.I.; Schütt, F.; Thakur, V.K.; Mishra, Y.K. Fundamentals and scopes of
doped carbon nanotubes towards energy and biosensing applications. Mater. Today Energy 2018, 9, 154–186.
[CrossRef]
30. Thakur, S.; Sharma, B.; Verma, A.; Chaudhary, J.; Tamulevicius, S.; Thakur, V.K. Recent approaches in guar
gum hydrogel synthesis for water purification. Int. J. Polym. Anal. Charact. 2018, 23, 621–632. [CrossRef]
31. Nasajpour, A.; Ansari, S.; Rinoldi, C.; Rad, A.S.; Aghaloo, T.; Shin, S.R.; Mishra, Y.K.; Adelung, R.;
Swieszkowski, W.; Annabi, N.; et al. Tissue Regeneration: A Multifunctional Polymeric Periodontal
Membrane with Osteogenic and Antibacterial Characteristics (Adv. Funct. Mater. 3/2018). Adv. Funct. Mater.
2018, 28, 1870021. [CrossRef]
32. Jayakumar, R.; Prabaharan, M.; Nair, S.V.; Tamura, H. Novel chitin and chitosan nanofibers in biomedical
applications. Biotechnol. Adv. 2010, 28, 142–150. [CrossRef] [PubMed]
33. Thakur, V.K.; Thakur, M.K. Recent Advances in Graft Copolymerization and Applications of Chitosan:
A Review. ACS Sustain. Chem. Eng. 2014, 2, 2637–2652. [CrossRef]
34. Thakur, V.K.; Voicu, S.I. Recent advances in cellulose and chitosan based membranes for water purification:
A concise review. Carbohydr. Polym. 2016, 146, 148–165. [CrossRef] [PubMed]
35. Xi, H.; Zhao, H. Silk fibroin coaxial bead-on-string fiber materials and their drug release behaviors in different
pH. J. Mater. Sci. 2019, 54, 4246–4258. [CrossRef]
36. Voicu, S.I.; Condruz, R.M.; Mitran, V.; Cimpean, A.; Miculescu, F.; Andronescu, C.; Miculescu, M.; Thakur, V.K.
Sericin Covalent Immobilization onto Cellulose Acetate Membrane for Biomedical Applications. ACS Sustain.
Chem. Eng. 2016, 4, 1765–1774. [CrossRef]
37. Wenk, E.; Wandrey, A.J.; Merkle, H.P.; Meinel, L. Silk fibroin spheres as a platform for controlled drug
delivery. J. Control. Release 2008, 132, 26–34. [CrossRef] [PubMed]
38. Valentini, L.; Bon, S.B.; Pugno, N.M. Combining Living Microorganisms with Regenerated Silk Provides
Nanofibril-Based Thin Films with Heat-Responsive Wrinkled States for Smart Food Packaging. Nanomaterials
2018, 8, 518. [CrossRef] [PubMed]
39. Bedford, N.M.; Steckl, A.J. Photocatalytic Self Cleaning Textile Fibers by Coaxial Electrospinning. ACS Appl.
Mater. Interfaces 2010, 2, 2448–2455. [CrossRef]
288
Nanomaterials 2019, 9, 404
40. Montalban, M.G.; Coburn, J.M.; Abel Lozano-Perez, A.; Cenis, J.L.; Villora, G.; Kaplan, D.L. Production of
Curcumin-Loaded Silk Fibroin Nanoparticles for Cancer Therapy. Nanomaterials 2018, 8, 126. [CrossRef]
[PubMed]
41. Zhou, C.-Z.; Confalonieri, F.; Jacquet, M.; Perasso, R.; Li, Z.-G.; Janin, J. Silk fibroin: Structural implications of
a remarkable amino acid sequence. Proteins Struct. Funct. Bioinform. 2001, 44, 119–122. [CrossRef] [PubMed]
42. Cai, Z.; Mo, X.; Zhang, K.; Fan, L.; Yin, A.; He, C.; Wang, H. Fabrication of Chitosan/Silk Fibroin Composite
Nanofibers for Wound-dressing Applications. Int. J. Mol. Sci. 2010, 11, 3529–3539. [CrossRef] [PubMed]
43. Chen, Z.G.; Wang, P.W.; Wei, B.; Mo, X.M.; Cui, F.Z. Electrospun collagen–chitosan nanofiber: A biomimetic
extracellular matrix for endothelial cell and smooth muscle cell. Acta Biomater. 2010, 6, 372–382. [CrossRef]
[PubMed]
44. Cho, M.K.; Singu, B.S.; Na, Y.H.; Yoon, K.R. Fabrication and characterization of double-network
agarose/polyacrylamide nanofibers by electrospinning. J. Appl. Polym. Sci. 2016, 133. [CrossRef]
45. Hu, W.-W.; Lin, C.-H.; Hong, Z.-J. The enrichment of cancer stem cells using composite
alginate/polycaprolactone nanofibers. Carbohydr. Polym. 2019, 206, 70–79. [CrossRef] [PubMed]
46. Wang, J.; Salem, D.R.; Sani, R.K. Extremophilic exopolysaccharides: A review and new perspectives on
engineering strategies and applications. Carbohydr. Polym. 2019, 205, 8–26. [CrossRef] [PubMed]
47. Iqbal, N.; Khan, A.S.; Asif, A.; Yar, M.; Haycock, J.W.; Rehman, I.U. Recent concepts in biodegradable
polymers for tissue engineering paradigms: A critical review. Int. Mater. Rev. 2019, 64, 91–126. [CrossRef]
48. Clark, C.M.; Bottomley, L.; Jackson, P. The development of a training package for community pharmacists
focused on medicines use review in common skin diseases. Pharm. World Sci. 2008, 30, 377–378.
49. Lorenzini, G.C.; Hellstrom, D. Medication Packaging and Older Patients: A Systematic Review. Packag.
Technol. Sci. 2017, 30, 525–558. [CrossRef]
50. Jenke, D. Evaluation of the chemical compatibility of plastic contact materials and pharmaceutical products;
safety considerations related to extractables and leachables. J. Pharm. Sci. 2007, 96, 2566–2581. [CrossRef]
[PubMed]
51. Maitz, M.F. Applications of synthetic polymers in clinical medicine. Biosurf. Biotribol. 2015, 1, 161–176.
[CrossRef]
52. Jenke, D.R. Extractables and leachables considerations for prefilled syringes. Expert Opin. Drug Deliv. 2014,
11, 1591–1600. [CrossRef] [PubMed]
53. Sampson, J.; de Korte, D. DEHP-plasticised PVC: Relevance to blood services. Transfus. Med. Oxf. Engl. 2011,
21, 73–83. [CrossRef] [PubMed]
54. Frank, R.D.; Müller, U.; Lanzmich, R.; Groeger, C.; Floege, J. Anticoagulant-free Genius haemodialysis using
low molecular weight heparin-coated circuits. Nephrol. Dial. Transplant. 2006, 21, 1013–1018. [CrossRef]
[PubMed]
55. Hornsey, V.S.; McColl, K.; Drummond, O.; Macgregor, I.R.; Prowse, C.V. Platelet storage in Fresenius/NPBI
polyolefin and BTHC-PVC bags: A direct comparison. Transfus. Med. Oxf. Engl. 2008, 18, 223–227. [CrossRef]
[PubMed]
56. Kretschmer, V.; Marschall, R.; Schulzki, T.; Härtel, B.; Neumann, H.J. New polyolefin foil for 5-day storage of
platelet concentrates (PC) collected by apheresis. Transfus. Med. Hemother. 1992, 19, 141–144. [CrossRef]
57. Sunohara, T.; Masuda, T. Cellulose triacetate as a high-performance membrane. Contrib. Nephrol. 2011, 173,
156–163. [PubMed]
58. Miculescu, M.; Thakur, V.K.; Miculescu, F.; Voicu, S.I. Graphene-based polymer nanocomposite membranes:
A review. Polym. Adv. Technol. 2016, 27, 844–859. [CrossRef]
59. Johnson, D.G.; Khire, T.S.; Lyubarskaya, Y.L.; Smith, K.J.P.; Desormeaux, J.-P.S.; Taylor, J.G.; Gaborski, T.R.;
Shestopalov, A.A.; Striemer, C.C.; McGrath, J.L. Ultrathin silicon membranes for wearable dialysis.
Adv. Chronic Kidney Dis. 2013, 20, 508–515. [CrossRef] [PubMed]
60. Venkatesan, N.; Shroff, S.; Jayachandran, K.; Doble, M. Polymers as ureteral stents. J. Endourol. 2010, 24,
191–198. [CrossRef] [PubMed]
61. Fernando, I.P.S.; Kim, D.; Nah, J.-W.; Jeon, Y.-J. Advances in functionalizing fucoidans and alginates
(bio)polymers by structural modifications: A review. Chem. Eng. J. 2019, 355, 33–48. [CrossRef]
62. Bayer, I.S. Thermomechanical Properties of Polylactic Acid-Graphene Composites: A State-of-the-Art Review
for Biomedical Applications. Materials 2017, 10, 748. [CrossRef] [PubMed]
289
Nanomaterials 2019, 9, 404
63. Gunathilake, T.M.S.U.; Ching, Y.C.; Ching, K.Y.; Chuah, C.H.; Abdullah, L.C. Biomedical and Microbiological
Applications of Bio-Based Porous Materials: A Review. Polymers 2017, 9, 160. [CrossRef]
64. Gigli, M.; Fabbri, M.; Lotti, N.; Gamberini, R.; Rimini, B.; Munari, A. Poly(butylene succinate)-based
polyesters for biomedical applications: A review. Eur. Polym. J. 2016, 75, 431–460. [CrossRef]
65. Dubey, S.P.; Thakur, V.K.; Krishnaswamy, S.; Abhyankar, H.A.; Marchante, V.; Brighton, J.L. Progress in
environmental-friendly polymer nanocomposite material from PLA: Synthesis, processing and applications.
Vacuum 2017, 146, 655–663. [CrossRef]
66. Madhumitha, G.; Fowsiya, J.; Roopan, S.M.; Thakur, V.K. Recent advances in starch–clay nanocomposites.
Int. J. Polym. Anal. Charact. 2018, 23, 331–345. [CrossRef]
67. Coscia, M.G.; Bhardwaj, J.; Singh, N.; Santonicola, M.G.; Richardson, R.; Thakur, V.K.; Rahatekar, S.
Manufacturing & characterization of regenerated cellulose/curcumin based sustainable composites fibers
spun from environmentally benign solvents. Ind. Crop. Prod. 2018, 111, 536–543.
68. Thakur, V.K.; Singha, A.S. Rapid Synthesis, Characterization, and Physicochemical Analysis of
Biopolymer-Based Graft Copolymers. Int. J. Polym. Anal. Charact. 2011, 16, 153–164. [CrossRef]
69. Jones, O.G.; McClements, D.J. Functional Biopolymer Particles: Design, Fabrication, and Applications.
Compr. Rev. Food Sci. Food Saf. 2010, 9, 374–397. [CrossRef]
70. Reakasame, S.; Boccaccini, A.R. Oxidized Alginate-Based Hydrogels for Tissue Engineering Applications:
A Review. Biomacromolecules 2018, 19, 3–21. [CrossRef] [PubMed]
71. Aguero, L.; Zaldivar-Silva, D.; Pena, L.; Dias, M.L. Alginate microparticles as oral colon drug delivery device:
A review. Carbohydr. Polym. 2017, 168, 32–43. [CrossRef] [PubMed]
72. Draget, K.I.; Taylor, C. Chemical, physical and biological properties of alginates and their biomedical
implications. Food Hydrocoll. 2011, 25, 251–256. [CrossRef]
73. Zia, K.M.; Zia, F.; Zuber, M.; Rehman, S.; Ahmad, M.N. Alginate based polyurethanes: A review of recent
advances and perspective. Int. J. Biol. Macromol. 2015, 79, 377–387. [CrossRef] [PubMed]
74. Venkatesan, J.; Bhatnagar, I.; Manivasagan, P.; Kang, K.-H.; Kim, S.-K. Alginate composites for bone tissue
engineering: A review. Int. J. Biol. Macromol. 2015, 72, 269–281. [CrossRef] [PubMed]
75. Saltz, A.; Kandalam, U. Mesenchymal stem cells and alginate microcarriers for craniofacial bone tissue
engineering: A review. J. Biomed. Mater. Res. A 2016, 104, 1276–1284. [CrossRef] [PubMed]
76. Pawar, S.N.; Edgar, K.J. Alginate derivatization: A review of chemistry, properties and applications.
Biomaterials 2012, 33, 3279–3305. [CrossRef] [PubMed]
77. You, J.-O.; Park, S.-B.; Park, H.-Y.; Haam, S.; Chung, C.-H.; Kim, W.-S. Preparation of regular sized Ca-alginate
microspheres using membrane emulsification method. J. Microencapsul. 2001, 18, 521–532. [PubMed]
78. de Vos, P.; Faas, M.M.; Strand, B.; Calafiore, R. Alginate-based microcapsules for immunoisolation of
pancreatic islets. Biomaterials 2006, 27, 5603–5617. [CrossRef] [PubMed]
79. Hecht, H.; Srebnik, S. Structural Characterization of Sodium Alginate and Calcium Alginate.
Biomacromolecules 2016, 17, 2160–2167. [CrossRef] [PubMed]
80. Lee, K.Y.; Mooney, D.J. Alginate: Properties and biomedical applications. Prog. Polym. Sci. 2012, 37, 106–126.
[CrossRef] [PubMed]
81. Yang, J.-S.; Xie, Y.-J.; He, W. Research progress on chemical modification of alginate: A review. Carbohydr.
Polym. 2011, 84, 33–39. [CrossRef]
82. Bhat, S.D.; Aminabhavi, T.M. Pervaporation separation using sodium alginate and its modified
membranes—A review. Sep. Purif. Rev. 2007, 36, 203–229. [CrossRef]
83. Franklin, M.J.; Ohman, D.E. Mutant analysis and cellular localization of the AlgI, AlgJ, and AlgF proteins
required for O acetylation of alginate in Pseudomonas aeruginosa. J. Bacteriol. 2002, 184, 3000–3007. [CrossRef]
[PubMed]
84. El-Sherbiny, I.M. Enhanced pH-responsive carrier system based on alginate and chemically modified
carboxymethyl chitosan for oral delivery of protein drugs: Preparation and in-vitro assessment.
Carbohydr. Polym. 2010, 80, 1125–1136. [CrossRef]
85. Rinaudo, M. Biomaterials based on a natural polysaccharide: Alginate. TIP 2014, 17, 92–96. [CrossRef]
86. Soares, R.M.D.; Siqueira, N.M.; Prabhakaram, M.P.; Ramakrishna, S. Electrospinning and electrospray of
bio-based and natural polymers for biomaterials development. Mater. Sci. Eng. C-Mater. Biol. Appl. 2018, 92,
969–982. [CrossRef] [PubMed]
290
Nanomaterials 2019, 9, 404
87. Lutz, M.; Engelbrecht, L.; Laurie, A.; Dyayiya, N. Using CLEM to investigate the distribution of nano-sized
antimicrobial agents within an EVOH matrix. Int. J. Polym. Anal. Charact. 2018, 23, 300–312. [CrossRef]
88. Miguel, S.P.; Figueira, D.R.; Simoes, D.; Ribeiro, M.P.; Coutinho, P.; Ferreira, P.; Correia, I.J. Electrospun
polymeric nanofibres as wound dressings: A review. Colloids Surf. B-Biointerfaces 2018, 169, 60–71. [CrossRef]
[PubMed]
89. DeFrates, K.G.; Moore, R.; Borgesi, J.; Lin, G.; Mulderig, T.; Beachley, V.; Hu, X. Protein-Based Fiber Materials
in Medicine: A Review. Nanomaterials 2018, 8, 457. [CrossRef] [PubMed]
90. Jakobsson, A.; Ottosson, M.; Zalis, M.C.; O’Carroll, D.; Johansson, U.E.; Johansson, F. Three-dimensional
functional human neuronal networks in uncompressed low-density electrospun fiber scaffolds.
Nanomed. Nanotechnol. Biol. Med. 2017, 13, 1563–1573. [CrossRef] [PubMed]
91. Venugopal, J.; Zhang, Y.Z.; Ramakrishna, S. Electrospun nanofibres: Biomedical applications. Proc. Inst.
Mech. Eng. Part N J. Nanoeng. Nanosyst. 2004, 218, 35–45. [CrossRef]
92. Hassan, M.K.; Abukmail, A.; Hassiba, A.J.; Mauritz, K.A.; Elzatahry, A.A. PVA/Chitosan/Silver
Nanoparticles Electrospun Nanocomposites: Molecular Relaxations Investigated by Modern Broadband
Dielectric Spectroscopy. Nanomaterials 2018, 8, 888. [CrossRef] [PubMed]
93. Cheng, J.; Jun, Y.; Qin, J.; Lee, S.-H. Electrospinning versus microfluidic spinning of functional fibers for
biomedical applications. Biomaterials 2017, 114, 121–143. [CrossRef] [PubMed]
94. Olsson, R.T.; Kraemer, R.; López-Rubio, A.; Torres-Giner, S.; Ocio, M.J.; Lagarón, J.M. Extraction of
Microfibrils from Bacterial Cellulose Networks for Electrospinning of Anisotropic Biohybrid Fiber Yarns.
Macromolecules 2010, 43, 4201–4209. [CrossRef]
95. Reneker, D.H.; Yarin, A.L. Electrospinning jets and polymer nanofibers. Polymer 2008, 49, 2387–2425.
[CrossRef]
96. Alehosseini, A.; Ghorani, B.; Sarabi-Jamab, M.; Tucker, N. Principles of electrospraying: A new approach
in protection of bioactive compounds in foods. Crit. Rev. Food Sci. Nutr. 2018, 58, 2346–2363. [CrossRef]
[PubMed]
97. Akhgari, A.; Shakib, Z.; Sanati, S. A review on electrospun nanofibers for oral drug delivery. Nanomed. J.
2017, 4, 197–207.
98. Kitsara, M.; Agbulut, O.; Kontziampasis, D.; Chen, Y.; Menasche, P. Fibers for hearts: A critical review on
electrospinning for cardiac tissue engineering. Acta Biomater. 2017, 48, 20–40. [CrossRef] [PubMed]
99. Jesus Villarreal-Gomez, L.; Manuel Cornejo-Bravo, J.; Vera-Graziano, R.; Grande, D. Electrospinning as a
powerful technique for biomedical applications: A critically selected survey. J. Biomater. Sci.-Polym. Ed. 2016,
27, 157–176. [CrossRef] [PubMed]
100. Pham, Q.P.; Sharma, U.; Mikos, A.G. Electrospinning of polymeric nanofibers for tissue engineering
applications: A review. Tissue Eng. 2006, 12, 1197–1211. [CrossRef] [PubMed]
101. Asghari, F.; Samiei, M.; Adibkia, K.; Akbarzadeh, A.; Davaran, S. Biodegradable and biocompatible polymers
for tissue engineering application: A review. Artif. Cells Nanomed. Biotechnol. 2017, 45, 185–192. [CrossRef]
[PubMed]
102. Khorshidi, S.; Solouk, A.; Mirzadeh, H.; Mazinani, S.; Lagaron, J.M.; Sharifi, S.; Ramakrishna, S. A review of
key challenges of electrospun scaffolds for tissue-engineering applications. J. Tissue Eng. Regen. Med. 2016,
10, 715–738. [CrossRef] [PubMed]
103. Sharma, J.; Zhang, X.; Sarker, T.; Yan, X.; Washburn, L.; Qu, H.; Guo, Z.; Kucknoor, A.; Wei, S. Biocompatible
electrospun tactic poly(methyl methacrylate) blend fibers. Polymer 2014, 55, 3261–3269. [CrossRef]
104. Cheng, H.; Yang, X.; Che, X.; Yang, M.; Zhai, G. Biomedical application and controlled drug release of
electrospun fibrous materials. Mater. Sci. Eng. C-Mater. Biol. Appl. 2018, 90, 750–763. [CrossRef] [PubMed]
105. Munteanu, B.S.; Vasile, C. Antioxidant, antibacterial/antifungal nanostructures for medical and food
packaging applications. J. Nanosci. Nanomed. 2017, 1, 15–20.
106. Al-Enizi, A.M.; Zagho, M.M.; Elzatahry, A.A. Polymer-Based Electrospun Nanofibers for Biomedical
Applications. Nanomaterials 2018, 8, 259. [CrossRef] [PubMed]
107. Hassiba, A.J.; El Zowalaty, M.E.; Nasrallah, G.K.; Webster, T.J.; Luyt, A.S.; Abdullah, A.M.; Elzatahry, A.A.
Review of recent research on biomedical applications of electrospun polymer nanofibers for improved
wound healing. Nanomedicine 2016, 11, 715–737. [CrossRef] [PubMed]
108. Son, W.K.; Youk, J.H.; Park, W.H. Antimicrobial cellulose acetate nanofibers containing silver nanoparticles.
Carbohydr. Polym. 2006, 65, 430–434. [CrossRef]
291
Nanomaterials 2019, 9, 404
109. Xu, X.; Zhou, M. Antimicrobial gelatin nanofibers containing silver nanoparticles. Fibers Polym. 2008, 9,
685–690. [CrossRef]
110. Sheikh, F.A.; Ju, H.W.; Lee, J.M.; Moon, B.M.; Park, H.J.; Lee, O.J.; Kim, J.-H.; Kim, D.-K.; Park, C.H. 3D
electrospun silk fibroin nanofibers for fabrication of artificial skin. Nanomed. Nanotechnol. Biol. Med. 2015, 11,
681–691. [CrossRef] [PubMed]
111. Tijing, L.D.; Ruelo, M.T.G.; Amarjargal, A.; Pant, H.R.; Park, C.-H.; Kim, C.S. One-step fabrication of
antibacterial (silver nanoparticles/poly(ethylene oxide))—Polyurethane bicomponent hybrid nanofibrous
mat by dual-spinneret electrospinning. Mater. Chem. Phys. 2012, 134, 557–561. [CrossRef]
112. Munteanu, B.S.; Aytac, Z.; Pricope, G.M.; Uyar, T.; Vasile, C. Polylactic acid (PLA)/Silver-NP/VitaminE
bionanocomposite electrospun nanofibers with antibacterial and antioxidant activity. J. Nanopart. Res. 2014,
16, 2643. [CrossRef]
113. Motealleh, B.; Zahedi, P.; Rezaeian, I.; Moghimi, M.; Abdolghaffari, A.H.; Zarandi, M.A. Morphology,
drug release, antibacterial, cell proliferation, and histology studies of chamomile-loaded wound dressing
mats based on electrospun nanofibrous poly(ε-caprolactone)/polystyrene blends. J. Biomed. Mater. Res. B
Appl. Biomater. 2014, 102, 977–987. [CrossRef] [PubMed]
114. Suganya, S.; Ram, T.S.; Lakshmi, B.S.; Giridev, V.R. Herbal drug incorporated antibacterial nanofibrous
mat fabricated by electrospinning: An excellent matrix for wound dressings. J. Appl. Polym. Sci. 2011, 121,
2893–2899. [CrossRef]
115. Cowan, M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999, 12, 564–582. [CrossRef]
[PubMed]
116. Zhang, W.; Ronca, S.; Mele, E. Electrospun Nanofibres Containing Antimicrobial Plant Extracts. Nanomaterials
2017, 7, 42. [CrossRef] [PubMed]
117. Liakos, I.; Rizzello, L.; Hajiali, H.; Brunetti, V.; Carzino, R.; Pompa, P.P.; Athanassiou, A.; Mele, E. Fibrous
wound dressings encapsulating essential oils as natural antimicrobial agents. J. Mater. Chem. B 2015, 3,
1583–1589. [CrossRef]
118. Kontogiannopoulos, K.N.; Assimopoulou, A.N.; Tsivintzelis, I.; Panayiotou, C.; Papageorgiou, V.P.
Electrospun fiber mats containing shikonin and derivatives with potential biomedical applications.
Int. J. Pharm. 2011, 409, 216–228. [CrossRef] [PubMed]
119. Kayaci, F.; Ertas, Y.; Uyar, T. Enhanced Thermal Stability of Eugenol by Cyclodextrin Inclusion Complex
Encapsulated in Electrospun Polymeric Nanofibers. J. Agric. Food Chem. 2013, 61, 8156–8165. [CrossRef]
[PubMed]
120. Archana, D.; Singh, B.K.; Dutta, J.; Dutta, P.K. In vivo evaluation of chitosan-PVP-titanium dioxide
nanocomposite as wound dressing material. Carbohydr. Polym. 2013, 95, 530–539. [CrossRef] [PubMed]
121. Saquing, C.D.; Tang, C.; Monian, B.; Bonino, C.A.; Manasco, J.L.; Alsberg, E.; Khan, S.A.
Alginate–Polyethylene Oxide Blend Nanofibers and the Role of the Carrier Polymer in Electrospinning.
Ind. Eng. Chem. Res. 2013, 52, 8692–8704. [CrossRef]
122. Kayaci, F.; Sen, H.S.; Durgun, E.; Uyar, T. Electrospun nylon 6,6 nanofibers functionalized with cyclodextrins
for removal of toluene vapor. J. Appl. Polym. Sci. 2015, 132. [CrossRef]
123. Álvarez-Paino, M.; Muñoz-Bonilla, A.; Fernández-García, M. Antimicrobial Polymers in the Nano-World.
Nanomaterials 2017, 7, 48. [CrossRef] [PubMed]
124. Zhang, J.; Wang, X.-X.; Zhang, B.; Ramakrishna, S.; Yu, M.; Ma, J.-W.; Long, Y.-Z. In Situ Assembly of
Well-Dispersed Ag Nanoparticles throughout Electrospun Alginate Nanofibers for Monitoring Human
Breath—Smart Fabrics. ACS Appl. Mater. Interfaces 2018, 10, 19863–19870. [CrossRef] [PubMed]
125. Unnithan, A.R.; Gnanasekaran, G.; Sathishkumar, Y.; Lee, Y.S.; Kim, C.S. Electrospun antibacterial
polyurethane-cellulose acetate-zein composite mats for wound dressing. Carbohydr. Polym. 2014, 102,
884–892. [CrossRef] [PubMed]
126. Cerqueira, M.A.; Jose Fabra, M.; Lorena Castro-Mayorga, J.; Bourbon, A.I.; Pastrana, L.M.; Vicente, A.A.;
Lagaron, J.M. Use of Electrospinning to Develop Antimicrobial Biodegradable Multilayer Systems:
Encapsulation of Cinnamaldehyde and Their Physicochemical Characterization. Food Bioprocess Technol.
2016, 9, 1874–1884. [CrossRef]
127. Parreidt, T.S.; Müller, K.; Schmid, M. Alginate-Based Edible Films and Coatings for Food Packaging
Applications. Foods 2018, 7, 170. [CrossRef] [PubMed]
292
Nanomaterials 2019, 9, 404
128. Goudarzi, V.; Shahabi-Ghahfarrokhi, I. Development of photo-modified starchikefiran/TiO2
bio-nanocomposite as an environmentally-friendly food packaging material. Int. J. Biol. Macromol.
2018, 116, 1082–1088. [CrossRef] [PubMed]
129. Oner, M.; Kizil, G.; Keskin, G.; Pochat-Bohatier, C.; Bechelany, M. The Effect of Boron Nitride on the Thermal
and Mechanical Properties of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate). Nanomaterials 2018, 8, 940.
[CrossRef] [PubMed]
130. Zakuwan, S.Z.; Ahmad, I. Synergistic Effect of Hybridized Cellulose Nanocrystals and Organically Modified
Montmorillonite on kappa-Carrageenan Bionanocomposites. Nanomaterials 2018, 8, 874. [CrossRef]
[PubMed]
131. Huang, Y.; Mei, L.; Chen, X.; Wang, Q. Recent Developments in Food Packaging Based on Nanomaterials.
Nanomaterials 2018, 8, 830. [CrossRef] [PubMed]
132. Wardhono, E.Y.; Wahyudi, H.; Agustina, S.; Oudet, F.; Pinem, M.P.; Clausse, D.; Saleh, K.; Guenin, E.
Ultrasonic Irradiation Coupled with Microwave Treatment for Eco-friendly Process of Isolating Bacterial
Cellulose Nanocrystals. Nanomaterials 2018, 8, 859. [CrossRef] [PubMed]
133. Yang, C.-L.; Chen, J.-P.; Wei, K.-C.; Chen, J.-Y.; Huang, C.-W.; Liao, Z.-X. Release of Doxorubicin by a
Folate-Grafted, Chitosan-Coated Magnetic Nanoparticle. Nanomaterials 2017, 7, 85. [CrossRef] [PubMed]
134. Nagar, P.; Goyal, P.; Gupta, A.; Sharma, A.K.; Kumar, P. Synthesis, characterization and evaluation of retinoic
acid-polyethylene glycol nanoassembly as efficient drug delivery system. Nano-Struct. Nano-Objects 2018, 14,
110–117. [CrossRef]
135. Thakur, S.; Sharma, B.; Verma, A.; Chaudhary, J.; Tamulevicius, S.; Thakur, V.K. Recent progress in sodium
alginate based sustainable hydrogels for environmental applications. J. Clean. Prod. 2018, 198, 143–159.
[CrossRef]
136. Li, J.; He, J.; Huang, Y. Role of alginate in antibacterial finishing of textiles. Int. J. Biol. Macromol. 2017, 94,
466–473. [CrossRef] [PubMed]
137. Pan, L.; Wang, Z.; Yang, Q.; Huang, R. Efficient Removal of Lead, Copper and Cadmium Ions from Water
by a Porous Calcium Alginate/Graphene Oxide Composite Aerogel. Nanomaterials 2018, 8, 957. [CrossRef]
[PubMed]
138. Song, W.; Su, X.; Gregory, D.A.; Li, W.; Cai, Z.; Zhao, X. Magnetic Alginate/Chitosan Nanoparticles for
Targeted Delivery of Curcumin into Human Breast Cancer Cells. Nanomaterials 2018, 8, 907. [CrossRef]
[PubMed]
139. Tang, S.; Wang, Z.; Li, P.; Li, W.; Li, C.; Wang, Y.; Chu, P.K. Degradable and Photocatalytic Antibacterial
Au-TiO2/Sodium Alginate Nanocomposite Films for Active Food Packaging. Nanomaterials 2018, 8, 930.
[CrossRef] [PubMed]
140. Liu, Z.; Li, J.; Zhao, X.; Li, Z.; Li, Q. Surface Coating for Flame Retardancy and Pyrolysis Behavior of Polyester
Fabric Based on Calcium Alginate Nanocomposites. Nanomaterials 2018, 8, 875. [CrossRef] [PubMed]
141. Zhao, L.; Wang, Y.; Zhao, X.; Deng, Y.; Li, Q.; Xia, Y. Green Preparation of Ag-Au Bimetallic Nanoparticles
Supported on Graphene with Alginate for Non-Enzymatic Hydrogen Peroxide Detection. Nanomaterials
2018, 8, 507. [CrossRef] [PubMed]
142. Qin, Y. The characterization of alginate wound dressings with different fiber and textile structures. J. Appl.
Polym. Sci. 2006, 100, 2516–2520. [CrossRef]
143. Qin, Y. The gel swelling properties of alginate fibers and their applications in wound management.
Polym. Adv. Technol. 2008, 19, 6–14. [CrossRef]
144. Kim, H.W.; Kim, B.R.; Rhee, Y.H. Imparting durable antimicrobial properties to cotton fabrics using
alginate–quaternary ammonium complex nanoparticles. Carbohydr. Polym. 2010, 79, 1057–1062. [CrossRef]
145. Thombare, N.; Jha, U.; Mishra, S.; Siddiqui, M.Z. Guar gum as a promising starting material for diverse
applications: A review. Int. J. Biol. Macromol. 2016, 88, 361–372. [CrossRef] [PubMed]
146. Singha, A.S.; Kumar Thakur, V. Saccaharum Cilliare Fiber Reinforced Polymer Composites. E-J. Chem. 2008,
5, 782–791. [CrossRef]
147. Singha, A.S.; Thakur, V.K. Synthesis, Characterisation and Analysis of Hibiscus Sabdariffa Fibre Reinforced
Polymer Matrix Based Composites. Polym. Polym. Compos. 2009, 17, 189–194. [CrossRef]
148. Singha, A.S.; Thakur, V.K. Mechanical, Thermal and Morphological Properties of Grewia Optiva
Fiber/Polymer Matrix Composites. Polym.-Plast. Technol. Eng. 2009, 48, 201–208. [CrossRef]
293
Nanomaterials 2019, 9, 404
149. Thakur, S.; Govender, P.P.; Mamo, M.A.; Tamulevicius, S.; Mishra, Y.K.; Thakur, V.K. Progress in lignin
hydrogels and nanocomposites for water purification: Future perspectives. Vacuum 2017, 146, 342–355.
[CrossRef]
150. Thakur, V.K.; Thakur, M.K. Recent advances in green hydrogels from lignin: A review. Int. J. Biol. Macromol.
2015, 72, 834–847. [CrossRef] [PubMed]
151. Singha, A.S.; Shama, A.; Thakur, V.K. X-ray Diffraction, Morphological, and Thermal Studies on
Methylmethacrylate Graft Copolymerized Saccharum ciliare Fiber. Int. J. Polym. Anal. Charact. 2008,
13, 447–462. [CrossRef]
152. Singha, A.S.; Thakur, V.K. Fabrication and Characterization of H. sabdariffa Fiber-Reinforced Green Polymer
Composites. Polym.-Plast. Technol. Eng. 2009, 48, 482–487. [CrossRef]
153. Zhang, Y.; Li, Y.; Thakur, V.K.; Gao, Z.; Gu, J.; Kessler, M.R. High-performance thermosets with tailored
properties derived from methacrylated eugenol and epoxy-based vinyl ester. Polym. Int. 2018, 67, 544–549.
[CrossRef]
154. Kim, G.; Park, K. Alginate-nanofibers fabricated by an electrohydrodynamic process. Polym. Eng. Sci. 2009,
49, 2242–2248. [CrossRef]
155. Mokhena, T.C.; Jacobs, V.; Luyt, A.S. A review on electrospun bio-based polymers for water treatment.
eXPRESS Polym. Lett. 2015, 9, 839–880. [CrossRef]
156. Mendes, A.C.; Stephansen, K.; Chronakis, I.S. Electrospinning of food proteins and polysaccharides. Food
Hydrocoll. 2017, 68, 53–68. [CrossRef]
157. Qasim, S.B.; Zafar, M.S.; Najeeb, S.; Khurshid, Z.; Shah, A.H.; Husain, S.; Rehman, I.U. Electrospinning of
Chitosan-Based Solutions for Tissue Engineering and Regenerative Medicine. Int. J. Mol. Sci. 2018, 19, 407.
[CrossRef] [PubMed]
158. Lotfian, S.; Giraudmaillet, C.; Yoosefinejad, A.; Thakur, V.K.; Nezhad, H.Y. Electrospun Piezoelectric Polymer
Nanofiber Layers for Enabling in Situ Measurement in High-Performance Composite Laminates. ACS Omega
2018, 3, 8891–8902. [CrossRef]
159. Zhu, H.; Zhang, Q.; Zhu, S. Alginate Hydrogel: A Shapeable and Versatile Platform for in Situ Preparation
of Metal–Organic Framework–Polymer Composites. ACS Appl. Mater. Interfaces 2016, 8, 17395–17401.
[CrossRef] [PubMed]
160. Hashimoto, T.; Suzuki, Y.; Suzuki, K.; Nakashima, T.; Tanihara, M.; Ide, C. Review—Peripheral nerve
regeneration using non-tubular alginate gel crosslinked with covalent bonds. J. Mater. Sci.-Mater. Med. 2005,
16, 503–509. [CrossRef] [PubMed]
161. Miculescu, F.; Maidaniuc, A.; Miculescu, M.; Dan Batalu, N.; Cătălin Ciocoiu, R.; Voicu, Ş.I.;
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